,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,421231,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,60,ACTB,https://ctdbase.org/detail.go?type=gene&acc=60,,,60.0,ACTB,9606,Homo sapiens (human),Valproic acid results in increased expression of ACTB mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
1,421232,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,60,ACTB,https://ctdbase.org/detail.go?type=gene&acc=60,,,60.0,ACTB,9606,Homo sapiens (human),Valproic acid results in increased methylation of ACTB gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
2,421233,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,60,ACTB,https://ctdbase.org/detail.go?type=gene&acc=60,,,60.0,ACTB,10116,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of ACTB mRNA,,,PMID:23665938,https://www.ncbi.nlm.nih.gov/pubmed/23665938,23665938,,
3,421726,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,170487,ACTL10,https://ctdbase.org/detail.go?type=gene&acc=170487,,,170487.0,ACTL10,9606,Homo sapiens (human),Valproic acid results in increased methylation of ACTL10 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
4,421727,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,86,ACTL6A,https://ctdbase.org/detail.go?type=gene&acc=86,,,86.0,ACTL6A,10090,Mus musculus (house mouse),Valproic acid results in decreased expression of ACTL6A mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
5,421728,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51412,ACTL6B,https://ctdbase.org/detail.go?type=gene&acc=51412,,,51412.0,ACTL6B,9606,Homo sapiens (human),Valproic acid results in increased methylation of ACTL6B gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
6,421729,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10881,ACTL7A,https://ctdbase.org/detail.go?type=gene&acc=10881,,,10881.0,ACTL7A,9606,Homo sapiens (human),Valproic acid results in increased methylation of ACTL7A gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
7,421730,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10880,ACTL7B,https://ctdbase.org/detail.go?type=gene&acc=10880,,,10880.0,ACTL7B,9606,Homo sapiens (human),Valproic acid affects the expression of ACTL7B mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
8,421731,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10880,ACTL7B,https://ctdbase.org/detail.go?type=gene&acc=10880,,,10880.0,ACTL7B,9606,Homo sapiens (human),Valproic acid results in increased methylation of ACTL7B gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
9,421732,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,81569,ACTL8,https://ctdbase.org/detail.go?type=gene&acc=81569,,,81569.0,ACTL8,9606,Homo sapiens (human),Valproic acid results in increased methylation of ACTL8 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
10,422176,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,81,ACTN4,https://ctdbase.org/detail.go?type=gene&acc=81,,,81.0,ACTN4,10090,Mus musculus (house mouse),Valproic acid affects the expression of ACTN4 mRNA,,,PMID:17292431,https://www.ncbi.nlm.nih.gov/pubmed/17292431,17292431,,
11,422177,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55860,ACTR10,https://ctdbase.org/detail.go?type=gene&acc=55860,,,55860.0,ACTR10,9606,Homo sapiens (human),Valproic acid results in increased expression of ACTR10 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
12,422178,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10121,ACTR1A,https://ctdbase.org/detail.go?type=gene&acc=10121,,,10121.0,ACTR1A,9606,Homo sapiens (human),Valproic acid affects the expression of ACTR1A mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
13,422179,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10120,ACTR1B,https://ctdbase.org/detail.go?type=gene&acc=10120,,,10120.0,ACTR1B,9606,Homo sapiens (human),Valproic acid results in decreased expression of ACTR1B mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
14,422180,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10097,ACTR2,https://ctdbase.org/detail.go?type=gene&acc=10097,,,10097.0,ACTR2,9606,Homo sapiens (human),Valproic acid results in decreased methylation of ACTR2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
15,422181,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10096,ACTR3,https://ctdbase.org/detail.go?type=gene&acc=10096,,,10096.0,ACTR3,9606,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ACTR3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
16,422182,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10096,ACTR3,https://ctdbase.org/detail.go?type=gene&acc=10096,,,10096.0,ACTR3,9606,Homo sapiens (human),Valproic acid affects the expression of ACTR3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
17,422183,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10096,ACTR3,https://ctdbase.org/detail.go?type=gene&acc=10096,,,10096.0,ACTR3,9606,Homo sapiens (human),Valproic acid results in decreased expression of ACTR3 mRNA,,,PMID:23179753|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|29154799,,
18,422184,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10096,ACTR3,https://ctdbase.org/detail.go?type=gene&acc=10096,,,10096.0,ACTR3,9606,Homo sapiens (human),Valproic acid results in decreased methylation of ACTR3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
19,422185,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,57180,ACTR3B,https://ctdbase.org/detail.go?type=gene&acc=57180,,,57180.0,ACTR3B,9606,Homo sapiens (human),Valproic acid results in decreased methylation of ACTR3B gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
20,422506,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,79605,PGBD5,https://ctdbase.org/detail.go?type=gene&acc=79605,,,79605.0,PGBD5,9606,Homo sapiens (human),Valproic acid affects the expression of PGBD5 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
21,422671,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,130399,ACVR1C,https://ctdbase.org/detail.go?type=gene&acc=130399,,,130399.0,ACVR1C,10116,Rattus norvegicus (Norway rat),Valproic acid results in decreased expression of ACVR1C mRNA,,,PMID:29427782,https://www.ncbi.nlm.nih.gov/pubmed/29427782,29427782,,
22,422672,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,92,ACVR2A,https://ctdbase.org/detail.go?type=gene&acc=92,,,92.0,ACVR2A,9606,Homo sapiens (human),Valproic acid affects the expression of ACVR2A mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
23,422673,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,92,ACVR2A,https://ctdbase.org/detail.go?type=gene&acc=92,,,92.0,ACVR2A,9606,Homo sapiens (human),Valproic acid results in decreased expression of ACVR2A mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
24,423804,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9749,PHACTR2,https://ctdbase.org/detail.go?type=gene&acc=9749,,,9749.0,PHACTR2,9606,Homo sapiens (human),Valproic acid results in decreased expression of PHACTR2 mRNA,,,PMID:23179753|PMID:24935251|PMID:26272509|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24935251|26272509|29154799,,
25,423805,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9749,PHACTR2,https://ctdbase.org/detail.go?type=gene&acc=9749,,,9749.0,PHACTR2,9606,Homo sapiens (human),Valproic acid results in decreased methylation of PHACTR2 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
26,423806,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,9749,PHACTR2,https://ctdbase.org/detail.go?type=gene&acc=9749,,,9749.0,PHACTR2,9606,Homo sapiens (human),Valproic acid results in increased expression of PHACTR2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
27,423807,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,116154,PHACTR3,https://ctdbase.org/detail.go?type=gene&acc=116154,,,116154.0,PHACTR3,9606,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PHACTR3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
28,423808,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,116154,PHACTR3,https://ctdbase.org/detail.go?type=gene&acc=116154,,,116154.0,PHACTR3,9606,Homo sapiens (human),Valproic acid affects the expression of PHACTR3 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
29,423809,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,116154,PHACTR3,https://ctdbase.org/detail.go?type=gene&acc=116154,,,116154.0,PHACTR3,9606,Homo sapiens (human),Valproic acid results in decreased expression of PHACTR3 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
30,423810,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,116154,PHACTR3,https://ctdbase.org/detail.go?type=gene&acc=116154,,,116154.0,PHACTR3,9606,Homo sapiens (human),Valproic acid results in increased expression of PHACTR3 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
31,423811,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,116154,PHACTR3,https://ctdbase.org/detail.go?type=gene&acc=116154,,,116154.0,PHACTR3,9606,Homo sapiens (human),Valproic acid results in increased methylation of PHACTR3 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
32,423812,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,116154,PHACTR3,https://ctdbase.org/detail.go?type=gene&acc=116154,,,116154.0,PHACTR3,10090,Mus musculus (house mouse),Valproic acid results in increased expression of PHACTR3 mRNA,,,PMID:21427059,https://www.ncbi.nlm.nih.gov/pubmed/21427059,21427059,,
33,423813,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,65979,PHACTR4,https://ctdbase.org/detail.go?type=gene&acc=65979,,,65979.0,PHACTR4,9606,Homo sapiens (human),Valproic acid affects the expression of PHACTR4 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
34,424497,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5252,PHF1,https://ctdbase.org/detail.go?type=gene&acc=5252,,,5252.0,PHF1,9606,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
35,424498,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5252,PHF1,https://ctdbase.org/detail.go?type=gene&acc=5252,,,5252.0,PHF1,9606,Homo sapiens (human),Valproic acid affects the expression of PHF1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
36,424499,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5252,PHF1,https://ctdbase.org/detail.go?type=gene&acc=5252,,,5252.0,PHF1,9606,Homo sapiens (human),Valproic acid results in decreased expression of PHF1 mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
37,424500,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,5252,PHF1,https://ctdbase.org/detail.go?type=gene&acc=5252,,,5252.0,PHF1,9606,Homo sapiens (human),Valproic acid results in increased expression of PHF1 mRNA,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
38,424501,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55274,PHF10,https://ctdbase.org/detail.go?type=gene&acc=55274,,,55274.0,PHF10,9606,Homo sapiens (human),"[NOG protein co-treated with valproic acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PHF10 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
39,424502,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55274,PHF10,https://ctdbase.org/detail.go?type=gene&acc=55274,,,55274.0,PHF10,9606,Homo sapiens (human),Valproic acid affects the expression of PHF10 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
40,424503,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55274,PHF10,https://ctdbase.org/detail.go?type=gene&acc=55274,,,55274.0,PHF10,9606,Homo sapiens (human),Valproic acid results in decreased expression of PHF10 mRNA,,,PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|24935251|26272509|27188386|28001369,,
41,424504,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51131,PHF11,https://ctdbase.org/detail.go?type=gene&acc=51131,,,51131.0,PHF11,9606,Homo sapiens (human),Valproic acid affects the expression of PHF11 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
42,424505,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51131,PHF11,https://ctdbase.org/detail.go?type=gene&acc=51131,,,51131.0,PHF11,9606,Homo sapiens (human),Valproic acid results in decreased expression of PHF11 mRNA,,,PMID:23179753|PMID:24935251|PMID:25192806|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/25192806|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|24935251|25192806|28001369|29154799,,
43,425317,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,84844,PHF5A,https://ctdbase.org/detail.go?type=gene&acc=84844,,,84844.0,PHF5A,9606,Homo sapiens (human),Valproic acid results in decreased expression of PHF5A mRNA,,,PMID:23179753|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/27188386,23179753|27188386,,
44,427201,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10401,PIAS3,https://ctdbase.org/detail.go?type=gene&acc=10401,,,10401.0,PIAS3,9606,Homo sapiens (human),Valproic acid results in decreased expression of PIAS3 mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
45,427202,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10401,PIAS3,https://ctdbase.org/detail.go?type=gene&acc=10401,,,10401.0,PIAS3,10090,Mus musculus (house mouse),Valproic acid affects the expression of PIAS3 mRNA,,,PMID:17963808,https://www.ncbi.nlm.nih.gov/pubmed/17963808,17963808,,
46,427203,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10401,PIAS3,https://ctdbase.org/detail.go?type=gene&acc=10401,,,10401.0,PIAS3,10116,Rattus norvegicus (Norway rat),Valproic acid results in increased expression of PIAS3 mRNA,,,PMID:21318169,https://www.ncbi.nlm.nih.gov/pubmed/21318169,21318169,,
47,427204,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,51588,PIAS4,https://ctdbase.org/detail.go?type=gene&acc=51588,,,51588.0,PIAS4,9606,Homo sapiens (human),Valproic acid results in increased methylation of PIAS4 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
48,427205,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10464,PIBF1,https://ctdbase.org/detail.go?type=gene&acc=10464,,,10464.0,PIBF1,9606,Homo sapiens (human),Valproic acid affects the expression of PIBF1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
49,427206,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10464,PIBF1,https://ctdbase.org/detail.go?type=gene&acc=10464,,,10464.0,PIBF1,9606,Homo sapiens (human),Valproic acid results in decreased expression of PIBF1 mRNA,,,PMID:23179753,https://www.ncbi.nlm.nih.gov/pubmed/23179753,23179753,,
50,427207,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,10464,PIBF1,https://ctdbase.org/detail.go?type=gene&acc=10464,,,10464.0,PIBF1,9606,Homo sapiens (human),Valproic acid results in decreased methylation of PIBF1 gene,,,PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/29154799,29154799,,
51,427208,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,8301,PICALM,https://ctdbase.org/detail.go?type=gene&acc=8301,,,8301.0,PICALM,9606,Homo sapiens (human),Valproic acid results in increased expression of PICALM mRNA,,,PMID:23179753|PMID:28001369|PMID:29154799,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/28001369|https://www.ncbi.nlm.nih.gov/pubmed/29154799,23179753|28001369|29154799,,
52,427209,3121,Comparative Toxicogenomics Database (CTD),Valproic Acid,D014635,Valproic Acid,https://ctdbase.org/detail.go?type=chem&acc=D014635,55022,PID1,https://ctdbase.org/detail.go?type=gene&acc=55022,,,55022.0,PID1,9606,Homo sapiens (human),Valproic acid affects the expression of PID1 mRNA,,,PMID:25979313,https://www.ncbi.nlm.nih.gov/pubmed/25979313,25979313,,
53,421234,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,79685,SAP30L,https://ctdbase.org/detail.go?type=gene&acc=79685,,,79685.0,SAP30L,10090,Mus musculus (house mouse),Fenthion results in decreased expression of SAP30L mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
54,421235,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,51669,SARAF,https://ctdbase.org/detail.go?type=gene&acc=51669,,,51669.0,SARAF,10090,Mus musculus (house mouse),Fenthion results in decreased expression of SARAF mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
55,421236,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,54938,SARS2,https://ctdbase.org/detail.go?type=gene&acc=54938,,,54938.0,SARS2,10090,Mus musculus (house mouse),Fenthion results in increased expression of SARS2 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
56,421237,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,9733,SART3,https://ctdbase.org/detail.go?type=gene&acc=9733,,,9733.0,SART3,10090,Mus musculus (house mouse),Fenthion results in decreased expression of SART3 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
57,421238,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,55776,SAYSD1,https://ctdbase.org/detail.go?type=gene&acc=55776,,,55776.0,SAYSD1,10090,Mus musculus (house mouse),Fenthion results in decreased expression of SAYSD1 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
58,421239,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,6305,SBF1,https://ctdbase.org/detail.go?type=gene&acc=6305,,,6305.0,SBF1,10090,Mus musculus (house mouse),Fenthion results in decreased expression of SBF1 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
59,421240,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,388228,SBK1,https://ctdbase.org/detail.go?type=gene&acc=388228,,,388228.0,SBK1,10090,Mus musculus (house mouse),Fenthion results in decreased expression of SBK1 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
60,422497,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,1893,ECM1,https://ctdbase.org/detail.go?type=gene&acc=1893,,,1893.0,ECM1,10090,Mus musculus (house mouse),Fenthion results in increased expression of ECM1 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
61,422498,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,51295,ECSIT,https://ctdbase.org/detail.go?type=gene&acc=51295,,,51295.0,ECSIT,10090,Mus musculus (house mouse),Fenthion results in decreased expression of ECSIT mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
62,422499,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,23644,EDC4,https://ctdbase.org/detail.go?type=gene&acc=23644,,,23644.0,EDC4,10090,Mus musculus (house mouse),Fenthion results in decreased expression of EDC4 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
63,422500,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,55741,EDEM2,https://ctdbase.org/detail.go?type=gene&acc=55741,,,55741.0,EDEM2,10090,Mus musculus (house mouse),Fenthion results in decreased expression of EDEM2 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
64,422501,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,8721,EDF1,https://ctdbase.org/detail.go?type=gene&acc=8721,,,8721.0,EDF1,10090,Mus musculus (house mouse),Fenthion results in decreased expression of EDF1 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
65,422502,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,1938,EEF2,https://ctdbase.org/detail.go?type=gene&acc=1938,,,1938.0,EEF2,10090,Mus musculus (house mouse),Fenthion results in increased expression of EEF2 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
66,422503,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,399665,EEIG1,https://ctdbase.org/detail.go?type=gene&acc=399665,,,399665.0,EEIG1,10090,Mus musculus (house mouse),Fenthion results in decreased expression of EEIG1 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
67,422504,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,1947,EFNB1,https://ctdbase.org/detail.go?type=gene&acc=1947,,,1947.0,EFNB1,10090,Mus musculus (house mouse),Fenthion results in decreased expression of EFNB1 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
68,422505,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,112399,EGLN3,https://ctdbase.org/detail.go?type=gene&acc=112399,,,112399.0,EGLN3,10090,Mus musculus (house mouse),Fenthion results in decreased expression of EGLN3 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
69,422679,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,60386,SLC25A19,https://ctdbase.org/detail.go?type=gene&acc=60386,,,60386.0,SLC25A19,10090,Mus musculus (house mouse),Fenthion results in decreased expression of SLC25A19 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
70,422680,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,79085,SLC25A23,https://ctdbase.org/detail.go?type=gene&acc=79085,,,79085.0,SLC25A23,10090,Mus musculus (house mouse),Fenthion results in increased expression of SLC25A23 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
71,425782,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,26515,TIMM10B,https://ctdbase.org/detail.go?type=gene&acc=26515,,,26515.0,TIMM10B,10090,Mus musculus (house mouse),Fenthion results in increased expression of TIMM10B mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
72,425783,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,10245,TIMM17B,https://ctdbase.org/detail.go?type=gene&acc=10245,,,10245.0,TIMM17B,10090,Mus musculus (house mouse),Fenthion results in increased expression of TIMM17B mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
73,425784,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,30058,TIMM8A1,https://ctdbase.org/detail.go?type=gene&acc=30058,,,30058.0,Timm8a1,10090,Mus musculus (house mouse),Fenthion results in increased expression of TIMM8A1 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
74,425785,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,26521,TIMM8B,https://ctdbase.org/detail.go?type=gene&acc=26521,,,26521.0,TIMM8B,10090,Mus musculus (house mouse),Fenthion results in increased expression of TIMM8B mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
75,425786,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,51300,TIMMDC1,https://ctdbase.org/detail.go?type=gene&acc=51300,,,51300.0,TIMMDC1,10090,Mus musculus (house mouse),Fenthion results in decreased expression of TIMMDC1 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
76,425787,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,7077,TIMP2,https://ctdbase.org/detail.go?type=gene&acc=7077,,,7077.0,TIMP2,10090,Mus musculus (house mouse),Fenthion results in increased expression of TIMP2 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
77,425788,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,64129,TINAGL1,https://ctdbase.org/detail.go?type=gene&acc=64129,,,64129.0,TINAGL1,10090,Mus musculus (house mouse),Fenthion results in increased expression of TINAGL1 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
78,426593,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,8841,HDAC3,https://ctdbase.org/detail.go?type=gene&acc=8841,,,8841.0,HDAC3,10090,Mus musculus (house mouse),Fenthion results in decreased expression of HDAC3 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
79,426594,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,84717,HDGFL2,https://ctdbase.org/detail.go?type=gene&acc=84717,,,84717.0,HDGFL2,10090,Mus musculus (house mouse),Fenthion results in decreased expression of HDGFL2 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
80,427051,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,55262,TRAPPC14,https://ctdbase.org/detail.go?type=gene&acc=55262,,,55262.0,TRAPPC14,10090,Mus musculus (house mouse),Fenthion results in decreased expression of TRAPPC14 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
81,427052,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,27095,TRAPPC3,https://ctdbase.org/detail.go?type=gene&acc=27095,,,27095.0,TRAPPC3,10090,Mus musculus (house mouse),Fenthion results in increased expression of TRAPPC3 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
82,427053,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,51499,TRIAP1,https://ctdbase.org/detail.go?type=gene&acc=51499,,,51499.0,TRIAP1,10090,Mus musculus (house mouse),Fenthion results in increased expression of TRIAP1 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
83,427054,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,23321,TRIM2,https://ctdbase.org/detail.go?type=gene&acc=23321,,,23321.0,TRIM2,10090,Mus musculus (house mouse),Fenthion results in increased expression of TRIM2 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
84,427055,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,7706,TRIM25,https://ctdbase.org/detail.go?type=gene&acc=7706,,,7706.0,TRIM25,10090,Mus musculus (house mouse),Fenthion results in decreased expression of TRIM25 mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
85,427056,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,7204,TRIO,https://ctdbase.org/detail.go?type=gene&acc=7204,,,7204.0,TRIO,10090,Mus musculus (house mouse),Fenthion results in decreased expression of TRIO mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
86,428351,3346,Comparative Toxicogenomics Database (CTD),Fenthion,D005284,Fenthion,https://ctdbase.org/detail.go?type=chem&acc=D005284,9445,ITM2B,https://ctdbase.org/detail.go?type=gene&acc=9445,,,9445.0,ITM2B,10090,Mus musculus (house mouse),Fenthion results in increased expression of ITM2B mRNA,,,PMID:34813904,https://www.ncbi.nlm.nih.gov/pubmed/34813904,34813904,,
87,423953,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,699,BUB1,https://ctdbase.org/detail.go?type=gene&acc=699,,,699.0,BUB1,7955,Danio rerio (zebrafish),Fipronil results in decreased expression of BUB1 mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
88,423954,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,567006,BUB1BB,https://ctdbase.org/detail.go?type=gene&acc=567006,,,567006.0,bub1bb,7955,Danio rerio (zebrafish),Fipronil results in increased expression of BUB1BB mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
89,423955,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,8896,BUD31,https://ctdbase.org/detail.go?type=gene&acc=8896,,,8896.0,BUD31,10116,Rattus norvegicus (Norway rat),Fipronil results in decreased expression of BUD31 mRNA,,,PMID:34044035,https://www.ncbi.nlm.nih.gov/pubmed/34044035,34044035,,
90,423956,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,387723,C10ORF143,https://ctdbase.org/detail.go?type=gene&acc=387723,,,387723.0,C10orf143,9606,Homo sapiens (human),[fipronil co-treated with DEET] results in decreased expression of C10ORF143 mrna|fipronil results in decreased expression of C10ORF143 mRNA,,,PMID:28991164,https://www.ncbi.nlm.nih.gov/pubmed/28991164,28991164,,
91,423957,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,360851,C13H1ORF53,https://ctdbase.org/detail.go?type=gene&acc=360851,,,360851.0,C13h1orf53,10116,Rattus norvegicus (Norway rat),Fipronil results in increased expression of C13H1ORF53 mRNA,,,PMID:23962444,https://www.ncbi.nlm.nih.gov/pubmed/23962444,23962444,,
92,423958,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,293059,C1H15ORF40,https://ctdbase.org/detail.go?type=gene&acc=293059,,,293059.0,C1h15orf40,10116,Rattus norvegicus (Norway rat),Fipronil results in increased expression of C1H15ORF40 mRNA,,,PMID:34044035,https://www.ncbi.nlm.nih.gov/pubmed/34044035,34044035,,
93,423959,3352,Comparative Toxicogenomics Database (CTD),Fipronil,C082360,fipronil,https://ctdbase.org/detail.go?type=chem&acc=C082360,713,C1QB,https://ctdbase.org/detail.go?type=gene&acc=713,,,713.0,C1QB,7955,Danio rerio (zebrafish),Fipronil results in decreased expression of C1QB mRNA,,,PMID:32977147,https://www.ncbi.nlm.nih.gov/pubmed/32977147,32977147,,
94,426895,3440,Drug Gene Interaction database (DGIdb),Furosemide,,FUROSEMIDE,https://www.dgidb.org/drugs/rxcui:4603,,ABCC4,https://www.dgidb.org/genes/hgnc:55,,,10257.0,ABCC4,9606,Homo sapiens (human),,,,,,,,
95,426896,3442,Comparative Toxicogenomics Database (CTD),Fusaric acid,D005669,Fusaric Acid,https://ctdbase.org/detail.go?type=chem&acc=D005669,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),Fusaric acid results in decreased expression of ACHE protein|glycyrrhizic acid inhibits the reaction [fusaric acid results in decreased expression of ACHE protein],,,PMID:31150628,https://www.ncbi.nlm.nih.gov/pubmed/31150628,31150628,,
96,426897,3442,Comparative Toxicogenomics Database (CTD),Fusaric acid,D005669,Fusaric Acid,https://ctdbase.org/detail.go?type=chem&acc=D005669,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090,Mus musculus (house mouse),Fusaric acid affects the phosphorylation of AKT1 protein,,,PMID:32156565,https://www.ncbi.nlm.nih.gov/pubmed/32156565,32156565,,
97,426898,3442,Comparative Toxicogenomics Database (CTD),Fusaric acid,D005669,Fusaric Acid,https://ctdbase.org/detail.go?type=chem&acc=D005669,9474,ATG5,https://ctdbase.org/detail.go?type=gene&acc=9474,,,9474.0,ATG5,9606,Homo sapiens (human),Fusaric acid results in increased expression of ATG5 mRNA,,,PMID:30582969,https://www.ncbi.nlm.nih.gov/pubmed/30582969,30582969,,
98,426899,3442,Comparative Toxicogenomics Database (CTD),Fusaric acid,D005669,Fusaric Acid,https://ctdbase.org/detail.go?type=chem&acc=D005669,10533,ATG7,https://ctdbase.org/detail.go?type=gene&acc=10533,,,10533.0,ATG7,9606,Homo sapiens (human),Fusaric acid results in increased expression of ATG7 mRNA,,,PMID:30582969,https://www.ncbi.nlm.nih.gov/pubmed/30582969,30582969,,
99,426900,3442,Comparative Toxicogenomics Database (CTD),Fusaric acid,D005669,Fusaric Acid,https://ctdbase.org/detail.go?type=chem&acc=D005669,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116,Rattus norvegicus (Norway rat),Glycyrrhizic acid inhibits the reaction [fusaric acid results in decreased expression of BDNF protein]|fusaric acid results in decreased expression of BDNF protein,,,PMID:31150628,https://www.ncbi.nlm.nih.gov/pubmed/31150628,31150628,,
100,427682,3442,Comparative Toxicogenomics Database (CTD),Fusaric acid,D005669,Fusaric Acid,https://ctdbase.org/detail.go?type=chem&acc=D005669,22059,TRP53,https://ctdbase.org/detail.go?type=gene&acc=22059,,,22059.0,Trp53,10090,Mus musculus (house mouse),Fusaric acid affects the phosphorylation of TRP53 protein,,,PMID:32156565,https://www.ncbi.nlm.nih.gov/pubmed/32156565,32156565,,
101,427683,3442,Comparative Toxicogenomics Database (CTD),Fusaric acid,D005669,Fusaric Acid,https://ctdbase.org/detail.go?type=chem&acc=D005669,7351,UCP2,https://ctdbase.org/detail.go?type=gene&acc=7351,,,7351.0,UCP2,9606,Homo sapiens (human),Fusaric acid results in decreased expression of UCP2 protein,,,PMID:30582969,https://www.ncbi.nlm.nih.gov/pubmed/30582969,30582969,,
102,427684,3446,Comparative Toxicogenomics Database (CTD),Gabapentin,D000077206,Gabapentin,https://ctdbase.org/detail.go?type=chem&acc=D000077206,51166,AADAT,https://ctdbase.org/detail.go?type=gene&acc=51166,,,51166.0,AADAT,10116,Rattus norvegicus (Norway rat),Gabapentin results in decreased activity of AADAT protein,,,PMID:16765940,https://www.ncbi.nlm.nih.gov/pubmed/16765940,16765940,,
103,427685,3446,Comparative Toxicogenomics Database (CTD),Gabapentin,D000077206,Gabapentin,https://ctdbase.org/detail.go?type=chem&acc=D000077206,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243.0,ABCB1,9606,Homo sapiens (human),Gabapentin results in decreased activity of ABCB1 protein,,,PMID:18408562,https://www.ncbi.nlm.nih.gov/pubmed/18408562,18408562,,
104,427686,3446,Comparative Toxicogenomics Database (CTD),Gabapentin,D000077206,Gabapentin,https://ctdbase.org/detail.go?type=chem&acc=D000077206,40348,ACCOAS,https://ctdbase.org/detail.go?type=gene&acc=40348,,,40348.0,AcCoAS,7227,Drosophila melanogaster (fruit fly),[gabapentin co-treated with pentylenetetrazole] affects the expression of ACCOAS mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
105,497491,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,115,ADCY9,https://ctdbase.org/detail.go?type=gene&acc=115,,,115.0,ADCY9,10116,Rattus norvegicus (Norway rat),Gentamicins affects the expression of ADCY9 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
106,497492,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,118,ADD1,https://ctdbase.org/detail.go?type=gene&acc=118,,,118.0,ADD1,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of ADD1 mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
107,497493,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,120,ADD3,https://ctdbase.org/detail.go?type=gene&acc=120,,,120.0,ADD3,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of ADD3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
108,497494,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,120,ADD3,https://ctdbase.org/detail.go?type=gene&acc=120,,,120.0,ADD3,10116,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of ADD3 mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
109,497495,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,575,ADGRB1,https://ctdbase.org/detail.go?type=gene&acc=575,,,575.0,ADGRB1,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of ADGRB1 mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
110,497496,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,976,ADGRE5,https://ctdbase.org/detail.go?type=gene&acc=976,,,976.0,ADGRE5,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of ADGRE5 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
111,497497,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,976,ADGRE5,https://ctdbase.org/detail.go?type=gene&acc=976,,,976.0,ADGRE5,10116,Rattus norvegicus (Norway rat),Gentamicins results in increased expression of ADGRE5 mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
112,497498,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,221393,ADGRF4,https://ctdbase.org/detail.go?type=gene&acc=221393,,,221393.0,ADGRF4,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of ADGRF4 mRNA,,,PMID:22061828,https://www.ncbi.nlm.nih.gov/pubmed/22061828,22061828,,
113,497499,3467,Comparative Toxicogenomics Database (CTD),Gentamicin,D005839,Gentamicins,https://ctdbase.org/detail.go?type=chem&acc=D005839,221395,ADGRF5,https://ctdbase.org/detail.go?type=gene&acc=221395,,,221395.0,ADGRF5,10116,Rattus norvegicus (Norway rat),Gentamicins results in decreased expression of ADGRF5 mRNA,,,PMID:22061828|PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/22061828|https://www.ncbi.nlm.nih.gov/pubmed/33387578,22061828|33387578,,
114,425308,3676,Comparative Toxicogenomics Database (CTD),Lidocaine,D008012,Lidocaine,https://ctdbase.org/detail.go?type=chem&acc=D008012,7345,UCHL1,https://ctdbase.org/detail.go?type=gene&acc=7345,,,7345.0,UCHL1,9606,Homo sapiens (human),NNAT protein inhibits the reaction [lidocaine results in decreased expression of UCHL1 protein]|lidocaine results in decreased expression of UCHL1 protein|ngf protein inhibits the reaction [lidocaine results in decreased expression of UCHL1 protein],,,PMID:34193770,https://www.ncbi.nlm.nih.gov/pubmed/34193770,34193770,,
115,425309,3676,Comparative Toxicogenomics Database (CTD),Lidocaine,D008012,Lidocaine,https://ctdbase.org/detail.go?type=chem&acc=D008012,7349,UCN,https://ctdbase.org/detail.go?type=gene&acc=7349,,,7349.0,UCN,10116,Rattus norvegicus (Norway rat),Lidocaine results in increased expression of UCN mRNA,,,PMID:35283115,https://www.ncbi.nlm.nih.gov/pubmed/35283115,35283115,,
116,425310,3676,Comparative Toxicogenomics Database (CTD),Lidocaine,D008012,Lidocaine,https://ctdbase.org/detail.go?type=chem&acc=D008012,7351,UCP2,https://ctdbase.org/detail.go?type=gene&acc=7351,,,7351.0,UCP2,10116,Rattus norvegicus (Norway rat),Lidocaine results in increased expression of UCP2 mRNA,,,PMID:35283115,https://www.ncbi.nlm.nih.gov/pubmed/35283115,35283115,,
117,425311,3676,Comparative Toxicogenomics Database (CTD),Lidocaine,D008012,Lidocaine,https://ctdbase.org/detail.go?type=chem&acc=D008012,222643,UNC5CL,https://ctdbase.org/detail.go?type=gene&acc=222643,,,222643.0,UNC5CL,10116,Rattus norvegicus (Norway rat),Lidocaine results in increased expression of UNC5CL mRNA,,,PMID:35283115,https://www.ncbi.nlm.nih.gov/pubmed/35283115,35283115,,
118,425312,3676,Comparative Toxicogenomics Database (CTD),Lidocaine,D008012,Lidocaine,https://ctdbase.org/detail.go?type=chem&acc=D008012,81622,UNC93B1,https://ctdbase.org/detail.go?type=gene&acc=81622,,,81622.0,UNC93B1,10116,Rattus norvegicus (Norway rat),Lidocaine results in increased expression of UNC93B1 mRNA,,,PMID:35283115,https://www.ncbi.nlm.nih.gov/pubmed/35283115,35283115,,
119,425313,3676,Comparative Toxicogenomics Database (CTD),Lidocaine,D008012,Lidocaine,https://ctdbase.org/detail.go?type=chem&acc=D008012,11274,USP18,https://ctdbase.org/detail.go?type=gene&acc=11274,,,11274.0,USP18,10116,Rattus norvegicus (Norway rat),Lidocaine results in increased expression of USP18 mRNA,,,PMID:35283115,https://www.ncbi.nlm.nih.gov/pubmed/35283115,35283115,,
120,425314,3676,Comparative Toxicogenomics Database (CTD),Lidocaine,D008012,Lidocaine,https://ctdbase.org/detail.go?type=chem&acc=D008012,10911,UTS2,https://ctdbase.org/detail.go?type=gene&acc=10911,,,10911.0,UTS2,10116,Rattus norvegicus (Norway rat),Lidocaine results in increased expression of UTS2 mRNA,,,PMID:35283115,https://www.ncbi.nlm.nih.gov/pubmed/35283115,35283115,,
121,425315,3676,Comparative Toxicogenomics Database (CTD),Lidocaine,D008012,Lidocaine,https://ctdbase.org/detail.go?type=chem&acc=D008012,7409,VAV1,https://ctdbase.org/detail.go?type=gene&acc=7409,,,7409.0,VAV1,10116,Rattus norvegicus (Norway rat),Lidocaine results in increased expression of VAV1 mRNA,,,PMID:35283115,https://www.ncbi.nlm.nih.gov/pubmed/35283115,35283115,,
122,425316,3676,Comparative Toxicogenomics Database (CTD),Lidocaine,D008012,Lidocaine,https://ctdbase.org/detail.go?type=chem&acc=D008012,1462,VCAN,https://ctdbase.org/detail.go?type=gene&acc=1462,,,1462.0,VCAN,10116,Rattus norvegicus (Norway rat),Lidocaine results in increased expression of VCAN mRNA,,,PMID:35283115,https://www.ncbi.nlm.nih.gov/pubmed/35283115,35283115,,
123,421865,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,56261,GPCPD1,https://ctdbase.org/detail.go?type=gene&acc=56261,,,56261.0,GPCPD1,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of GPCPD1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
124,421866,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,2819,GPD1,https://ctdbase.org/detail.go?type=gene&acc=2819,,,2819.0,GPD1,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin] results in increased expression of GPD1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
125,421867,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,23171,GPD1L,https://ctdbase.org/detail.go?type=gene&acc=23171,,,23171.0,GPD1L,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of GPD1L mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of GPD1L mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
126,421868,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,407734,GPM6AB,https://ctdbase.org/detail.go?type=gene&acc=407734,,,407734.0,gpm6ab,90988,Pimephales promelas (fathead minnow),Indomethacin results in increased expression of GPM6AB mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
127,421869,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,2824,GPM6B,https://ctdbase.org/detail.go?type=gene&acc=2824,,,2824.0,GPM6B,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin] results in increased expression of GPM6B mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
128,421870,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,11321,GPN1,https://ctdbase.org/detail.go?type=gene&acc=11321,,,11321.0,GPN1,90988,Pimephales promelas (fathead minnow),Indomethacin results in increased expression of GPN1 mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
129,421871,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,10457,GPNMB,https://ctdbase.org/detail.go?type=gene&acc=10457,,,10457.0,GPNMB,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GPNMB mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
130,422336,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,2878,GPX3,https://ctdbase.org/detail.go?type=gene&acc=2878,,,2878.0,GPX3,10116,Rattus norvegicus (Norway rat),Indomethacin inhibits the reaction [formaldehyde results in increased expression of GPX3 mrna],,,PMID:21983654,https://www.ncbi.nlm.nih.gov/pubmed/21983654,21983654,,
131,422337,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,2878,GPX3,https://ctdbase.org/detail.go?type=gene&acc=2878,,,2878.0,GPX3,10116,Rattus norvegicus (Norway rat),Indomethacin results in increased expression of GPX3 mrna|rebamipide inhibits the reaction [indomethacin results in increased expression of GPX3 mrna],,,PMID:18299717,https://www.ncbi.nlm.nih.gov/pubmed/18299717,18299717,,
132,423655,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,283464,GXYLT1,https://ctdbase.org/detail.go?type=gene&acc=283464,,,283464.0,GXYLT1,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of GXYLT1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
133,423656,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,2992,GYG1,https://ctdbase.org/detail.go?type=gene&acc=2992,,,2992.0,GYG1,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of GYG1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
134,423657,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,8908,GYG2,https://ctdbase.org/detail.go?type=gene&acc=8908,,,8908.0,GYG2,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin] results in increased expression of GYG2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
135,423658,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,3005,H1-0,https://ctdbase.org/detail.go?type=gene&acc=3005,,,3005.0,H1-0,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of H1-0 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
136,425145,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,9146,HGS,https://ctdbase.org/detail.go?type=gene&acc=9146,,,9146.0,HGS,10116,Rattus norvegicus (Norway rat),Indomethacin results in increased expression of HGS mRNA,,,PMID:36868495,https://www.ncbi.nlm.nih.gov/pubmed/36868495,36868495,,
137,425146,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,11112,HIBADH,https://ctdbase.org/detail.go?type=gene&acc=11112,,,11112.0,HIBADH,10116,Rattus norvegicus (Norway rat),Indomethacin results in decreased expression of HIBADH mRNA,,,PMID:36868495,https://www.ncbi.nlm.nih.gov/pubmed/36868495,36868495,,
138,425147,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,394135,HIBADHB,https://ctdbase.org/detail.go?type=gene&acc=394135,,,394135.0,hibadhb,90988,Pimephales promelas (fathead minnow),Indomethacin results in increased expression of HIBADHB mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
139,425148,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,26275,HIBCH,https://ctdbase.org/detail.go?type=gene&acc=26275,,,26275.0,HIBCH,10116,Rattus norvegicus (Norway rat),Indomethacin results in decreased expression of HIBCH mRNA,,,PMID:36868495,https://www.ncbi.nlm.nih.gov/pubmed/36868495,36868495,,
140,425149,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,3090,HIC1,https://ctdbase.org/detail.go?type=gene&acc=3090,,,3090.0,HIC1,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of HIC1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
141,425150,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,55662,HIF1AN,https://ctdbase.org/detail.go?type=gene&acc=55662,,,55662.0,HIF1AN,90988,Pimephales promelas (fathead minnow),Indomethacin results in increased expression of HIF1AN mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
142,425151,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,64344,HIF3A,https://ctdbase.org/detail.go?type=gene&acc=64344,,,64344.0,HIF3A,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of HIF3A mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
143,426436,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,29911,HOOK2,https://ctdbase.org/detail.go?type=gene&acc=29911,,,29911.0,HOOK2,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HOOK2 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of HOOK2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
144,427361,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,3297,HSF1,https://ctdbase.org/detail.go?type=gene&acc=3297,,,3297.0,HSF1,9606,Homo sapiens (human),Indomethacin results in increased activity of HSF1 protein,,,PMID:10701834|PMID:12065054,https://www.ncbi.nlm.nih.gov/pubmed/10701834|https://www.ncbi.nlm.nih.gov/pubmed/12065054,10701834|12065054,,
145,427362,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,3297,HSF1,https://ctdbase.org/detail.go?type=gene&acc=3297,,,3297.0,HSF1,10090,Mus musculus (house mouse),Indomethacin results in increased activity of HSF1 protein,,,PMID:14706622,https://www.ncbi.nlm.nih.gov/pubmed/14706622,14706622,,
146,427363,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,3320,HSP90AA1,https://ctdbase.org/detail.go?type=gene&acc=3320,,,3320.0,HSP90AA1,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of HSP90AA1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HSP90AA1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
147,427364,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,3326,HSP90AB1,https://ctdbase.org/detail.go?type=gene&acc=3326,,,3326.0,HSP90AB1,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of HSP90AB1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HSP90AB1 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of HSP90AB1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
148,427365,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,7184,HSP90B1,https://ctdbase.org/detail.go?type=gene&acc=7184,,,7184.0,HSP90B1,90988,Pimephales promelas (fathead minnow),Indomethacin results in increased expression of HSP90B1 mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
149,427366,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,259217,HSPA12A,https://ctdbase.org/detail.go?type=gene&acc=259217,,,259217.0,HSPA12A,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of HSPA12A mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of HSPA12A mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
150,428190,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,3064,HTT,https://ctdbase.org/detail.go?type=gene&acc=3064,,,3064.0,HTT,90988,Pimephales promelas (fathead minnow),Indomethacin results in decreased expression of HTT mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
151,428191,3715,Comparative Toxicogenomics Database (CTD),Indomethacin,D007213,Indomethacin,https://ctdbase.org/detail.go?type=chem&acc=D007213,15573,HUG,https://ctdbase.org/detail.go?type=gene&acc=15573,,,15573.0,hug,90988,Pimephales promelas (fathead minnow),Indomethacin results in increased expression of HUG mRNA,,,PMID:28201806,https://www.ncbi.nlm.nih.gov/pubmed/28201806,28201806,,
152,420904,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,9606,Homo sapiens (human),SIRT1 protein promotes the reaction [[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]],,,PMID:26435214,https://www.ncbi.nlm.nih.gov/pubmed/26435214,26435214,,
153,420905,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10090,Mus musculus (house mouse),Tetrachlorodibenzodioxin promotes the reaction [[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTA2 mrna]|[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of ACTA2 mRNA,,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
154,420906,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10090,Mus musculus (house mouse),[INS1 protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein],,,PMID:27396813,https://www.ncbi.nlm.nih.gov/pubmed/27396813,27396813,,
155,420907,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10116,Rattus norvegicus (Norway rat),PTPN1 protein inhibits the reaction [[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mrna]]|ptpn1 protein inhibits the reaction [[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]]|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 mrna],,,PMID:26739621,https://www.ncbi.nlm.nih.gov/pubmed/26739621,26739621,,
156,420908,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,59,ACTA2,https://ctdbase.org/detail.go?type=gene&acc=59,,,59.0,ACTA2,10116,Rattus norvegicus (Norway rat),[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein],,,PMID:26739621|PMID:29535048,https://www.ncbi.nlm.nih.gov/pubmed/26739621|https://www.ncbi.nlm.nih.gov/pubmed/29535048,26739621|29535048,,
157,422674,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,59352,LGR6,https://ctdbase.org/detail.go?type=gene&acc=59352,,,59352.0,LGR6,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of LGR6 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
158,422675,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,3972,LHB,https://ctdbase.org/detail.go?type=gene&acc=3972,,,3972.0,LHB,9606,Homo sapiens (human),[LHB protein co-treated with 1-methyl-3-isobutylxanthine] results in increased abundance of cyclic AMP,,,PMID:23071612,https://www.ncbi.nlm.nih.gov/pubmed/23071612,23071612,,
159,422676,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,3973,LHCGR,https://ctdbase.org/detail.go?type=gene&acc=3973,,,3973.0,LHCGR,9606,Homo sapiens (human),1-methyl-3-isobutylxanthine inhibits the reaction [T-2 toxin inhibits the reaction [FSHB protein results in increased expression of LHCGR mrna]],,,PMID:30951242,https://www.ncbi.nlm.nih.gov/pubmed/30951242,30951242,,
160,422677,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,10184,LHFPL2,https://ctdbase.org/detail.go?type=gene&acc=10184,,,10184.0,LHFPL2,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of LHFPL2 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of LHFPL2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
161,422678,3758,Comparative Toxicogenomics Database (CTD),3-Isobutyl-1-methylxanthine,D015056,1-Methyl-3-isobutylxanthine,https://ctdbase.org/detail.go?type=chem&acc=D015056,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,10090,Mus musculus (house mouse),[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of MPC2 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of CYCS mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of JAM2 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of CD36 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of RETSAT mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of FABP4 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of NDUFA5 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of PCYOX1 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of ACADM mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of AIFM2 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of ARXES2 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of ETFDH mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of HADHB mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of GSDME mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of RBPMS mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of CIDEA mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of NR1H3 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of LPCAT3 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of ELMOD3 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of ASPA mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of REEP6 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of SLC1A5 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of CLSTN3 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of TFRC mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of PARM1 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of CES1D mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of RXRG mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of ENDOG mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of MCRIP2 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of PCK1 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of SLC25A33 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of MCUR1 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of PLIN2 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of PACC1 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of POR mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of KCNK3 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of MRAP mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of COX7A1 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of PPP2R5A mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of IFI27L2A mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of ACO2 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of KRT79 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of AKR1B1 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of PRXL2A mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of COX8B mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of NOCT mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of SLC25A20 mrna|[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased expression of LETMD1 mRNA,,,PMID:24848799,https://www.ncbi.nlm.nih.gov/pubmed/24848799,24848799,,
162,420909,3763,Comparative Toxicogenomics Database (CTD),Isoflurane,D007530,Isoflurane,https://ctdbase.org/detail.go?type=chem&acc=D007530,11142,PKIG,https://ctdbase.org/detail.go?type=gene&acc=11142,,,11142.0,PKIG,10090,Mus musculus (house mouse),Isoflurane results in decreased methylation of PKIG mRNA,,,PMID:35249202,https://www.ncbi.nlm.nih.gov/pubmed/35249202,35249202,,
163,421083,3763,Comparative Toxicogenomics Database (CTD),Isoflurane,D007530,Isoflurane,https://ctdbase.org/detail.go?type=chem&acc=D007530,5972,REN,https://ctdbase.org/detail.go?type=gene&acc=5972,,,5972.0,REN,9606,Homo sapiens (human),[labetalol co-treated with isoflurane] results in increased expression of REN protein,,,PMID:1897344,https://www.ncbi.nlm.nih.gov/pubmed/1897344,1897344,,
164,421084,3763,Comparative Toxicogenomics Database (CTD),Isoflurane,D007530,Isoflurane,https://ctdbase.org/detail.go?type=chem&acc=D007530,80196,RNF34,https://ctdbase.org/detail.go?type=gene&acc=80196,,,80196.0,RNF34,10090,Mus musculus (house mouse),Isoflurane results in decreased methylation of RNF34 mRNA,,,PMID:35249202,https://www.ncbi.nlm.nih.gov/pubmed/35249202,35249202,,
165,421085,3763,Comparative Toxicogenomics Database (CTD),Isoflurane,D007530,Isoflurane,https://ctdbase.org/detail.go?type=chem&acc=D007530,6232,RPS27,https://ctdbase.org/detail.go?type=gene&acc=6232,,,6232.0,RPS27,10090,Mus musculus (house mouse),Isoflurane results in decreased methylation of RPS27 mRNA,,,PMID:35249202,https://www.ncbi.nlm.nih.gov/pubmed/35249202,35249202,,
166,421086,3763,Comparative Toxicogenomics Database (CTD),Isoflurane,D007530,Isoflurane,https://ctdbase.org/detail.go?type=chem&acc=D007530,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194.0,RPS6,10116,Rattus norvegicus (Norway rat),IGF1 protein inhibits the reaction [isoflurane results in decreased phosphorylation of RPS6 protein]|isoflurane results in decreased phosphorylation of RPS6 protein,,,PMID:25597859,https://www.ncbi.nlm.nih.gov/pubmed/25597859,25597859,,
167,421087,3763,Comparative Toxicogenomics Database (CTD),Isoflurane,D007530,Isoflurane,https://ctdbase.org/detail.go?type=chem&acc=D007530,6280,S100A9,https://ctdbase.org/detail.go?type=gene&acc=6280,,,6280.0,S100A9,10090,Mus musculus (house mouse),Isoflurane results in increased expression of S100A9 mRNA,,,PMID:24747151,https://www.ncbi.nlm.nih.gov/pubmed/24747151,24747151,,
168,421088,3763,Comparative Toxicogenomics Database (CTD),Isoflurane,D007530,Isoflurane,https://ctdbase.org/detail.go?type=chem&acc=D007530,56681,SAR1A,https://ctdbase.org/detail.go?type=gene&acc=56681,,,56681.0,SAR1A,10090,Mus musculus (house mouse),Isoflurane results in decreased expression of SAR1A protein,,,PMID:35249202,https://www.ncbi.nlm.nih.gov/pubmed/35249202,35249202,,
169,421089,3763,Comparative Toxicogenomics Database (CTD),Isoflurane,D007530,Isoflurane,https://ctdbase.org/detail.go?type=chem&acc=D007530,6388,SDF2,https://ctdbase.org/detail.go?type=gene&acc=6388,,,6388.0,SDF2,10090,Mus musculus (house mouse),Isoflurane results in decreased expression of SDF2 protein,,,PMID:35249202,https://www.ncbi.nlm.nih.gov/pubmed/35249202,35249202,,
170,421090,3763,Comparative Toxicogenomics Database (CTD),Isoflurane,D007530,Isoflurane,https://ctdbase.org/detail.go?type=chem&acc=D007530,6400,SEL1L,https://ctdbase.org/detail.go?type=gene&acc=6400,,,6400.0,SEL1L,10090,Mus musculus (house mouse),Isoflurane results in decreased expression of SEL1L protein,,,PMID:35249202,https://www.ncbi.nlm.nih.gov/pubmed/35249202,35249202,,
171,421091,3763,Comparative Toxicogenomics Database (CTD),Isoflurane,D007530,Isoflurane,https://ctdbase.org/detail.go?type=chem&acc=D007530,5270,SERPINE2,https://ctdbase.org/detail.go?type=gene&acc=5270,,,5270.0,SERPINE2,10090,Mus musculus (house mouse),Isoflurane results in increased expression of SERPINE2 protein,,,PMID:35249202,https://www.ncbi.nlm.nih.gov/pubmed/35249202,35249202,,
172,423143,3806,Drug Gene Interaction database (DGIdb),Juglone,,JUGLONE,https://www.dgidb.org/drugs/chembl:CHEMBL43612,,ALOX15,https://www.dgidb.org/genes/hgnc:433,,,246.0,ALOX15,9606,Homo sapiens (human),,,,,,,,
173,423144,3820,BindingDB,Kenpaullone,7266,"14-bromo-8,18-diazatetracyclo[9.7.0.0^{2,7}.0^{12,17}]octadeca-1(11),2,4,6,12(17),13,15-heptaen-9-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7266,91,Cyclin-dependent kinase 1/G2/mitotic-specific cyclin-B,https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=91,Q9DGD3,Cyclin-dependent kinase 1,100049478.0,cdk1,8090,Oryzias latipes (Japanese medaka),,IC50 (nM),400,PMID:14698171|DOI:10.1016/j.bmcl.2003.10.062,https://www.ncbi.nlm.nih.gov/pubmed/14698171|https://doi.org/10.1016/j.bmcl.2003.10.062,14698171,10.1016/j.bmcl.2003.10.062,
174,423145,3820,BindingDB,Kenpaullone,7266,"14-bromo-8,18-diazatetracyclo[9.7.0.0^{2,7}.0^{12,17}]octadeca-1(11),2,4,6,12(17),13,15-heptaen-9-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7266,105,Cyclin-dependent kinase 5 activator 1 [99-307],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=105,Q15078,Cyclin-dependent kinase 5 activator 1,8851.0,CDK5R1,9606,Homo sapiens (human),,IC50 (nM),850,PMID:14698171|DOI:10.1016/j.bmcl.2003.10.062,https://www.ncbi.nlm.nih.gov/pubmed/14698171|https://doi.org/10.1016/j.bmcl.2003.10.062,14698171,10.1016/j.bmcl.2003.10.062,
175,423146,3820,BindingDB,Kenpaullone,7266,"14-bromo-8,18-diazatetracyclo[9.7.0.0^{2,7}.0^{12,17}]octadeca-1(11),2,4,6,12(17),13,15-heptaen-9-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=7266,947,Glycogen synthase kinase-3 beta,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=947,P18266,Glycogen synthase kinase-3 beta,84027.0,Gsk3b,10116,Rattus norvegicus (Norway rat),,IC50 (nM),23,PMID:14698171|DOI:10.1016/j.bmcl.2003.10.062,https://www.ncbi.nlm.nih.gov/pubmed/14698171|https://doi.org/10.1016/j.bmcl.2003.10.062,14698171,10.1016/j.bmcl.2003.10.062,
176,423147,3821,IUPHAR/BPS Guide to PHARMACOLOGY,Ketamine,4233,ketamine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4233,459,GluN2D,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=459,O15399,"Glutamate receptor ionotropic, NMDA 2D",2906.0,GRIN2D,9606,Homo sapiens (human),,,5.41 - 5.49,,,,,
177,423148,3821,IUPHAR/BPS Guide to PHARMACOLOGY,Ketamine,4233,ketamine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4233,458,GluN2C,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=458,Q14957,"Glutamate receptor ionotropic, NMDA 2C",2905.0,GRIN2C,9606,Homo sapiens (human),,pIC50,6.18,PMID:17303642,https://www.ncbi.nlm.nih.gov/pubmed/17303642,17303642,,
178,423149,3821,IUPHAR/BPS Guide to PHARMACOLOGY,Ketamine,4233,ketamine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4233,456,GluN2A,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=456,Q12879,"Glutamate receptor ionotropic, NMDA 2A",2903.0,GRIN2A,9606,Homo sapiens (human),,,7.07,,,,,
179,423315,3878,Comparative Toxicogenomics Database (CTD),Lamotrigine,D000077213,Lamotrigine,https://ctdbase.org/detail.go?type=chem&acc=D000077213,268,AMH,https://ctdbase.org/detail.go?type=gene&acc=268,,,268.0,AMH,9606,Homo sapiens (human),[carbamazepine co-treated with lamotrigine] results in increased secretion of AMH protein,,,PMID:37505509,https://www.ncbi.nlm.nih.gov/pubmed/37505509,37505509,,
180,423316,3878,Comparative Toxicogenomics Database (CTD),Lamotrigine,D000077213,Lamotrigine,https://ctdbase.org/detail.go?type=chem&acc=D000077213,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),Lamotrigine results in increased expression of BCL2 protein|lamotrigine results in increased expression of BCL2 mRNA,,,PMID:18719996,https://www.ncbi.nlm.nih.gov/pubmed/18719996,18719996,,
181,423317,3878,Comparative Toxicogenomics Database (CTD),Lamotrigine,D000077213,Lamotrigine,https://ctdbase.org/detail.go?type=chem&acc=D000077213,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116,Rattus norvegicus (Norway rat),Lamotrigine results in increased expression of BDNF protein|lamotrigine results in increased expression of BDNF mRNA,,,PMID:18719996,https://www.ncbi.nlm.nih.gov/pubmed/18719996,18719996,,
182,423318,3878,Comparative Toxicogenomics Database (CTD),Lamotrigine,D000077213,Lamotrigine,https://ctdbase.org/detail.go?type=chem&acc=D000077213,1586,CYP17A1,https://ctdbase.org/detail.go?type=gene&acc=1586,,,1586.0,CYP17A1,9606,Homo sapiens (human),Lamotrigine results in decreased activity of CYP17A1 protein,,,PMID:15730543,https://www.ncbi.nlm.nih.gov/pubmed/15730543,15730543,,
183,424663,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606,Homo sapiens (human),CYP2C19 affects the reaction [lansoprazole affects the susceptibility to tacrolimus],,,PMID:15285851,https://www.ncbi.nlm.nih.gov/pubmed/15285851,15285851,,
184,424664,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606,Homo sapiens (human),CYP2C19 affects the susceptibility to [tacrolimus co-treated with lansoprazole],,,PMID:17377957,https://www.ncbi.nlm.nih.gov/pubmed/17377957,17377957,,
185,424665,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606,Homo sapiens (human),CYP2C19 gene affects the susceptibility to lansoprazole,,,PMID:11929404|PMID:15963082,https://www.ncbi.nlm.nih.gov/pubmed/11929404|https://www.ncbi.nlm.nih.gov/pubmed/15963082,11929404|15963082,,
186,425014,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557.0,CYP2C19,9606,Homo sapiens (human),Lansoprazole results in decreased activity of CYP2C19 protein,,,PMID:11274899|PMID:20575631,https://www.ncbi.nlm.nih.gov/pubmed/11274899|https://www.ncbi.nlm.nih.gov/pubmed/20575631,11274899|20575631,,
187,425015,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,293989,CYP2C6V1,https://ctdbase.org/detail.go?type=gene&acc=293989,,,293989.0,Cyp2c6v1,10116,Rattus norvegicus (Norway rat),Lansoprazole results in increased expression of CYP2C6V1 mRNA,,,PMID:14550749,https://www.ncbi.nlm.nih.gov/pubmed/14550749,14550749,,
188,425016,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,293989,CYP2C6V1,https://ctdbase.org/detail.go?type=gene&acc=293989,,,293989.0,Cyp2c6v1,10116,Rattus norvegicus (Norway rat),Lansoprazole results in increased expression of CYP2C6V1 protein,,,PMID:9152597,https://www.ncbi.nlm.nih.gov/pubmed/9152597,9152597,,
189,425017,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,1558,CYP2C8,https://ctdbase.org/detail.go?type=gene&acc=1558,,,1558.0,CYP2C8,9606,Homo sapiens (human),CYP2C8 protein affects the metabolism of lansoprazole,,,PMID:7870052,https://www.ncbi.nlm.nih.gov/pubmed/7870052,7870052,,
190,425018,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,1558,CYP2C8,https://ctdbase.org/detail.go?type=gene&acc=1558,,,1558.0,CYP2C8,9606,Homo sapiens (human),CYP2C8 protein results in increased hydroxylation of lansoprazole,,,PMID:8627562,https://www.ncbi.nlm.nih.gov/pubmed/8627562,8627562,,
191,425019,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606,Homo sapiens (human),CYP2C9 protein results in increased hydroxylation of lansoprazole,,,PMID:12975331|PMID:8627562,https://www.ncbi.nlm.nih.gov/pubmed/12975331|https://www.ncbi.nlm.nih.gov/pubmed/8627562,12975331|8627562,,
192,425020,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,1559,CYP2C9,https://ctdbase.org/detail.go?type=gene&acc=1559,,,1559.0,CYP2C9,9606,Homo sapiens (human),Lansoprazole inhibits the reaction [CYP2C9 protein results in increased hydroxylation of diclofenac],,,PMID:15258107,https://www.ncbi.nlm.nih.gov/pubmed/15258107,15258107,,
193,425021,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,1571,CYP2E1,https://ctdbase.org/detail.go?type=gene&acc=1571,,,1571.0,CYP2E1,10090,Mus musculus (house mouse),Lansoprazole results in decreased degradation of CYP2E1 protein|lansoprazole results in increased expression of and results in increased activity of CYP2E1 protein,,,PMID:36243147,https://www.ncbi.nlm.nih.gov/pubmed/36243147,36243147,,
194,425621,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,2520,GAST,https://ctdbase.org/detail.go?type=gene&acc=2520,,,2520.0,GAST,10116,Rattus norvegicus (Norway rat),Lansoprazole results in increased expression of GAST protein,,,PMID:11680587|PMID:11975934|PMID:12438555|PMID:20095383,https://www.ncbi.nlm.nih.gov/pubmed/11680587|https://www.ncbi.nlm.nih.gov/pubmed/11975934|https://www.ncbi.nlm.nih.gov/pubmed/12438555|https://www.ncbi.nlm.nih.gov/pubmed/20095383,11680587|11975934|12438555|20095383,,
195,425622,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,9606,Homo sapiens (human),"Lansoprazole inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]",,,PMID:23769903,https://www.ncbi.nlm.nih.gov/pubmed/23769903,23769903,,
196,425623,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,57817,HAMP,https://ctdbase.org/detail.go?type=gene&acc=57817,,,57817.0,HAMP,9606,Homo sapiens (human),Lansoprazole results in increased expression of HAMP mRNA,,,PMID:31669099,https://www.ncbi.nlm.nih.gov/pubmed/31669099,31669099,,
197,425624,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lansoprazole results in increased activity of HMOX1 promoter]|lansoprazole results in increased expression of HMOX1 protein|2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [lansoprazole results in increased expression of HMOX1 mrna]|lansoprazole results in increased activity of HMOX1 promoter,,,PMID:19764090,https://www.ncbi.nlm.nih.gov/pubmed/19764090,19764090,,
198,425625,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),Lansoprazole results in increased activity of and results in increased expression of HMOX1 protein,,,PMID:16712795,https://www.ncbi.nlm.nih.gov/pubmed/16712795,16712795,,
199,425626,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,9606,Homo sapiens (human),Lansoprazole results in increased expression of HMOX1 mRNA,,,PMID:16712795|PMID:19764090,https://www.ncbi.nlm.nih.gov/pubmed/16712795|https://www.ncbi.nlm.nih.gov/pubmed/19764090,16712795|19764090,,
200,425627,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Lansoprazole inhibits the reaction [diatrizoate meglumine results in increased expression of HMOX1 mrna],,,PMID:28412091,https://www.ncbi.nlm.nih.gov/pubmed/28412091,28412091,,
201,425628,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Lansoprazole results in increased expression of HMOX1 mRNA,,,PMID:19628634|PMID:28412091,https://www.ncbi.nlm.nih.gov/pubmed/19628634|https://www.ncbi.nlm.nih.gov/pubmed/28412091,19628634|28412091,,
202,425629,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Lansoprazole results in increased expression of HMOX1 protein|u 0126 inhibits the reaction [lansoprazole results in increased expression of HMOX1 protein]|tin protoporphyrin IX inhibits the reaction [lansoprazole inhibits the reaction [CXCL1 protein results in increased expression of HMOX1 protein]]|nfe2l2 mRNA affects the reaction [lansoprazole results in increased expression of HMOX1 mrna]|lansoprazole inhibits the reaction [CXCL1 protein results in increased expression of HMOX1 protein]|nfe2l2 mRNA affects the reaction [lansoprazole results in increased expression of HMOX1 protein],,,PMID:19628634,https://www.ncbi.nlm.nih.gov/pubmed/19628634,19628634,,
203,425942,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,4137,MAPT,https://ctdbase.org/detail.go?type=gene&acc=4137,,,4137.0,MAPT,9606,Homo sapiens (human),Lansoprazole binds to MAPT protein alternative form,,,PMID:20110603,https://www.ncbi.nlm.nih.gov/pubmed/20110603,20110603,,
204,425943,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116,Rattus norvegicus (Norway rat),Lansoprazole inhibits the reaction [indomethacin results in increased activity of MPO protein],,,PMID:17151854|PMID:17895592|PMID:18726076,https://www.ncbi.nlm.nih.gov/pubmed/17151854|https://www.ncbi.nlm.nih.gov/pubmed/17895592|https://www.ncbi.nlm.nih.gov/pubmed/18726076,17151854|17895592|18726076,,
205,425944,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,4353,MPO,https://ctdbase.org/detail.go?type=gene&acc=4353,,,4353.0,MPO,10116,Rattus norvegicus (Norway rat),Lansoprazole inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased expression of MPO protein],,,PMID:24337826,https://www.ncbi.nlm.nih.gov/pubmed/24337826,24337826,,
206,425945,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Lansoprazole inhibits the reaction [diatrizoate meglumine results in increased expression of NFE2L2 mrna]|lansoprazole results in increased expression of NFE2L2 mRNA,,,PMID:28412091,https://www.ncbi.nlm.nih.gov/pubmed/28412091,28412091,,
207,425946,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Lansoprazole results in increased phosphorylation of NFE2L2 protein|nfe2l2 mRNA affects the reaction [lansoprazole results in increased expression of HMOX1 mrna]|nfe2l2 mRNA affects the reaction [lansoprazole results in increased expression of HMOX1 protein],,,PMID:19628634,https://www.ncbi.nlm.nih.gov/pubmed/19628634,19628634,,
208,425947,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792.0,NFKBIA,10116,Rattus norvegicus (Norway rat),Lansoprazole inhibits the reaction [ethanol results in decreased expression of and results in increased phosphorylation of NFKBIA protein],,,PMID:29339218,https://www.ncbi.nlm.nih.gov/pubmed/29339218,29339218,,
209,425948,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,7376,NR1H2,https://ctdbase.org/detail.go?type=gene&acc=7376,,,7376.0,NR1H2,9606,Homo sapiens (human),Lansoprazole results in increased activity of NR1H2 protein,,,PMID:20060385,https://www.ncbi.nlm.nih.gov/pubmed/20060385,20060385,,
210,425949,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,10062,NR1H3,https://ctdbase.org/detail.go?type=gene&acc=10062,,,10062.0,NR1H3,9606,Homo sapiens (human),Lansoprazole results in increased activity of NR1H3 protein,,,PMID:20060385,https://www.ncbi.nlm.nih.gov/pubmed/20060385,20060385,,
211,425950,3883,Comparative Toxicogenomics Database (CTD),Lansoprazole,D064747,Lansoprazole,https://ctdbase.org/detail.go?type=chem&acc=D064747,8856,NR1I2,https://ctdbase.org/detail.go?type=gene&acc=8856,,,8856.0,NR1I2,9606,Homo sapiens (human),Lansoprazole results in increased activity of NR1I2 protein,,,PMID:25455453,https://www.ncbi.nlm.nih.gov/pubmed/25455453,25455453,,
212,421559,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,5372,PMM1,https://ctdbase.org/detail.go?type=gene&acc=5372,,,5372.0,PMM1,10116,Rattus norvegicus (Norway rat),Leflunomide results in increased expression of PMM1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
213,421560,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,441194,PMS2CL,https://ctdbase.org/detail.go?type=gene&acc=441194,,,441194.0,PMS2CL,9606,Homo sapiens (human),Leflunomide results in increased expression of PMS2CL mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
214,421561,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,25957,PNISR,https://ctdbase.org/detail.go?type=gene&acc=25957,,,25957.0,PNISR,9606,Homo sapiens (human),Leflunomide results in decreased expression of PNISR mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
215,421562,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,84968,PNMA6A,https://ctdbase.org/detail.go?type=gene&acc=84968,,,84968.0,PNMA6A,9606,Homo sapiens (human),Leflunomide results in increased expression of PNMA6A mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
216,421563,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,5411,PNN,https://ctdbase.org/detail.go?type=gene&acc=5411,,,5411.0,PNN,9606,Homo sapiens (human),Leflunomide results in decreased expression of PNN mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
217,421564,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,57104,PNPLA2,https://ctdbase.org/detail.go?type=gene&acc=57104,,,57104.0,PNPLA2,10116,Rattus norvegicus (Norway rat),Leflunomide results in increased expression of PNPLA2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
218,421565,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,375775,PNPLA7,https://ctdbase.org/detail.go?type=gene&acc=375775,,,375775.0,PNPLA7,10116,Rattus norvegicus (Norway rat),Leflunomide results in increased expression of PNPLA7 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
219,421566,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,50640,PNPLA8,https://ctdbase.org/detail.go?type=gene&acc=50640,,,50640.0,PNPLA8,10116,Rattus norvegicus (Norway rat),Leflunomide results in increased expression of PNPLA8 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
220,421567,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,55629,PNRC2,https://ctdbase.org/detail.go?type=gene&acc=55629,,,55629.0,PNRC2,9606,Homo sapiens (human),Leflunomide results in decreased expression of PNRC2 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
221,421568,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,25886,POC1A,https://ctdbase.org/detail.go?type=gene&acc=25886,,,25886.0,POC1A,9606,Homo sapiens (human),Leflunomide results in decreased expression of POC1A mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
222,424133,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,112,ADCY6,https://ctdbase.org/detail.go?type=gene&acc=112,,,112.0,ADCY6,9606,Homo sapiens (human),Leflunomide results in decreased expression of ADCY6 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
223,424134,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,115,ADCY9,https://ctdbase.org/detail.go?type=gene&acc=115,,,115.0,ADCY9,9606,Homo sapiens (human),Leflunomide results in increased expression of ADCY9 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
224,424318,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,9289,ADGRG1,https://ctdbase.org/detail.go?type=gene&acc=9289,,,9289.0,ADGRG1,9606,Homo sapiens (human),Leflunomide results in increased expression of ADGRG1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
225,424319,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,222487,ADGRG3,https://ctdbase.org/detail.go?type=gene&acc=222487,,,222487.0,ADGRG3,9606,Homo sapiens (human),Leflunomide results in increased expression of ADGRG3 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
226,424320,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,125,ADH1B,https://ctdbase.org/detail.go?type=gene&acc=125,,,125.0,ADH1B,9606,Homo sapiens (human),Leflunomide results in decreased expression of ADH1B mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
227,424321,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,130,ADH6,https://ctdbase.org/detail.go?type=gene&acc=130,,,130.0,ADH6,9606,Homo sapiens (human),Leflunomide results in decreased expression of ADH6 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
228,424322,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,79602,ADIPOR2,https://ctdbase.org/detail.go?type=gene&acc=79602,,,79602.0,ADIPOR2,9606,Homo sapiens (human),Leflunomide results in decreased expression of ADIPOR2 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
229,424323,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,133,ADM,https://ctdbase.org/detail.go?type=gene&acc=133,,,133.0,ADM,9606,Homo sapiens (human),Leflunomide results in increased expression of ADM mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
230,424324,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,79924,ADM2,https://ctdbase.org/detail.go?type=gene&acc=79924,,,79924.0,ADM2,9606,Homo sapiens (human),Leflunomide results in increased expression of ADM2 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
231,424506,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,54936,ADPRS,https://ctdbase.org/detail.go?type=gene&acc=54936,,,54936.0,ADPRS,9606,Homo sapiens (human),Leflunomide results in decreased expression of ADPRS mRNA,,,PMID:28988120|PMID:29427785,https://www.ncbi.nlm.nih.gov/pubmed/28988120|https://www.ncbi.nlm.nih.gov/pubmed/29427785,28988120|29427785,,
232,424863,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,8574,AKR7A2,https://ctdbase.org/detail.go?type=gene&acc=8574,,,8574.0,AKR7A2,10116,Rattus norvegicus (Norway rat),Leflunomide results in increased expression of AKR7A2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
233,424864,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,84335,AKT1S1,https://ctdbase.org/detail.go?type=gene&acc=84335,,,84335.0,AKT1S1,9606,Homo sapiens (human),Leflunomide results in decreased expression of AKT1S1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
234,424865,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,84335,AKT1S1,https://ctdbase.org/detail.go?type=gene&acc=84335,,,84335.0,AKT1S1,10116,Rattus norvegicus (Norway rat),Leflunomide results in increased expression of AKT1S1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
235,424866,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,64400,AKTIP,https://ctdbase.org/detail.go?type=gene&acc=64400,,,64400.0,AKTIP,9606,Homo sapiens (human),Leflunomide results in decreased expression of AKTIP mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
236,426595,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,374569,ASPG,https://ctdbase.org/detail.go?type=gene&acc=374569,,,374569.0,ASPG,10116,Rattus norvegicus (Norway rat),Leflunomide results in decreased expression of ASPG mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
237,426596,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,259266,ASPM,https://ctdbase.org/detail.go?type=gene&acc=259266,,,259266.0,ASPM,9606,Homo sapiens (human),Leflunomide results in decreased expression of ASPM mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
238,426597,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,445,ASS1,https://ctdbase.org/detail.go?type=gene&acc=445,,,445.0,ASS1,10090,Mus musculus (house mouse),Leflunomide results in increased expression of ASS1 mRNA,,,PMID:19751817,https://www.ncbi.nlm.nih.gov/pubmed/19751817,19751817,,
239,426598,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,84896,ATAD1,https://ctdbase.org/detail.go?type=gene&acc=84896,,,84896.0,ATAD1,9606,Homo sapiens (human),Leflunomide results in increased expression of ATAD1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
240,426599,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,54454,ATAD2B,https://ctdbase.org/detail.go?type=gene&acc=54454,,,54454.0,ATAD2B,9606,Homo sapiens (human),Leflunomide results in increased expression of ATAD2B mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
241,426600,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,79969,ATAT1,https://ctdbase.org/detail.go?type=gene&acc=79969,,,79969.0,ATAT1,9606,Homo sapiens (human),Leflunomide results in decreased expression of ATAT1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
242,426601,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606,Homo sapiens (human),Leflunomide results in increased expression of ATF3 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
243,427367,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,142891,SAMD8,https://ctdbase.org/detail.go?type=gene&acc=142891,,,142891.0,SAMD8,9606,Homo sapiens (human),Leflunomide results in increased expression of SAMD8 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
244,427368,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,54809,SAMD9,https://ctdbase.org/detail.go?type=gene&acc=54809,,,54809.0,SAMD9,9606,Homo sapiens (human),Leflunomide results in decreased expression of SAMD9 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
245,427369,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,25939,SAMHD1,https://ctdbase.org/detail.go?type=gene&acc=25939,,,25939.0,SAMHD1,9606,Homo sapiens (human),Leflunomide results in decreased expression of SAMHD1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
246,427522,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,222389,BEND7,https://ctdbase.org/detail.go?type=gene&acc=222389,,,222389.0,BEND7,9606,Homo sapiens (human),Leflunomide results in increased expression of BEND7 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
247,427523,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,8553,BHLHE40,https://ctdbase.org/detail.go?type=gene&acc=8553,,,8553.0,BHLHE40,9606,Homo sapiens (human),Leflunomide results in increased expression of BHLHE40 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
248,427524,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,80114,BICC1,https://ctdbase.org/detail.go?type=gene&acc=80114,,,80114.0,BICC1,9606,Homo sapiens (human),Leflunomide results in increased expression of BICC1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
249,427525,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,23299,BICD2,https://ctdbase.org/detail.go?type=gene&acc=23299,,,23299.0,BICD2,9606,Homo sapiens (human),Leflunomide results in decreased expression of BICD2 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
250,427526,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,92558,BICDL1,https://ctdbase.org/detail.go?type=gene&acc=92558,,,92558.0,BICDL1,9606,Homo sapiens (human),Leflunomide results in increased expression of BICDL1 mRNA,,,PMID:28988120,https://www.ncbi.nlm.nih.gov/pubmed/28988120,28988120,,
251,428990,3899,Comparative Toxicogenomics Database (CTD),Leflunomide,D000077339,Leflunomide,https://ctdbase.org/detail.go?type=chem&acc=D000077339,12349,CAR2,https://ctdbase.org/detail.go?type=gene&acc=12349,,,12349.0,Car2,10116,Rattus norvegicus (Norway rat),Leflunomide results in decreased expression of CAR2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
252,422013,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,9330,GTF3C3,https://ctdbase.org/detail.go?type=gene&acc=9330,,,9330.0,GTF3C3,10116,Rattus norvegicus (Norway rat),Methapyrilene results in decreased expression of GTF3C3 mRNA,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
253,422014,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,85865,GTPBP10,https://ctdbase.org/detail.go?type=gene&acc=85865,,,85865.0,GTPBP10,10116,Rattus norvegicus (Norway rat),Methapyrilene results in decreased expression of GTPBP10 mRNA,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
254,422015,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,54676,GTPBP2,https://ctdbase.org/detail.go?type=gene&acc=54676,,,54676.0,GTPBP2,10116,Rattus norvegicus (Norway rat),Methapyrilene results in decreased expression of GTPBP2 mRNA,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
255,422016,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,51512,GTSE1,https://ctdbase.org/detail.go?type=gene&acc=51512,,,51512.0,GTSE1,10116,Rattus norvegicus (Norway rat),Methapyrilene results in increased expression of GTSE1 mRNA,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
256,422017,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,2977,GUCY1A2,https://ctdbase.org/detail.go?type=gene&acc=2977,,,2977.0,GUCY1A2,9606,Homo sapiens (human),Methapyrilene results in increased methylation of GUCY1A2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
257,422018,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,2984,GUCY2C,https://ctdbase.org/detail.go?type=gene&acc=2984,,,2984.0,GUCY2C,9606,Homo sapiens (human),Methapyrilene results in decreased methylation of GUCY2C intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
258,422019,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,3000,GUCY2D,https://ctdbase.org/detail.go?type=gene&acc=3000,,,3000.0,GUCY2D,9606,Homo sapiens (human),Methapyrilene results in increased methylation of GUCY2D intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
259,422020,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10116,Rattus norvegicus (Norway rat),Methapyrilene results in decreased expression of GULO mRNA,,,PMID:16393664,https://www.ncbi.nlm.nih.gov/pubmed/16393664,16393664,,
260,422021,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,728411,GUSBP1,https://ctdbase.org/detail.go?type=gene&acc=728411,,,728411.0,GUSBP1,9606,Homo sapiens (human),Methapyrilene results in increased methylation of GUSBP1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
261,422022,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,375513,GUSBP4,https://ctdbase.org/detail.go?type=gene&acc=375513,,,375513.0,GUSBP4,9606,Homo sapiens (human),Methapyrilene results in decreased methylation of GUSBP4 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
262,423484,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,101929664,HORMAD2-AS1,https://ctdbase.org/detail.go?type=gene&acc=101929664,,,101929664.0,HORMAD2-AS1,9606,Homo sapiens (human),Methapyrilene results in increased methylation of HORMAD2-AS1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
263,423485,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,3228,HOXC12,https://ctdbase.org/detail.go?type=gene&acc=3228,,,3228.0,HOXC12,9606,Homo sapiens (human),Methapyrilene results in increased methylation of HOXC12 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
264,423486,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,50809,HP1BP3,https://ctdbase.org/detail.go?type=gene&acc=50809,,,50809.0,HP1BP3,10116,Rattus norvegicus (Norway rat),Methapyrilene results in decreased expression of HP1BP3 mRNA,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
265,423487,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,3241,HPCAL1,https://ctdbase.org/detail.go?type=gene&acc=3241,,,3241.0,HPCAL1,9606,Homo sapiens (human),Methapyrilene results in increased methylation of HPCAL1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
266,425446,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,26512,INTS6,https://ctdbase.org/detail.go?type=gene&acc=26512,,,26512.0,INTS6,10116,Rattus norvegicus (Norway rat),Methapyrilene results in increased expression of INTS6 mRNA,,,PMID:30467583,https://www.ncbi.nlm.nih.gov/pubmed/30467583,30467583,,
267,425447,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,25896,INTS7,https://ctdbase.org/detail.go?type=gene&acc=25896,,,25896.0,INTS7,9606,Homo sapiens (human),Methapyrilene results in decreased methylation of INTS7 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
268,425448,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,55656,INTS8,https://ctdbase.org/detail.go?type=gene&acc=55656,,,55656.0,INTS8,9606,Homo sapiens (human),Methapyrilene results in decreased methylation of INTS8 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
269,425449,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,55756,INTS9,https://ctdbase.org/detail.go?type=gene&acc=55756,,,55756.0,INTS9,9606,Homo sapiens (human),Methapyrilene results in increased methylation of INTS9 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
270,425450,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,79711,IPO4,https://ctdbase.org/detail.go?type=gene&acc=79711,,,79711.0,IPO4,9606,Homo sapiens (human),Methapyrilene results in decreased methylation of IPO4 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
271,425451,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,79711,IPO4,https://ctdbase.org/detail.go?type=gene&acc=79711,,,79711.0,IPO4,10116,Rattus norvegicus (Norway rat),Methapyrilene results in increased expression of IPO4 mRNA,,,PMID:28935588,https://www.ncbi.nlm.nih.gov/pubmed/28935588,28935588,,
272,425452,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,10527,IPO7,https://ctdbase.org/detail.go?type=gene&acc=10527,,,10527.0,IPO7,9606,Homo sapiens (human),Methapyrilene results in increased methylation of IPO7 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
273,425453,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,64768,IPPK,https://ctdbase.org/detail.go?type=gene&acc=64768,,,64768.0,IPPK,9606,Homo sapiens (human),Methapyrilene results in increased methylation of IPPK promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
274,425454,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,79781,IQCA1,https://ctdbase.org/detail.go?type=gene&acc=79781,,,79781.0,IQCA1,9606,Homo sapiens (human),Methapyrilene results in decreased methylation of IQCA1 intron|methapyrilene results in increased methylation of IQCA1 promoter,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
275,425455,4098,Comparative Toxicogenomics Database (CTD),Methapyrilene,D008701,Methapyrilene,https://ctdbase.org/detail.go?type=chem&acc=D008701,23288,IQCE,https://ctdbase.org/detail.go?type=gene&acc=23288,,,23288.0,IQCE,9606,Homo sapiens (human),Methapyrilene results in decreased methylation of IQCE intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
276,427827,4115,Comparative Toxicogenomics Database (CTD),Methoxychlor,D008731,Methoxychlor,https://ctdbase.org/detail.go?type=chem&acc=D008731,8038,ADAM12,https://ctdbase.org/detail.go?type=gene&acc=8038,,,8038.0,ADAM12,10116,Rattus norvegicus (Norway rat),Methoxychlor affects the methylation of ADAM12 gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
277,427828,4115,Comparative Toxicogenomics Database (CTD),Methoxychlor,D008731,Methoxychlor,https://ctdbase.org/detail.go?type=chem&acc=D008731,8745,ADAM23,https://ctdbase.org/detail.go?type=gene&acc=8745,,,8745.0,ADAM23,10116,Rattus norvegicus (Norway rat),Methoxychlor affects the methylation of ADAM23 gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
278,427829,4115,Comparative Toxicogenomics Database (CTD),Methoxychlor,D008731,Methoxychlor,https://ctdbase.org/detail.go?type=chem&acc=D008731,11498,ADAM4,https://ctdbase.org/detail.go?type=gene&acc=11498,,,11498.0,Adam4,10116,Rattus norvegicus (Norway rat),Methoxychlor affects the methylation of ADAM4 gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
279,427830,4115,Comparative Toxicogenomics Database (CTD),Methoxychlor,D008731,Methoxychlor,https://ctdbase.org/detail.go?type=chem&acc=D008731,8754,ADAM9,https://ctdbase.org/detail.go?type=gene&acc=8754,,,8754.0,ADAM9,10116,Rattus norvegicus (Norway rat),Methoxychlor affects the methylation of ADAM9 gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
280,427831,4115,Comparative Toxicogenomics Database (CTD),Methoxychlor,D008731,Methoxychlor,https://ctdbase.org/detail.go?type=chem&acc=D008731,81792,ADAMTS12,https://ctdbase.org/detail.go?type=gene&acc=81792,,,81792.0,ADAMTS12,10116,Rattus norvegicus (Norway rat),Methoxychlor affects the methylation of ADAMTS12 gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
281,427832,4115,Comparative Toxicogenomics Database (CTD),Methoxychlor,D008731,Methoxychlor,https://ctdbase.org/detail.go?type=chem&acc=D008731,140766,ADAMTS14,https://ctdbase.org/detail.go?type=gene&acc=140766,,,140766.0,ADAMTS14,10116,Rattus norvegicus (Norway rat),Methoxychlor affects the methylation of ADAMTS14 gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
282,427833,4115,Comparative Toxicogenomics Database (CTD),Methoxychlor,D008731,Methoxychlor,https://ctdbase.org/detail.go?type=chem&acc=D008731,170692,ADAMTS18,https://ctdbase.org/detail.go?type=gene&acc=170692,,,170692.0,ADAMTS18,10116,Rattus norvegicus (Norway rat),Methoxychlor affects the methylation of ADAMTS18 gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
283,427834,4115,Comparative Toxicogenomics Database (CTD),Methoxychlor,D008731,Methoxychlor,https://ctdbase.org/detail.go?type=chem&acc=D008731,9508,ADAMTS3,https://ctdbase.org/detail.go?type=gene&acc=9508,,,9508.0,ADAMTS3,10116,Rattus norvegicus (Norway rat),Methoxychlor affects the methylation of ADAMTS3 gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
284,427835,4115,Comparative Toxicogenomics Database (CTD),Methoxychlor,D008731,Methoxychlor,https://ctdbase.org/detail.go?type=chem&acc=D008731,92949,ADAMTSL1,https://ctdbase.org/detail.go?type=gene&acc=92949,,,92949.0,ADAMTSL1,10116,Rattus norvegicus (Norway rat),Methoxychlor affects the methylation of ADAMTSL1 gene,,,PMID:35440735,https://www.ncbi.nlm.nih.gov/pubmed/35440735,35440735,,
285,534799,4119,Drug Gene Interaction database (DGIdb),Methoxyvone,,METHOXYVONE,https://www.dgidb.org/drugs/chembl:CHEMBL1591080,,SMN2,https://www.dgidb.org/genes/hgnc:11118,,,6607.0,SMN2,9606,Homo sapiens (human),,,,,,,,
286,422829,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,113791,PIK3IP1,https://ctdbase.org/detail.go?type=gene&acc=113791,,,113791.0,PIK3IP1,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of PIK3IP1 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
287,422830,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,5295,PIK3R1,https://ctdbase.org/detail.go?type=gene&acc=5295,,,5295.0,PIK3R1,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of PIK3R1 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
288,422831,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,8503,PIK3R3,https://ctdbase.org/detail.go?type=gene&acc=8503,,,8503.0,PIK3R3,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of PIK3R3 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
289,422994,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,23533,PIK3R5,https://ctdbase.org/detail.go?type=gene&acc=23533,,,23533.0,PIK3R5,9606,Homo sapiens (human),Methyl methanesulfonate results in decreased expression of PIK3R5 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
290,422995,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,29990,PILRB,https://ctdbase.org/detail.go?type=gene&acc=29990,,,29990.0,PILRB,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of PILRB mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
291,422996,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,11040,PIM2,https://ctdbase.org/detail.go?type=gene&acc=11040,,,11040.0,PIM2,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of PIM2 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
292,422997,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,100537725,PIMR118,https://ctdbase.org/detail.go?type=gene&acc=100537725,,,100537725.0,pimr118,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of PIMR118 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
293,424315,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,1263,PLK3,https://ctdbase.org/detail.go?type=gene&acc=1263,,,1263.0,PLK3,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of PLK3 mRNA,,,PMID:22100608|PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/23649840,22100608|23649840,,
294,424316,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,10733,PLK4,https://ctdbase.org/detail.go?type=gene&acc=10733,,,10733.0,PLK4,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of PLK4 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
295,424317,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,5352,PLOD2,https://ctdbase.org/detail.go?type=gene&acc=5352,,,5352.0,PLOD2,9606,Homo sapiens (human),Methyl methanesulfonate results in decreased expression of PLOD2 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
296,424857,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,5366,PMAIP1,https://ctdbase.org/detail.go?type=gene&acc=5366,,,5366.0,PMAIP1,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of PMAIP1 mRNA,,,PMID:20713136|PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/20713136|https://www.ncbi.nlm.nih.gov/pubmed/23649840,20713136|23649840,,
297,424858,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,321239,PMELA,https://ctdbase.org/detail.go?type=gene&acc=321239,,,321239.0,pmela,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of PMELA mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
298,424859,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,5371,PML,https://ctdbase.org/detail.go?type=gene&acc=5371,,,5371.0,PML,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of PML mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
299,424860,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,5372,PMM1,https://ctdbase.org/detail.go?type=gene&acc=5372,,,5372.0,PMM1,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of PMM1 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
300,426771,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,150274,HSCB,https://ctdbase.org/detail.go?type=gene&acc=150274,,,150274.0,HSCB,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of HSCB mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
301,426772,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,3292,HSD17B1,https://ctdbase.org/detail.go?type=gene&acc=3292,,,3292.0,HSD17B1,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of HSD17B1 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
302,428182,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,3421,IDH3G,https://ctdbase.org/detail.go?type=gene&acc=3421,,,3421.0,IDH3G,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in increased expression of IDH3G mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
303,428183,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,3422,IDI1,https://ctdbase.org/detail.go?type=gene&acc=3422,,,3422.0,IDI1,9606,Homo sapiens (human),Methyl methanesulfonate results in decreased expression of IDI1 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
304,428184,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,51278,IER5,https://ctdbase.org/detail.go?type=gene&acc=51278,,,51278.0,IER5,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of IER5 mRNA,,,PMID:21527772|PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/21527772|https://www.ncbi.nlm.nih.gov/pubmed/23649840,21527772|23649840,,
305,428185,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,389792,IER5L,https://ctdbase.org/detail.go?type=gene&acc=389792,,,389792.0,IER5L,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of IER5L mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
306,428186,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,389792,IER5L,https://ctdbase.org/detail.go?type=gene&acc=389792,,,389792.0,IER5L,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of IER5L mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
307,428187,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,25900,IFFO1,https://ctdbase.org/detail.go?type=gene&acc=25900,,,25900.0,IFFO1,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of IFFO1 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
308,428188,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,563794,IFFO1B,https://ctdbase.org/detail.go?type=gene&acc=563794,,,563794.0,iffo1b,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of IFFO1B mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
309,428189,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,64135,IFIH1,https://ctdbase.org/detail.go?type=gene&acc=64135,,,64135.0,IFIH1,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of IFIH1 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
310,428663,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,55764,IFT122,https://ctdbase.org/detail.go?type=gene&acc=55764,,,55764.0,IFT122,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of IFT122 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
311,428664,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,9742,IFT140,https://ctdbase.org/detail.go?type=gene&acc=9742,,,9742.0,IFT140,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of IFT140 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
312,428665,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,26160,IFT172,https://ctdbase.org/detail.go?type=gene&acc=26160,,,26160.0,IFT172,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of IFT172 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
313,428666,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,90410,IFT20,https://ctdbase.org/detail.go?type=gene&acc=90410,,,90410.0,IFT20,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of IFT20 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
314,428667,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,64792,IFT22,https://ctdbase.org/detail.go?type=gene&acc=64792,,,64792.0,IFT22,7955,Danio rerio (zebrafish),Methyl methanesulfonate results in decreased expression of IFT22 mRNA,,,PMID:26011545,https://www.ncbi.nlm.nih.gov/pubmed/26011545,26011545,,
315,428668,4156,Comparative Toxicogenomics Database (CTD),Methyl methanesulfonate,D008741,Methyl Methanesulfonate,https://ctdbase.org/detail.go?type=chem&acc=D008741,64792,IFT22,https://ctdbase.org/detail.go?type=gene&acc=64792,,,64792.0,IFT22,9606,Homo sapiens (human),Methyl methanesulfonate results in increased expression of IFT22 mRNA,,,PMID:23649840,https://www.ncbi.nlm.nih.gov/pubmed/23649840,23649840,,
316,424861,4158,ChEMBL,Methylphenidate,CHEMBL796,METHYLPHENIDATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL796/,CHEMBL222,Norepinephrine transporter,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL222/,P23975,Sodium-dependent noradrenaline transporter ,6530.0,SLC6A2,9606,Homo sapiens (human),Norepinephrine transporter inhibitor,,,PMID:23284812,https://www.ncbi.nlm.nih.gov/pubmed/23284812,23284812,,
317,424862,4158,DrugBank,Methylphenidate,DB00422,Methylphenidate,https://www.drugbank.ca/drugs/DB00422,BE0000647,Sodium-dependent dopamine transporter,https://www.drugbank.ca/bio_entities/BE0000647,Q01959,Sodium-dependent dopamine transporter ,6531.0,SLC6A3,9606,Homo sapiens (human),Inhibitor,,,PMID:10025684|PMID:10037500|PMID:10199939|PMID:10403500|PMID:10414438|PMID:11752352|PMID:9537821|PMID:15303308|PMID:18698001|PMID:17201613|PMID:16806100,https://www.ncbi.nlm.nih.gov/pubmed/10025684|https://www.ncbi.nlm.nih.gov/pubmed/10037500|https://www.ncbi.nlm.nih.gov/pubmed/10199939|https://www.ncbi.nlm.nih.gov/pubmed/10403500|https://www.ncbi.nlm.nih.gov/pubmed/10414438|https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/9537821|https://www.ncbi.nlm.nih.gov/pubmed/15303308|https://www.ncbi.nlm.nih.gov/pubmed/18698001|https://www.ncbi.nlm.nih.gov/pubmed/17201613|https://www.ncbi.nlm.nih.gov/pubmed/16806100,10025684|10037500|10199939|10403500|10414438|11752352|9537821|15303308|18698001|17201613|16806100,,
318,535230,4171,Drug Gene Interaction database (DGIdb),Metoprolol,,METOPROLOL,https://www.dgidb.org/drugs/rxcui:6918,,SLC4A1,https://www.dgidb.org/genes/hgnc:11027,,,6521.0,SLC4A1,9606,Homo sapiens (human),,,,,,,,
319,535231,4177,Toxin and Toxin Target Database (T3DB),Mexazolam,T3D4649,Mexazolam,http://www.t3db.ca/toxins/T3D4649,BE0000795,Gamma-aminobutyric acid receptor subunit alpha-1,http://www.t3db.ca/biodb/bio_entities/BE0000795,P14867,Gamma-aminobutyric acid receptor subunit alpha-1,2554.0,GABRA1,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
320,535232,4177,Toxin and Toxin Target Database (T3DB),Mexazolam,T3D4649,Mexazolam,http://www.t3db.ca/toxins/T3D4649,BE0000381,Gamma-aminobutyric acid receptor subunit alpha-2,http://www.t3db.ca/biodb/bio_entities/BE0000381,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,2555.0,GABRA2,9606,Homo sapiens (human),,,,PMID:6738302|PMID:2867566,https://www.ncbi.nlm.nih.gov/pubmed/6738302|https://www.ncbi.nlm.nih.gov/pubmed/2867566,6738302|2867566,,
321,535233,4177,Toxin and Toxin Target Database (T3DB),Mexazolam,T3D4649,Mexazolam,http://www.t3db.ca/toxins/T3D4649,BE0000523,Gamma-aminobutyric acid receptor subunit alpha-3,http://www.t3db.ca/biodb/bio_entities/BE0000523,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,2556.0,GABRA3,9606,Homo sapiens (human),,,,PMID:6738302|PMID:2867566,https://www.ncbi.nlm.nih.gov/pubmed/6738302|https://www.ncbi.nlm.nih.gov/pubmed/2867566,6738302|2867566,,
322,535234,4177,Toxin and Toxin Target Database (T3DB),Mexazolam,T3D4649,Mexazolam,http://www.t3db.ca/toxins/T3D4649,BE0000471,Gamma-aminobutyric acid receptor subunit alpha-5,http://www.t3db.ca/biodb/bio_entities/BE0000471,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,2558.0,GABRA5,9606,Homo sapiens (human),,,,PMID:6738302|PMID:2867566,https://www.ncbi.nlm.nih.gov/pubmed/6738302|https://www.ncbi.nlm.nih.gov/pubmed/2867566,6738302|2867566,,
323,535719,4177,Toxin and Toxin Target Database (T3DB),Mexazolam,T3D4649,Mexazolam,http://www.t3db.ca/toxins/T3D4649,BE0000129,Gamma-aminobutyric acid receptor subunit rho-1,http://www.t3db.ca/biodb/bio_entities/BE0000129,P24046,Gamma-aminobutyric acid receptor subunit rho-1,2569.0,GABRR1,9606,Homo sapiens (human),,,,PMID:6738302|PMID:2867566,https://www.ncbi.nlm.nih.gov/pubmed/6738302|https://www.ncbi.nlm.nih.gov/pubmed/2867566,6738302|2867566,,
324,535720,4177,Toxin and Toxin Target Database (T3DB),Mexazolam,T3D4649,Mexazolam,http://www.t3db.ca/toxins/T3D4649,BE0003598,Gamma-aminobutyric acid receptor subunit rho-2,http://www.t3db.ca/biodb/bio_entities/BE0003598,P28476,Gamma-aminobutyric acid receptor subunit rho-2,2570.0,GABRR2,9606,Homo sapiens (human),,,,PMID:6738302|PMID:2867566,https://www.ncbi.nlm.nih.gov/pubmed/6738302|https://www.ncbi.nlm.nih.gov/pubmed/2867566,6738302|2867566,,
325,425780,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,24,ABCA4,https://ctdbase.org/detail.go?type=gene&acc=24,,,24.0,ABCA4,9606,Homo sapiens (human),Entinostat results in increased expression of ABCA4 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
326,425781,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,23461,ABCA5,https://ctdbase.org/detail.go?type=gene&acc=23461,,,23461.0,ABCA5,9606,Homo sapiens (human),Entinostat results in decreased expression of ABCA5 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
327,426901,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,221442,ADCY10P1,https://ctdbase.org/detail.go?type=gene&acc=221442,,,221442.0,ADCY10P1,9606,Homo sapiens (human),Entinostat results in decreased expression of ADCY10P1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
328,426902,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,221442,ADCY10P1,https://ctdbase.org/detail.go?type=gene&acc=221442,,,221442.0,ADCY10P1,9606,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ADCY10P1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
329,426903,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,108,ADCY2,https://ctdbase.org/detail.go?type=gene&acc=108,,,108.0,ADCY2,9606,Homo sapiens (human),Entinostat results in increased expression of ADCY2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
330,426904,4261,Comparative Toxicogenomics Database (CTD),Entinostat,C118739,entinostat,https://ctdbase.org/detail.go?type=chem&acc=C118739,108,ADCY2,https://ctdbase.org/detail.go?type=gene&acc=108,,,108.0,ADCY2,9606,Homo sapiens (human),"[NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ADCY2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
331,535545,4354,DrugBank,n-Bromoacetyl-aminoethyl phosphate,DB02257,N-Bromoacetyl-Aminoethyl Phosphate,https://www.drugbank.ca/drugs/DB02257,BE0001469,Glucose-6-phosphate isomerase B,https://www.drugbank.ca/bio_entities/BE0001469,P13376,Glucose-6-phosphate isomerase B,,,1422,Geobacillus stearothermophilus,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
332,535546,4362,Drug Gene Interaction database (DGIdb),N-ethylmaleimide,,N-ETHYLMALEIMIDE,https://www.dgidb.org/drugs/drugbank:DB02967,,GMNN,https://www.dgidb.org/genes/hgnc:17493,,,51053.0,GMNN,9606,Homo sapiens (human),,,,,,,,
333,535547,4397,Drug Gene Interaction database (DGIdb),N6-2-(4-Aminophenyl)ethyladenosine,,LY2940094,https://www.dgidb.org/drugs/iuphar.ligand:9462,,OPRL1,https://www.dgidb.org/genes/hgnc:8155,,,4987.0,OPRL1,9606,Homo sapiens (human),,,,,,,,
334,535548,4409,Drug Gene Interaction database (DGIdb),Nabumetone,,NABUMETONE,https://www.dgidb.org/drugs/rxcui:31448,,PTGS2,https://www.dgidb.org/genes/hgnc:9605,,,5743.0,PTGS2,9606,Homo sapiens (human),,,,,,,,
335,427677,4440,Drug Gene Interaction database (DGIdb),Naratriptan,,NARATRIPTAN,https://www.dgidb.org/drugs/rxcui:141366,,HTR1B,https://www.dgidb.org/genes/hgnc:5287,,,3351.0,HTR1B,9606,Homo sapiens (human),,,,,,,,
336,427678,4440,Drug Gene Interaction database (DGIdb),Naratriptan,,NARATRIPTAN,https://www.dgidb.org/drugs/rxcui:141366,,HTR1B,https://www.dgidb.org/genes/hgnc:5287,,,3351.0,HTR1B,9606,Homo sapiens (human),,,,,,,,
337,427679,4463,Drug Gene Interaction database (DGIdb),Nevirapine,,NEVIRAPINE,https://www.dgidb.org/drugs/rxcui:53654,,TCF19,https://www.dgidb.org/genes/hgnc:11629,,,6941.0,TCF19,9606,Homo sapiens (human),,,,,,,,
338,427680,4463,Drug Gene Interaction database (DGIdb),Nevirapine,,NEVIRAPINE,https://www.dgidb.org/drugs/rxcui:53654,,HLA-DRB1,https://www.dgidb.org/genes/hgnc:4948,,,3123.0,HLA-DRB1,9606,Homo sapiens (human),,,,,,,,
339,427681,4463,Drug Gene Interaction database (DGIdb),Nevirapine,,NEVIRAPINE,https://www.dgidb.org/drugs/rxcui:53654,,CYP2C9,https://www.dgidb.org/genes/hgnc:2623,,,1559.0,CYP2C9,9606,Homo sapiens (human),,,,,,,,
340,428027,4463,BindingDB,Nevirapine,1434,"11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=1434,59,Gag-Pol polyprotein [588-1027]/[588-1147],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=59,P04585,Gag-Pol polyprotein,155348.0,gag-pol,11706,HIV-1 M:B_HXB2R,,IC50 (nM),2.6,PMID:15519161|DOI:10.1016/j.bmc.2004.08.050,https://www.ncbi.nlm.nih.gov/pubmed/15519161|https://doi.org/10.1016/j.bmc.2004.08.050,15519161,10.1016/j.bmc.2004.08.050,
341,534476,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,873,CBR1,https://ctdbase.org/detail.go?type=gene&acc=873,,,873.0,CBR1,10116,Rattus norvegicus (Norway rat),Nimesulide results in increased expression of CBR1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
342,534477,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,203260,CCDC107,https://ctdbase.org/detail.go?type=gene&acc=203260,,,203260.0,CCDC107,10116,Rattus norvegicus (Norway rat),Nimesulide results in decreased expression of CCDC107 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
343,534478,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,8030,CCDC6,https://ctdbase.org/detail.go?type=gene&acc=8030,,,8030.0,CCDC6,10116,Rattus norvegicus (Norway rat),Nimesulide results in increased expression of CCDC6 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
344,534479,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,151887,CCDC80,https://ctdbase.org/detail.go?type=gene&acc=151887,,,151887.0,CCDC80,10116,Rattus norvegicus (Norway rat),Nimesulide results in decreased expression of CCDC80 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
345,534480,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,9606,Homo sapiens (human),Nimesulide results in decreased expression of CCL2 protein,,,PMID:17380299,https://www.ncbi.nlm.nih.gov/pubmed/17380299,17380299,,
346,534481,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10090,Mus musculus (house mouse),[nimesulide results in decreased activity of PTGS2 protein] which results in increased expression of CCL2 mRNA,,,PMID:22561872,https://www.ncbi.nlm.nih.gov/pubmed/22561872,22561872,,
347,534482,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,6347,CCL2,https://ctdbase.org/detail.go?type=gene&acc=6347,,,6347.0,CCL2,10116,Rattus norvegicus (Norway rat),Nimesulide inhibits the reaction [dietary fats results in increased expression of CCL2 mrna]|nimesulide inhibits the reaction [dietary fats results in increased expression of CCL2 protein],,,PMID:20039930,https://www.ncbi.nlm.nih.gov/pubmed/20039930,20039930,,
348,535870,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,1164,CKS2,https://ctdbase.org/detail.go?type=gene&acc=1164,,,1164.0,CKS2,10116,Rattus norvegicus (Norway rat),Nimesulide results in decreased expression of CKS2 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
349,535871,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,56650,CLDND1,https://ctdbase.org/detail.go?type=gene&acc=56650,,,56650.0,CLDND1,10116,Rattus norvegicus (Norway rat),Nimesulide results in increased expression of CLDND1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
350,535872,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,165530,CLEC4F,https://ctdbase.org/detail.go?type=gene&acc=165530,,,165530.0,CLEC4F,10116,Rattus norvegicus (Norway rat),Nimesulide results in decreased expression of CLEC4F mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
351,535873,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,6249,CLIP1,https://ctdbase.org/detail.go?type=gene&acc=6249,,,6249.0,CLIP1,10116,Rattus norvegicus (Norway rat),Nimesulide results in increased expression of CLIP1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
352,535874,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,8192,CLPP,https://ctdbase.org/detail.go?type=gene&acc=8192,,,8192.0,CLPP,10116,Rattus norvegicus (Norway rat),Nimesulide results in increased expression of CLPP mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
353,535875,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,10845,CLPX,https://ctdbase.org/detail.go?type=gene&acc=10845,,,10845.0,CLPX,10116,Rattus norvegicus (Norway rat),Nimesulide results in decreased expression of CLPX mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
354,535876,4495,Comparative Toxicogenomics Database (CTD),Nimesulide,C012655,nimesulide,https://ctdbase.org/detail.go?type=chem&acc=C012655,1212,CLTB,https://ctdbase.org/detail.go?type=gene&acc=1212,,,1212.0,CLTB,10116,Rattus norvegicus (Norway rat),Nimesulide results in increased expression of CLTB mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
355,428352,4497,DrugBank,Nimodipine,DB00393,Nimodipine,https://www.drugbank.ca/drugs/DB00393,BE0000668,Mineralocorticoid receptor,https://www.drugbank.ca/bio_entities/BE0000668,P08235,Mineralocorticoid receptor ,4306.0,NR3C2,9606,Homo sapiens (human),Antagonist,,,PMID:18250364,https://www.ncbi.nlm.nih.gov/pubmed/18250364,18250364,,
356,428353,4497,DrugBank,Nimodipine,DB00393,Nimodipine,https://www.drugbank.ca/drugs/DB00393,BE0003721,Aryl hydrocarbon receptor,https://www.drugbank.ca/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606,Homo sapiens (human),Agonist,,,PMID:17327465,https://www.ncbi.nlm.nih.gov/pubmed/17327465,17327465,,
357,428354,4497,DrugBank,Nimodipine,DB00393,Nimodipine,https://www.drugbank.ca/drugs/DB00393,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606,Homo sapiens (human),Substrate,,,PMID:11501176|PMID:16681041,https://www.ncbi.nlm.nih.gov/pubmed/11501176|https://www.ncbi.nlm.nih.gov/pubmed/16681041,11501176|16681041,,
358,428355,4499,DrugBank,Nisoldipine,DB00401,Nisoldipine,https://www.drugbank.ca/drugs/DB00401,BE0000430,Voltage-dependent L-type calcium channel subunit alpha-1C,https://www.drugbank.ca/bio_entities/BE0000430,Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,775.0,CACNA1C,9606,Homo sapiens (human),Inhibitor,,,PMID:11752352|PMID:9584217|PMID:9846638|PMID:7592963,https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/9584217|https://www.ncbi.nlm.nih.gov/pubmed/9846638|https://www.ncbi.nlm.nih.gov/pubmed/7592963,11752352|9584217|9846638|7592963,,
359,428356,4499,DrugBank,Nisoldipine,DB00401,Nisoldipine,https://www.drugbank.ca/drugs/DB00401,BE0000691,Voltage-dependent calcium channel subunit alpha-2/delta-1,https://www.drugbank.ca/bio_entities/BE0000691,P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,781.0,CACNA2D1,9606,Homo sapiens (human),Inhibitor,,,PMID:11752352,https://www.ncbi.nlm.nih.gov/pubmed/11752352,11752352,,
360,428357,4499,DrugBank,Nisoldipine,DB00401,Nisoldipine,https://www.drugbank.ca/drugs/DB00401,BE0002354,Voltage-dependent L-type calcium channel subunit beta-2,https://www.drugbank.ca/bio_entities/BE0002354,Q08289,Voltage-dependent L-type calcium channel subunit beta-2,783.0,CACNB2,9606,Homo sapiens (human),Inhibitor,,,PMID:11752352,https://www.ncbi.nlm.nih.gov/pubmed/11752352,11752352,,
361,428358,4499,DrugBank,Nisoldipine,DB00401,Nisoldipine,https://www.drugbank.ca/drugs/DB00401,BE0002359,Voltage-dependent L-type calcium channel subunit alpha-1D,https://www.drugbank.ca/bio_entities/BE0002359,Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D ,776.0,CACNA1D,9606,Homo sapiens (human),Inhibitor,,,PMID:19029287,https://www.ncbi.nlm.nih.gov/pubmed/19029287,19029287,,
362,428359,4499,DrugBank,Nisoldipine,DB00401,Nisoldipine,https://www.drugbank.ca/drugs/DB00401,BE0002355,Voltage-dependent L-type calcium channel subunit alpha-1S,https://www.drugbank.ca/bio_entities/BE0002355,Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,779.0,CACNA1S,9606,Homo sapiens (human),Inhibitor,,,PMID:16675661,https://www.ncbi.nlm.nih.gov/pubmed/16675661,16675661,,
363,428360,4499,DrugBank,Nisoldipine,DB00401,Nisoldipine,https://www.drugbank.ca/drugs/DB00401,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606,Homo sapiens (human),Substrate,,,PMID:17655375|PMID:24816159,https://www.ncbi.nlm.nih.gov/pubmed/17655375|https://www.ncbi.nlm.nih.gov/pubmed/24816159,17655375|24816159,,
364,428498,4510,Drug Gene Interaction database (DGIdb),Nitroglycerin,,NITROGLYCERIN,https://www.dgidb.org/drugs/rxcui:4917,,HIF1A,https://www.dgidb.org/genes/hgnc:4910,,,3091.0,HIF1A,9606,Homo sapiens (human),Inhibitor,,,,,,,
365,428499,4541,Drug Gene Interaction database (DGIdb),Norfluoxetine,,FREMANEZUMAB,https://www.dgidb.org/drugs/iuphar.ligand:9208,,CALCRL,https://www.dgidb.org/genes/hgnc:16709,,,10203.0,CALCRL,9606,Homo sapiens (human),,,,,,,,
366,428500,4543,Drug Gene Interaction database (DGIdb),Nortriptyline,,NORTRIPTYLINE,https://www.dgidb.org/drugs/rxcui:7531,,GNB3,https://www.dgidb.org/genes/hgnc:4400,,,2784.0,GNB3,9606,Homo sapiens (human),,,,,,,,
367,428501,4543,Drug Gene Interaction database (DGIdb),Nortriptyline,,NORTRIPTYLINE,https://www.dgidb.org/drugs/rxcui:7531,,FCHSD1,https://www.dgidb.org/genes/hgnc:25463,,,89848.0,FCHSD1,9606,Homo sapiens (human),,,,,,,,
368,428502,4543,Drug Gene Interaction database (DGIdb),Nortriptyline,,NORTRIPTYLINE,https://www.dgidb.org/drugs/rxcui:7531,,RGS4,https://www.dgidb.org/genes/hgnc:10000,,,5999.0,RGS4,9606,Homo sapiens (human),,,,,,,,
369,428503,4543,Drug Gene Interaction database (DGIdb),Nortriptyline,,NORTRIPTYLINE,https://www.dgidb.org/drugs/rxcui:7531,,EPHX1,https://www.dgidb.org/genes/hgnc:3401,,,2052.0,EPHX1,9606,Homo sapiens (human),,,,,,,,
370,428504,4543,Drug Gene Interaction database (DGIdb),Nortriptyline,,NORTRIPTYLINE,https://www.dgidb.org/drugs/rxcui:7531,,BDNF,https://www.dgidb.org/genes/hgnc:1033,,,627.0,BDNF,9606,Homo sapiens (human),,,,,,,,
371,428505,4543,Drug Gene Interaction database (DGIdb),Nortriptyline,,NORTRIPTYLINE,https://www.dgidb.org/drugs/rxcui:7531,,AKT1,https://www.dgidb.org/genes/hgnc:391,,,207.0,AKT1,9606,Homo sapiens (human),,,,,,,,
372,428506,4543,Drug Gene Interaction database (DGIdb),Nortriptyline,,NORTRIPTYLINE,https://www.dgidb.org/drugs/rxcui:7531,,ATXN2,https://www.dgidb.org/genes/hgnc:10555,,,6311.0,ATXN2,9606,Homo sapiens (human),,,,,,,,
373,428507,4548,Comparative Toxicogenomics Database (CTD),"2,6-Diamino-N-((1-(oxotridecyl)-2-piperidinyl)methyl)hexanamide",C069701,NPC 15437,https://ctdbase.org/detail.go?type=chem&acc=C069701,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,10116,Rattus norvegicus (Norway rat),NPC 15437 inhibits the reaction [capsaicin results in increased phosphorylation of CREB1 protein],,,PMID:16159392,https://www.ncbi.nlm.nih.gov/pubmed/16159392,16159392,,
374,428669,4583,Drug Gene Interaction database (DGIdb),Ofloxacin,,OFLOXACIN,https://www.dgidb.org/drugs/rxcui:7623,,G6PD,https://www.dgidb.org/genes/hgnc:4057,,,2539.0,G6PD,9606,Homo sapiens (human),,,,,,,,
375,428670,4585,DrugBank,,DB00334,Olanzapine,https://www.drugbank.ca/drugs/DB00334,BE0000451,5-hydroxytryptamine receptor 2A,https://www.drugbank.ca/bio_entities/BE0000451,P28223,5-hydroxytryptamine receptor 2A,3356.0,HTR2A,9606,Homo sapiens (human),Antagonist,,,PMID:14530903|PMID:15358979|PMID:15816787|PMID:16038601|PMID:16905159|PMID:11752352|PMID:17316700|PMID:17848919|PMID:10227113|PMID:25032030,https://www.ncbi.nlm.nih.gov/pubmed/14530903|https://www.ncbi.nlm.nih.gov/pubmed/15358979|https://www.ncbi.nlm.nih.gov/pubmed/15816787|https://www.ncbi.nlm.nih.gov/pubmed/16038601|https://www.ncbi.nlm.nih.gov/pubmed/16905159|https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/17316700|https://www.ncbi.nlm.nih.gov/pubmed/17848919|https://www.ncbi.nlm.nih.gov/pubmed/10227113|https://www.ncbi.nlm.nih.gov/pubmed/25032030,14530903|15358979|15816787|16038601|16905159|11752352|17316700|17848919|10227113|25032030,,
376,428671,4585,DrugBank,,DB00334,Olanzapine,https://www.drugbank.ca/drugs/DB00334,BE0000756,D(2) dopamine receptor,https://www.drugbank.ca/bio_entities/BE0000756,P14416,D(2) dopamine receptor,1813.0,DRD2,9606,Homo sapiens (human),Antagonist,,,PMID:11752352|PMID:16730699|PMID:14575800|PMID:17092971|PMID:17067304|PMID:16513877|PMID:17316700|PMID:17848919|PMID:25032030,https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/16730699|https://www.ncbi.nlm.nih.gov/pubmed/14575800|https://www.ncbi.nlm.nih.gov/pubmed/17092971|https://www.ncbi.nlm.nih.gov/pubmed/17067304|https://www.ncbi.nlm.nih.gov/pubmed/16513877|https://www.ncbi.nlm.nih.gov/pubmed/17316700|https://www.ncbi.nlm.nih.gov/pubmed/17848919|https://www.ncbi.nlm.nih.gov/pubmed/25032030,11752352|16730699|14575800|17092971|17067304|16513877|17316700|17848919|25032030,,
377,428672,4585,DrugBank,,DB00334,Olanzapine,https://www.drugbank.ca/drugs/DB00334,BE0000020,D(1A) dopamine receptor,https://www.drugbank.ca/bio_entities/BE0000020,P21728,D(1A) dopamine receptor,1812.0,DRD1,9606,Homo sapiens (human),Antagonist,,,PMID:11752352|PMID:17848919|PMID:10227113|PMID:25032030,https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/17848919|https://www.ncbi.nlm.nih.gov/pubmed/10227113|https://www.ncbi.nlm.nih.gov/pubmed/25032030,11752352|17848919|10227113|25032030,,
378,428820,4585,DrugBank,,DB00334,Olanzapine,https://www.drugbank.ca/drugs/DB00334,BE0000311,5-hydroxytryptamine receptor 3A,https://www.drugbank.ca/bio_entities/BE0000311,P46098,5-hydroxytryptamine receptor 3A,3359.0,HTR3A,9606,Homo sapiens (human),Antagonist,,,PMID:17848919|PMID:25032030,https://www.ncbi.nlm.nih.gov/pubmed/17848919|https://www.ncbi.nlm.nih.gov/pubmed/25032030,17848919|25032030,,
379,428821,4585,DrugBank,,DB00334,Olanzapine,https://www.drugbank.ca/drugs/DB00334,BE0000945,5-hydroxytryptamine receptor 6,https://www.drugbank.ca/bio_entities/BE0000945,P50406,5-hydroxytryptamine receptor 6,3362.0,HTR6,9606,Homo sapiens (human),Antagonist,,,PMID:17848919|PMID:25032030,https://www.ncbi.nlm.nih.gov/pubmed/17848919|https://www.ncbi.nlm.nih.gov/pubmed/25032030,17848919|25032030,,
380,428822,4585,DrugBank,,DB00334,Olanzapine,https://www.drugbank.ca/drugs/DB00334,BE0000442,Histamine H1 receptor,https://www.drugbank.ca/bio_entities/BE0000442,P35367,Histamine H1 receptor,3269.0,HRH1,9606,Homo sapiens (human),Antagonist,,,PMID:11752352|PMID:15729086|PMID:16141369|PMID:15893120|PMID:17316700|PMID:10227113|PMID:25032030,https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/15729086|https://www.ncbi.nlm.nih.gov/pubmed/16141369|https://www.ncbi.nlm.nih.gov/pubmed/15893120|https://www.ncbi.nlm.nih.gov/pubmed/17316700|https://www.ncbi.nlm.nih.gov/pubmed/10227113|https://www.ncbi.nlm.nih.gov/pubmed/25032030,11752352|15729086|16141369|15893120|17316700|10227113|25032030,,
381,428823,4585,DrugBank,,DB00334,Olanzapine,https://www.drugbank.ca/drugs/DB00334,BE0000501,Alpha-1A adrenergic receptor,https://www.drugbank.ca/bio_entities/BE0000501,P35348,Alpha-1A adrenergic receptor,148.0,ADRA1A,9606,Homo sapiens (human),Antagonist,,,PMID:17848919|PMID:10227113|PMID:25032030,https://www.ncbi.nlm.nih.gov/pubmed/17848919|https://www.ncbi.nlm.nih.gov/pubmed/10227113|https://www.ncbi.nlm.nih.gov/pubmed/25032030,17848919|10227113|25032030,,
382,428824,4585,DrugBank,,DB00334,Olanzapine,https://www.drugbank.ca/drugs/DB00334,BE0000575,Alpha-1B adrenergic receptor,https://www.drugbank.ca/bio_entities/BE0000575,P35368,Alpha-1B adrenergic receptor,147.0,ADRA1B,9606,Homo sapiens (human),Antagonist,,,PMID:11752352|PMID:17316700|PMID:17848919|PMID:10227113,https://www.ncbi.nlm.nih.gov/pubmed/11752352|https://www.ncbi.nlm.nih.gov/pubmed/17316700|https://www.ncbi.nlm.nih.gov/pubmed/17848919|https://www.ncbi.nlm.nih.gov/pubmed/10227113,11752352|17316700|17848919|10227113,,
383,428825,4585,DrugBank,,DB00334,Olanzapine,https://www.drugbank.ca/drugs/DB00334,BE0000092,Muscarinic acetylcholine receptor M1,https://www.drugbank.ca/bio_entities/BE0000092,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606,Homo sapiens (human),Antagonist,,,PMID:17316700|PMID:17848919|PMID:10227113|PMID:25032030,https://www.ncbi.nlm.nih.gov/pubmed/17316700|https://www.ncbi.nlm.nih.gov/pubmed/17848919|https://www.ncbi.nlm.nih.gov/pubmed/10227113|https://www.ncbi.nlm.nih.gov/pubmed/25032030,17316700|17848919|10227113|25032030,,
384,428826,4585,DrugBank,,DB00334,Olanzapine,https://www.drugbank.ca/drugs/DB00334,BE0000560,Muscarinic acetylcholine receptor M2,https://www.drugbank.ca/bio_entities/BE0000560,P08172,Muscarinic acetylcholine receptor M2,1129.0,CHRM2,9606,Homo sapiens (human),Antagonist,,,PMID:17848919|PMID:10227113|PMID:25032030,https://www.ncbi.nlm.nih.gov/pubmed/17848919|https://www.ncbi.nlm.nih.gov/pubmed/10227113|https://www.ncbi.nlm.nih.gov/pubmed/25032030,17848919|10227113|25032030,,
385,422988,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,10116,Rattus norvegicus (Norway rat),[phenobarbital co-treated with diethylnitrosamine] results in increased expression of GSTA2 protein,,,PMID:20935162,https://www.ncbi.nlm.nih.gov/pubmed/20935162,20935162,,
386,422989,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,10116,Rattus norvegicus (Norway rat),Phenobarbital results in decreased expression of GSTA2 mRNA,,,PMID:10476907|PMID:16940010,https://www.ncbi.nlm.nih.gov/pubmed/10476907|https://www.ncbi.nlm.nih.gov/pubmed/16940010,10476907|16940010,,
387,422990,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,10116,Rattus norvegicus (Norway rat),Phenobarbital results in increased expression of GSTA2 mRNA,,,PMID:10762607|PMID:11328961|PMID:12883083|PMID:1394205|PMID:16510358|PMID:16940010|PMID:17381134|PMID:19162173|PMID:19631232|PMID:23273579|PMID:31465819,https://www.ncbi.nlm.nih.gov/pubmed/10762607|https://www.ncbi.nlm.nih.gov/pubmed/11328961|https://www.ncbi.nlm.nih.gov/pubmed/12883083|https://www.ncbi.nlm.nih.gov/pubmed/1394205|https://www.ncbi.nlm.nih.gov/pubmed/16510358|https://www.ncbi.nlm.nih.gov/pubmed/16940010|https://www.ncbi.nlm.nih.gov/pubmed/17381134|https://www.ncbi.nlm.nih.gov/pubmed/19162173|https://www.ncbi.nlm.nih.gov/pubmed/19631232|https://www.ncbi.nlm.nih.gov/pubmed/23273579|https://www.ncbi.nlm.nih.gov/pubmed/31465819,10762607|11328961|12883083|1394205|16510358|16940010|17381134|19162173|19631232|23273579|31465819,,
388,422991,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,10116,Rattus norvegicus (Norway rat),Phenobarbital results in increased stability of GSTA2 mRNA,,,PMID:10762607,https://www.ncbi.nlm.nih.gov/pubmed/10762607,10762607,,
389,422992,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,10116,Rattus norvegicus (Norway rat),Pirinixic acid promotes the reaction [phenobarbital results in increased expression of GSTA2 mrna],,,PMID:19631232,https://www.ncbi.nlm.nih.gov/pubmed/19631232,19631232,,
390,422993,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,2940,GSTA3,https://ctdbase.org/detail.go?type=gene&acc=2940,,,2940.0,GSTA3,9615,Canis lupus familiaris (dog),Phenobarbital results in increased expression of GSTA3 protein,,,PMID:19952500,https://www.ncbi.nlm.nih.gov/pubmed/19952500,19952500,,
391,423150,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,2940,GSTA3,https://ctdbase.org/detail.go?type=gene&acc=2940,,,2940.0,GSTA3,9606,Homo sapiens (human),Phenobarbital results in decreased expression of GSTA3 mRNA,,,PMID:19084549,https://www.ncbi.nlm.nih.gov/pubmed/19084549,19084549,,
392,423151,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,2940,GSTA3,https://ctdbase.org/detail.go?type=gene&acc=2940,,,2940.0,GSTA3,10116,Rattus norvegicus (Norway rat),Phenobarbital results in increased expression of GSTA3 mRNA,,,PMID:11328961,https://www.ncbi.nlm.nih.gov/pubmed/11328961,11328961,,
393,423319,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,221357,GSTA5,https://ctdbase.org/detail.go?type=gene&acc=221357,,,221357.0,GSTA5,9606,Homo sapiens (human),Phenobarbital results in decreased expression of GSTA5 mRNA,,,PMID:19084549,https://www.ncbi.nlm.nih.gov/pubmed/19084549,19084549,,
394,423320,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,221357,GSTA5,https://ctdbase.org/detail.go?type=gene&acc=221357,,,221357.0,GSTA5,10090,Mus musculus (house mouse),Phenobarbital results in increased expression of GSTA5 mrna|[methionine co-treated with choline co-treated with folic acid co-treated with betaine co-treated with vitamin B 12 co-treated with zinc co-treated with phenobarbital] results in increased expression of GSTA5 mRNA,,,PMID:33549593,https://www.ncbi.nlm.nih.gov/pubmed/33549593,33549593,,
395,423321,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,221357,GSTA5,https://ctdbase.org/detail.go?type=gene&acc=221357,,,221357.0,GSTA5,10116,Rattus norvegicus (Norway rat),"Phenobarbital results in increased expression of and results in increased activity of GSTA5 protein|phenobarbital promotes the reaction [GSTA5 protein affects the metabolism of aflatoxin B1-2,3-oxide]",,,PMID:8198522,https://www.ncbi.nlm.nih.gov/pubmed/8198522,8198522,,
396,423322,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,221357,GSTA5,https://ctdbase.org/detail.go?type=gene&acc=221357,,,221357.0,GSTA5,10116,Rattus norvegicus (Norway rat),Phenobarbital results in increased expression of GSTA5 protein,,,PMID:24090815,https://www.ncbi.nlm.nih.gov/pubmed/24090815,24090815,,
397,423323,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,79807,GSTCD,https://ctdbase.org/detail.go?type=gene&acc=79807,,,79807.0,GSTCD,10090,Mus musculus (house mouse),Phenobarbital affects the expression of GSTCD mRNA,,,PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/23091169,23091169,,
398,425012,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,2966,GTF2H2,https://ctdbase.org/detail.go?type=gene&acc=2966,,,2966.0,GTF2H2,10090,Mus musculus (house mouse),Phenobarbital results in increased expression of GTF2H2 mRNA,,,PMID:19270015,https://www.ncbi.nlm.nih.gov/pubmed/19270015,19270015,,
399,425013,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,9569,GTF2IRD1,https://ctdbase.org/detail.go?type=gene&acc=9569,,,9569.0,GTF2IRD1,10116,Rattus norvegicus (Norway rat),Phenobarbital results in increased expression of GTF2IRD1 mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
400,426087,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,54363,HAO1,https://ctdbase.org/detail.go?type=gene&acc=54363,,,54363.0,HAO1,10090,Mus musculus (house mouse),NR1I3 protein affects the reaction [phenobarbital results in decreased expression of HAO1 mrna]|phenobarbital results in decreased expression of HAO1 mRNA,,,PMID:19482888,https://www.ncbi.nlm.nih.gov/pubmed/19482888,19482888,,
401,426088,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,51179,HAO2,https://ctdbase.org/detail.go?type=gene&acc=51179,,,51179.0,HAO2,10090,Mus musculus (house mouse),NR1I3 protein affects the reaction [phenobarbital results in increased expression of HAO2 mrna],,,PMID:19482888,https://www.ncbi.nlm.nih.gov/pubmed/19482888,19482888,,
402,426089,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,51179,HAO2,https://ctdbase.org/detail.go?type=gene&acc=51179,,,51179.0,HAO2,10090,Mus musculus (house mouse),Phenobarbital affects the expression of HAO2 mRNA,,,PMID:23091169,https://www.ncbi.nlm.nih.gov/pubmed/23091169,23091169,,
403,426090,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,51179,HAO2,https://ctdbase.org/detail.go?type=gene&acc=51179,,,51179.0,HAO2,10090,Mus musculus (house mouse),Phenobarbital results in increased expression of HAO2 mRNA,,,PMID:19270015|PMID:19482888,https://www.ncbi.nlm.nih.gov/pubmed/19270015|https://www.ncbi.nlm.nih.gov/pubmed/19482888,19270015|19482888,,
404,426091,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,51179,HAO2,https://ctdbase.org/detail.go?type=gene&acc=51179,,,51179.0,HAO2,10116,Rattus norvegicus (Norway rat),Phenobarbital results in decreased expression of HAO2 mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
405,426092,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,8520,HAT1,https://ctdbase.org/detail.go?type=gene&acc=8520,,,8520.0,HAT1,9606,Homo sapiens (human),Phenobarbital affects the expression of HAT1 mRNA,,,PMID:19159669,https://www.ncbi.nlm.nih.gov/pubmed/19159669,19159669,,
406,427836,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,3242,HPD,https://ctdbase.org/detail.go?type=gene&acc=3242,,,3242.0,HPD,10116,Rattus norvegicus (Norway rat),Phenobarbital results in increased expression of HPD mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
407,497671,4763,Comparative Toxicogenomics Database (CTD),Phenobarbital,D010634,Phenobarbital,https://ctdbase.org/detail.go?type=chem&acc=D010634,169200,TMEM64,https://ctdbase.org/detail.go?type=gene&acc=169200,,,169200.0,TMEM64,10090,Mus musculus (house mouse),Phenobarbital results in increased expression of TMEM64 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
408,534943,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,27146,FAM184B,https://ctdbase.org/detail.go?type=gene&acc=27146,,,27146.0,FAM184B,7955,Danio rerio (zebrafish),Phosphinothricin results in decreased expression of FAM184B mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
409,534944,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,100333552,FAM196A,https://ctdbase.org/detail.go?type=gene&acc=100333552,,,100333552.0,fam196a,7955,Danio rerio (zebrafish),Phosphinothricin results in decreased expression of FAM196A mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
410,535877,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,26354,GNL3,https://ctdbase.org/detail.go?type=gene&acc=26354,,,26354.0,GNL3,7955,Danio rerio (zebrafish),Phosphinothricin results in increased expression of GNL3 mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
411,535878,4794,Comparative Toxicogenomics Database (CTD),Glufosinate,C003121,phosphinothricin,https://ctdbase.org/detail.go?type=chem&acc=C003121,54552,GNL3L,https://ctdbase.org/detail.go?type=gene&acc=54552,,,54552.0,GNL3L,7955,Danio rerio (zebrafish),Phosphinothricin results in increased expression of GNL3L mRNA,,,PMID:31545209,https://www.ncbi.nlm.nih.gov/pubmed/31545209,31545209,,
412,591906,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,9606,Homo sapiens (human),[metformin co-treated with pioglitazone] results in decreased expression of IGF1 mrna|pioglitazone results in decreased expression of IGF1 mRNA,,,PMID:32589349,https://www.ncbi.nlm.nih.gov/pubmed/32589349,32589349,,
413,591907,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,285313,IGSF10,https://ctdbase.org/detail.go?type=gene&acc=285313,,,285313.0,IGSF10,10090,Mus musculus (house mouse),[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of IGSF10 mRNA,,,PMID:27935865,https://www.ncbi.nlm.nih.gov/pubmed/27935865,27935865,,
414,591908,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551.0,IKBKB,9606,Homo sapiens (human),Pioglitazone results in decreased expression of IKBKB mRNA,,,PMID:32589349,https://www.ncbi.nlm.nih.gov/pubmed/32589349,32589349,,
415,591909,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,10090,Mus musculus (house mouse),Pioglitazone results in increased expression of IL10 protein,,,PMID:27918843,https://www.ncbi.nlm.nih.gov/pubmed/27918843,27918843,,
416,591910,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,3586,IL10,https://ctdbase.org/detail.go?type=gene&acc=3586,,,3586.0,IL10,10116,Rattus norvegicus (Norway rat),Pioglitazone inhibits the reaction [propionic acid results in decreased expression of IL10 protein],,,PMID:31348919,https://www.ncbi.nlm.nih.gov/pubmed/31348919,31348919,,
417,591911,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,3596,IL13,https://ctdbase.org/detail.go?type=gene&acc=3596,,,3596.0,IL13,10090,Mus musculus (house mouse),"Pioglitazone inhibits the reaction [toluene 2,4-diisocyanate results in increased expression of IL13 protein]",,,PMID:17015710,https://www.ncbi.nlm.nih.gov/pubmed/17015710,17015710,,
418,591912,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,3606,IL18,https://ctdbase.org/detail.go?type=gene&acc=3606,,,3606.0,IL18,10116,Rattus norvegicus (Norway rat),Pioglitazone inhibits the reaction [aldosterone results in increased expression of IL18 mrna]|pioglitazone inhibits the reaction [AGT protein alternative form results in increased expression of IL18 mrna]|pioglitazone inhibits the reaction [EDN1 protein results in increased expression of IL18 mrna],,,PMID:18660453,https://www.ncbi.nlm.nih.gov/pubmed/18660453,18660453,,
419,591913,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,9606,Homo sapiens (human),Pioglitazone results in increased expression of IL1A mRNA,,,PMID:32816093,https://www.ncbi.nlm.nih.gov/pubmed/32816093,32816093,,
420,591914,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9606,Homo sapiens (human),Pioglitazone affects the susceptibility to INS protein,,,PMID:20415685,https://www.ncbi.nlm.nih.gov/pubmed/20415685,20415685,,
421,596368,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,100136658,PPARB,https://ctdbase.org/detail.go?type=gene&acc=100136658,,,100136658.0,,9606,Homo sapiens (human),Pioglitazone binds to PPARB protein,,,PMID:23843199,https://www.ncbi.nlm.nih.gov/pubmed/23843199,23843199,,
422,596369,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,5467,PPARD,https://ctdbase.org/detail.go?type=gene&acc=5467,,,5467.0,PPARD,9606,Homo sapiens (human),Pioglitazone binds to PPARD protein|pioglitazone results in increased activity of [PPARD protein binds to RXRA protein],,,PMID:11779144,https://www.ncbi.nlm.nih.gov/pubmed/11779144,11779144,,
423,596370,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,5467,PPARD,https://ctdbase.org/detail.go?type=gene&acc=5467,,,5467.0,PPARD,9606,Homo sapiens (human),Pioglitazone results in increased activity of PPARD protein,,,PMID:23150725,https://www.ncbi.nlm.nih.gov/pubmed/23150725,23150725,,
424,596371,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,5155,PDGFB,https://ctdbase.org/detail.go?type=gene&acc=5155,,,5155.0,PDGFB,9606,Homo sapiens (human),Pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased degradation of CDKN1B protein]|prkaa1 protein affects the reaction [pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of RPS6 protein]]|pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of CCND1 protein]|[pdgfb protein binds to PDGFB protein] inhibits the reaction [pioglitazone results in decreased phosphorylation of MAPK1 protein]|pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of RPS6 protein]|pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of RPS6KB1 protein]|pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of CDKN1A protein]|[pdgfb protein binds to PDGFB protein] inhibits the reaction [pioglitazone results in decreased phosphorylation of MAPK3 protein]|pioglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of EIF4EBP1 protein],,,PMID:26643070,https://www.ncbi.nlm.nih.gov/pubmed/26643070,26643070,,
425,596372,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,5156,PDGFRA,https://ctdbase.org/detail.go?type=gene&acc=5156,,,5156.0,PDGFRA,10090,Mus musculus (house mouse),[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PDGFRA mRNA,,,PMID:27935865,https://www.ncbi.nlm.nih.gov/pubmed/27935865,27935865,,
426,596373,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,5166,PDK4,https://ctdbase.org/detail.go?type=gene&acc=5166,,,5166.0,PDK4,9606,Homo sapiens (human),Pioglitazone results in increased expression of PDK4 mRNA,,,PMID:30031879,https://www.ncbi.nlm.nih.gov/pubmed/30031879,30031879,,
427,596374,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,23089,PEG10,https://ctdbase.org/detail.go?type=gene&acc=23089,,,23089.0,PEG10,9606,Homo sapiens (human),Pioglitazone results in increased expression of PEG10 mRNA,,,PMID:30031879,https://www.ncbi.nlm.nih.gov/pubmed/30031879,30031879,,
428,596375,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,84808,PERM1,https://ctdbase.org/detail.go?type=gene&acc=84808,,,84808.0,PERM1,10090,Mus musculus (house mouse),[N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PERM1 mRNA,,,PMID:27935865,https://www.ncbi.nlm.nih.gov/pubmed/27935865,27935865,,
429,597488,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606,Homo sapiens (human),Pioglitazone promotes the reaction [PPARG protein results in increased expression of PCSK9 mrna],,,PMID:22593575,https://www.ncbi.nlm.nih.gov/pubmed/22593575,22593575,,
430,597489,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606,Homo sapiens (human),Pioglitazone results in increased activity of PPARG protein,,,PMID:15273253|PMID:16324916|PMID:17030193|PMID:17290005|PMID:21597168|PMID:23150725,https://www.ncbi.nlm.nih.gov/pubmed/15273253|https://www.ncbi.nlm.nih.gov/pubmed/16324916|https://www.ncbi.nlm.nih.gov/pubmed/17030193|https://www.ncbi.nlm.nih.gov/pubmed/17290005|https://www.ncbi.nlm.nih.gov/pubmed/21597168|https://www.ncbi.nlm.nih.gov/pubmed/23150725,15273253|16324916|17030193|17290005|21597168|23150725,,
431,597490,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606,Homo sapiens (human),Pioglitazone results in increased activity of [PPARG protein alternative form binds to RXRA protein],,,PMID:11779144,https://www.ncbi.nlm.nih.gov/pubmed/11779144,11779144,,
432,597491,4829,Comparative Toxicogenomics Database (CTD),Pioglitazone,D000077205,Pioglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077205,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,9606,Homo sapiens (human),Pioglitazone results in increased expression of PPARG mRNA,,,PMID:11172467|PMID:19201410|PMID:21354099|PMID:32473317,https://www.ncbi.nlm.nih.gov/pubmed/11172467|https://www.ncbi.nlm.nih.gov/pubmed/19201410|https://www.ncbi.nlm.nih.gov/pubmed/21354099|https://www.ncbi.nlm.nih.gov/pubmed/32473317,11172467|19201410|21354099|32473317,,
433,604151,4943,Toxin and Toxin Target Database (T3DB),Propofol,T3D2900,Propofol,http://www.t3db.ca/toxins/T3D2900,BE0004797,GABA-A receptor (anion channel),http://www.t3db.ca/biodb/bio_entities/BE0004797,O00591,Gamma-aminobutyric acid receptor subunit pi,2568.0,GABRP,9606,Homo sapiens (human),,,,,,,,
434,604152,4943,Toxin and Toxin Target Database (T3DB),Propofol,T3D2900,Propofol,http://www.t3db.ca/toxins/T3D2900,BE0004797,GABA-A receptor (anion channel),http://www.t3db.ca/biodb/bio_entities/BE0004797,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,55879.0,GABRQ,9606,Homo sapiens (human),,,,,,,,
435,604630,4944,Toxin and Toxin Target Database (T3DB),Propoxur,T3D1003,Propoxur,http://www.t3db.ca/toxins/T3D1003,BE0005464,C-X-C motif chemokine 9,http://www.t3db.ca/biodb/bio_entities/BE0005464,Q07325,C-X-C motif chemokine 9,4283.0,CXCL9,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
436,604631,4944,Toxin and Toxin Target Database (T3DB),Propoxur,T3D1003,Propoxur,http://www.t3db.ca/toxins/T3D1003,BE0001085,Intercellular adhesion molecule 1,http://www.t3db.ca/biodb/bio_entities/BE0001085,P05362,Intercellular adhesion molecule 1,3383.0,ICAM1,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
437,604632,4944,Toxin and Toxin Target Database (T3DB),Propoxur,T3D1003,Propoxur,http://www.t3db.ca/toxins/T3D1003,BE0004734,Interleukin-1 alpha,http://www.t3db.ca/biodb/bio_entities/BE0004734,P01583,Interleukin-1 alpha,3552.0,IL1A,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
438,607892,5092,IUPHAR/BPS Guide to PHARMACOLOGY,Rolipram,5260,rolipram,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5260,1300,phosphodiesterase 4A,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=1300,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606,Homo sapiens (human),Inhibition,pIC50,9,PMID:9177268,https://www.ncbi.nlm.nih.gov/pubmed/9177268,9177268,,
439,608592,5104,Comparative Toxicogenomics Database (CTD),Roxarsone,D012406,Roxarsone,https://ctdbase.org/detail.go?type=chem&acc=D012406,3082,HGF,https://ctdbase.org/detail.go?type=gene&acc=3082,,,3082.0,HGF,9606,Homo sapiens (human),Roxarsone results in increased expression of HGF mRNA,,,PMID:18414637,https://www.ncbi.nlm.nih.gov/pubmed/18414637,18414637,,
440,608593,5104,Comparative Toxicogenomics Database (CTD),Roxarsone,D012406,Roxarsone,https://ctdbase.org/detail.go?type=chem&acc=D012406,3184,HNRNPD,https://ctdbase.org/detail.go?type=gene&acc=3184,,,3184.0,HNRNPD,9031,Gallus gallus (chicken),Roxarsone results in decreased expression of HNRNPD protein,,,PMID:21652273,https://www.ncbi.nlm.nih.gov/pubmed/21652273,21652273,,
441,608594,5104,Comparative Toxicogenomics Database (CTD),Roxarsone,D012406,Roxarsone,https://ctdbase.org/detail.go?type=chem&acc=D012406,394142,HPDA,https://ctdbase.org/detail.go?type=gene&acc=394142,,,394142.0,hpda,7957,Carassius auratus (goldfish),Roxarsone results in increased expression of HPDA protein,,,PMID:30005308,https://www.ncbi.nlm.nih.gov/pubmed/30005308,30005308,,
442,608595,5104,Comparative Toxicogenomics Database (CTD),Roxarsone,D012406,Roxarsone,https://ctdbase.org/detail.go?type=chem&acc=D012406,84842,HPDL,https://ctdbase.org/detail.go?type=gene&acc=84842,,,84842.0,HPDL,7957,Carassius auratus (goldfish),Roxarsone results in increased expression of HPDL protein,,,PMID:30005308,https://www.ncbi.nlm.nih.gov/pubmed/30005308,30005308,,
443,608596,5104,Comparative Toxicogenomics Database (CTD),Roxarsone,D012406,Roxarsone,https://ctdbase.org/detail.go?type=chem&acc=D012406,692591,HSP20.4,https://ctdbase.org/detail.go?type=gene&acc=692591,,,692591.0,,6396,Eisenia fetida (common brandling worm),Roxarsone results in increased expression of HSP20.4 protein,,,PMID:25903172,https://www.ncbi.nlm.nih.gov/pubmed/25903172,25903172,,
444,608597,5104,Comparative Toxicogenomics Database (CTD),Roxarsone,D012406,Roxarsone,https://ctdbase.org/detail.go?type=chem&acc=D012406,107577,INF1,https://ctdbase.org/detail.go?type=gene&acc=107577,,,107577.0,Inf1,9606,Homo sapiens (human),Roxarsone results in decreased expression of INF1 mRNA,,,PMID:18414637,https://www.ncbi.nlm.nih.gov/pubmed/18414637,18414637,,
445,608598,5104,Comparative Toxicogenomics Database (CTD),Roxarsone,D012406,Roxarsone,https://ctdbase.org/detail.go?type=chem&acc=D012406,55705,IPO9,https://ctdbase.org/detail.go?type=gene&acc=55705,,,55705.0,IPO9,9031,Gallus gallus (chicken),Roxarsone results in decreased expression of IPO9 mRNA,,,PMID:23155029,https://www.ncbi.nlm.nih.gov/pubmed/23155029,23155029,,
446,421092,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,1495,CTNNA1,https://ctdbase.org/detail.go?type=gene&acc=1495,,,1495.0,CTNNA1,9606,Homo sapiens (human),[decitabine co-treated with vorinostat] affects the expression of CTNNA1 mRNA,,,PMID:17330099,https://www.ncbi.nlm.nih.gov/pubmed/17330099,17330099,,
447,423478,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,80824,DUSP16,https://ctdbase.org/detail.go?type=gene&acc=80824,,,80824.0,DUSP16,9606,Homo sapiens (human),Vorinostat results in increased expression of DUSP16 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
448,423479,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,1846,DUSP4,https://ctdbase.org/detail.go?type=gene&acc=1846,,,1846.0,DUSP4,9606,Homo sapiens (human),Vorinostat results in decreased expression of DUSP4 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
449,423480,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,574029,DUSP5P1,https://ctdbase.org/detail.go?type=gene&acc=574029,,,574029.0,DUSP5P1,9606,Homo sapiens (human),Vorinostat results in increased expression of DUSP5P1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
450,423481,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,1778,DYNC1H1,https://ctdbase.org/detail.go?type=gene&acc=1778,,,1778.0,DYNC1H1,9606,Homo sapiens (human),Vorinostat results in decreased expression of DYNC1H1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
451,423482,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,79659,DYNC2H1,https://ctdbase.org/detail.go?type=gene&acc=79659,,,79659.0,DYNC2H1,9606,Homo sapiens (human),Vorinostat results in increased expression of DYNC2H1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
452,423483,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,8444,DYRK3,https://ctdbase.org/detail.go?type=gene&acc=8444,,,8444.0,DYRK3,9606,Homo sapiens (human),Vorinostat results in increased expression of DYRK3 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
453,533950,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,10927,SPIN1,https://ctdbase.org/detail.go?type=gene&acc=10927,,,10927.0,SPIN1,9606,Homo sapiens (human),Vorinostat results in decreased expression of SPIN1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
454,533951,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,143379,SPMIP5,https://ctdbase.org/detail.go?type=gene&acc=143379,,,143379.0,SPMIP5,9606,Homo sapiens (human),"[NOG protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPMIP5 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
455,533952,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9606,Homo sapiens (human),Vorinostat results in increased expression of SPP1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
456,533953,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,10252,SPRY1,https://ctdbase.org/detail.go?type=gene&acc=10252,,,10252.0,SPRY1,9606,Homo sapiens (human),"[NOG protein co-treated with vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SPRY1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
457,533954,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,10252,SPRY1,https://ctdbase.org/detail.go?type=gene&acc=10252,,,10252.0,SPRY1,9606,Homo sapiens (human),Vorinostat results in decreased expression of SPRY1 mRNA,,,PMID:26272509|PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386,26272509|27188386,,
458,533955,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,10253,SPRY2,https://ctdbase.org/detail.go?type=gene&acc=10253,,,10253.0,SPRY2,9606,Homo sapiens (human),Vorinostat results in decreased expression of SPRY2 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
459,533956,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6711,SPTBN1,https://ctdbase.org/detail.go?type=gene&acc=6711,,,6711.0,SPTBN1,9606,Homo sapiens (human),Vorinostat results in decreased expression of SPTBN1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
460,535235,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6812,STXBP1,https://ctdbase.org/detail.go?type=gene&acc=6812,,,6812.0,STXBP1,9606,Homo sapiens (human),Vorinostat results in decreased expression of STXBP1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
461,535236,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,9515,STXBP5L,https://ctdbase.org/detail.go?type=gene&acc=9515,,,9515.0,STXBP5L,9606,Homo sapiens (human),Vorinostat results in increased expression of STXBP5L mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
462,535237,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,6815,STYX,https://ctdbase.org/detail.go?type=gene&acc=6815,,,6815.0,STYX,9606,Homo sapiens (human),Vorinostat results in decreased expression of STYX mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
463,535238,5311,Comparative Toxicogenomics Database (CTD),Vorinostat,D000077337,Vorinostat,https://ctdbase.org/detail.go?type=chem&acc=D000077337,10923,SUB1,https://ctdbase.org/detail.go?type=gene&acc=10923,,,10923.0,SUB1,9606,Homo sapiens (human),Vorinostat results in increased expression of SUB1 mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
464,422832,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,55186,SLC25A36,https://ctdbase.org/detail.go?type=gene&acc=55186,,,55186.0,SLC25A36,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of SLC25A36 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
465,422833,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,364991,SLC25A36L1,https://ctdbase.org/detail.go?type=gene&acc=364991,,,364991.0,Slc25a36l1,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of SLC25A36L1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
466,422834,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,54977,SLC25A38,https://ctdbase.org/detail.go?type=gene&acc=54977,,,54977.0,SLC25A38,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of SLC25A38 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
467,422835,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,293,SLC25A6,https://ctdbase.org/detail.go?type=gene&acc=293,,,293.0,SLC25A6,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in increased expression of SLC25A6 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
468,422836,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,11001,SLC27A2,https://ctdbase.org/detail.go?type=gene&acc=11001,,,11001.0,SLC27A2,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of SLC27A2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
469,422837,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,2030,SLC29A1,https://ctdbase.org/detail.go?type=gene&acc=2030,,,2030.0,SLC29A1,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in increased expression of SLC29A1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
470,422838,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,10090,Mus musculus (house mouse),Sulfadimethoxine results in increased expression of SLC2A1 mRNA,,,PMID:19000923,https://www.ncbi.nlm.nih.gov/pubmed/19000923,19000923,,
471,423950,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,440087,SMCO3,https://ctdbase.org/detail.go?type=gene&acc=440087,,,440087.0,SMCO3,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of SMCO3 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
472,423951,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,56935,SMCO4,https://ctdbase.org/detail.go?type=gene&acc=56935,,,56935.0,SMCO4,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in increased expression of SMCO4 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
473,423952,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,91689,SMDT1,https://ctdbase.org/detail.go?type=gene&acc=91689,,,91689.0,SMDT1,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in increased expression of SMDT1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
474,426763,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,6897,TARS1,https://ctdbase.org/detail.go?type=gene&acc=6897,,,6897.0,TARS1,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in increased expression of TARS1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
475,426764,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,80835,TAS1R1,https://ctdbase.org/detail.go?type=gene&acc=80835,,,80835.0,TAS1R1,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in increased expression of TAS1R1 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
476,426765,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,387348,TAS2R120,https://ctdbase.org/detail.go?type=gene&acc=387348,,,387348.0,Tas2r120,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of TAS2R120 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
477,426766,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,387354,TAS2R129,https://ctdbase.org/detail.go?type=gene&acc=387354,,,387354.0,Tas2r129,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of TAS2R129 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
478,426767,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,128387,TATDN3,https://ctdbase.org/detail.go?type=gene&acc=128387,,,128387.0,TATDN3,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of TATDN3 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
479,426768,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,30851,TAX1BP3,https://ctdbase.org/detail.go?type=gene&acc=30851,,,30851.0,TAX1BP3,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in increased expression of TAX1BP3 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
480,426769,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,36405,TAZ,https://ctdbase.org/detail.go?type=gene&acc=36405,,,36405.0,Taz,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in increased expression of TAZ mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
481,426770,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,79735,TBC1D17,https://ctdbase.org/detail.go?type=gene&acc=79735,,,79735.0,TBC1D17,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of TBC1D17 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
482,427527,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,7021,TFAP2B,https://ctdbase.org/detail.go?type=gene&acc=7021,,,7021.0,TFAP2B,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of TFAP2B mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
483,427528,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,7023,TFAP4,https://ctdbase.org/detail.go?type=gene&acc=7023,,,7023.0,TFAP4,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of TFAP4 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
484,427529,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,51106,TFB1M,https://ctdbase.org/detail.go?type=gene&acc=51106,,,51106.0,TFB1M,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in increased expression of TFB1M mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
485,427530,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,7024,TFCP2,https://ctdbase.org/detail.go?type=gene&acc=7024,,,7024.0,TFCP2,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in decreased expression of TFCP2 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
486,497670,5323,Comparative Toxicogenomics Database (CTD),Sulfadimethoxine,D013412,Sulfadimethoxine,https://ctdbase.org/detail.go?type=chem&acc=D013412,10524,KAT5,https://ctdbase.org/detail.go?type=gene&acc=10524,,,10524.0,KAT5,10116,Rattus norvegicus (Norway rat),Sulfadimethoxine results in increased expression of KAT5 mRNA,,,PMID:30047161,https://www.ncbi.nlm.nih.gov/pubmed/30047161,30047161,,
487,590509,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of PCNA mRNA",,,PMID:22698814|PMID:28903501|PMID:31170421,https://www.ncbi.nlm.nih.gov/pubmed/22698814|https://www.ncbi.nlm.nih.gov/pubmed/28903501|https://www.ncbi.nlm.nih.gov/pubmed/31170421,22698814|28903501|31170421,,
488,590510,5382,Comparative Toxicogenomics Database (CTD),Tcpobop,C028474,"1,4-bis(2-(3,5-dichloropyridyloxy))benzene",https://ctdbase.org/detail.go?type=chem&acc=C028474,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10090,Mus musculus (house mouse),"1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of PCNA protein",,,PMID:21391223|PMID:21705713|PMID:31170421,https://www.ncbi.nlm.nih.gov/pubmed/21391223|https://www.ncbi.nlm.nih.gov/pubmed/21705713|https://www.ncbi.nlm.nih.gov/pubmed/31170421,21391223|21705713|31170421,,
489,533805,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,85236,H2BC12,https://ctdbase.org/detail.go?type=gene&acc=85236,,,85236.0,H2BC12,10090,Mus musculus (house mouse),Thalidomide results in decreased expression of H2BC12 mRNA,,,PMID:26217789,https://www.ncbi.nlm.nih.gov/pubmed/26217789,26217789,,
490,535085,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10090,Mus musculus (house mouse),Thalidomide inhibits the reaction [paraquat results in increased expression of IL6 mrna],,,PMID:23510834,https://www.ncbi.nlm.nih.gov/pubmed/23510834,23510834,,
491,535086,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Thalidomide inhibits the reaction [irinotecan results in increased expression of IL6 protein],,,PMID:16815871,https://www.ncbi.nlm.nih.gov/pubmed/16815871,16815871,,
492,535087,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,10116,Rattus norvegicus (Norway rat),Thalidomide inhibits the reaction [paraquat results in increased expression of IL6 protein]|thalidomide inhibits the reaction [paraquat results in increased expression of IL6 mrna],,,PMID:26221080,https://www.ncbi.nlm.nih.gov/pubmed/26221080,26221080,,
493,535088,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),Thalidomide results in decreased expression of IL6,,,PMID:17013434,https://www.ncbi.nlm.nih.gov/pubmed/17013434,17013434,,
494,535089,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,3572,IL6ST,https://ctdbase.org/detail.go?type=gene&acc=3572,,,3572.0,IL6ST,9606,Homo sapiens (human),Thalidomide results in decreased expression of IL6ST mRNA,,,PMID:15618473,https://www.ncbi.nlm.nih.gov/pubmed/15618473,15618473,,
495,535090,5426,Comparative Toxicogenomics Database (CTD),Thalidomide,D013792,Thalidomide,https://ctdbase.org/detail.go?type=chem&acc=D013792,54556,ING3,https://ctdbase.org/detail.go?type=gene&acc=54556,,,54556.0,ING3,9606,Homo sapiens (human),Thalidomide analog results in increased expression of ING3 mRNA,,,PMID:20525221,https://www.ncbi.nlm.nih.gov/pubmed/20525221,20525221,,
496,598805,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,286343,LURAP1L,https://ctdbase.org/detail.go?type=gene&acc=286343,,,286343.0,LURAP1L,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased methylation of LURAP1L gene,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
497,598806,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,9261,MAPKAPK2,https://ctdbase.org/detail.go?type=gene&acc=9261,,,9261.0,MAPKAPK2,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of MAPKAPK2 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
498,598807,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,9665,MARF1,https://ctdbase.org/detail.go?type=gene&acc=9665,,,9665.0,MARF1,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased expression of MARF1 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
499,598808,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,116931,MED12L,https://ctdbase.org/detail.go?type=gene&acc=116931,,,116931.0,MED12L,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased expression of MED12L mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
500,598809,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,57721,METTL14,https://ctdbase.org/detail.go?type=gene&acc=57721,,,57721.0,METTL14,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased expression of METTL14 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
501,598810,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,366792,METTL7B,https://ctdbase.org/detail.go?type=gene&acc=366792,,,366792.0,Mettl7b,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of METTL7B mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
502,598811,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,8076,MFAP5,https://ctdbase.org/detail.go?type=gene&acc=8076,,,8076.0,MFAP5,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased methylation of MFAP5 gene,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
503,598812,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,4282,MIF,https://ctdbase.org/detail.go?type=gene&acc=4282,,,4282.0,MIF,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of MIF mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
504,598813,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,406906,MIR122,https://ctdbase.org/detail.go?type=gene&acc=406906,,,406906.0,MIR122,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of MIR122 mRNA,,,PMID:34626815,https://www.ncbi.nlm.nih.gov/pubmed/34626815,34626815,,
505,599714,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,26873,OPLAH,https://ctdbase.org/detail.go?type=gene&acc=26873,,,26873.0,OPLAH,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of OPLAH mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
506,599715,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,93129,ORAI3,https://ctdbase.org/detail.go?type=gene&acc=93129,,,93129.0,ORAI3,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased methylation of ORAI3 gene,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
507,599716,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,5019,OXCT1,https://ctdbase.org/detail.go?type=gene&acc=5019,,,5019.0,OXCT1,10116,Rattus norvegicus (Norway rat),Thiabendazole affects the expression of OXCT1 mRNA,,,PMID:18539377,https://www.ncbi.nlm.nih.gov/pubmed/18539377,18539377,,
508,599717,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,116224,PABIR1,https://ctdbase.org/detail.go?type=gene&acc=116224,,,116224.0,PABIR1,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased methylation of PABIR1 gene,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
509,599718,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,55010,PARPBP,https://ctdbase.org/detail.go?type=gene&acc=55010,,,55010.0,PARPBP,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased methylation of PARPBP gene,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
510,599719,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,390,RND3,https://ctdbase.org/detail.go?type=gene&acc=390,,,390.0,RND3,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased methylation of RND3 gene|[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased expression of RND3 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
511,599720,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,6097,RORC,https://ctdbase.org/detail.go?type=gene&acc=6097,,,6097.0,RORC,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of RORC mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
512,600402,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,4092,SMAD7,https://ctdbase.org/detail.go?type=gene&acc=4092,,,4092.0,SMAD7,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased expression of SMAD7 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
513,600403,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,23676,SMPX,https://ctdbase.org/detail.go?type=gene&acc=23676,,,23676.0,SMPX,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased methylation of SMPX gene,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
514,600404,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,23020,SNRNP200,https://ctdbase.org/detail.go?type=gene&acc=23020,,,23020.0,SNRNP200,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of SNRNP200 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
515,600405,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,8723,SNX4,https://ctdbase.org/detail.go?type=gene&acc=8723,,,8723.0,SNX4,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased expression of SNX4 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
516,600892,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,9524,TECR,https://ctdbase.org/detail.go?type=gene&acc=9524,,,9524.0,TECR,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of TECR mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
517,600893,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,23483,TGDS,https://ctdbase.org/detail.go?type=gene&acc=23483,,,23483.0,TGDS,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased expression of TGDS mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
518,600894,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,7045,TGFBI,https://ctdbase.org/detail.go?type=gene&acc=7045,,,7045.0,TGFBI,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of TGFBI mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
519,600895,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,93643,TJAP1,https://ctdbase.org/detail.go?type=gene&acc=93643,,,93643.0,TJAP1,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased expression of TJAP1 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
520,600896,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,7086,TKT,https://ctdbase.org/detail.go?type=gene&acc=7086,,,7086.0,TKT,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of TKT mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
521,600897,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,7009,TMBIM6,https://ctdbase.org/detail.go?type=gene&acc=7009,,,7009.0,TMBIM6,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of TMBIM6 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
522,600898,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,203197,TMEM268,https://ctdbase.org/detail.go?type=gene&acc=203197,,,203197.0,TMEM268,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased expression of TMEM268 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
523,600899,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,7127,TNFAIP2,https://ctdbase.org/detail.go?type=gene&acc=7127,,,7127.0,TNFAIP2,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased expression of TNFAIP2 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
524,605279,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,311,ANXA11,https://ctdbase.org/detail.go?type=gene&acc=311,,,311.0,ANXA11,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in decreased expression of ANXA11 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
525,606291,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,8727,CTNNAL1,https://ctdbase.org/detail.go?type=gene&acc=8727,,,8727.0,CTNNAL1,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased expression of CTNNAL1 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
526,606292,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,23316,CUX2,https://ctdbase.org/detail.go?type=gene&acc=23316,,,23316.0,CUX2,10116,Rattus norvegicus (Norway rat),[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with thiabendazole] results in increased expression of CUX2 mRNA,,,PMID:33854195,https://www.ncbi.nlm.nih.gov/pubmed/33854195,33854195,,
527,606293,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9031,Gallus gallus (chicken),Thiabendazole results in increased expression of CYP1A1 protein|thiabendazole results in increased expression of CYP1A1 mRNA,,,PMID:16714371,https://www.ncbi.nlm.nih.gov/pubmed/16714371,16714371,,
528,606294,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,9606,Homo sapiens (human),Thiabendazole results in increased expression of CYP1A1 mRNA,,,PMID:11226373|PMID:8900397,https://www.ncbi.nlm.nih.gov/pubmed/11226373|https://www.ncbi.nlm.nih.gov/pubmed/8900397,11226373|8900397,,
529,606295,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10116,Rattus norvegicus (Norway rat),Herbimycin inhibits the reaction [thiabendazole results in increased activity of CYP1A1 protein]|herbimycin inhibits the reaction [thiabendazole results in increased expression of CYP1A1 protein]|thiabendazole results in increased activity of CYP1A1 protein|herbimycin inhibits the reaction [thiabendazole results in increased expression of CYP1A1 mrna],,,PMID:14987951,https://www.ncbi.nlm.nih.gov/pubmed/14987951,14987951,,
530,606296,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10116,Rattus norvegicus (Norway rat),Thiabendazole results in increased expression of CYP1A1 mRNA,,,PMID:14987951|PMID:15110098,https://www.ncbi.nlm.nih.gov/pubmed/14987951|https://www.ncbi.nlm.nih.gov/pubmed/15110098,14987951|15110098,,
531,606297,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,10116,Rattus norvegicus (Norway rat),Thiabendazole results in increased expression of CYP1A1 protein,,,PMID:10103034|PMID:14987951,https://www.ncbi.nlm.nih.gov/pubmed/10103034|https://www.ncbi.nlm.nih.gov/pubmed/14987951,10103034|14987951,,
532,606298,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606,Homo sapiens (human),CYP1A2 protein affects the metabolism of thiabendazole|beta-naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of thiabendazole],,,PMID:10936227,https://www.ncbi.nlm.nih.gov/pubmed/10936227,10936227,,
533,606299,5430,Comparative Toxicogenomics Database (CTD),Thiabendazole,D013827,Thiabendazole,https://ctdbase.org/detail.go?type=chem&acc=D013827,1544,CYP1A2,https://ctdbase.org/detail.go?type=gene&acc=1544,,,1544.0,CYP1A2,9606,Homo sapiens (human),CYP1A2 protein affects the metabolism of thiabendazole,,,PMID:10936227|PMID:12920490,https://www.ncbi.nlm.nih.gov/pubmed/10936227|https://www.ncbi.nlm.nih.gov/pubmed/12920490,10936227|12920490,,
534,534634,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,6913,TBX15,https://ctdbase.org/detail.go?type=gene&acc=6913,,,6913.0,TBX15,7955,Danio rerio (zebrafish),Thiram results in increased expression of TBX15 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
535,534635,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,30253,TBX2B,https://ctdbase.org/detail.go?type=gene&acc=30253,,,30253.0,tbx2b,7955,Danio rerio (zebrafish),Thiram results in decreased expression of TBX2B mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
536,534636,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,6926,TBX3,https://ctdbase.org/detail.go?type=gene&acc=6926,,,6926.0,TBX3,7955,Danio rerio (zebrafish),Thiram results in decreased expression of TBX3 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
537,535540,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,55585,UBE2Q1,https://ctdbase.org/detail.go?type=gene&acc=55585,,,55585.0,UBE2Q1,7955,Danio rerio (zebrafish),Thiram results in decreased expression of UBE2Q1 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
538,535541,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,54926,UBE2R2,https://ctdbase.org/detail.go?type=gene&acc=54926,,,54926.0,UBE2R2,7955,Danio rerio (zebrafish),Thiram results in decreased expression of UBE2R2 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
539,535542,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,10277,UBE4B,https://ctdbase.org/detail.go?type=gene&acc=10277,,,10277.0,UBE4B,7955,Danio rerio (zebrafish),Thiram results in decreased expression of UBE4B mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
540,535543,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,56061,UBFD1,https://ctdbase.org/detail.go?type=gene&acc=56061,,,56061.0,UBFD1,7955,Danio rerio (zebrafish),Thiram results in decreased expression of UBFD1 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
541,535544,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,38456,UBI-P63E,https://ctdbase.org/detail.go?type=gene&acc=38456,,,38456.0,Ubi-p63E,7955,Danio rerio (zebrafish),Thiram results in decreased expression of UBI-P63E mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
542,536031,5455,Comparative Toxicogenomics Database (CTD),Thiram,D013893,Thiram,https://ctdbase.org/detail.go?type=chem&acc=D013893,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,9606,Homo sapiens (human),Thiram inhibits the reaction [TNF protein results in increased expression of VCAM1 protein],,,PMID:25752435,https://www.ncbi.nlm.nih.gov/pubmed/25752435,25752435,,
543,608044,5556,Toxin and Toxin Target Database (T3DB),Triazolam,T3D2564,Triazolam,http://www.t3db.ca/toxins/T3D2564,BE0003597,Gamma-aminobutyric acid receptor subunit theta,http://www.t3db.ca/biodb/bio_entities/BE0003597,Q9UN88,Gamma-aminobutyric acid receptor subunit theta,55879.0,GABRQ,9606,Homo sapiens (human),,,,PMID:11752090|PMID:18384456,https://www.ncbi.nlm.nih.gov/pubmed/11752090|https://www.ncbi.nlm.nih.gov/pubmed/18384456,11752090|18384456,,
544,534329,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606,Homo sapiens (human),Troglitazone results in decreased secretion of SERPINE1 protein,,,PMID:10768100,https://www.ncbi.nlm.nih.gov/pubmed/10768100,10768100,,
545,534330,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,5054,SERPINE1,https://ctdbase.org/detail.go?type=gene&acc=5054,,,5054.0,SERPINE1,9606,Homo sapiens (human),Troglitazone results in increased expression of SERPINE1 mRNA,,,PMID:19140230|PMID:19631733,https://www.ncbi.nlm.nih.gov/pubmed/19140230|https://www.ncbi.nlm.nih.gov/pubmed/19631733,19140230|19631733,,
546,534331,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,57477,SHROOM4,https://ctdbase.org/detail.go?type=gene&acc=57477,,,57477.0,SHROOM4,10090,Mus musculus (house mouse),Troglitazone results in decreased expression of SHROOM4 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
547,534332,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,6478,SIAH2,https://ctdbase.org/detail.go?type=gene&acc=6478,,,6478.0,SIAH2,10090,Mus musculus (house mouse),Troglitazone results in decreased expression of SIAH2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
548,534333,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,150094,SIK1,https://ctdbase.org/detail.go?type=gene&acc=150094,,,150094.0,SIK1,10090,Mus musculus (house mouse),Troglitazone results in decreased expression of SIK1 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
549,534334,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,23387,SIK3,https://ctdbase.org/detail.go?type=gene&acc=23387,,,23387.0,SIK3,10090,Mus musculus (house mouse),Troglitazone results in decreased expression of SIK3 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
550,535388,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,6502,SKP2,https://ctdbase.org/detail.go?type=gene&acc=6502,,,6502.0,SKP2,9606,Homo sapiens (human),SKP2 protein results in decreased susceptibility to troglitazone,,,PMID:12717389,https://www.ncbi.nlm.nih.gov/pubmed/12717389,12717389,,
551,535389,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,6502,SKP2,https://ctdbase.org/detail.go?type=gene&acc=6502,,,6502.0,SKP2,9606,Homo sapiens (human),Troglitazone results in decreased expression of SKP2 mRNA,,,PMID:12717389|PMID:19140230,https://www.ncbi.nlm.nih.gov/pubmed/12717389|https://www.ncbi.nlm.nih.gov/pubmed/19140230,12717389|19140230,,
552,535390,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,6502,SKP2,https://ctdbase.org/detail.go?type=gene&acc=6502,,,6502.0,SKP2,9606,Homo sapiens (human),Troglitazone results in decreased expression of SKP2 protein,,,PMID:12717389|PMID:14618613,https://www.ncbi.nlm.nih.gov/pubmed/12717389|https://www.ncbi.nlm.nih.gov/pubmed/14618613,12717389|14618613,,
553,535391,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,122060,SLAIN1,https://ctdbase.org/detail.go?type=gene&acc=122060,,,122060.0,SLAIN1,10116,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of SLAIN1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
554,535392,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,7884,SLBP,https://ctdbase.org/detail.go?type=gene&acc=7884,,,7884.0,SLBP,9606,Homo sapiens (human),Troglitazone results in decreased expression of SLBP mRNA,,,PMID:19140230,https://www.ncbi.nlm.nih.gov/pubmed/19140230,19140230,,
555,535393,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,6554,SLC10A1,https://ctdbase.org/detail.go?type=gene&acc=6554,,,6554.0,SLC10A1,9606,Homo sapiens (human),Troglitazone results in decreased expression of SLC10A1 mRNA,,,PMID:25572481,https://www.ncbi.nlm.nih.gov/pubmed/25572481,25572481,,
556,535394,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,6555,SLC10A2,https://ctdbase.org/detail.go?type=gene&acc=6555,,,6555.0,SLC10A2,10090,Mus musculus (house mouse),Troglitazone results in increased expression of SLC10A2 mRNA,,,PMID:28973697,https://www.ncbi.nlm.nih.gov/pubmed/28973697,28973697,,
557,535395,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,6555,SLC10A2,https://ctdbase.org/detail.go?type=gene&acc=6555,,,6555.0,SLC10A2,10116,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of SLC10A2 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
558,535396,5591,Comparative Toxicogenomics Database (CTD),Troglitazone,D000077288,Troglitazone,https://ctdbase.org/detail.go?type=chem&acc=D000077288,6557,SLC12A1,https://ctdbase.org/detail.go?type=gene&acc=6557,,,6557.0,SLC12A1,10116,Rattus norvegicus (Norway rat),Troglitazone results in decreased expression of SLC12A1 mRNA,,,PMID:21515302,https://www.ncbi.nlm.nih.gov/pubmed/21515302,21515302,,
559,426083,5634,Comparative Toxicogenomics Database (CTD),Undecylenic Acid,C538763,undecylenic acid,https://ctdbase.org/detail.go?type=chem&acc=C538763,2730,GCLM,https://ctdbase.org/detail.go?type=gene&acc=2730,,,2730.0,GCLM,9606,Homo sapiens (human),Undecylenic acid results in increased expression of GCLM mRNA,,,PMID:27965148,https://www.ncbi.nlm.nih.gov/pubmed/27965148,27965148,,
560,426084,5634,Comparative Toxicogenomics Database (CTD),Undecylenic Acid,C538763,undecylenic acid,https://ctdbase.org/detail.go?type=chem&acc=C538763,3315,HSPB1,https://ctdbase.org/detail.go?type=gene&acc=3315,,,3315.0,HSPB1,9606,Homo sapiens (human),Undecylenic acid results in decreased expression of and affects the localization of HSPB1 protein|undecylenic acid results in increased expression of HSPB1 mRNA,,,PMID:21469165,https://www.ncbi.nlm.nih.gov/pubmed/21469165,21469165,,
561,426085,5634,Comparative Toxicogenomics Database (CTD),Undecylenic Acid,C538763,undecylenic acid,https://ctdbase.org/detail.go?type=chem&acc=C538763,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,9606,Homo sapiens (human),Undecylenic acid results in increased expression of and results in increased secretion of IL1A protein,,,PMID:21469165,https://www.ncbi.nlm.nih.gov/pubmed/21469165,21469165,,
562,426086,5634,Comparative Toxicogenomics Database (CTD),Undecylenic Acid,C538763,undecylenic acid,https://ctdbase.org/detail.go?type=chem&acc=C538763,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606,Homo sapiens (human),Undecylenic acid results in decreased expression of SOD1 protein|undecylenic acid results in increased expression of SOD1 mRNA,,,PMID:21469165,https://www.ncbi.nlm.nih.gov/pubmed/21469165,21469165,,
563,426437,5656,Toxin and Toxin Target Database (T3DB),Venlafaxine,T3D2736,Venlafaxine,http://www.t3db.ca/toxins/T3D2736,BE0000451,5-hydroxytryptamine receptor 2A,http://www.t3db.ca/biodb/bio_entities/BE0000451,P28223,5-hydroxytryptamine receptor 2A,3356.0,HTR2A,9606,Homo sapiens (human),"Venlafaxine and its active metabolite, O-desmethylvenlafaxine (ODV), inhibit the reuptake of both serotonin and norepinephrine with a potency greater for the 5-HT than for the NE reuptake process. both venlafaxine and the ODV metabolite have weak inhibitory effects on the reuptake of dopamine but, unlike the tricyclics and similar to ssris, they are not active at histaminergic, muscarinic, or alpha(1)-adrenergic receptors.",,,PMID:15918077|PMID:17503984|PMID:9165554|PMID:9180828|PMID:11454918|PMID:11750180,https://www.ncbi.nlm.nih.gov/pubmed/15918077|https://www.ncbi.nlm.nih.gov/pubmed/17503984|https://www.ncbi.nlm.nih.gov/pubmed/9165554|https://www.ncbi.nlm.nih.gov/pubmed/9180828|https://www.ncbi.nlm.nih.gov/pubmed/11454918|https://www.ncbi.nlm.nih.gov/pubmed/11750180,15918077|17503984|9165554|9180828|11454918|11750180,,
564,426438,5656,Toxin and Toxin Target Database (T3DB),Venlafaxine,T3D2736,Venlafaxine,http://www.t3db.ca/toxins/T3D2736,BE0000797,5-hydroxytryptamine receptor 1B,http://www.t3db.ca/biodb/bio_entities/BE0000797,P28222,5-hydroxytryptamine receptor 1B,3351.0,HTR1B,9606,Homo sapiens (human),"Venlafaxine and its active metabolite, O-desmethylvenlafaxine (ODV), inhibit the reuptake of both serotonin and norepinephrine with a potency greater for the 5-HT than for the NE reuptake process. both venlafaxine and the ODV metabolite have weak inhibitory effects on the reuptake of dopamine but, unlike the tricyclics and similar to ssris, they are not active at histaminergic, muscarinic, or alpha(1)-adrenergic receptors.",,,PMID:10884561|PMID:11834247|PMID:11454918|PMID:11750180,https://www.ncbi.nlm.nih.gov/pubmed/10884561|https://www.ncbi.nlm.nih.gov/pubmed/11834247|https://www.ncbi.nlm.nih.gov/pubmed/11454918|https://www.ncbi.nlm.nih.gov/pubmed/11750180,10884561|11834247|11454918|11750180,,
565,426439,5656,Toxin and Toxin Target Database (T3DB),Venlafaxine,T3D2736,Venlafaxine,http://www.t3db.ca/toxins/T3D2736,BE0000289,Alpha-2A adrenergic receptor,http://www.t3db.ca/biodb/bio_entities/BE0000289,P08913,Alpha-2A adrenergic receptor,150.0,ADRA2A,9606,Homo sapiens (human),,,,PMID:7855217|PMID:9400006|PMID:11454918|PMID:11750180,https://www.ncbi.nlm.nih.gov/pubmed/7855217|https://www.ncbi.nlm.nih.gov/pubmed/9400006|https://www.ncbi.nlm.nih.gov/pubmed/11454918|https://www.ncbi.nlm.nih.gov/pubmed/11750180,7855217|9400006|11454918|11750180,,
566,426440,5656,Toxin and Toxin Target Database (T3DB),Venlafaxine,T3D2736,Venlafaxine,http://www.t3db.ca/toxins/T3D2736,BE0000533,5-hydroxytryptamine receptor 2C,http://www.t3db.ca/biodb/bio_entities/BE0000533,P28335,5-hydroxytryptamine receptor 2C,3358.0,HTR2C,9606,Homo sapiens (human),,,,PMID:7855217|PMID:11454918|PMID:11750180,https://www.ncbi.nlm.nih.gov/pubmed/7855217|https://www.ncbi.nlm.nih.gov/pubmed/11454918|https://www.ncbi.nlm.nih.gov/pubmed/11750180,7855217|11454918|11750180,,
567,426441,5656,Toxin and Toxin Target Database (T3DB),Venlafaxine,T3D2736,Venlafaxine,http://www.t3db.ca/toxins/T3D2736,BE0000560,Muscarinic acetylcholine receptor M2,http://www.t3db.ca/biodb/bio_entities/BE0000560,P08172,Muscarinic acetylcholine receptor M2,1129.0,CHRM2,9606,Homo sapiens (human),,,,PMID:7855217|PMID:8100134|PMID:11750180,https://www.ncbi.nlm.nih.gov/pubmed/7855217|https://www.ncbi.nlm.nih.gov/pubmed/8100134|https://www.ncbi.nlm.nih.gov/pubmed/11750180,7855217|8100134|11750180,,
568,426442,5656,Toxin and Toxin Target Database (T3DB),Venlafaxine,T3D2736,Venlafaxine,http://www.t3db.ca/toxins/T3D2736,BE0000659,5-hydroxytryptamine receptor 1D,http://www.t3db.ca/biodb/bio_entities/BE0000659,P28221,5-hydroxytryptamine receptor 1D,3352.0,HTR1D,9606,Homo sapiens (human),,,,PMID:11454918|PMID:11750180,https://www.ncbi.nlm.nih.gov/pubmed/11454918|https://www.ncbi.nlm.nih.gov/pubmed/11750180,11454918|11750180,,
569,426443,5656,Toxin and Toxin Target Database (T3DB),Venlafaxine,T3D2736,Venlafaxine,http://www.t3db.ca/toxins/T3D2736,BE0000442,Histamine H1 receptor,http://www.t3db.ca/biodb/bio_entities/BE0000442,P35367,Histamine H1 receptor,3269.0,HRH1,9606,Homo sapiens (human),,,,PMID:7855217|PMID:11750180,https://www.ncbi.nlm.nih.gov/pubmed/7855217|https://www.ncbi.nlm.nih.gov/pubmed/11750180,7855217|11750180,,
570,426444,5656,Toxin and Toxin Target Database (T3DB),Venlafaxine,T3D2736,Venlafaxine,http://www.t3db.ca/toxins/T3D2736,BE0000092,Muscarinic acetylcholine receptor M1,http://www.t3db.ca/biodb/bio_entities/BE0000092,P11229,Muscarinic acetylcholine receptor M1,1128.0,CHRM1,9606,Homo sapiens (human),,,,PMID:8100134|PMID:11750180,https://www.ncbi.nlm.nih.gov/pubmed/8100134|https://www.ncbi.nlm.nih.gov/pubmed/11750180,8100134|11750180,,
571,592054,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,55802,DCP1A,https://ctdbase.org/detail.go?type=gene&acc=55802,,,55802.0,DCP1A,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of DCP1A mRNA,,,PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/18301758,18301758,,
572,592055,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,127579,DCST2,https://ctdbase.org/detail.go?type=gene&acc=127579,,,127579.0,DCST2,10090,Mus musculus (house mouse),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DCST2 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
573,592056,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,81501,DCSTAMP,https://ctdbase.org/detail.go?type=gene&acc=81501,,,81501.0,DCSTAMP,10090,Mus musculus (house mouse),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DCSTAMP mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
574,592057,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1638,DCT,https://ctdbase.org/detail.go?type=gene&acc=1638,,,1638.0,DCT,10090,Mus musculus (house mouse),[pirinixic acid co-treated with PPARA] results in decreased expression of DCT mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
575,592058,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1638,DCT,https://ctdbase.org/detail.go?type=gene&acc=1638,,,1638.0,DCT,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of DCT mRNA,,,PMID:20813756|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/23811191,20813756|23811191,,
576,592059,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1639,DCTN1,https://ctdbase.org/detail.go?type=gene&acc=1639,,,1639.0,DCTN1,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of DCTN1 mRNA,,,PMID:17426115,https://www.ncbi.nlm.nih.gov/pubmed/17426115,17426115,,
577,592060,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,51164,DCTN4,https://ctdbase.org/detail.go?type=gene&acc=51164,,,51164.0,DCTN4,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of DCTN4 mRNA,,,PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/18301758,18301758,,
578,592061,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,84516,DCTN5,https://ctdbase.org/detail.go?type=gene&acc=84516,,,84516.0,DCTN5,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DCTN5 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
579,592062,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,84516,DCTN5,https://ctdbase.org/detail.go?type=gene&acc=84516,,,84516.0,DCTN5,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of DCTN5 mRNA,,,PMID:20813756|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/23811191,20813756|23811191,,
580,592260,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,54165,DCUN1D1,https://ctdbase.org/detail.go?type=gene&acc=54165,,,54165.0,DCUN1D1,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of DCUN1D1 mRNA,,,PMID:18445702,https://www.ncbi.nlm.nih.gov/pubmed/18445702,18445702,,
581,592261,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,55208,DCUN1D2,https://ctdbase.org/detail.go?type=gene&acc=55208,,,55208.0,DCUN1D2,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of DCUN1D2 mrna|ppara protein affects the reaction [pirinixic acid results in increased expression of DCUN1D2 mrna],,,PMID:21318169,https://www.ncbi.nlm.nih.gov/pubmed/21318169,21318169,,
582,592262,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,123879,DCUN1D3,https://ctdbase.org/detail.go?type=gene&acc=123879,,,123879.0,DCUN1D3,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DCUN1D3 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
583,592263,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,123879,DCUN1D3,https://ctdbase.org/detail.go?type=gene&acc=123879,,,123879.0,DCUN1D3,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of DCUN1D3 mRNA,,,PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/18301758,18301758,,
584,592456,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1643,DDB2,https://ctdbase.org/detail.go?type=gene&acc=1643,,,1643.0,DDB2,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of DDB2 mRNA,,,PMID:18301758|PMID:20813756|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/18301758|https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/23811191,18301758|20813756|23811191,,
585,592457,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644.0,DDC,10116,Rattus norvegicus (Norway rat),Pirinixic acid results in decreased expression of DDC mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
586,593578,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1672,DEFB1,https://ctdbase.org/detail.go?type=gene&acc=1672,,,1672.0,DEFB1,10090,Mus musculus (house mouse),PPARA protein promotes the reaction [pirinixic acid results in increased expression of DEFB1 mrna],,,PMID:20059764,https://www.ncbi.nlm.nih.gov/pubmed/20059764,20059764,,
587,593579,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,244332,DEFB14,https://ctdbase.org/detail.go?type=gene&acc=244332,,,244332.0,Defb14,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of DEFB14 mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
588,595538,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,27123,DKK2,https://ctdbase.org/detail.go?type=gene&acc=27123,,,27123.0,DKK2,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DKK2 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
589,595539,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,27122,DKK3,https://ctdbase.org/detail.go?type=gene&acc=27122,,,27122.0,DKK3,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of DKK3 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
590,595540,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1737,DLAT,https://ctdbase.org/detail.go?type=gene&acc=1737,,,1737.0,DLAT,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of DLAT mRNA,,,PMID:16985257|PMID:17426115|PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/16985257|https://www.ncbi.nlm.nih.gov/pubmed/17426115|https://www.ncbi.nlm.nih.gov/pubmed/18301758,16985257|17426115|18301758,,
591,595541,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,10395,DLC1,https://ctdbase.org/detail.go?type=gene&acc=10395,,,10395.0,DLC1,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DLC1 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
592,595542,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1738,DLD,https://ctdbase.org/detail.go?type=gene&acc=1738,,,1738.0,DLD,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of DLD mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
593,595543,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,8847,DLEU2,https://ctdbase.org/detail.go?type=gene&acc=8847,,,8847.0,DLEU2,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of DLEU2 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
594,595544,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1740,DLG2,https://ctdbase.org/detail.go?type=gene&acc=1740,,,1740.0,DLG2,10116,Rattus norvegicus (Norway rat),Pirinixic acid results in increased expression of DLG2 mRNA,,,PMID:12832660,https://www.ncbi.nlm.nih.gov/pubmed/12832660,12832660,,
595,595545,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1742,DLG4,https://ctdbase.org/detail.go?type=gene&acc=1742,,,1742.0,DLG4,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of DLG4 mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
596,595546,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,9231,DLG5,https://ctdbase.org/detail.go?type=gene&acc=9231,,,9231.0,DLG5,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of DLG5 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
597,600555,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1879,EBF1,https://ctdbase.org/detail.go?type=gene&acc=1879,,,1879.0,EBF1,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of EBF1 mrna|[pirinixic acid co-treated with PPARA] results in increased expression of EBF1 mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
598,600556,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1879,EBF1,https://ctdbase.org/detail.go?type=gene&acc=1879,,,1879.0,EBF1,10116,Rattus norvegicus (Norway rat),Pirinixic acid results in increased expression of EBF1 mRNA,,,PMID:12832660,https://www.ncbi.nlm.nih.gov/pubmed/12832660,12832660,,
599,600557,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,84650,EBPL,https://ctdbase.org/detail.go?type=gene&acc=84650,,,84650.0,EBPL,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of EBPL mRNA,,,PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/18301758,18301758,,
600,600558,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1889,ECE1,https://ctdbase.org/detail.go?type=gene&acc=1889,,,1889.0,ECE1,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of ECE1 mRNA,,,PMID:17426115|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/17426115|https://www.ncbi.nlm.nih.gov/pubmed/23811191,17426115|23811191,,
601,600559,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,9427,ECEL1,https://ctdbase.org/detail.go?type=gene&acc=9427,,,9427.0,ECEL1,10090,Mus musculus (house mouse),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ECEL1 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
602,600560,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1891,ECH1,https://ctdbase.org/detail.go?type=gene&acc=1891,,,1891.0,ECH1,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of ECH1 mRNA,,,PMID:15375163|PMID:16357043|PMID:17118139|PMID:17426115|PMID:17950772|PMID:18301758|PMID:18467677|PMID:20059764|PMID:20813756|PMID:20936131|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/15375163|https://www.ncbi.nlm.nih.gov/pubmed/16357043|https://www.ncbi.nlm.nih.gov/pubmed/17118139|https://www.ncbi.nlm.nih.gov/pubmed/17426115|https://www.ncbi.nlm.nih.gov/pubmed/17950772|https://www.ncbi.nlm.nih.gov/pubmed/18301758|https://www.ncbi.nlm.nih.gov/pubmed/18467677|https://www.ncbi.nlm.nih.gov/pubmed/20059764|https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/20936131|https://www.ncbi.nlm.nih.gov/pubmed/23811191,15375163|16357043|17118139|17426115|17950772|18301758|18467677|20059764|20813756|20936131|23811191,,
603,600561,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1891,ECH1,https://ctdbase.org/detail.go?type=gene&acc=1891,,,1891.0,ECH1,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of ECH1 protein,,,PMID:12727805,https://www.ncbi.nlm.nih.gov/pubmed/12727805,12727805,,
604,603750,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,1999,ELF3,https://ctdbase.org/detail.go?type=gene&acc=1999,,,1999.0,ELF3,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of ELF3 mRNA,,,PMID:17426115,https://www.ncbi.nlm.nih.gov/pubmed/17426115,17426115,,
605,603751,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,2004,ELK3,https://ctdbase.org/detail.go?type=gene&acc=2004,,,2004.0,ELK3,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of ELK3 mRNA,,,PMID:18445702,https://www.ncbi.nlm.nih.gov/pubmed/18445702,18445702,,
606,603752,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,2005,ELK4,https://ctdbase.org/detail.go?type=gene&acc=2005,,,2005.0,ELK4,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of ELK4 mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
607,603753,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,22936,ELL2,https://ctdbase.org/detail.go?type=gene&acc=22936,,,22936.0,ELL2,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of ELL2 mRNA,,,PMID:18445702,https://www.ncbi.nlm.nih.gov/pubmed/18445702,18445702,,
608,603951,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,55531,ELMOD1,https://ctdbase.org/detail.go?type=gene&acc=55531,,,55531.0,ELMOD1,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of ELMOD1 mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
609,603952,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,84173,ELMOD3,https://ctdbase.org/detail.go?type=gene&acc=84173,,,84173.0,ELMOD3,10090,Mus musculus (house mouse),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ELMOD3 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
610,603953,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,84173,ELMOD3,https://ctdbase.org/detail.go?type=gene&acc=84173,,,84173.0,ELMOD3,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of ELMOD3 mRNA,,,PMID:17426115|PMID:18301758|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/17426115|https://www.ncbi.nlm.nih.gov/pubmed/18301758|https://www.ncbi.nlm.nih.gov/pubmed/23811191,17426115|18301758|23811191,,
611,603954,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,6921,ELOC,https://ctdbase.org/detail.go?type=gene&acc=6921,,,6921.0,ELOC,10116,Rattus norvegicus (Norway rat),Pirinixic acid results in increased expression of ELOC mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
612,603955,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,64834,ELOVL1,https://ctdbase.org/detail.go?type=gene&acc=64834,,,64834.0,ELOVL1,10116,Rattus norvegicus (Norway rat),Pirinixic acid results in increased activity of ELOVL1 protein,,,PMID:15654130,https://www.ncbi.nlm.nih.gov/pubmed/15654130,15654130,,
613,603956,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,54898,ELOVL2,https://ctdbase.org/detail.go?type=gene&acc=54898,,,54898.0,ELOVL2,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ELOVL2 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
614,603957,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,54898,ELOVL2,https://ctdbase.org/detail.go?type=gene&acc=54898,,,54898.0,ELOVL2,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of ELOVL2 mRNA,,,PMID:18445702,https://www.ncbi.nlm.nih.gov/pubmed/18445702,18445702,,
615,603958,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,54898,ELOVL2,https://ctdbase.org/detail.go?type=gene&acc=54898,,,54898.0,ELOVL2,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of ELOVL2 mRNA,,,PMID:15375163,https://www.ncbi.nlm.nih.gov/pubmed/15375163,15375163,,
616,604153,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,83401,ELOVL3,https://ctdbase.org/detail.go?type=gene&acc=83401,,,83401.0,ELOVL3,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ELOVL3 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
617,604154,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,83401,ELOVL3,https://ctdbase.org/detail.go?type=gene&acc=83401,,,83401.0,ELOVL3,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of ELOVL3 mRNA,,,PMID:16357043|PMID:17726147|PMID:18301758|PMID:18445702|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/16357043|https://www.ncbi.nlm.nih.gov/pubmed/17726147|https://www.ncbi.nlm.nih.gov/pubmed/18301758|https://www.ncbi.nlm.nih.gov/pubmed/18445702|https://www.ncbi.nlm.nih.gov/pubmed/23811191,16357043|17726147|18301758|18445702|23811191,,
618,604155,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,60481,ELOVL5,https://ctdbase.org/detail.go?type=gene&acc=60481,,,60481.0,ELOVL5,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of ELOVL5 mRNA,,,PMID:16790840|PMID:18301758|PMID:20813756|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/16790840|https://www.ncbi.nlm.nih.gov/pubmed/18301758|https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/23811191,16790840|18301758|20813756|23811191,,
619,604156,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,60481,ELOVL5,https://ctdbase.org/detail.go?type=gene&acc=60481,,,60481.0,ELOVL5,10090,Mus musculus (house mouse),PPARA protein affects the reaction [pirinixic acid results in increased expression of ELOVL5 mrna],,,PMID:16790840,https://www.ncbi.nlm.nih.gov/pubmed/16790840,16790840,,
620,604157,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,60481,ELOVL5,https://ctdbase.org/detail.go?type=gene&acc=60481,,,60481.0,ELOVL5,10116,Rattus norvegicus (Norway rat),Pirinixic acid results in increased expression of ELOVL5 mrna|pirinixic acid results in increased activity of ELOVL5 protein,,,PMID:15654130,https://www.ncbi.nlm.nih.gov/pubmed/15654130,15654130,,
621,604158,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,79071,ELOVL6,https://ctdbase.org/detail.go?type=gene&acc=79071,,,79071.0,ELOVL6,9606,Homo sapiens (human),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ELOVL6 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
622,604159,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,79071,ELOVL6,https://ctdbase.org/detail.go?type=gene&acc=79071,,,79071.0,ELOVL6,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of ELOVL6 mRNA,,,PMID:18445702,https://www.ncbi.nlm.nih.gov/pubmed/18445702,18445702,,
623,604160,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,79071,ELOVL6,https://ctdbase.org/detail.go?type=gene&acc=79071,,,79071.0,ELOVL6,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of ELOVL6 mRNA,,,PMID:16790840|PMID:18467677,https://www.ncbi.nlm.nih.gov/pubmed/16790840|https://www.ncbi.nlm.nih.gov/pubmed/18467677,16790840|18467677,,
624,605120,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,2028,ENPEP,https://ctdbase.org/detail.go?type=gene&acc=2028,,,2028.0,ENPEP,10090,Mus musculus (house mouse),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ENPEP mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
625,605121,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,2028,ENPEP,https://ctdbase.org/detail.go?type=gene&acc=2028,,,2028.0,ENPEP,10090,Mus musculus (house mouse),[pirinixic acid co-treated with PPARA] results in decreased expression of ENPEP mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
626,605122,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,2028,ENPEP,https://ctdbase.org/detail.go?type=gene&acc=2028,,,2028.0,ENPEP,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of ENPEP mRNA,,,PMID:16221962|PMID:20059764|PMID:20813756|PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/16221962|https://www.ncbi.nlm.nih.gov/pubmed/20059764|https://www.ncbi.nlm.nih.gov/pubmed/20813756|https://www.ncbi.nlm.nih.gov/pubmed/23811191,16221962|20059764|20813756|23811191,,
627,605123,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,2028,ENPEP,https://ctdbase.org/detail.go?type=gene&acc=2028,,,2028.0,ENPEP,10090,Mus musculus (house mouse),PPARA protein promotes the reaction [pirinixic acid results in decreased expression of ENPEP mrna],,,PMID:20059764,https://www.ncbi.nlm.nih.gov/pubmed/20059764,20059764,,
628,606455,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,29924,EPN1,https://ctdbase.org/detail.go?type=gene&acc=29924,,,29924.0,EPN1,10116,Rattus norvegicus (Norway rat),Pirinixic acid results in increased expression of EPN1 mRNA,,,PMID:19162173,https://www.ncbi.nlm.nih.gov/pubmed/19162173,19162173,,
629,606456,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,2056,EPO,https://ctdbase.org/detail.go?type=gene&acc=2056,,,2056.0,EPO,10090,Mus musculus (house mouse),NCF1 protein promotes the reaction [pirinixic acid results in decreased expression of EPO mrna]|pirinixic acid results in decreased expression of EPO mRNA,,,PMID:17950772,https://www.ncbi.nlm.nih.gov/pubmed/17950772,17950772,,
630,606457,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,83481,EPPK1,https://ctdbase.org/detail.go?type=gene&acc=83481,,,83481.0,EPPK1,10090,Mus musculus (house mouse),Pirinixic acid results in decreased expression of EPPK1 mRNA,,,PMID:17426115,https://www.ncbi.nlm.nih.gov/pubmed/17426115,17426115,,
631,606458,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,83481,EPPK1,https://ctdbase.org/detail.go?type=gene&acc=83481,,,83481.0,EPPK1,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of EPPK1 mRNA,,,PMID:18445702,https://www.ncbi.nlm.nih.gov/pubmed/18445702,18445702,,
632,606459,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,2060,EPS15,https://ctdbase.org/detail.go?type=gene&acc=2060,,,2060.0,EPS15,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of EPS15 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
633,607343,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,2098,ESD,https://ctdbase.org/detail.go?type=gene&acc=2098,,,2098.0,ESD,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of ESD mRNA,,,PMID:16221962,https://www.ncbi.nlm.nih.gov/pubmed/16221962,16221962,,
634,607344,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,2098,ESD,https://ctdbase.org/detail.go?type=gene&acc=2098,,,2098.0,ESD,10116,Rattus norvegicus (Norway rat),Pirinixic acid affects the expression of ESD mRNA,,,PMID:19483382,https://www.ncbi.nlm.nih.gov/pubmed/19483382,19483382,,
635,607345,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,11082,ESM1,https://ctdbase.org/detail.go?type=gene&acc=11082,,,11082.0,ESM1,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of ESM1 mRNA,,,PMID:23811191,https://www.ncbi.nlm.nih.gov/pubmed/23811191,23811191,,
636,608414,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,2160,F11,https://ctdbase.org/detail.go?type=gene&acc=2160,,,2160.0,F11,10090,Mus musculus (house mouse),Pirinixic acid affects the expression of F11 mRNA,,,PMID:19136022,https://www.ncbi.nlm.nih.gov/pubmed/19136022,19136022,,
637,608415,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,2160,F11,https://ctdbase.org/detail.go?type=gene&acc=2160,,,2160.0,F11,10090,Mus musculus (house mouse),[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of F11 mRNA,,,PMID:19710929,https://www.ncbi.nlm.nih.gov/pubmed/19710929,19710929,,
638,608416,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,2160,F11,https://ctdbase.org/detail.go?type=gene&acc=2160,,,2160.0,F11,10090,Mus musculus (house mouse),[pirinixic acid co-treated with PPARA] results in decreased expression of F11 mRNA,,,PMID:20813756,https://www.ncbi.nlm.nih.gov/pubmed/20813756,20813756,,
639,609315,5694,Comparative Toxicogenomics Database (CTD),Pirinixic acid,C006253,pirinixic acid,https://ctdbase.org/detail.go?type=chem&acc=C006253,2171,FABP5,https://ctdbase.org/detail.go?type=gene&acc=2171,,,2171.0,FABP5,10090,Mus musculus (house mouse),Pirinixic acid results in increased expression of FABP5 mRNA,,,PMID:18301758,https://www.ncbi.nlm.nih.gov/pubmed/18301758,18301758,,
640,428818,5727,Comparative Toxicogenomics Database (CTD),Zinc Chloride,C016837,zinc chloride,https://ctdbase.org/detail.go?type=chem&acc=C016837,3630,INS,https://ctdbase.org/detail.go?type=gene&acc=3630,,,3630.0,INS,9913,Bos taurus (cattle),INS protein promotes the reaction [zinc chloride results in increased uptake of glucose]|zinc chloride promotes the reaction [INS protein results in increased uptake of glucose],,,PMID:11340092,https://www.ncbi.nlm.nih.gov/pubmed/11340092,11340092,,
641,428819,5727,Comparative Toxicogenomics Database (CTD),Zinc Chloride,C016837,zinc chloride,https://ctdbase.org/detail.go?type=chem&acc=C016837,51141,INSIG2,https://ctdbase.org/detail.go?type=gene&acc=51141,,,51141.0,INSIG2,9606,Homo sapiens (human),Zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of INSIG2 mrna],,,PMID:22202117,https://www.ncbi.nlm.nih.gov/pubmed/22202117,22202117,,
642,428987,5727,Comparative Toxicogenomics Database (CTD),Zinc Chloride,C016837,zinc chloride,https://ctdbase.org/detail.go?type=chem&acc=C016837,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10090,Mus musculus (house mouse),Acetylcysteine inhibits the reaction [zinc chloride results in increased expression of JUN mrna],,,PMID:11306679,https://www.ncbi.nlm.nih.gov/pubmed/11306679,11306679,,
643,428988,5727,Comparative Toxicogenomics Database (CTD),Zinc Chloride,C016837,zinc chloride,https://ctdbase.org/detail.go?type=chem&acc=C016837,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10090,Mus musculus (house mouse),Pyrazolanthrone inhibits the reaction [[[cupric chloride results in increased abundance of copper] co-treated with [zinc chloride results in increased abundance of zinc]] results in increased phosphorylation of JUN protein]|[[cupric chloride results in increased abundance of copper] co-treated with [zinc chloride results in increased abundance of zinc]] results in increased phosphorylation of JUN protein,,,PMID:30768131,https://www.ncbi.nlm.nih.gov/pubmed/30768131,30768131,,
644,428989,5727,Comparative Toxicogenomics Database (CTD),Zinc Chloride,C016837,zinc chloride,https://ctdbase.org/detail.go?type=chem&acc=C016837,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725.0,JUN,10090,Mus musculus (house mouse),Zinc chloride results in increased expression of JUN mRNA,,,PMID:11306679|PMID:19000923,https://www.ncbi.nlm.nih.gov/pubmed/11306679|https://www.ncbi.nlm.nih.gov/pubmed/19000923,11306679|19000923,,
645,535711,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,10090,Mus musculus (house mouse),Dexamethasone inhibits the reaction [zymosan results in increased phosphorylation of and results in increased activity of MAPK8 protein],,,PMID:10874129,https://www.ncbi.nlm.nih.gov/pubmed/10874129,10874129,,
646,535712,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,10116,Rattus norvegicus (Norway rat),Dexamethasone affects the phosphorylation of MAPK8 protein,,,PMID:18234956,https://www.ncbi.nlm.nih.gov/pubmed/18234956,18234956,,
647,535713,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,23162,MAPK8IP3,https://ctdbase.org/detail.go?type=gene&acc=23162,,,23162.0,MAPK8IP3,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of MAPK8IP3 mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
648,535714,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10090,Mus musculus (house mouse),[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased phosphorylation of MAPK9 protein|pentagalloylglucose inhibits the reaction [[1-methyl-3-isobutylxanthine co-treated with dexamethasone co-treated with INS protein] results in increased phosphorylation of MAPK9 protein],,,PMID:30721698,https://www.ncbi.nlm.nih.gov/pubmed/30721698,30721698,,
649,535715,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10090,Mus musculus (house mouse),Dexamethasone inhibits the reaction [lipopolysaccharides results in increased expression of MAPK9 protein]|[il10 protein co-treated with dexamethasone] inhibits the reaction [lipopolysaccharides results in increased expression of MAPK9 protein],,,PMID:37177863,https://www.ncbi.nlm.nih.gov/pubmed/37177863,37177863,,
650,535716,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601.0,MAPK9,10090,Mus musculus (house mouse),Dexamethasone inhibits the reaction [lipopolysaccharides results in increased phosphorylation of MAPK9 protein],,,PMID:27568862|PMID:35616142,https://www.ncbi.nlm.nih.gov/pubmed/27568862|https://www.ncbi.nlm.nih.gov/pubmed/35616142,27568862|35616142,,
651,535717,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,79109,MAPKAP1,https://ctdbase.org/detail.go?type=gene&acc=79109,,,79109.0,MAPKAP1,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of MAPKAP1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
652,535718,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,9261,MAPKAPK2,https://ctdbase.org/detail.go?type=gene&acc=9261,,,9261.0,MAPKAPK2,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of MAPKAPK2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
653,590697,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,7955,Danio rerio (zebrafish),Glipizide inhibits the reaction [dexamethasone results in increased expression of PCK1 mrna]|metformin inhibits the reaction [dexamethasone results in increased expression of PCK1 mrna]|dexamethasone results in increased expression of PCK1 mrna|rosiglitazone inhibits the reaction [dexamethasone results in increased expression of PCK1 mrna],,,PMID:17446233,https://www.ncbi.nlm.nih.gov/pubmed/17446233,17446233,,
654,590698,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,9031,Gallus gallus (chicken),Dexamethasone results in decreased expression of PCK1 mRNA,,,PMID:21356098,https://www.ncbi.nlm.nih.gov/pubmed/21356098,21356098,,
655,590699,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,9031,Gallus gallus (chicken),Dexamethasone results in increased expression of PCK1 mRNA,,,PMID:34464682,https://www.ncbi.nlm.nih.gov/pubmed/34464682,34464682,,
656,590700,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,9606,Homo sapiens (human),Dexamethasone results in increased expression of PCK1 mRNA,,,PMID:25047013,https://www.ncbi.nlm.nih.gov/pubmed/25047013,25047013,,
657,590701,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,9606,Homo sapiens (human),Dexamethasone results in increased expression of PCK1 protein,,,PMID:26616219|PMID:34273429,https://www.ncbi.nlm.nih.gov/pubmed/26616219|https://www.ncbi.nlm.nih.gov/pubmed/34273429,26616219|34273429,,
658,590702,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin] results in increased expression of PCK1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
659,590703,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,9606,Homo sapiens (human),[mifepristone co-treated with dexamethasone] results in decreased expression of PCK1 mrna|monobutyl phthalate promotes the reaction [dexamethasone results in increased expression of PCK1 protein]|mifepristone inhibits the reaction [dexamethasone results in increased expression of PCK1 protein]|[monobutyl phthalate co-treated with dexamethasone] results in increased expression of PCK1 mRNA,,,PMID:34273429,https://www.ncbi.nlm.nih.gov/pubmed/34273429,34273429,,
660,590859,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,1265,CNN2,https://ctdbase.org/detail.go?type=gene&acc=1265,,,1265.0,CNN2,10090,Mus musculus (house mouse),[dexamethasone co-treated with rosiglitazone co-treated with 1-methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CNN2 mRNA,,,PMID:16054899,https://www.ncbi.nlm.nih.gov/pubmed/16054899,16054899,,
661,590860,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,1266,CNN3,https://ctdbase.org/detail.go?type=gene&acc=1266,,,1266.0,CNN3,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of CNN3 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of CNN3 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
662,590861,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,55571,CNOT11,https://ctdbase.org/detail.go?type=gene&acc=55571,,,55571.0,CNOT11,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of CNOT11 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
663,590862,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,4850,CNOT4,https://ctdbase.org/detail.go?type=gene&acc=4850,,,4850.0,CNOT4,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of CNOT4 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
664,590863,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,246175,CNOT6L,https://ctdbase.org/detail.go?type=gene&acc=246175,,,246175.0,CNOT6L,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of CNOT6L mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
665,590864,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,246175,CNOT6L,https://ctdbase.org/detail.go?type=gene&acc=246175,,,246175.0,CNOT6L,9940,Ovis aries (sheep),[[biotin co-treated with pantothenic acid co-treated with INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with rosiglitazone] results in increased susceptibility to bisphenol A] which results in decreased expression of CNOT6L mRNA,,,PMID:35504463,https://www.ncbi.nlm.nih.gov/pubmed/35504463,35504463,,
666,591557,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644.0,DDC,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of DDC mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
667,591558,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644.0,DDC,9031,Gallus gallus (chicken),Dexamethasone results in decreased expression of DDC mRNA,,,PMID:34464682,https://www.ncbi.nlm.nih.gov/pubmed/34464682,34464682,,
668,591559,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644.0,DDC,10090,Mus musculus (house mouse),Dexamethasone results in increased expression of DDC mRNA,,,PMID:22733784,https://www.ncbi.nlm.nih.gov/pubmed/22733784,22733784,,
669,591560,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,562868,DDHD1A,https://ctdbase.org/detail.go?type=gene&acc=562868,,,562868.0,ddhd1a,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of DDHD1A mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
670,591561,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,570320,DDHD1B,https://ctdbase.org/detail.go?type=gene&acc=570320,,,570320.0,ddhd1b,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of DDHD1B mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
671,592649,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,23047,PDS5B,https://ctdbase.org/detail.go?type=gene&acc=23047,,,23047.0,PDS5B,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of PDS5B mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
672,592650,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,3651,PDX1,https://ctdbase.org/detail.go?type=gene&acc=3651,,,3651.0,PDX1,10116,Rattus norvegicus (Norway rat),Dexamethasone results in decreased expression of PDX1 mRNA,,,PMID:25851902|PMID:31778773|PMID:32791177,https://www.ncbi.nlm.nih.gov/pubmed/25851902|https://www.ncbi.nlm.nih.gov/pubmed/31778773|https://www.ncbi.nlm.nih.gov/pubmed/32791177,25851902|31778773|32791177,,
673,592651,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,109731405,PDXDC2P,https://ctdbase.org/detail.go?type=gene&acc=109731405,,,109731405.0,PDXDC2P,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of PDXDC2P mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PDXDC2P mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of PDXDC2P mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
674,592652,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,283970,PDXDC2P-NPIPB14P,https://ctdbase.org/detail.go?type=gene&acc=283970,,,283970.0,PDXDC2P-NPIPB14P,9606,Homo sapiens (human),Dexamethasone results in decreased expression of PDXDC2P-NPIPB14P mRNA,,,PMID:25047013,https://www.ncbi.nlm.nih.gov/pubmed/25047013,25047013,,
675,592653,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,8566,PDXK,https://ctdbase.org/detail.go?type=gene&acc=8566,,,8566.0,PDXK,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of PDXK mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of PDXK mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
676,592654,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,791775,PDXKA,https://ctdbase.org/detail.go?type=gene&acc=791775,,,791775.0,pdxka,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of PDXKA mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
677,593754,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,321383,PFN2A,https://ctdbase.org/detail.go?type=gene&acc=321383,,,321383.0,pfn2a,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of PFN2A mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
678,593755,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,643834,PGA3,https://ctdbase.org/detail.go?type=gene&acc=643834,,,643834.0,PGA3,9031,Gallus gallus (chicken),Dexamethasone results in increased expression of PGA3 mRNA,,,PMID:34464682,https://www.ncbi.nlm.nih.gov/pubmed/34464682,34464682,,
679,594106,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,51226,COPZ2,https://ctdbase.org/detail.go?type=gene&acc=51226,,,51226.0,COPZ2,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of COPZ2 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of COPZ2 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
680,594107,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,80219,COQ10B,https://ctdbase.org/detail.go?type=gene&acc=80219,,,80219.0,COQ10B,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of COQ10B mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
681,594108,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,84274,COQ5,https://ctdbase.org/detail.go?type=gene&acc=84274,,,84274.0,COQ5,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of COQ5 mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
682,594109,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,10229,COQ7,https://ctdbase.org/detail.go?type=gene&acc=10229,,,10229.0,COQ7,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of COQ7 mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
683,594110,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,79934,COQ8B,https://ctdbase.org/detail.go?type=gene&acc=79934,,,79934.0,COQ8B,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of COQ8B mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
684,594111,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,79934,COQ8B,https://ctdbase.org/detail.go?type=gene&acc=79934,,,79934.0,COQ8B,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of COQ8B mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
685,594112,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,57017,COQ9,https://ctdbase.org/detail.go?type=gene&acc=57017,,,57017.0,COQ9,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of COQ9 mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
686,594113,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5229,PGGT1B,https://ctdbase.org/detail.go?type=gene&acc=5229,,,5229.0,PGGT1B,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of PGGT1B mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in increased expression of PGGT1B mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
687,594114,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5230,PGK1,https://ctdbase.org/detail.go?type=gene&acc=5230,,,5230.0,PGK1,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of PGK1 mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
688,594115,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,5230,PGK1,https://ctdbase.org/detail.go?type=gene&acc=5230,,,5230.0,PGK1,10090,Mus musculus (house mouse),Dexamethasone results in decreased expression of PGK1 protein,,,PMID:33567340,https://www.ncbi.nlm.nih.gov/pubmed/33567340,33567340,,
689,597154,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,65083,NOL6,https://ctdbase.org/detail.go?type=gene&acc=65083,,,65083.0,NOL6,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of NOL6 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
690,597155,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,51406,NOL7,https://ctdbase.org/detail.go?type=gene&acc=51406,,,51406.0,NOL7,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of NOL7 mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
691,597156,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,55035,NOL8,https://ctdbase.org/detail.go?type=gene&acc=55035,,,55035.0,NOL8,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of NOL8 mrna|[ins protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol A] results in decreased expression of NOL8 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
692,597157,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,9221,NOLC1,https://ctdbase.org/detail.go?type=gene&acc=9221,,,9221.0,NOLC1,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of NOLC1 mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
693,597158,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,23420,NOMO1,https://ctdbase.org/detail.go?type=gene&acc=23420,,,23420.0,NOMO1,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in decreased expression of NOMO1 mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
694,597159,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,4841,NONO,https://ctdbase.org/detail.go?type=gene&acc=4841,,,4841.0,NONO,9606,Homo sapiens (human),[INS protein co-treated with dexamethasone co-treated with 1-methyl-3-isobutylxanthine co-treated with indomethacin co-treated with bisphenol F] results in increased expression of NONO mRNA,,,PMID:28628672,https://www.ncbi.nlm.nih.gov/pubmed/28628672,28628672,,
695,597160,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,55505,NOP10,https://ctdbase.org/detail.go?type=gene&acc=55505,,,55505.0,NOP10,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of NOP10 mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
696,597161,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,51491,NOP16,https://ctdbase.org/detail.go?type=gene&acc=51491,,,51491.0,NOP16,7955,Danio rerio (zebrafish),Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of NOP16 mrna],,,PMID:27941970,https://www.ncbi.nlm.nih.gov/pubmed/27941970,27941970,,
697,597658,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10090,Mus musculus (house mouse),Lipopolysaccharides inhibits the reaction [dexamethasone results in increased expression of NOS2],,,PMID:21356098,https://www.ncbi.nlm.nih.gov/pubmed/21356098,21356098,,
698,597659,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Acetylcarnitine affects the reaction [dexamethasone results in increased expression of NOS2 mrna]|melatonin affects the reaction [dexamethasone results in increased expression of NOS2 mrna],,,PMID:21986892,https://www.ncbi.nlm.nih.gov/pubmed/21986892,21986892,,
699,597660,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,10116,Rattus norvegicus (Norway rat),Dexamethasone inhibits the reaction [carrageenan results in increased expression of NOS2 mrna],,,PMID:27803785,https://www.ncbi.nlm.nih.gov/pubmed/27803785,27803785,,
700,600058,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,7025,NR2F1,https://ctdbase.org/detail.go?type=gene&acc=7025,,,7025.0,NR2F1,10116,Rattus norvegicus (Norway rat),Dexamethasone results in decreased expression of NR2F1 mrna|testosterone inhibits the reaction [dexamethasone results in decreased expression of NR2F1 mrna],,,PMID:20032058,https://www.ncbi.nlm.nih.gov/pubmed/20032058,20032058,,
701,600059,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,7026,NR2F2,https://ctdbase.org/detail.go?type=gene&acc=7026,,,7026.0,NR2F2,10116,Rattus norvegicus (Norway rat),[dibutyl phthalate co-treated with dexamethasone] results in increased expression of NR2F2 protein|dexamethasone results in increased expression of NR2F2 protein|[[dibutyl phthalate co-treated with dexamethasone] results in increased expression of NR2F2 protein] which results in decreased abundance of testosterone|[dexamethasone results in increased expression of NR2F2 protein] which results in decreased abundance of testosterone,,,PMID:22615892,https://www.ncbi.nlm.nih.gov/pubmed/22615892,22615892,,
702,600060,5743,Comparative Toxicogenomics Database (CTD),Dexamethasone,D003907,Dexamethasone,https://ctdbase.org/detail.go?type=chem&acc=D003907,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,10029,Cricetulus griseus (Chinese hamster),NR3C1 protein mutant form results in decreased susceptibility to dexamethasone,,,PMID:28803809,https://www.ncbi.nlm.nih.gov/pubmed/28803809,28803809,,
703,534128,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2960,GTF2E1,https://ctdbase.org/detail.go?type=gene&acc=2960,,,2960.0,GTF2E1,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in decreased expression of GTF2E1 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
704,534129,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2960,GTF2E1,https://ctdbase.org/detail.go?type=gene&acc=2960,,,2960.0,GTF2E1,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of GTF2E1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
705,534130,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2961,GTF2E2,https://ctdbase.org/detail.go?type=gene&acc=2961,,,2961.0,GTF2E2,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in increased expression of GTF2E2 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
706,534131,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2967,GTF2H3,https://ctdbase.org/detail.go?type=gene&acc=2967,,,2967.0,GTF2H3,9606,Homo sapiens (human),Estradiol results in decreased expression of GTF2H3 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
707,534132,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2969,GTF2I,https://ctdbase.org/detail.go?type=gene&acc=2969,,,2969.0,GTF2I,9606,Homo sapiens (human),Estradiol results in decreased phosphorylation of GTF2I protein,,,PMID:27026707,https://www.ncbi.nlm.nih.gov/pubmed/27026707,27026707,,
708,534133,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2969,GTF2I,https://ctdbase.org/detail.go?type=gene&acc=2969,,,2969.0,GTF2I,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in decreased expression of GTF2I mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
709,534134,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2975,GTF3C1,https://ctdbase.org/detail.go?type=gene&acc=2975,,,2975.0,GTF3C1,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of GTF3C1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
710,534135,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9329,GTF3C4,https://ctdbase.org/detail.go?type=gene&acc=9329,,,9329.0,GTF3C4,9606,Homo sapiens (human),Estradiol results in increased expression of GTF3C4 mRNA,,,PMID:23019147|PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/23019147|https://www.ncbi.nlm.nih.gov/pubmed/31614463,23019147|31614463,,
711,534325,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),Tetrachlorodibenzodioxin promotes the reaction [estradiol results in increased degradation of ESR1 protein],,,PMID:10922479,https://www.ncbi.nlm.nih.gov/pubmed/10922479,10922479,,
712,534326,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),TGFB3 protein inhibits the reaction [estradiol results in increased expression of ESR1 mrna],,,PMID:26224478,https://www.ncbi.nlm.nih.gov/pubmed/26224478,26224478,,
713,534327,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),Tri-(2-ethylhexyl)trimellitate promotes the reaction [estradiol results in increased activity of ESR1 protein],,,PMID:16756374,https://www.ncbi.nlm.nih.gov/pubmed/16756374,16756374,,
714,534328,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),Trichostatin A promotes the reaction [estradiol results in decreased expression of ESR1 mrna],,,PMID:22476901,https://www.ncbi.nlm.nih.gov/pubmed/22476901,22476901,,
715,534628,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10449,ACAA2,https://ctdbase.org/detail.go?type=gene&acc=10449,,,10449.0,ACAA2,10090,Mus musculus (house mouse),Estradiol results in decreased expression of ACAA2 mRNA,,,PMID:19484750,https://www.ncbi.nlm.nih.gov/pubmed/19484750,19484750,,
716,534629,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10449,ACAA2,https://ctdbase.org/detail.go?type=gene&acc=10449,,,10449.0,ACAA2,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in decreased expression of ACAA2 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
717,534630,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10449,ACAA2,https://ctdbase.org/detail.go?type=gene&acc=10449,,,10449.0,ACAA2,10116,Rattus norvegicus (Norway rat),Estradiol affects the expression of ACAA2 protein,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
718,534631,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31.0,ACACA,9606,Homo sapiens (human),Estradiol results in increased expression of ACACA mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
719,534632,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31.0,ACACA,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of ACACA mRNA,,,PMID:26164745,https://www.ncbi.nlm.nih.gov/pubmed/26164745,26164745,,
720,534633,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31.0,ACACA,9823,Sus scrofa (pig),Estradiol results in increased phosphorylation of ACACA protein,,,PMID:15967841,https://www.ncbi.nlm.nih.gov/pubmed/15967841,15967841,,
721,535081,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,243529,H1F10,https://ctdbase.org/detail.go?type=gene&acc=243529,,,243529.0,H1f10,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of H1F10 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
722,535082,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,50708,H1F2,https://ctdbase.org/detail.go?type=gene&acc=50708,,,50708.0,H1f2,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of H1F2 protein,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
723,535083,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,50709,H1F4,https://ctdbase.org/detail.go?type=gene&acc=50709,,,50709.0,H1f4,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of H1F4 protein,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
724,535084,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,56702,H1F5,https://ctdbase.org/detail.go?type=gene&acc=56702,,,56702.0,H1f5,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of H1F5 protein,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
725,589822,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10611,PDLIM5,https://ctdbase.org/detail.go?type=gene&acc=10611,,,10611.0,PDLIM5,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of PDLIM5 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
726,589823,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9260,PDLIM7,https://ctdbase.org/detail.go?type=gene&acc=9260,,,9260.0,PDLIM7,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of PDLIM7 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
727,589824,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9260,PDLIM7,https://ctdbase.org/detail.go?type=gene&acc=9260,,,9260.0,PDLIM7,10090,Mus musculus (house mouse),Estradiol results in increased expression of PDLIM7 mRNA,,,PMID:19484750,https://www.ncbi.nlm.nih.gov/pubmed/19484750,19484750,,
728,589825,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,57546,PDP2,https://ctdbase.org/detail.go?type=gene&acc=57546,,,57546.0,PDP2,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in decreased expression of PDP2 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
729,589826,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,5170,PDPK1,https://ctdbase.org/detail.go?type=gene&acc=5170,,,5170.0,PDPK1,9606,Homo sapiens (human),[progesterone co-treated with estradiol] results in decreased expression of PDPK1 mRNA,,,PMID:17404688,https://www.ncbi.nlm.nih.gov/pubmed/17404688,17404688,,
730,589827,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,5170,PDPK1,https://ctdbase.org/detail.go?type=gene&acc=5170,,,5170.0,PDPK1,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of PDPK1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
731,589828,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10630,PDPN,https://ctdbase.org/detail.go?type=gene&acc=10630,,,10630.0,PDPN,9606,Homo sapiens (human),[estradiol co-treated with progesterone] results in increased expression of PDPN mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
732,589829,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10630,PDPN,https://ctdbase.org/detail.go?type=gene&acc=10630,,,10630.0,PDPN,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of PDPN mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
733,589990,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,23047,PDS5B,https://ctdbase.org/detail.go?type=gene&acc=23047,,,23047.0,PDS5B,9606,Homo sapiens (human),Estradiol results in increased expression of PDS5B mrna|[estradiol co-treated with tetrachlorodibenzodioxin] results in increased expression of PDS5B mRNA,,,PMID:19619570,https://www.ncbi.nlm.nih.gov/pubmed/19619570,19619570,,
734,589991,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,23047,PDS5B,https://ctdbase.org/detail.go?type=gene&acc=23047,,,23047.0,PDS5B,9606,Homo sapiens (human),Estradiol results in decreased expression of PDS5B mRNA,,,PMID:21185374,https://www.ncbi.nlm.nih.gov/pubmed/21185374,21185374,,
735,590331,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,5900,RALGDS,https://ctdbase.org/detail.go?type=gene&acc=5900,,,5900.0,RALGDS,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of RALGDS mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
736,590332,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9649,RALGPS1,https://ctdbase.org/detail.go?type=gene&acc=9649,,,9649.0,RALGPS1,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of RALGPS1 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
737,590333,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,55103,RALGPS2,https://ctdbase.org/detail.go?type=gene&acc=55103,,,55103.0,RALGPS2,9606,Homo sapiens (human),Estradiol results in increased expression of RALGPS2 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
738,590334,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,22913,RALY,https://ctdbase.org/detail.go?type=gene&acc=22913,,,22913.0,RALY,7955,Danio rerio (zebrafish),Estradiol affects the expression of RALY mRNA,,,PMID:23557687,https://www.ncbi.nlm.nih.gov/pubmed/23557687,23557687,,
739,590335,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,22913,RALY,https://ctdbase.org/detail.go?type=gene&acc=22913,,,22913.0,RALY,10090,Mus musculus (house mouse),Estradiol affects the expression of RALY mRNA,,,PMID:15598610,https://www.ncbi.nlm.nih.gov/pubmed/15598610,15598610,,
740,590336,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10267,RAMP1,https://ctdbase.org/detail.go?type=gene&acc=10267,,,10267.0,RAMP1,9606,Homo sapiens (human),Estradiol affects the expression of RAMP1 mRNA,,,PMID:22574217,https://www.ncbi.nlm.nih.gov/pubmed/22574217,22574217,,
741,590337,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10267,RAMP1,https://ctdbase.org/detail.go?type=gene&acc=10267,,,10267.0,RAMP1,10090,Mus musculus (house mouse),Estradiol affects the expression of RAMP1 mRNA,,,PMID:15598610,https://www.ncbi.nlm.nih.gov/pubmed/15598610,15598610,,
742,590338,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10267,RAMP1,https://ctdbase.org/detail.go?type=gene&acc=10267,,,10267.0,RAMP1,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of RAMP1 mRNA,,,PMID:15469997,https://www.ncbi.nlm.nih.gov/pubmed/15469997,15469997,,
743,590339,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10266,RAMP2,https://ctdbase.org/detail.go?type=gene&acc=10266,,,10266.0,RAMP2,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of RAMP2 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
744,590340,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10266,RAMP2,https://ctdbase.org/detail.go?type=gene&acc=10266,,,10266.0,RAMP2,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in increased expression of RAMP2 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
745,590694,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,55679,LIMS2,https://ctdbase.org/detail.go?type=gene&acc=55679,,,55679.0,LIMS2,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of LIMS2 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
746,590695,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,55957,LIN37,https://ctdbase.org/detail.go?type=gene&acc=55957,,,55957.0,LIN37,9606,Homo sapiens (human),Estradiol results in decreased expression of LIN37 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
747,590696,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,55957,LIN37,https://ctdbase.org/detail.go?type=gene&acc=55957,,,55957.0,LIN37,8090,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of LIN37 mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
748,591212,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,5916,RARG,https://ctdbase.org/detail.go?type=gene&acc=5916,,,5916.0,RARG,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of RARG mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
749,591213,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,5916,RARG,https://ctdbase.org/detail.go?type=gene&acc=5916,,,5916.0,RARG,9606,Homo sapiens (human),Estradiol results in decreased expression of RARG mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
750,591214,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,5918,RARRES1,https://ctdbase.org/detail.go?type=gene&acc=5918,,,5918.0,RARRES1,9606,Homo sapiens (human),[progesterone co-treated with estradiol] results in decreased expression of RARRES1 mRNA,,,PMID:17404688,https://www.ncbi.nlm.nih.gov/pubmed/17404688,17404688,,
751,591215,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,5918,RARRES1,https://ctdbase.org/detail.go?type=gene&acc=5918,,,5918.0,RARRES1,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of RARRES1 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
752,591412,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,22821,RASA3,https://ctdbase.org/detail.go?type=gene&acc=22821,,,22821.0,RASA3,9606,Homo sapiens (human),Estradiol affects the expression of RASA3 mRNA,,,PMID:22574217,https://www.ncbi.nlm.nih.gov/pubmed/22574217,22574217,,
753,591413,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,22821,RASA3,https://ctdbase.org/detail.go?type=gene&acc=22821,,,22821.0,RASA3,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of RASA3 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
754,591414,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,22821,RASA3,https://ctdbase.org/detail.go?type=gene&acc=22821,,,22821.0,RASA3,9606,Homo sapiens (human),Estradiol results in increased expression of RASA3 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
755,592449,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4000,LMNA,https://ctdbase.org/detail.go?type=gene&acc=4000,,,4000.0,LMNA,7955,Danio rerio (zebrafish),Estradiol affects the expression of LMNA mRNA,,,PMID:23557687,https://www.ncbi.nlm.nih.gov/pubmed/23557687,23557687,,
756,592450,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4000,LMNA,https://ctdbase.org/detail.go?type=gene&acc=4000,,,4000.0,LMNA,9606,Homo sapiens (human),Estradiol results in increased phosphorylation of LMNA protein,,,PMID:27026707,https://www.ncbi.nlm.nih.gov/pubmed/27026707,27026707,,
757,592451,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4000,LMNA,https://ctdbase.org/detail.go?type=gene&acc=4000,,,4000.0,LMNA,8090,Oryzias latipes (Japanese medaka),Estradiol results in increased expression of LMNA mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
758,592452,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4000,LMNA,https://ctdbase.org/detail.go?type=gene&acc=4000,,,4000.0,LMNA,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of LMNA mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
759,592453,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4001,LMNB1,https://ctdbase.org/detail.go?type=gene&acc=4001,,,4001.0,LMNB1,9606,Homo sapiens (human),Estradiol results in decreased expression of LMNB1 mRNA,,,PMID:20106945|PMID:21632981,https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/21632981,20106945|21632981,,
760,592454,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4001,LMNB1,https://ctdbase.org/detail.go?type=gene&acc=4001,,,4001.0,LMNB1,9606,Homo sapiens (human),Estradiol results in decreased phosphorylation of LMNB1 protein,,,PMID:27026707,https://www.ncbi.nlm.nih.gov/pubmed/27026707,27026707,,
761,592455,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4001,LMNB1,https://ctdbase.org/detail.go?type=gene&acc=4001,,,4001.0,LMNB1,9606,Homo sapiens (human),Estradiol results in increased expression of LMNB1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
762,593756,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,101054525,PGR-AS1,https://ctdbase.org/detail.go?type=gene&acc=101054525,,,101054525.0,PGR-AS1,9606,Homo sapiens (human),Estradiol results in increased expression of PGR-AS1 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
763,593757,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10857,PGRMC1,https://ctdbase.org/detail.go?type=gene&acc=10857,,,10857.0,PGRMC1,8090,Oryzias latipes (Japanese medaka),Estradiol results in increased expression of PGRMC1 mRNA,,,PMID:25611945,https://www.ncbi.nlm.nih.gov/pubmed/25611945,25611945,,
764,593758,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10857,PGRMC1,https://ctdbase.org/detail.go?type=gene&acc=10857,,,10857.0,PGRMC1,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of PGRMC1 mrna|estradiol results in increased expression of PGRMC1 protein,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
765,593759,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10424,PGRMC2,https://ctdbase.org/detail.go?type=gene&acc=10424,,,10424.0,PGRMC2,9606,Homo sapiens (human),Estradiol affects the expression of PGRMC2 mRNA,,,PMID:22574217,https://www.ncbi.nlm.nih.gov/pubmed/22574217,22574217,,
766,593760,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10424,PGRMC2,https://ctdbase.org/detail.go?type=gene&acc=10424,,,10424.0,PGRMC2,9606,Homo sapiens (human),[estradiol co-treated with bucladesine co-treated with medroxyprogesterone acetate] results in increased expression of PGRMC2 mRNA,,,PMID:20823114,https://www.ncbi.nlm.nih.gov/pubmed/20823114,20823114,,
767,593761,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9489,PGS1,https://ctdbase.org/detail.go?type=gene&acc=9489,,,9489.0,PGS1,9606,Homo sapiens (human),[estradiol co-treated with norethindrone acetate] results in increased expression of PGS1 mRNA,,,PMID:22217510,https://www.ncbi.nlm.nih.gov/pubmed/22217510,22217510,,
768,593762,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,221692,PHACTR1,https://ctdbase.org/detail.go?type=gene&acc=221692,,,221692.0,PHACTR1,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of PHACTR1 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
769,593948,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,1911,PHC1,https://ctdbase.org/detail.go?type=gene&acc=1911,,,1911.0,PHC1,7955,Danio rerio (zebrafish),Estradiol affects the expression of PHC1 mRNA,,,PMID:23557687,https://www.ncbi.nlm.nih.gov/pubmed/23557687,23557687,,
770,593949,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,80012,PHC3,https://ctdbase.org/detail.go?type=gene&acc=80012,,,80012.0,PHC3,9606,Homo sapiens (human),Estradiol results in increased expression of PHC3 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
771,593950,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,150368,PHETA2,https://ctdbase.org/detail.go?type=gene&acc=150368,,,150368.0,PHETA2,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of PHETA2 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
772,593951,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,5251,PHEX,https://ctdbase.org/detail.go?type=gene&acc=5251,,,5251.0,PHEX,8090,Oryzias latipes (Japanese medaka),Estradiol results in increased expression of PHEX mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
773,593952,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,57649,PHF12,https://ctdbase.org/detail.go?type=gene&acc=57649,,,57649.0,PHF12,9606,Homo sapiens (human),Estradiol results in increased expression of PHF12 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
774,593953,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,26147,PHF19,https://ctdbase.org/detail.go?type=gene&acc=26147,,,26147.0,PHF19,9606,Homo sapiens (human),Estradiol results in decreased expression of PHF19 mRNA,,,PMID:32387340,https://www.ncbi.nlm.nih.gov/pubmed/32387340,32387340,,
775,593954,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,26147,PHF19,https://ctdbase.org/detail.go?type=gene&acc=26147,,,26147.0,PHF19,9606,Homo sapiens (human),Estradiol results in increased expression of PHF19 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
776,593955,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,51105,PHF20L1,https://ctdbase.org/detail.go?type=gene&acc=51105,,,51105.0,PHF20L1,9606,Homo sapiens (human),Estradiol results in decreased expression of PHF20L1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
777,594261,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,5257,PHKB,https://ctdbase.org/detail.go?type=gene&acc=5257,,,5257.0,PHKB,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of PHKB mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
778,594262,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,22822,PHLDA1,https://ctdbase.org/detail.go?type=gene&acc=22822,,,22822.0,PHLDA1,9606,Homo sapiens (human),Estradiol affects the expression of PHLDA1 mRNA,,,PMID:25321415,https://www.ncbi.nlm.nih.gov/pubmed/25321415,25321415,,
779,594263,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,22822,PHLDA1,https://ctdbase.org/detail.go?type=gene&acc=22822,,,22822.0,PHLDA1,9606,Homo sapiens (human),[estradiol co-treated with progesterone] results in decreased expression of PHLDA1 mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
780,594264,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,22822,PHLDA1,https://ctdbase.org/detail.go?type=gene&acc=22822,,,22822.0,PHLDA1,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of PHLDA1 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
781,594265,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,22822,PHLDA1,https://ctdbase.org/detail.go?type=gene&acc=22822,,,22822.0,PHLDA1,9606,Homo sapiens (human),Estradiol results in increased expression of PHLDA1 mRNA,,,PMID:18556351|PMID:20106945|PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/18556351|https://www.ncbi.nlm.nih.gov/pubmed/20106945|https://www.ncbi.nlm.nih.gov/pubmed/31614463,18556351|20106945|31614463,,
782,594266,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,22822,PHLDA1,https://ctdbase.org/detail.go?type=gene&acc=22822,,,22822.0,PHLDA1,10090,Mus musculus (house mouse),[estradiol co-treated with progesterone] results in increased expression of PHLDA1 mRNA,,,PMID:18556351,https://www.ncbi.nlm.nih.gov/pubmed/18556351,18556351,,
783,594267,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,22822,PHLDA1,https://ctdbase.org/detail.go?type=gene&acc=22822,,,22822.0,PHLDA1,10090,Mus musculus (house mouse),Estradiol results in increased expression of PHLDA1 mRNA,,,PMID:19484750,https://www.ncbi.nlm.nih.gov/pubmed/19484750,19484750,,
784,594268,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,7262,PHLDA2,https://ctdbase.org/detail.go?type=gene&acc=7262,,,7262.0,PHLDA2,9606,Homo sapiens (human),Estradiol affects the expression of PHLDA2 mRNA,,,PMID:22574217,https://www.ncbi.nlm.nih.gov/pubmed/22574217,22574217,,
785,594269,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,7262,PHLDA2,https://ctdbase.org/detail.go?type=gene&acc=7262,,,7262.0,PHLDA2,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of PHLDA2 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
786,594408,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,162466,PHOSPHO1,https://ctdbase.org/detail.go?type=gene&acc=162466,,,162466.0,PHOSPHO1,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of PHOSPHO1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
787,594409,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,57157,PHTF2,https://ctdbase.org/detail.go?type=gene&acc=57157,,,57157.0,PHTF2,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in increased expression of PHTF2 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
788,594410,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,57157,PHTF2,https://ctdbase.org/detail.go?type=gene&acc=57157,,,57157.0,PHTF2,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of PHTF2 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
789,594411,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,157638,LRATD2,https://ctdbase.org/detail.go?type=gene&acc=157638,,,157638.0,LRATD2,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of LRATD2 mRNA,,,PMID:35192832,https://www.ncbi.nlm.nih.gov/pubmed/35192832,35192832,,
790,594412,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,987,LRBA,https://ctdbase.org/detail.go?type=gene&acc=987,,,987.0,LRBA,10116,Rattus norvegicus (Norway rat),Estradiol affects the expression of LRBA mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
791,594413,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,987,LRBA,https://ctdbase.org/detail.go?type=gene&acc=987,,,987.0,LRBA,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of LRBA mRNA,,,PMID:35192832,https://www.ncbi.nlm.nih.gov/pubmed/35192832,35192832,,
792,594414,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,100507055,LRCOL1,https://ctdbase.org/detail.go?type=gene&acc=100507055,,,100507055.0,LRCOL1,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in decreased expression of LRCOL1 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
793,594415,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,57622,LRFN1,https://ctdbase.org/detail.go?type=gene&acc=57622,,,57622.0,LRFN1,9606,Homo sapiens (human),Estradiol results in increased expression of LRFN1 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
794,594416,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,57497,LRFN2,https://ctdbase.org/detail.go?type=gene&acc=57497,,,57497.0,LRFN2,9606,Homo sapiens (human),Estradiol results in decreased expression of LRFN2 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
795,596366,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,359845,RFLNB,https://ctdbase.org/detail.go?type=gene&acc=359845,,,359845.0,RFLNB,10090,Mus musculus (house mouse),Estradiol results in decreased expression of RFLNB mRNA,,,PMID:19484750,https://www.ncbi.nlm.nih.gov/pubmed/19484750,19484750,,
796,596367,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,23180,RFTN1,https://ctdbase.org/detail.go?type=gene&acc=23180,,,23180.0,RFTN1,9606,Homo sapiens (human),Estradiol results in increased expression of RFTN1 mrna|[estradiol co-treated with tetrachlorodibenzodioxin] results in increased expression of RFTN1 mRNA,,,PMID:19619570,https://www.ncbi.nlm.nih.gov/pubmed/19619570,19619570,,
797,597333,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Fulvestrant inhibits the reaction [estradiol results in increased expression of ESR2 mrna],,,PMID:18973785|PMID:26867312|PMID:28882636,https://www.ncbi.nlm.nih.gov/pubmed/18973785|https://www.ncbi.nlm.nih.gov/pubmed/26867312|https://www.ncbi.nlm.nih.gov/pubmed/28882636,18973785|26867312|28882636,,
798,597334,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Fulvestrant inhibits the reaction [estradiol results in increased expression of ESR2 protein],,,PMID:28882636,https://www.ncbi.nlm.nih.gov/pubmed/28882636,28882636,,
799,597335,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Genistein inhibits the reaction [estradiol binds to ESR2 protein],,,PMID:10964929|PMID:11368622|PMID:16566672|PMID:9751507,https://www.ncbi.nlm.nih.gov/pubmed/10964929|https://www.ncbi.nlm.nih.gov/pubmed/11368622|https://www.ncbi.nlm.nih.gov/pubmed/16566672|https://www.ncbi.nlm.nih.gov/pubmed/9751507,10964929|11368622|16566672|9751507,,
800,597336,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Methoxyacetic acid promotes the reaction [estradiol results in increased activity of ESR2 protein],,,PMID:15103026|PMID:18486176,https://www.ncbi.nlm.nih.gov/pubmed/15103026|https://www.ncbi.nlm.nih.gov/pubmed/18486176,15103026|18486176,,
801,597337,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Perfluorooctanoic acid promotes the reaction [estradiol results in increased activity of ESR2 protein]|perfluorooctane sulfonic acid promotes the reaction [estradiol results in increased activity of ESR2 protein],,,PMID:29601859,https://www.ncbi.nlm.nih.gov/pubmed/29601859,29601859,,
802,597338,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Tamoxifen inhibits the reaction [estradiol results in increased expression of ESR2 mrna]|polychlorinated biphenyls metabolite inhibits the reaction [estradiol results in increased expression of ESR2 mrna],,,PMID:12377985,https://www.ncbi.nlm.nih.gov/pubmed/12377985,12377985,,
803,597339,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2100,ESR2,https://ctdbase.org/detail.go?type=gene&acc=2100,,,2100.0,ESR2,9606,Homo sapiens (human),Propolis inhibits the reaction [estradiol binds to ESR2 protein],,,PMID:25786527,https://www.ncbi.nlm.nih.gov/pubmed/25786527,25786527,,
804,599906,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,51132,RLIM,https://ctdbase.org/detail.go?type=gene&acc=51132,,,51132.0,RLIM,9606,Homo sapiens (human),Estradiol results in increased expression of RLIM mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
805,599907,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6013,RLN1,https://ctdbase.org/detail.go?type=gene&acc=6013,,,6013.0,RLN1,7955,Danio rerio (zebrafish),Estradiol affects the expression of RLN1 mRNA,,,PMID:23557687,https://www.ncbi.nlm.nih.gov/pubmed/23557687,23557687,,
806,599908,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6013,RLN1,https://ctdbase.org/detail.go?type=gene&acc=6013,,,6013.0,RLN1,9606,Homo sapiens (human),Tetrachlorodibenzodioxin inhibits the reaction [estradiol results in increased expression of RLN1 mrna]|estradiol results in increased expression of RLN1 mRNA,,,PMID:19416221,https://www.ncbi.nlm.nih.gov/pubmed/19416221,19416221,,
807,599909,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6019,RLN2,https://ctdbase.org/detail.go?type=gene&acc=6019,,,6019.0,RLN2,9606,Homo sapiens (human),EGF protein inhibits the reaction [estradiol results in increased expression of RLN2 mrna],,,PMID:24758408,https://www.ncbi.nlm.nih.gov/pubmed/24758408,24758408,,
808,599910,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6019,RLN2,https://ctdbase.org/detail.go?type=gene&acc=6019,,,6019.0,RLN2,9606,Homo sapiens (human),Estradiol affects the expression of RLN2 mrna|esr2 protein affects the reaction [estradiol results in increased expression of RLN2 mrna],,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
809,599911,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6019,RLN2,https://ctdbase.org/detail.go?type=gene&acc=6019,,,6019.0,RLN2,9606,Homo sapiens (human),Estradiol results in increased expression of RLN2 mRNA,,,PMID:19416221|PMID:24758408,https://www.ncbi.nlm.nih.gov/pubmed/19416221|https://www.ncbi.nlm.nih.gov/pubmed/24758408,19416221|24758408,,
810,599912,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6019,RLN2,https://ctdbase.org/detail.go?type=gene&acc=6019,,,6019.0,RLN2,9606,Homo sapiens (human),Fulvestrant inhibits the reaction [estradiol results in increased expression of RLN2 mrna]|tetrachlorodibenzodioxin inhibits the reaction [estradiol results in increased expression of RLN2 mrna],,,PMID:19416221,https://www.ncbi.nlm.nih.gov/pubmed/19416221,19416221,,
811,600562,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,10535,RNASEH2A,https://ctdbase.org/detail.go?type=gene&acc=10535,,,10535.0,RNASEH2A,9606,Homo sapiens (human),Estradiol results in increased expression of RNASEH2A mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
812,600563,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,440400,RNASEK,https://ctdbase.org/detail.go?type=gene&acc=440400,,,440400.0,RNASEK,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of RNASEK mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
813,600564,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,751692,RNASEKA,https://ctdbase.org/detail.go?type=gene&acc=751692,,,751692.0,rnaseka,8090,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of RNASEKA mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
814,600724,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,153443,SRFBP1,https://ctdbase.org/detail.go?type=gene&acc=153443,,,153443.0,SRFBP1,10090,Mus musculus (house mouse),Estradiol results in decreased expression of SRFBP1 mRNA,,,PMID:19484750,https://www.ncbi.nlm.nih.gov/pubmed/19484750,19484750,,
815,600725,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,57522,SRGAP1,https://ctdbase.org/detail.go?type=gene&acc=57522,,,57522.0,SRGAP1,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in increased expression of SRGAP1 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
816,600726,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9901,SRGAP3,https://ctdbase.org/detail.go?type=gene&acc=9901,,,9901.0,SRGAP3,9606,Homo sapiens (human),Estradiol affects the expression of SRGAP3 mRNA,,,PMID:25321415,https://www.ncbi.nlm.nih.gov/pubmed/25321415,25321415,,
817,600727,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9901,SRGAP3,https://ctdbase.org/detail.go?type=gene&acc=9901,,,9901.0,SRGAP3,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of SRGAP3 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
818,600728,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9901,SRGAP3,https://ctdbase.org/detail.go?type=gene&acc=9901,,,9901.0,SRGAP3,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of SRGAP3 mRNA,,,PMID:26945725,https://www.ncbi.nlm.nih.gov/pubmed/26945725,26945725,,
819,601053,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,84282,RNF135,https://ctdbase.org/detail.go?type=gene&acc=84282,,,84282.0,RNF135,9606,Homo sapiens (human),[estradiol co-treated with norethindrone acetate] results in increased expression of RNF135 mRNA,,,PMID:22217510,https://www.ncbi.nlm.nih.gov/pubmed/22217510,22217510,,
820,601054,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,11236,RNF139,https://ctdbase.org/detail.go?type=gene&acc=11236,,,11236.0,RNF139,9606,Homo sapiens (human),[estradiol co-treated with progesterone] results in decreased expression of RNF139 mrna|estradiol results in decreased expression of RNF139 mRNA,,,PMID:21453500,https://www.ncbi.nlm.nih.gov/pubmed/21453500,21453500,,
821,601055,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,11236,RNF139,https://ctdbase.org/detail.go?type=gene&acc=11236,,,11236.0,RNF139,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of RNF139 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
822,601056,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9604,RNF14,https://ctdbase.org/detail.go?type=gene&acc=9604,,,9604.0,RNF14,9606,Homo sapiens (human),Estradiol affects the expression of RNF14 mRNA,,,PMID:14699072,https://www.ncbi.nlm.nih.gov/pubmed/14699072,14699072,,
823,601057,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9604,RNF14,https://ctdbase.org/detail.go?type=gene&acc=9604,,,9604.0,RNF14,9606,Homo sapiens (human),[estradiol binds to ESR2 protein] which results in increased expression of RNF14 mRNA,,,PMID:20404318,https://www.ncbi.nlm.nih.gov/pubmed/20404318,20404318,,
824,601058,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,50862,RNF141,https://ctdbase.org/detail.go?type=gene&acc=50862,,,50862.0,RNF141,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of RNF141 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
825,601059,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9781,RNF144A,https://ctdbase.org/detail.go?type=gene&acc=9781,,,9781.0,RNF144A,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of RNF144A mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
826,601060,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,255488,RNF144B,https://ctdbase.org/detail.go?type=gene&acc=255488,,,255488.0,RNF144B,9606,Homo sapiens (human),[estradiol binds to ESR2 protein] which results in increased expression of RNF144B mRNA,,,PMID:20404318,https://www.ncbi.nlm.nih.gov/pubmed/20404318,20404318,,
827,601759,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6047,RNF4,https://ctdbase.org/detail.go?type=gene&acc=6047,,,6047.0,RNF4,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of RNF4 protein,,,PMID:14749358,https://www.ncbi.nlm.nih.gov/pubmed/14749358,14749358,,
828,601912,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,170463,SSBP4,https://ctdbase.org/detail.go?type=gene&acc=170463,,,170463.0,SSBP4,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of SSBP4 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
829,601913,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,284297,SSC5D,https://ctdbase.org/detail.go?type=gene&acc=284297,,,284297.0,SSC5D,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of SSC5D mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
830,601914,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,54434,SSH1,https://ctdbase.org/detail.go?type=gene&acc=54434,,,54434.0,SSH1,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of SSH1 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
831,601915,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,85464,SSH2,https://ctdbase.org/detail.go?type=gene&acc=85464,,,85464.0,SSH2,9606,Homo sapiens (human),Estradiol affects the expression of SSH2 mRNA,,,PMID:22574217,https://www.ncbi.nlm.nih.gov/pubmed/22574217,22574217,,
832,601916,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,85464,SSH2,https://ctdbase.org/detail.go?type=gene&acc=85464,,,85464.0,SSH2,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of SSH2 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
833,601917,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,54961,SSH3,https://ctdbase.org/detail.go?type=gene&acc=54961,,,54961.0,SSH3,9606,Homo sapiens (human),Estradiol affects the expression of SSH3 mRNA,,,PMID:22574217,https://www.ncbi.nlm.nih.gov/pubmed/22574217,22574217,,
834,601918,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,8082,SSPN,https://ctdbase.org/detail.go?type=gene&acc=8082,,,8082.0,SSPN,9606,Homo sapiens (human),[estradiol co-treated with progesterone] results in decreased expression of SSPN mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
835,601919,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6745,SSR1,https://ctdbase.org/detail.go?type=gene&acc=6745,,,6745.0,SSR1,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of SSR1 mrna|estradiol results in decreased expression of SSR1 protein,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
836,601920,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6746,SSR2,https://ctdbase.org/detail.go?type=gene&acc=6746,,,6746.0,SSR2,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of SSR2 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
837,602586,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,171481,FABP10A,https://ctdbase.org/detail.go?type=gene&acc=171481,,,171481.0,fabp10a,8090,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of FABP10A mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
838,602587,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,646486,FABP12,https://ctdbase.org/detail.go?type=gene&acc=646486,,,646486.0,FABP12,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of FABP12 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
839,602588,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,791610,FABP1A,https://ctdbase.org/detail.go?type=gene&acc=791610,,,791610.0,fabp1a,7955,Danio rerio (zebrafish),Estradiol results in increased expression of FABP1A mRNA,,,PMID:31352104,https://www.ncbi.nlm.nih.gov/pubmed/31352104,31352104,,
840,602589,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2169,FABP2,https://ctdbase.org/detail.go?type=gene&acc=2169,,,2169.0,FABP2,7955,Danio rerio (zebrafish),Estradiol results in decreased expression of FABP2 mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
841,604303,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,165215,FAM171B,https://ctdbase.org/detail.go?type=gene&acc=165215,,,165215.0,FAM171B,9606,Homo sapiens (human),[raloxifene hydrochloride co-treated with estradiol] results in increased expression of FAM171B mRNA,,,PMID:21185374,https://www.ncbi.nlm.nih.gov/pubmed/21185374,21185374,,
842,604304,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,165215,FAM171B,https://ctdbase.org/detail.go?type=gene&acc=165215,,,165215.0,FAM171B,10090,Mus musculus (house mouse),Estradiol results in increased expression of FAM171B mRNA,,,PMID:19484750,https://www.ncbi.nlm.nih.gov/pubmed/19484750,19484750,,
843,604305,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,165215,FAM171B,https://ctdbase.org/detail.go?type=gene&acc=165215,,,165215.0,FAM171B,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of FAM171B mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
844,604306,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,220382,FAM181B,https://ctdbase.org/detail.go?type=gene&acc=220382,,,220382.0,FAM181B,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of FAM181B mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
845,604307,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,79632,FAM184A,https://ctdbase.org/detail.go?type=gene&acc=79632,,,79632.0,FAM184A,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in decreased expression of FAM184A mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
846,604308,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,79632,FAM184A,https://ctdbase.org/detail.go?type=gene&acc=79632,,,79632.0,FAM184A,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of FAM184A mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
847,604309,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,222234,FAM185A,https://ctdbase.org/detail.go?type=gene&acc=222234,,,222234.0,FAM185A,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of FAM185A mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
848,604310,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,148109,FAM187B,https://ctdbase.org/detail.go?type=gene&acc=148109,,,148109.0,FAM187B,8090,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of FAM187B mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
849,604623,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,79689,STEAP4,https://ctdbase.org/detail.go?type=gene&acc=79689,,,79689.0,STEAP4,9606,Homo sapiens (human),Estradiol results in increased expression of STEAP4 mRNA,,,PMID:21185374,https://www.ncbi.nlm.nih.gov/pubmed/21185374,21185374,,
850,604624,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,79689,STEAP4,https://ctdbase.org/detail.go?type=gene&acc=79689,,,79689.0,STEAP4,9606,Homo sapiens (human),[progesterone co-treated with estradiol] results in increased expression of STEAP4 mRNA,,,PMID:17404688,https://www.ncbi.nlm.nih.gov/pubmed/17404688,17404688,,
851,604625,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,79689,STEAP4,https://ctdbase.org/detail.go?type=gene&acc=79689,,,79689.0,STEAP4,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of STEAP4 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
852,604626,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,20862,STFA2,https://ctdbase.org/detail.go?type=gene&acc=20862,,,20862.0,Stfa2,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of STFA2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
853,604627,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,498087,STFA2L2,https://ctdbase.org/detail.go?type=gene&acc=498087,,,498087.0,Stfa2l2,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of STFA2L2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
854,604628,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,20863,STFA3,https://ctdbase.org/detail.go?type=gene&acc=20863,,,20863.0,Stfa3,10090,Mus musculus (house mouse),Estradiol promotes the reaction [lipopolysaccharides results in increased expression of STFA3 mrna],,,PMID:16977382,https://www.ncbi.nlm.nih.gov/pubmed/16977382,16977382,,
855,604629,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6491,STIL,https://ctdbase.org/detail.go?type=gene&acc=6491,,,6491.0,STIL,9606,Homo sapiens (human),Estradiol results in increased expression of STIL mRNA,,,PMID:19167446|PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/19167446|https://www.ncbi.nlm.nih.gov/pubmed/20106945,19167446|20106945,,
856,604799,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,203259,FAM219A,https://ctdbase.org/detail.go?type=gene&acc=203259,,,203259.0,FAM219A,9606,Homo sapiens (human),Estradiol results in increased expression of FAM219A mRNA,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
857,604800,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,100421577,FAM21EP,https://ctdbase.org/detail.go?type=gene&acc=100421577,,,100421577.0,FAM21EP,9606,Homo sapiens (human),Estradiol results in decreased expression of FAM21EP mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
858,604801,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,340277,FAM221A,https://ctdbase.org/detail.go?type=gene&acc=340277,,,340277.0,FAM221A,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of FAM221A mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
859,604802,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,84915,FAM222A,https://ctdbase.org/detail.go?type=gene&acc=84915,,,84915.0,FAM222A,9606,Homo sapiens (human),[estradiol binds to ESR2 protein] which results in increased expression of FAM222A mRNA,,,PMID:20404318,https://www.ncbi.nlm.nih.gov/pubmed/20404318,20404318,,
860,604803,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,84915,FAM222A,https://ctdbase.org/detail.go?type=gene&acc=84915,,,84915.0,FAM222A,9606,Homo sapiens (human),Estradiol results in increased expression of FAM222A mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
861,605270,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,417685,FAM64A,https://ctdbase.org/detail.go?type=gene&acc=417685,,,417685.0,FAM64A,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of FAM64A mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
862,605271,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,429087,FAM69A,https://ctdbase.org/detail.go?type=gene&acc=429087,,,429087.0,FAM69A,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of FAM69A mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
863,605272,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,421014,FAM69C,https://ctdbase.org/detail.go?type=gene&acc=421014,,,421014.0,FAM69C,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of FAM69C mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
864,605273,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,729533,FAM72A,https://ctdbase.org/detail.go?type=gene&acc=729533,,,729533.0,FAM72A,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of FAM72A mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
865,605274,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,286336,FAM78A,https://ctdbase.org/detail.go?type=gene&acc=286336,,,286336.0,FAM78A,9606,Homo sapiens (human),Estradiol results in decreased expression of FAM78A mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
866,605275,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,286336,FAM78A,https://ctdbase.org/detail.go?type=gene&acc=286336,,,286336.0,FAM78A,10090,Mus musculus (house mouse),Estradiol results in decreased expression of FAM78A mRNA,,,PMID:19484750,https://www.ncbi.nlm.nih.gov/pubmed/19484750,19484750,,
867,605276,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,84985,FAM83A,https://ctdbase.org/detail.go?type=gene&acc=84985,,,84985.0,FAM83A,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of FAM83A mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
868,605277,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,84985,FAM83A,https://ctdbase.org/detail.go?type=gene&acc=84985,,,84985.0,FAM83A,9606,Homo sapiens (human),Estradiol results in decreased expression of FAM83A mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
869,605278,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,222584,FAM83B,https://ctdbase.org/detail.go?type=gene&acc=222584,,,222584.0,FAM83B,9606,Homo sapiens (human),Estradiol results in decreased expression of FAM83B mRNA,,,PMID:21185374|PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/21185374|https://www.ncbi.nlm.nih.gov/pubmed/31614463,21185374|31614463,,
870,605442,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198.0,RPS6KB1,9606,Homo sapiens (human),Everolimus inhibits the reaction [estradiol results in increased phosphorylation of RPS6KB1 protein],,,PMID:16033851,https://www.ncbi.nlm.nih.gov/pubmed/16033851,16033851,,
871,605443,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198.0,RPS6KB1,10116,Rattus norvegicus (Norway rat),[estradiol co-treated with progesterone co-treated with methylnitrosourea] results in increased phosphorylation of RPS6KB1 protein,,,PMID:22465879,https://www.ncbi.nlm.nih.gov/pubmed/22465879,22465879,,
872,605632,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,22823,MTF2,https://ctdbase.org/detail.go?type=gene&acc=22823,,,22823.0,MTF2,7955,Danio rerio (zebrafish),Estradiol affects the expression of MTF2 mRNA,,,PMID:23557687,https://www.ncbi.nlm.nih.gov/pubmed/23557687,23557687,,
873,605633,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,51537,MTFP1,https://ctdbase.org/detail.go?type=gene&acc=51537,,,51537.0,MTFP1,9606,Homo sapiens (human),Estradiol results in increased expression of MTFP1 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
874,605634,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,51537,MTFP1,https://ctdbase.org/detail.go?type=gene&acc=51537,,,51537.0,MTFP1,10090,Mus musculus (house mouse),Estradiol results in decreased expression of MTFP1 mRNA,,,PMID:19484750,https://www.ncbi.nlm.nih.gov/pubmed/19484750,19484750,,
875,605635,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,51537,MTFP1,https://ctdbase.org/detail.go?type=gene&acc=51537,,,51537.0,MTFP1,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of MTFP1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
876,605636,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,113115,MTFR2,https://ctdbase.org/detail.go?type=gene&acc=113115,,,113115.0,MTFR2,27706,Micropterus salmoides (largemouth bass),[dieldrin co-treated with estradiol] results in decreased expression of MTFR2 mRNA,,,PMID:23041725,https://www.ncbi.nlm.nih.gov/pubmed/23041725,23041725,,
877,605637,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4522,MTHFD1,https://ctdbase.org/detail.go?type=gene&acc=4522,,,4522.0,MTHFD1,9606,Homo sapiens (human),Estradiol results in decreased expression of MTHFD1 mRNA,,,PMID:16705744,https://www.ncbi.nlm.nih.gov/pubmed/16705744,16705744,,
878,605638,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4522,MTHFD1,https://ctdbase.org/detail.go?type=gene&acc=4522,,,4522.0,MTHFD1,9606,Homo sapiens (human),Estradiol results in increased expression of MTHFD1 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
879,605639,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4522,MTHFD1,https://ctdbase.org/detail.go?type=gene&acc=4522,,,4522.0,MTHFD1,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of MTHFD1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
880,606117,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6804,STX1A,https://ctdbase.org/detail.go?type=gene&acc=6804,,,6804.0,STX1A,9606,Homo sapiens (human),Estradiol affects the expression of STX1A mRNA,,,PMID:22574217,https://www.ncbi.nlm.nih.gov/pubmed/22574217,22574217,,
881,606118,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6804,STX1A,https://ctdbase.org/detail.go?type=gene&acc=6804,,,6804.0,STX1A,9606,Homo sapiens (human),Estradiol results in increased expression of STX1A mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
882,606119,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,2054,STX2,https://ctdbase.org/detail.go?type=gene&acc=2054,,,2054.0,STX2,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of STX2 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
883,606120,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6809,STX3,https://ctdbase.org/detail.go?type=gene&acc=6809,,,6809.0,STX3,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in increased expression of STX3 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
884,606121,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,9482,STX8,https://ctdbase.org/detail.go?type=gene&acc=9482,,,9482.0,STX8,9606,Homo sapiens (human),Estradiol results in decreased expression of STX8 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
885,606122,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6812,STXBP1,https://ctdbase.org/detail.go?type=gene&acc=6812,,,6812.0,STXBP1,9606,Homo sapiens (human),Estradiol results in decreased expression of STXBP1 mRNA,,,PMID:21185374,https://www.ncbi.nlm.nih.gov/pubmed/21185374,21185374,,
886,606123,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,134957,STXBP5,https://ctdbase.org/detail.go?type=gene&acc=134957,,,134957.0,STXBP5,9606,Homo sapiens (human),[estradiol co-treated with norethindrone acetate] results in increased expression of STXBP5 mRNA,,,PMID:22217510,https://www.ncbi.nlm.nih.gov/pubmed/22217510,22217510,,
887,606124,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,29091,STXBP6,https://ctdbase.org/detail.go?type=gene&acc=29091,,,29091.0,STXBP6,9606,Homo sapiens (human),[estradiol co-treated with progesterone] results in increased expression of STXBP6 mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
888,606125,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,29091,STXBP6,https://ctdbase.org/detail.go?type=gene&acc=29091,,,29091.0,STXBP6,9606,Homo sapiens (human),Estradiol results in decreased expression of STXBP6 mRNA,,,PMID:23019147,https://www.ncbi.nlm.nih.gov/pubmed/23019147,23019147,,
889,606126,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,55359,STYK1,https://ctdbase.org/detail.go?type=gene&acc=55359,,,55359.0,STYK1,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in increased expression of STYK1 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
890,606300,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,54751,FBLIM1,https://ctdbase.org/detail.go?type=gene&acc=54751,,,54751.0,FBLIM1,10090,Mus musculus (house mouse),Estradiol inhibits the reaction [lipopolysaccharides results in increased expression of FBLIM1 mrna],,,PMID:16977382,https://www.ncbi.nlm.nih.gov/pubmed/16977382,16977382,,
891,606829,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,9606,Homo sapiens (human),"2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine inhibits the reaction [SULT1A1 protein results in increased sulfation of estradiol]|4-biphenylamine inhibits the reaction [SULT1A1 protein results in increased sulfation of estradiol]|n-hydroxy-4-aminobiphenyl inhibits the reaction [SULT1A1 protein results in increased sulfation of estradiol]",,,PMID:17433394,https://www.ncbi.nlm.nih.gov/pubmed/17433394,17433394,,
892,606830,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of SULT1A1 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
893,606831,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,9606,Homo sapiens (human),SULT1A1 gene polymorphism affects the sulfation of estradiol,,,PMID:16517757,https://www.ncbi.nlm.nih.gov/pubmed/16517757,16517757,,
894,606832,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,9606,Homo sapiens (human),SULT1A1 protein results in increased sulfation of estradiol,,,PMID:11181495|PMID:16517757|PMID:17433394,https://www.ncbi.nlm.nih.gov/pubmed/11181495|https://www.ncbi.nlm.nih.gov/pubmed/16517757|https://www.ncbi.nlm.nih.gov/pubmed/17433394,11181495|16517757|17433394,,
895,606833,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,10090,Mus musculus (house mouse),SULT1A1 protein results in increased sulfation of estradiol,,,PMID:11181495,https://www.ncbi.nlm.nih.gov/pubmed/11181495,11181495,,
896,606834,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6817,SULT1A1,https://ctdbase.org/detail.go?type=gene&acc=6817,,,6817.0,SULT1A1,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of SULT1A1 mRNA,,,PMID:31119341|PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/31119341|https://www.ncbi.nlm.nih.gov/pubmed/32145629,31119341|32145629,,
897,606980,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,422049,MUT,https://ctdbase.org/detail.go?type=gene&acc=422049,,,422049.0,MUT,10116,Rattus norvegicus (Norway rat),Estradiol affects the expression of MUT mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
898,606981,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,89853,MVB12B,https://ctdbase.org/detail.go?type=gene&acc=89853,,,89853.0,MVB12B,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of MVB12B mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
899,606982,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4597,MVD,https://ctdbase.org/detail.go?type=gene&acc=4597,,,4597.0,MVD,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of MVD mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
900,606983,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4598,MVK,https://ctdbase.org/detail.go?type=gene&acc=4598,,,4598.0,MVK,9606,Homo sapiens (human),Estradiol results in increased expression of MVK mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
901,606984,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4598,MVK,https://ctdbase.org/detail.go?type=gene&acc=4598,,,4598.0,MVK,10116,Rattus norvegicus (Norway rat),Estradiol affects the expression of MVK mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
902,606985,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4599,MX1,https://ctdbase.org/detail.go?type=gene&acc=4599,,,4599.0,MX1,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of MX1 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
903,606986,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4599,MX1,https://ctdbase.org/detail.go?type=gene&acc=4599,,,4599.0,MX1,9606,Homo sapiens (human),Estradiol results in decreased expression of MX1 mRNA,,,PMID:23373633,https://www.ncbi.nlm.nih.gov/pubmed/23373633,23373633,,
904,607337,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4602,MYB,https://ctdbase.org/detail.go?type=gene&acc=4602,,,4602.0,MYB,9606,Homo sapiens (human),Estradiol affects the expression of MYB mRNA,,,PMID:21826169,https://www.ncbi.nlm.nih.gov/pubmed/21826169,21826169,,
905,607338,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4602,MYB,https://ctdbase.org/detail.go?type=gene&acc=4602,,,4602.0,MYB,9606,Homo sapiens (human),[estradiol binds to ESR2 protein] which results in increased expression of MYB mRNA,,,PMID:20404318,https://www.ncbi.nlm.nih.gov/pubmed/20404318,20404318,,
906,607339,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4602,MYB,https://ctdbase.org/detail.go?type=gene&acc=4602,,,4602.0,MYB,9606,Homo sapiens (human),[estradiol co-treated with tetrachlorodibenzodioxin] results in decreased expression of MYB mRNA,,,PMID:19619570,https://www.ncbi.nlm.nih.gov/pubmed/19619570,19619570,,
907,607340,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4602,MYB,https://ctdbase.org/detail.go?type=gene&acc=4602,,,4602.0,MYB,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of MYB mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
908,607341,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4602,MYB,https://ctdbase.org/detail.go?type=gene&acc=4602,,,4602.0,MYB,9606,Homo sapiens (human),Estradiol results in increased expression of MYB mRNA,,,PMID:15223131|PMID:16029874|PMID:16474171|PMID:19167446|PMID:19619570|PMID:21185374|PMID:26865669|PMID:28591870|PMID:28711546|PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/15223131|https://www.ncbi.nlm.nih.gov/pubmed/16029874|https://www.ncbi.nlm.nih.gov/pubmed/16474171|https://www.ncbi.nlm.nih.gov/pubmed/19167446|https://www.ncbi.nlm.nih.gov/pubmed/19619570|https://www.ncbi.nlm.nih.gov/pubmed/21185374|https://www.ncbi.nlm.nih.gov/pubmed/26865669|https://www.ncbi.nlm.nih.gov/pubmed/28591870|https://www.ncbi.nlm.nih.gov/pubmed/28711546|https://www.ncbi.nlm.nih.gov/pubmed/31614463,15223131|16029874|16474171|19167446|19619570|21185374|26865669|28591870|28711546|31614463,,
909,607342,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4602,MYB,https://ctdbase.org/detail.go?type=gene&acc=4602,,,4602.0,MYB,9606,Homo sapiens (human),Raloxifene hydrochloride inhibits the reaction [estradiol results in increased expression of MYB mrna],,,PMID:21185374,https://www.ncbi.nlm.nih.gov/pubmed/21185374,21185374,,
910,607715,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4605,MYBL2,https://ctdbase.org/detail.go?type=gene&acc=4605,,,4605.0,MYBL2,9606,Homo sapiens (human),Estradiol results in decreased expression of MYBL2 mRNA,,,PMID:23373633,https://www.ncbi.nlm.nih.gov/pubmed/23373633,23373633,,
911,607716,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4605,MYBL2,https://ctdbase.org/detail.go?type=gene&acc=4605,,,4605.0,MYBL2,9606,Homo sapiens (human),Estradiol results in increased expression of MYBL2 mRNA,,,PMID:16474171|PMID:18310284|PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/16474171|https://www.ncbi.nlm.nih.gov/pubmed/18310284|https://www.ncbi.nlm.nih.gov/pubmed/19167446,16474171|18310284|19167446,,
912,607717,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4605,MYBL2,https://ctdbase.org/detail.go?type=gene&acc=4605,,,4605.0,MYBL2,10090,Mus musculus (house mouse),Estradiol results in increased expression of MYBL2 mrna|esr1 protein promotes the reaction [estradiol results in increased expression of MYBL2 mrna],,,PMID:25210133,https://www.ncbi.nlm.nih.gov/pubmed/25210133,25210133,,
913,607718,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4605,MYBL2,https://ctdbase.org/detail.go?type=gene&acc=4605,,,4605.0,MYBL2,10116,Rattus norvegicus (Norway rat),Estradiol results in increased expression of MYBL2 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
914,607719,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4604,MYBPC1,https://ctdbase.org/detail.go?type=gene&acc=4604,,,4604.0,MYBPC1,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of MYBPC1 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
915,607720,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4606,MYBPC2,https://ctdbase.org/detail.go?type=gene&acc=4606,,,4606.0,MYBPC2,10090,Mus musculus (house mouse),Estradiol results in decreased expression of MYBPC2 mRNA,,,PMID:19484750,https://www.ncbi.nlm.nih.gov/pubmed/19484750,19484750,,
916,607721,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4606,MYBPC2,https://ctdbase.org/detail.go?type=gene&acc=4606,,,4606.0,MYBPC2,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of MYBPC2 mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
917,607722,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606,Homo sapiens (human),4-fluorobenzoyl-TN-14003 inhibits the reaction [estradiol results in increased expression of MYC mrna],,,PMID:19584281,https://www.ncbi.nlm.nih.gov/pubmed/19584281,19584281,,
918,607723,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606,Homo sapiens (human),4-hydroxy-N-desmethyltamoxifen inhibits the reaction [estradiol results in increased expression of MYC mrna],,,PMID:19244106,https://www.ncbi.nlm.nih.gov/pubmed/19244106,19244106,,
919,607724,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,4609,MYC,https://ctdbase.org/detail.go?type=gene&acc=4609,,,4609.0,MYC,9606,Homo sapiens (human),Afimoxifene inhibits the reaction [estradiol results in increased expression of MYC mrna]|myc protein promotes the reaction [estradiol results in increased expression of GLS protein],,,PMID:27514991,https://www.ncbi.nlm.nih.gov/pubmed/27514991,27514991,,
920,607883,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,286151,FBXO43,https://ctdbase.org/detail.go?type=gene&acc=286151,,,286151.0,FBXO43,9606,Homo sapiens (human),Estradiol results in decreased expression of FBXO43 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
921,607884,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,286151,FBXO43,https://ctdbase.org/detail.go?type=gene&acc=286151,,,286151.0,FBXO43,8090,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of FBXO43 mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
922,607885,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,200933,FBXO45,https://ctdbase.org/detail.go?type=gene&acc=200933,,,200933.0,FBXO45,9606,Homo sapiens (human),Estradiol results in increased expression of FBXO45 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
923,607886,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,23403,FBXO46,https://ctdbase.org/detail.go?type=gene&acc=23403,,,23403.0,FBXO46,10116,Rattus norvegicus (Norway rat),Estradiol results in decreased expression of FBXO46 mRNA,,,PMID:20068009,https://www.ncbi.nlm.nih.gov/pubmed/20068009,20068009,,
924,607887,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,494188,FBXO47,https://ctdbase.org/detail.go?type=gene&acc=494188,,,494188.0,FBXO47,8090,Oryzias latipes (Japanese medaka),Estradiol results in decreased expression of FBXO47 mRNA,,,PMID:32622090,https://www.ncbi.nlm.nih.gov/pubmed/32622090,32622090,,
925,607888,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,26271,FBXO5,https://ctdbase.org/detail.go?type=gene&acc=26271,,,26271.0,FBXO5,9606,Homo sapiens (human),Estradiol results in increased expression of FBXO5 mRNA,,,PMID:16474171|PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/16474171|https://www.ncbi.nlm.nih.gov/pubmed/19167446,16474171|19167446,,
926,607889,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,26270,FBXO6,https://ctdbase.org/detail.go?type=gene&acc=26270,,,26270.0,FBXO6,9606,Homo sapiens (human),Estradiol affects the expression of FBXO6 mRNA,,,PMID:22574217,https://www.ncbi.nlm.nih.gov/pubmed/22574217,22574217,,
927,607890,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,26270,FBXO6,https://ctdbase.org/detail.go?type=gene&acc=26270,,,26270.0,FBXO6,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in decreased expression of FBXO6 mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
928,607891,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,26269,FBXO8,https://ctdbase.org/detail.go?type=gene&acc=26269,,,26269.0,FBXO8,9606,Homo sapiens (human),Estradiol results in decreased expression of FBXO8 mRNA,,,PMID:31614463,https://www.ncbi.nlm.nih.gov/pubmed/31614463,31614463,,
929,608589,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,79368,FCRL2,https://ctdbase.org/detail.go?type=gene&acc=79368,,,79368.0,FCRL2,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of FCRL2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
930,608590,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,83416,FCRL5,https://ctdbase.org/detail.go?type=gene&acc=83416,,,83416.0,FCRL5,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of FCRL5 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
931,608591,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,84824,FCRLA,https://ctdbase.org/detail.go?type=gene&acc=84824,,,84824.0,FCRLA,9606,Homo sapiens (human),[estradiol co-treated with TGFB1 protein] results in increased expression of FCRLA mRNA,,,PMID:30165855,https://www.ncbi.nlm.nih.gov/pubmed/30165855,30165855,,
932,608935,5757,Comparative Toxicogenomics Database (CTD),Estradiol,D004958,Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004958,6277,S100A6,https://ctdbase.org/detail.go?type=gene&acc=6277,,,6277.0,S100A6,10090,Mus musculus (house mouse),Estradiol results in increased expression of S100A6 protein|raloxifene hydrochloride inhibits the reaction [estradiol results in increased expression of S100A6 protein]|afimoxifene inhibits the reaction [estradiol results in increased expression of S100A6 protein]|desmethylarzoxifene inhibits the reaction [estradiol results in increased expression of S100A6 protein],,,PMID:26879975,https://www.ncbi.nlm.nih.gov/pubmed/26879975,26879975,,
933,421392,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,8800,PEX11A,https://ctdbase.org/detail.go?type=gene&acc=8800,,,8800.0,PEX11A,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of PEX11A mRNA,,,PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/22484513,22484513,,
934,421393,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,26227,PHGDH,https://ctdbase.org/detail.go?type=gene&acc=26227,,,26227.0,PHGDH,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of PHGDH mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
935,421394,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,5313,PKLR,https://ctdbase.org/detail.go?type=gene&acc=5313,,,5313.0,PKLR,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in decreased expression of PKLR mRNA,,,PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/22484513,22484513,,
936,421395,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,81579,PLA2G12A,https://ctdbase.org/detail.go?type=gene&acc=81579,,,81579.0,PLA2G12A,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of PLA2G12A mRNA,,,PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/22484513,22484513,,
937,421396,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,5322,PLA2G5,https://ctdbase.org/detail.go?type=gene&acc=5322,,,5322.0,PLA2G5,10090,Mus musculus (house mouse),[piperonyl butoxide co-treated with diethylnitrosamine] affects the methylation of PLA2G5 gene,,,PMID:23968726,https://www.ncbi.nlm.nih.gov/pubmed/23968726,23968726,,
938,421397,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,11145,PLAAT3,https://ctdbase.org/detail.go?type=gene&acc=11145,,,11145.0,PLAAT3,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in decreased expression of PLAAT3 mRNA,,,PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/22484513,22484513,,
939,421398,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,5339,PLEC,https://ctdbase.org/detail.go?type=gene&acc=5339,,,5339.0,PLEC,10090,Mus musculus (house mouse),[piperonyl butoxide co-treated with diethylnitrosamine] affects the methylation of PLEC gene,,,PMID:23968726,https://www.ncbi.nlm.nih.gov/pubmed/23968726,23968726,,
940,421399,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,54477,PLEKHA5,https://ctdbase.org/detail.go?type=gene&acc=54477,,,54477.0,PLEKHA5,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in decreased expression of PLEKHA5 mRNA,,,PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/22484513,22484513,,
941,421400,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,51177,PLEKHO1,https://ctdbase.org/detail.go?type=gene&acc=51177,,,51177.0,PLEKHO1,10090,Mus musculus (house mouse),[piperonyl butoxide co-treated with diethylnitrosamine] affects the methylation of PLEKHO1 gene,,,PMID:23968726,https://www.ncbi.nlm.nih.gov/pubmed/23968726,23968726,,
942,421863,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,5692,PSMB4,https://ctdbase.org/detail.go?type=gene&acc=5692,,,5692.0,PSMB4,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of PSMB4 mRNA,,,PMID:15890375|PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/15890375|https://www.ncbi.nlm.nih.gov/pubmed/22484513,15890375|22484513,,
943,421864,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,5693,PSMB5,https://ctdbase.org/detail.go?type=gene&acc=5693,,,5693.0,PSMB5,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of PSMB5 mRNA,,,PMID:15890375|PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/15890375|https://www.ncbi.nlm.nih.gov/pubmed/22484513,15890375|22484513,,
944,422328,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,5727,PTCH1,https://ctdbase.org/detail.go?type=gene&acc=5727,,,5727.0,PTCH1,10090,Mus musculus (house mouse),Piperonyl butoxide affects the reaction [PTCH1 protein affects the expression of GLI1 protein]|sag compound affects the reaction [piperonyl butoxide affects the reaction [PTCH1 protein affects the expression of GLI1 protein]],,,PMID:31642701,https://www.ncbi.nlm.nih.gov/pubmed/31642701,31642701,,
945,422329,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,7803,PTP4A1,https://ctdbase.org/detail.go?type=gene&acc=7803,,,7803.0,PTP4A1,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of PTP4A1 mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
946,422330,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,11099,PTPN21,https://ctdbase.org/detail.go?type=gene&acc=11099,,,11099.0,PTPN21,10090,Mus musculus (house mouse),[piperonyl butoxide co-treated with diethylnitrosamine] affects the methylation of PTPN21 gene,,,PMID:23968726,https://www.ncbi.nlm.nih.gov/pubmed/23968726,23968726,,
947,422331,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,5802,PTPRS,https://ctdbase.org/detail.go?type=gene&acc=5802,,,5802.0,PTPRS,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in decreased expression of PTPRS mRNA,,,PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/22484513,22484513,,
948,422332,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,9232,PTTG1,https://ctdbase.org/detail.go?type=gene&acc=9232,,,9232.0,PTTG1,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of PTTG1 mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
949,422333,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,97423,R74862,https://ctdbase.org/detail.go?type=gene&acc=97423,,,97423.0,R74862,10090,Mus musculus (house mouse),[piperonyl butoxide co-treated with diethylnitrosamine] affects the methylation of R74862 gene,,,PMID:23968726,https://www.ncbi.nlm.nih.gov/pubmed/23968726,23968726,,
950,422334,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,29127,RACGAP1,https://ctdbase.org/detail.go?type=gene&acc=29127,,,29127.0,RACGAP1,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of RACGAP1 mRNA,,,PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/22484513,22484513,,
951,422335,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,10111,RAD50,https://ctdbase.org/detail.go?type=gene&acc=10111,,,10111.0,RAD50,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of RAD50 mrna|triterpenes promotes the reaction [piperonyl butoxide results in increased expression of RAD50 mrna],,,PMID:18544911,https://www.ncbi.nlm.nih.gov/pubmed/18544911,18544911,,
952,423649,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,283652,SLC24A5,https://ctdbase.org/detail.go?type=gene&acc=283652,,,283652.0,SLC24A5,10090,Mus musculus (house mouse),[piperonyl butoxide co-treated with diethylnitrosamine] affects the methylation of SLC24A5 gene,,,PMID:23968726,https://www.ncbi.nlm.nih.gov/pubmed/23968726,23968726,,
953,423650,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,115019,SLC26A9,https://ctdbase.org/detail.go?type=gene&acc=115019,,,115019.0,SLC26A9,10090,Mus musculus (house mouse),[piperonyl butoxide co-treated with diethylnitrosamine] affects the methylation of SLC26A9 gene,,,PMID:23968726,https://www.ncbi.nlm.nih.gov/pubmed/23968726,23968726,,
954,423651,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with piperonyl butoxide] results in increased expression of SLC2A1 protein,,,PMID:28903497,https://www.ncbi.nlm.nih.gov/pubmed/28903497,28903497,,
955,423652,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,2542,SLC37A4,https://ctdbase.org/detail.go?type=gene&acc=2542,,,2542.0,SLC37A4,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in decreased expression of SLC37A4 mRNA,,,PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/22484513,22484513,,
956,423653,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,6520,SLC3A2,https://ctdbase.org/detail.go?type=gene&acc=6520,,,6520.0,SLC3A2,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of SLC3A2 mRNA,,,PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/22484513,22484513,,
957,423654,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,8140,SLC7A5,https://ctdbase.org/detail.go?type=gene&acc=8140,,,8140.0,SLC7A5,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of SLC7A5 mRNA,,,PMID:17498859,https://www.ncbi.nlm.nih.gov/pubmed/17498859,17498859,,
958,424135,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,6754,SSTR4,https://ctdbase.org/detail.go?type=gene&acc=6754,,,6754.0,SSTR4,10090,Mus musculus (house mouse),[piperonyl butoxide co-treated with diethylnitrosamine] affects the methylation of SSTR4 gene,,,PMID:23968726,https://www.ncbi.nlm.nih.gov/pubmed/23968726,23968726,,
959,424136,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,30815,ST6GALNAC6,https://ctdbase.org/detail.go?type=gene&acc=30815,,,30815.0,ST6GALNAC6,10090,Mus musculus (house mouse),[piperonyl butoxide co-treated with diethylnitrosamine] affects the methylation of ST6GALNAC6 gene,,,PMID:23968726,https://www.ncbi.nlm.nih.gov/pubmed/23968726,23968726,,
960,424137,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,8987,STBD1,https://ctdbase.org/detail.go?type=gene&acc=8987,,,8987.0,STBD1,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of STBD1 mRNA,,,PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/22484513,22484513,,
961,424138,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,10963,STIP1,https://ctdbase.org/detail.go?type=gene&acc=10963,,,10963.0,STIP1,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of STIP1 mRNA,,,PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/22484513,22484513,,
962,424139,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,3925,STMN1,https://ctdbase.org/detail.go?type=gene&acc=3925,,,3925.0,STMN1,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of STMN1 mRNA,,,PMID:15890375|PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/15890375|https://www.ncbi.nlm.nih.gov/pubmed/22484513,15890375|22484513,,
963,424140,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,100043194,SULT2A2,https://ctdbase.org/detail.go?type=gene&acc=100043194,,,100043194.0,Sult2a2,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of SULT2A2 mRNA,,,PMID:22008526,https://www.ncbi.nlm.nih.gov/pubmed/22008526,22008526,,
964,424141,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,6898,TAT,https://ctdbase.org/detail.go?type=gene&acc=6898,,,6898.0,TAT,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in decreased expression of TAT mRNA,,,PMID:15890375,https://www.ncbi.nlm.nih.gov/pubmed/15890375,15890375,,
965,425152,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,100128927,ZBTB42,https://ctdbase.org/detail.go?type=gene&acc=100128927,,,100128927.0,ZBTB42,10090,Mus musculus (house mouse),[piperonyl butoxide co-treated with diethylnitrosamine] affects the methylation of ZBTB42 gene,,,PMID:23968726,https://www.ncbi.nlm.nih.gov/pubmed/23968726,23968726,,
966,425153,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,51201,ZDHHC2,https://ctdbase.org/detail.go?type=gene&acc=51201,,,51201.0,ZDHHC2,10116,Rattus norvegicus (Norway rat),Piperonyl butoxide results in increased expression of ZDHHC2 mRNA,,,PMID:22484513,https://www.ncbi.nlm.nih.gov/pubmed/22484513,22484513,,
967,425154,5794,Comparative Toxicogenomics Database (CTD),Piperonyl butoxide,D010882,Piperonyl Butoxide,https://ctdbase.org/detail.go?type=chem&acc=D010882,29813,ZFP385A,https://ctdbase.org/detail.go?type=gene&acc=29813,,,29813.0,Zfp385a,10090,Mus musculus (house mouse),[piperonyl butoxide co-treated with diethylnitrosamine] affects the methylation of ZFP385A gene,,,PMID:23968726,https://www.ncbi.nlm.nih.gov/pubmed/23968726,23968726,,
968,591206,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,8705,B3GALT4,https://ctdbase.org/detail.go?type=gene&acc=8705,,,8705.0,B3GALT4,10116,Rattus norvegicus (Norway rat),Dextroamphetamine results in decreased expression of B3GALT4 mRNA,,,PMID:16715494,https://www.ncbi.nlm.nih.gov/pubmed/16715494,16715494,,
969,591207,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,9606,Homo sapiens (human),"[N-methyl-3,4-methylenedioxyamphetamine co-treated with methamphetamine co-treated with 4-methylthioamphetamine co-treated with dextroamphetamine] results in increased expression of BAK1 protein|dextroamphetamine results in increased expression of BAK1 protein",,,PMID:23820845,https://www.ncbi.nlm.nih.gov/pubmed/23820845,23820845,,
970,591208,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),"[N-methyl-3,4-methylenedioxyamphetamine co-treated with methamphetamine co-treated with 4-methylthioamphetamine co-treated with dextroamphetamine] results in increased expression of BAX protein|dextroamphetamine results in increased expression of BAX mrna|[n-methyl-3,4-methylenedioxyamphetamine co-treated with methamphetamine co-treated with 4-methylthioamphetamine co-treated with dextroamphetamine] results in increased expression of BAX mrna|dextroamphetamine results in increased expression of BAX protein",,,PMID:23820845,https://www.ncbi.nlm.nih.gov/pubmed/23820845,23820845,,
971,591209,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113.0,BBC3,9606,Homo sapiens (human),"[N-methyl-3,4-methylenedioxyamphetamine co-treated with methamphetamine co-treated with 4-methylthioamphetamine co-treated with dextroamphetamine] results in increased expression of BBC3 mrna|dextroamphetamine results in increased expression of BBC3 mrna|dextroamphetamine results in increased expression of BBC3 protein|[n-methyl-3,4-methylenedioxyamphetamine co-treated with methamphetamine co-treated with 4-methylthioamphetamine co-treated with dextroamphetamine] results in increased expression of BBC3 protein",,,PMID:23820845,https://www.ncbi.nlm.nih.gov/pubmed/23820845,23820845,,
972,591210,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,9606,Homo sapiens (human),"[N-methyl-3,4-methylenedioxyamphetamine co-treated with methamphetamine co-treated with 4-methylthioamphetamine co-treated with dextroamphetamine] results in decreased expression of BCL2 mrna|dextroamphetamine results in decreased expression of BCL2 mRNA",,,PMID:23820845,https://www.ncbi.nlm.nih.gov/pubmed/23820845,23820845,,
973,591211,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,9606,Homo sapiens (human),"Dextroamphetamine results in decreased expression of BCL2L1 mrna|[n-methyl-3,4-methylenedioxyamphetamine co-treated with methamphetamine co-treated with 4-methylthioamphetamine co-treated with dextroamphetamine] results in decreased expression of BCL2L1 mRNA",,,PMID:23820845,https://www.ncbi.nlm.nih.gov/pubmed/23820845,23820845,,
974,591405,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,9606,Homo sapiens (human),BDNF gene polymorphism affects the susceptibility to dextroamphetamine,,,PMID:16823800,https://www.ncbi.nlm.nih.gov/pubmed/16823800,16823800,,
975,591406,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10090,Mus musculus (house mouse),Dextroamphetamine results in increased expression of BDNF mRNA,,,PMID:18681898,https://www.ncbi.nlm.nih.gov/pubmed/18681898,18681898,,
976,591407,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116,Rattus norvegicus (Norway rat),Dextroamphetamine affects the expression of BDNF mRNA,,,PMID:19222557,https://www.ncbi.nlm.nih.gov/pubmed/19222557,19222557,,
977,591408,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116,Rattus norvegicus (Norway rat),Dextroamphetamine results in decreased expression of BDNF protein,,,PMID:16460767|PMID:17434716,https://www.ncbi.nlm.nih.gov/pubmed/16460767|https://www.ncbi.nlm.nih.gov/pubmed/17434716,16460767|17434716,,
978,591409,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116,Rattus norvegicus (Norway rat),Dextroamphetamine results in increased expression of BDNF mRNA,,,PMID:12213320,https://www.ncbi.nlm.nih.gov/pubmed/12213320,12213320,,
979,591410,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116,Rattus norvegicus (Norway rat),Dextroamphetamine results in increased expression of BDNF protein,,,PMID:12213320|PMID:27373168,https://www.ncbi.nlm.nih.gov/pubmed/12213320|https://www.ncbi.nlm.nih.gov/pubmed/27373168,12213320|27373168,,
980,591411,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,627,BDNF,https://ctdbase.org/detail.go?type=gene&acc=627,,,627.0,BDNF,10116,Rattus norvegicus (Norway rat),Valproic acid inhibits the reaction [dextroamphetamine results in decreased expression of BDNF protein]|lithium inhibits the reaction [dextroamphetamine results in decreased expression of BDNF protein],,,PMID:16460767,https://www.ncbi.nlm.nih.gov/pubmed/16460767,16460767,,
981,593571,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,10888,GPR83,https://ctdbase.org/detail.go?type=gene&acc=10888,,,10888.0,GPR83,10116,Rattus norvegicus (Norway rat),Dextroamphetamine results in increased expression of GPR83 mRNA,,,PMID:11698613,https://www.ncbi.nlm.nih.gov/pubmed/11698613,11698613,,
982,593572,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,2870,GRK6,https://ctdbase.org/detail.go?type=gene&acc=2870,,,2870.0,GRK6,10116,Rattus norvegicus (Norway rat),Dextroamphetamine results in increased expression of GRK6 mRNA,,,PMID:16715494,https://www.ncbi.nlm.nih.gov/pubmed/16715494,16715494,,
983,593573,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,2911,GRM1,https://ctdbase.org/detail.go?type=gene&acc=2911,,,2911.0,GRM1,10090,Mus musculus (house mouse),GRM1 protein affects the reaction [dextroamphetamine results in increased expression of PDYN mrna]|grm1 protein affects the susceptibility to dextroamphetamine,,,PMID:11566502,https://www.ncbi.nlm.nih.gov/pubmed/11566502,11566502,,
984,593574,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,2915,GRM5,https://ctdbase.org/detail.go?type=gene&acc=2915,,,2915.0,GRM5,10116,Rattus norvegicus (Norway rat),Cycloheximide inhibits the reaction [dextroamphetamine results in increased expression of GRM5 protein]|cycloheximide inhibits the reaction [dextroamphetamine results in increased expression of GRM5 mrna]|dextroamphetamine results in increased expression of GRM5 protein|dactinomycin inhibits the reaction [dextroamphetamine results in increased expression of GRM5 mrna]|dactinomycin inhibits the reaction [dextroamphetamine results in increased expression of GRM5 protein],,,PMID:11665859,https://www.ncbi.nlm.nih.gov/pubmed/11665859,11665859,,
985,593575,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,2915,GRM5,https://ctdbase.org/detail.go?type=gene&acc=2915,,,2915.0,GRM5,10116,Rattus norvegicus (Norway rat),Dextroamphetamine results in decreased expression of GRM5 mRNA,,,PMID:11303782,https://www.ncbi.nlm.nih.gov/pubmed/11303782,11303782,,
986,593576,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,2915,GRM5,https://ctdbase.org/detail.go?type=gene&acc=2915,,,2915.0,GRM5,10116,Rattus norvegicus (Norway rat),Dextroamphetamine results in increased expression of GRM5 mRNA,,,PMID:11303782|PMID:11665859,https://www.ncbi.nlm.nih.gov/pubmed/11303782|https://www.ncbi.nlm.nih.gov/pubmed/11665859,11303782|11665859,,
987,593577,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,2918,GRM8,https://ctdbase.org/detail.go?type=gene&acc=2918,,,2918.0,GRM8,10116,Rattus norvegicus (Norway rat),Dextroamphetamine results in increased expression of GRM8 mRNA,,,PMID:18255232,https://www.ncbi.nlm.nih.gov/pubmed/18255232,18255232,,
988,595062,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,4988,OPRM1,https://ctdbase.org/detail.go?type=gene&acc=4988,,,4988.0,OPRM1,10116,Rattus norvegicus (Norway rat),Dextroamphetamine affects the expression of OPRM1 mRNA,,,PMID:12629526,https://www.ncbi.nlm.nih.gov/pubmed/12629526,12629526,,
989,595063,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,5058,PAK1,https://ctdbase.org/detail.go?type=gene&acc=5058,,,5058.0,PAK1,10116,Rattus norvegicus (Norway rat),Dextroamphetamine results in increased phosphorylation of PAK1 protein|dextroamphetamine results in increased expression of PAK1 protein,,,PMID:18991853,https://www.ncbi.nlm.nih.gov/pubmed/18991853,18991853,,
990,595064,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,7849,PAX8,https://ctdbase.org/detail.go?type=gene&acc=7849,,,7849.0,PAX8,10090,Mus musculus (house mouse),Dextroamphetamine results in increased expression of PAX8 mRNA,,,PMID:12558987,https://www.ncbi.nlm.nih.gov/pubmed/12558987,12558987,,
991,595065,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,5173,PDYN,https://ctdbase.org/detail.go?type=gene&acc=5173,,,5173.0,PDYN,10090,Mus musculus (house mouse),Dextroamphetamine results in increased expression of PDYN mRNA,,,PMID:11566502|PMID:18681898,https://www.ncbi.nlm.nih.gov/pubmed/11566502|https://www.ncbi.nlm.nih.gov/pubmed/18681898,11566502|18681898,,
992,595066,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,5173,PDYN,https://ctdbase.org/detail.go?type=gene&acc=5173,,,5173.0,PDYN,10090,Mus musculus (house mouse),GRM1 protein affects the reaction [dextroamphetamine results in increased expression of PDYN mrna],,,PMID:11566502,https://www.ncbi.nlm.nih.gov/pubmed/11566502,11566502,,
993,595067,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,5173,PDYN,https://ctdbase.org/detail.go?type=gene&acc=5173,,,5173.0,PDYN,10116,Rattus norvegicus (Norway rat),Dextroamphetamine results in increased expression of PDYN mRNA,,,PMID:11532335|PMID:11897087|PMID:12105094|PMID:12523490|PMID:16459022,https://www.ncbi.nlm.nih.gov/pubmed/11532335|https://www.ncbi.nlm.nih.gov/pubmed/11897087|https://www.ncbi.nlm.nih.gov/pubmed/12105094|https://www.ncbi.nlm.nih.gov/pubmed/12523490|https://www.ncbi.nlm.nih.gov/pubmed/16459022,11532335|11897087|12105094|12523490|16459022,,
994,595068,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,5173,PDYN,https://ctdbase.org/detail.go?type=gene&acc=5173,,,5173.0,PDYN,10116,Rattus norvegicus (Norway rat),LY 306740 inhibits the reaction [dextroamphetamine results in increased expression of PDYN mrna],,,PMID:11897087,https://www.ncbi.nlm.nih.gov/pubmed/11897087,11897087,,
995,595069,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,5173,PDYN,https://ctdbase.org/detail.go?type=gene&acc=5173,,,5173.0,PDYN,10116,Rattus norvegicus (Norway rat),SL 327 inhibits the reaction [dextroamphetamine results in increased expression of PDYN mrna]|u 0126 inhibits the reaction [dextroamphetamine results in increased expression of PDYN mrna],,,PMID:16459022,https://www.ncbi.nlm.nih.gov/pubmed/16459022,16459022,,
996,595070,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,5173,PDYN,https://ctdbase.org/detail.go?type=gene&acc=5173,,,5173.0,PDYN,10116,Rattus norvegicus (Norway rat),U 69593 inhibits the reaction [dextroamphetamine results in increased expression of PDYN mrna],,,PMID:11532335,https://www.ncbi.nlm.nih.gov/pubmed/11532335,11532335,,
997,595537,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,871,SERPINH1,https://ctdbase.org/detail.go?type=gene&acc=871,,,871.0,SERPINH1,10090,Mus musculus (house mouse),Dextroamphetamine results in increased expression of SERPINH1 mRNA,,,PMID:12558987,https://www.ncbi.nlm.nih.gov/pubmed/12558987,12558987,,
998,595722,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,6469,SHH,https://ctdbase.org/detail.go?type=gene&acc=6469,,,6469.0,SHH,10116,Rattus norvegicus (Norway rat),SHH protein modified form affects the susceptibility to [dextroamphetamine co-treated with oxidopamine],,,PMID:11771942,https://www.ncbi.nlm.nih.gov/pubmed/11771942,11771942,,
999,595723,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,22933,SIRT2,https://ctdbase.org/detail.go?type=gene&acc=22933,,,22933.0,SIRT2,10090,Mus musculus (house mouse),Dextroamphetamine results in decreased expression of SIRT2 mRNA,,,PMID:12558987,https://www.ncbi.nlm.nih.gov/pubmed/12558987,12558987,,
1000,595724,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,57030,SLC17A7,https://ctdbase.org/detail.go?type=gene&acc=57030,,,57030.0,SLC17A7,10116,Rattus norvegicus (Norway rat),Dextroamphetamine results in increased expression of SLC17A7 protein,,,PMID:19932152,https://www.ncbi.nlm.nih.gov/pubmed/19932152,19932152,,
1001,596533,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,8940,TOP3B,https://ctdbase.org/detail.go?type=gene&acc=8940,,,8940.0,TOP3B,10090,Mus musculus (house mouse),Dextroamphetamine results in decreased expression of TOP3B mRNA,,,PMID:12558987,https://www.ncbi.nlm.nih.gov/pubmed/12558987,12558987,,
1002,596534,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,778785,TSC22,https://ctdbase.org/detail.go?type=gene&acc=778785,,,778785.0,,10090,Mus musculus (house mouse),Dextroamphetamine results in increased expression of TSC22 mRNA,,,PMID:12558987,https://www.ncbi.nlm.nih.gov/pubmed/12558987,12558987,,
1003,596535,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,10381,TUBB3,https://ctdbase.org/detail.go?type=gene&acc=10381,,,10381.0,TUBB3,10090,Mus musculus (house mouse),Dextroamphetamine results in decreased expression of TUBB3 mRNA,,,PMID:12558987,https://www.ncbi.nlm.nih.gov/pubmed/12558987,12558987,,
1004,596536,5826,Comparative Toxicogenomics Database (CTD),Dextroamphetamine,D003913,Dextroamphetamine,https://ctdbase.org/detail.go?type=chem&acc=D003913,22445,XLR3A,https://ctdbase.org/detail.go?type=gene&acc=22445,,,22445.0,Xlr3a,10090,Mus musculus (house mouse),Dextroamphetamine results in increased expression of XLR3A mRNA,,,PMID:12558987,https://www.ncbi.nlm.nih.gov/pubmed/12558987,12558987,,
1005,596537,5832,Comparative Toxicogenomics Database (CTD),Norethindrone Acetate,D000077563,Norethindrone Acetate,https://ctdbase.org/detail.go?type=chem&acc=D000077563,55,ACP3,https://ctdbase.org/detail.go?type=gene&acc=55,,,55.0,ACP3,9606,Homo sapiens (human),[estradiol co-treated with norethindrone acetate] results in increased expression of ACP3 mRNA,,,PMID:22217510,https://www.ncbi.nlm.nih.gov/pubmed/22217510,22217510,,
1006,595221,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,1601,DAB2,https://ctdbase.org/detail.go?type=gene&acc=1601,,,1601.0,DAB2,10116,Rattus norvegicus (Norway rat),AGT protein affects the reaction [DAB2 protein results in increased secretion of aldosterone],,,PMID:17303656,https://www.ncbi.nlm.nih.gov/pubmed/17303656,17303656,,
1007,595222,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,9249,DHRS3,https://ctdbase.org/detail.go?type=gene&acc=9249,,,9249.0,DHRS3,9606,Homo sapiens (human),Aldosterone promotes the reaction [[progesterone co-treated with 8-bromo cyclic adenosine monophosphate] results in increased expression of DHRS3 protein],,,PMID:23275455,https://www.ncbi.nlm.nih.gov/pubmed/23275455,23275455,,
1008,595223,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,10116,Rattus norvegicus (Norway rat),[EDN1 protein binds to and results in increased activity of EDNRA protein] promotes the reaction [aldosterone results in increased expression of IL18 mrna]|aldosterone results in increased expression of EDN1 protein,,,PMID:18660453,https://www.ncbi.nlm.nih.gov/pubmed/18660453,18660453,,
1009,595224,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,1909,EDNRA,https://ctdbase.org/detail.go?type=gene&acc=1909,,,1909.0,EDNRA,10116,Rattus norvegicus (Norway rat),[EDN1 protein binds to and results in increased activity of EDNRA protein] promotes the reaction [aldosterone results in increased expression of IL18 mrna]|[cyclo(trp-asp-pro-val-leu) binds to and results in decreased activity of EDNRA protein] inhibits the reaction [aldosterone results in increased expression of IL18 mrna],,,PMID:18660453,https://www.ncbi.nlm.nih.gov/pubmed/18660453,18660453,,
1010,595225,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956.0,EGFR,10116,Rattus norvegicus (Norway rat),Aldosterone results in increased expression of EGFR mRNA,,,PMID:11507004,https://www.ncbi.nlm.nih.gov/pubmed/11507004,11507004,,
1011,595226,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,2149,F2R,https://ctdbase.org/detail.go?type=gene&acc=2149,,,2149.0,F2R,10116,Rattus norvegicus (Norway rat),"[aldosterone co-treated with sodium chloride, dietary] results in increased expression of F2R mRNA",,,PMID:27773435,https://www.ncbi.nlm.nih.gov/pubmed/27773435,27773435,,
1012,595227,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,356,FASLG,https://ctdbase.org/detail.go?type=gene&acc=356,,,356.0,FASLG,10116,Rattus norvegicus (Norway rat),Aldosterone results in increased expression of FASLG protein,,,PMID:19001025,https://www.ncbi.nlm.nih.gov/pubmed/19001025,19001025,,
1013,595228,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,2621,GAS6,https://ctdbase.org/detail.go?type=gene&acc=2621,,,2621.0,GAS6,10116,Rattus norvegicus (Norway rat),Spironolactone inhibits the reaction [aldosterone results in increased expression of GAS6 protein]|nr3c2 protein promotes the reaction [aldosterone results in increased expression of GAS6 protein]|aldosterone results in increased expression of GAS6 protein,,,PMID:19564549,https://www.ncbi.nlm.nih.gov/pubmed/19564549,19564549,,
1014,595229,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,2626,GATA4,https://ctdbase.org/detail.go?type=gene&acc=2626,,,2626.0,GATA4,10116,Rattus norvegicus (Norway rat),Aldosterone results in increased expression of GATA4 protein,,,PMID:19966502,https://www.ncbi.nlm.nih.gov/pubmed/19966502,19966502,,
1015,595230,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,2729,GCLC,https://ctdbase.org/detail.go?type=gene&acc=2729,,,2729.0,GCLC,10116,Rattus norvegicus (Norway rat),Aldosterone results in increased expression of GCLC protein|tempol inhibits the reaction [aldosterone results in increased expression of GCLC protein]|spironolactone inhibits the reaction [aldosterone results in increased expression of GCLC protein],,,PMID:24512358|PMID:25204689,https://www.ncbi.nlm.nih.gov/pubmed/24512358|https://www.ncbi.nlm.nih.gov/pubmed/25204689,24512358|25204689,,
1016,595890,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,8648,NCOA1,https://ctdbase.org/detail.go?type=gene&acc=8648,,,8648.0,NCOA1,9606,Homo sapiens (human),[aldosterone binds to NR3C2 protein] which binds to NCOA1 protein alternative form,,,PMID:15761029,https://www.ncbi.nlm.nih.gov/pubmed/15761029,15761029,,
1017,595891,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,57727,NCOA5,https://ctdbase.org/detail.go?type=gene&acc=57727,,,57727.0,NCOA5,9606,Homo sapiens (human),[aldosterone binds to NR3C2 protein] which binds to NCOA5 protein,,,PMID:15761029,https://www.ncbi.nlm.nih.gov/pubmed/15761029,15761029,,
1018,595892,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,23054,NCOA6,https://ctdbase.org/detail.go?type=gene&acc=23054,,,23054.0,NCOA6,9606,Homo sapiens (human),[aldosterone binds to NR3C2 protein] which binds to NCOA6 protein alternative form,,,PMID:15761029,https://www.ncbi.nlm.nih.gov/pubmed/15761029,15761029,,
1019,595893,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,23327,NEDD4L,https://ctdbase.org/detail.go?type=gene&acc=23327,,,23327.0,NEDD4L,10090,Mus musculus (house mouse),Aldosterone inhibits the reaction [NEDD4L gene mutant form results in decreased cleavage of SCNN1A protein],,,PMID:23348737,https://www.ncbi.nlm.nih.gov/pubmed/23348737,23348737,,
1020,595894,5839,Comparative Toxicogenomics Database (CTD),Aldosterone,D000450,Aldosterone,https://ctdbase.org/detail.go?type=chem&acc=D000450,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10116,Rattus norvegicus (Norway rat),Aldosterone results in increased activity of NFE2L2 protein|tempol inhibits the reaction [aldosterone results in increased activity of NFE2L2 protein]|spironolactone inhibits the reaction [aldosterone results in increased activity of NFE2L2 protein],,,PMID:25204689,https://www.ncbi.nlm.nih.gov/pubmed/25204689,25204689,,
1021,599318,5862,DrugBank,Cysteine,DB00151,Cysteine,https://www.drugbank.ca/drugs/DB00151,BE0000079,Cysteine sulfinic acid decarboxylase,https://www.drugbank.ca/bio_entities/BE0000079,Q9Y600,Cysteine sulfinic acid decarboxylase,51380.0,CSAD,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:6953423|PMID:236774|PMID:7131091,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/6953423|https://www.ncbi.nlm.nih.gov/pubmed/236774|https://www.ncbi.nlm.nih.gov/pubmed/7131091,17139284|17016423|6953423|236774|7131091,,
1022,426261,5877,Drug Gene Interaction database (DGIdb),Methylprednisolone Acetate,,METHYLPREDNISOLONE ACETATE,https://www.dgidb.org/drugs/rxcui:155323,,NR3C1,https://www.dgidb.org/genes/hgnc:7978,,,2908.0,NR3C1,9606,Homo sapiens (human),,,,,,,,
1023,426262,5877,BindingDB,Methylprednisolone Acetate,233194,Methylprednisolone acetate,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=233194,10008,Glucose-6-phosphate 1-dehydrogenase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=10008,P11413,Glucose-6-phosphate 1-dehydrogenase,2539.0,G6PD,9606,Homo sapiens (human),,Ki (nM),5.405e+5,PMID:21054237|DOI:10.3109/14756360903489581,https://www.ncbi.nlm.nih.gov/pubmed/21054237|https://doi.org/10.3109/14756360903489581,21054237,10.3109/14756360903489581,
1024,426263,5881,Comparative Toxicogenomics Database (CTD),Prasterone,D003687,Dehydroepiandrosterone,https://ctdbase.org/detail.go?type=chem&acc=D003687,3732,CD82,https://ctdbase.org/detail.go?type=gene&acc=3732,,,3732.0,CD82,8022,Oncorhynchus mykiss (rainbow trout),Dehydroepiandrosterone results in increased expression of CD82 mRNA,,,PMID:17823450,https://www.ncbi.nlm.nih.gov/pubmed/17823450,17823450,,
1025,427200,5881,Comparative Toxicogenomics Database (CTD),Prasterone,D003687,Dehydroepiandrosterone,https://ctdbase.org/detail.go?type=chem&acc=D003687,1520,CTSS,https://ctdbase.org/detail.go?type=gene&acc=1520,,,1520.0,CTSS,8022,Oncorhynchus mykiss (rainbow trout),Dehydroepiandrosterone results in decreased expression of CTSS mRNA,,,PMID:17823450,https://www.ncbi.nlm.nih.gov/pubmed/17823450,17823450,,
1026,590151,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,3148,HMGB2,https://ctdbase.org/detail.go?type=gene&acc=3148,,,3148.0,HMGB2,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of HMGB2 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1027,590152,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,3149,HMGB3,https://ctdbase.org/detail.go?type=gene&acc=3149,,,3149.0,HMGB3,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of HMGB3 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1028,590153,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606,Homo sapiens (human),"1,2,5,6-dibenzanthracene results in decreased expression of HMGCR mRNA",,,PMID:16269432,https://www.ncbi.nlm.nih.gov/pubmed/16269432,16269432,,
1029,590154,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,3156,HMGCR,https://ctdbase.org/detail.go?type=gene&acc=3156,,,3156.0,HMGCR,9606,Homo sapiens (human),"[benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of HMGCR mRNA",,,PMID:17690111,https://www.ncbi.nlm.nih.gov/pubmed/17690111,17690111,,
1030,590155,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,3151,HMGN2,https://ctdbase.org/detail.go?type=gene&acc=3151,,,3151.0,HMGN2,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of HMGN2 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1031,590156,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,633596,HMGN2L6,https://ctdbase.org/detail.go?type=gene&acc=633596,,,633596.0,Hmgn2l6,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of HMGN2L6 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1032,590157,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,3176,HNMT,https://ctdbase.org/detail.go?type=gene&acc=3176,,,3176.0,HNMT,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of HNMT mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1033,590158,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,9455,HOMER2,https://ctdbase.org/detail.go?type=gene&acc=9455,,,9455.0,HOMER2,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of HOMER2 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1034,590159,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,29911,HOOK2,https://ctdbase.org/detail.go?type=gene&acc=29911,,,29911.0,HOOK2,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of HOOK2 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1035,590160,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,3248,HPGD,https://ctdbase.org/detail.go?type=gene&acc=3248,,,3248.0,HPGD,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of HPGD mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1036,591047,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,3691,ITGB4,https://ctdbase.org/detail.go?type=gene&acc=3691,,,3691.0,ITGB4,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of ITGB4 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1037,592803,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,4082,MARCKS,https://ctdbase.org/detail.go?type=gene&acc=4082,,,4082.0,MARCKS,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of MARCKS mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1038,592804,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,83742,MARVELD1,https://ctdbase.org/detail.go?type=gene&acc=83742,,,83742.0,MARVELD1,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of MARVELD1 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1039,592805,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,154141,MBOAT1,https://ctdbase.org/detail.go?type=gene&acc=154141,,,154141.0,MBOAT1,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in decreased expression of MBOAT1 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1040,595389,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,84812,PLCD4,https://ctdbase.org/detail.go?type=gene&acc=84812,,,84812.0,PLCD4,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of PLCD4 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1041,595390,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,5335,PLCG1,https://ctdbase.org/detail.go?type=gene&acc=5335,,,5335.0,PLCG1,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of PLCG1 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1042,595391,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,201164,PLD6,https://ctdbase.org/detail.go?type=gene&acc=201164,,,201164.0,PLD6,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of PLD6 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1043,595392,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,144100,PLEKHA7,https://ctdbase.org/detail.go?type=gene&acc=144100,,,144100.0,PLEKHA7,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of PLEKHA7 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1044,595393,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,55200,PLEKHG6,https://ctdbase.org/detail.go?type=gene&acc=55200,,,55200.0,PLEKHG6,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of PLEKHG6 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1045,595394,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,123,PLIN2,https://ctdbase.org/detail.go?type=gene&acc=123,,,123.0,PLIN2,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in decreased expression of PLIN2 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1046,595395,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,5347,PLK1,https://ctdbase.org/detail.go?type=gene&acc=5347,,,5347.0,PLK1,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of PLK1 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1047,596679,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,65055,REEP1,https://ctdbase.org/detail.go?type=gene&acc=65055,,,65055.0,REEP1,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of REEP1 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1048,596680,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,359845,RFLNB,https://ctdbase.org/detail.go?type=gene&acc=359845,,,359845.0,RFLNB,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of RFLNB mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1049,596681,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,28984,RGCC,https://ctdbase.org/detail.go?type=gene&acc=28984,,,28984.0,RGCC,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of RGCC mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1050,596682,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,6002,RGS12,https://ctdbase.org/detail.go?type=gene&acc=6002,,,6002.0,RGS12,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of RGS12 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1051,598462,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,23516,SLC39A14,https://ctdbase.org/detail.go?type=gene&acc=23516,,,23516.0,SLC39A14,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of SLC39A14 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1052,598463,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,8501,SLC43A1,https://ctdbase.org/detail.go?type=gene&acc=8501,,,8501.0,SLC43A1,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of SLC43A1 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1053,599130,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,9606,Homo sapiens (human),"[benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SPP1 mRNA",,,PMID:17690111,https://www.ncbi.nlm.nih.gov/pubmed/17690111,17690111,,
1054,599131,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10116,Rattus norvegicus (Norway rat),"[benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SPP1 mRNA",,,PMID:18711122,https://www.ncbi.nlm.nih.gov/pubmed/18711122,18711122,,
1055,599132,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,80176,SPSB1,https://ctdbase.org/detail.go?type=gene&acc=80176,,,80176.0,SPSB1,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in decreased expression of SPSB1 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1056,599133,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,6712,SPTBN2,https://ctdbase.org/detail.go?type=gene&acc=6712,,,6712.0,SPTBN2,10116,Rattus norvegicus (Norway rat),"[benzo(a)pyrene co-treated with 1,2,5,6-dibenzanthracene] affects the expression of SPTBN2 mRNA",,,PMID:18711122,https://www.ncbi.nlm.nih.gov/pubmed/18711122,18711122,,
1057,599134,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,9901,SRGAP3,https://ctdbase.org/detail.go?type=gene&acc=9901,,,9901.0,SRGAP3,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in decreased expression of SRGAP3 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1058,600900,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,7106,TSPAN4,https://ctdbase.org/detail.go?type=gene&acc=7106,,,7106.0,TSPAN4,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in increased expression of TSPAN4 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1059,600901,5889,Comparative Toxicogenomics Database (CTD),"Dibenz[a,h]anthracene",C026486,"1,2,5,6-dibenzanthracene",https://ctdbase.org/detail.go?type=chem&acc=C026486,23270,TSPYL4,https://ctdbase.org/detail.go?type=gene&acc=23270,,,23270.0,TSPYL4,10090,Mus musculus (house mouse),"1,2,5,6-dibenzanthracene results in decreased expression of TSPYL4 mRNA",,,PMID:26377693,https://www.ncbi.nlm.nih.gov/pubmed/26377693,26377693,,
1060,596975,5909,Drug Gene Interaction database (DGIdb),Pilocarpine Hydrochloride,,PILOCARPINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:235426,,FOS,https://www.dgidb.org/genes/hgnc:3796,,,2353.0,FOS,9606,Homo sapiens (human),,,,,,,,
1061,600232,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,31103,RAB27,https://ctdbase.org/detail.go?type=gene&acc=31103,,,31103.0,Rab27,7227,Drosophila melanogaster (fruit fly),Pentylenetetrazole affects the expression of RAB27 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1062,600233,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,270160,RAB39,https://ctdbase.org/detail.go?type=gene&acc=270160,,,270160.0,Rab39,7227,Drosophila melanogaster (fruit fly),Pentylenetetrazole affects the expression of RAB39 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1063,600234,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,40168,RAB8,https://ctdbase.org/detail.go?type=gene&acc=40168,,,40168.0,Rab8,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of RAB8 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1064,600235,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of RAC1 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1065,600236,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,5901,RAN,https://ctdbase.org/detail.go?type=gene&acc=5901,,,5901.0,RAN,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of RAN mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1066,600237,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,118436,RANBP16,https://ctdbase.org/detail.go?type=gene&acc=118436,,,118436.0,Ranbp16,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of RANBP16 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1067,600238,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,35223,RANGAP,https://ctdbase.org/detail.go?type=gene&acc=35223,,,35223.0,RanGAP,7227,Drosophila melanogaster (fruit fly),Pentylenetetrazole affects the expression of RANGAP mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1068,600719,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,42398,RH3,https://ctdbase.org/detail.go?type=gene&acc=42398,,,42398.0,Rh3,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of RH3 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1069,600720,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,39887,RH4,https://ctdbase.org/detail.go?type=gene&acc=39887,,,39887.0,Rh4,7227,Drosophila melanogaster (fruit fly),Pentylenetetrazole affects the expression of RH4 mrna|[pentylenetetrazole co-treated with vigabatrin] affects the expression of RH4 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1070,600721,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,41889,RH6,https://ctdbase.org/detail.go?type=gene&acc=41889,,,41889.0,Rh6,7227,Drosophila melanogaster (fruit fly),Pentylenetetrazole affects the expression of RH6 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1071,600722,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,6009,RHEB,https://ctdbase.org/detail.go?type=gene&acc=6009,,,6009.0,RHEB,7227,Drosophila melanogaster (fruit fly),[valproic acid co-treated with pentylenetetrazole] affects the expression of RHEB mrna|[gabapentin co-treated with pentylenetetrazole] affects the expression of RHEB mrna|pentylenetetrazole affects the expression of RHEB mrna|[pentylenetetrazole co-treated with vigabatrin] affects the expression of RHEB mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1072,600723,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,44879,RHI,https://ctdbase.org/detail.go?type=gene&acc=44879,,,44879.0,rhi,7227,Drosophila melanogaster (fruit fly),Pentylenetetrazole affects the expression of RHI mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1073,601618,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,33629,RPL40,https://ctdbase.org/detail.go?type=gene&acc=33629,,,33629.0,RpL40,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of RPL40 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1074,601619,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,6125,RPL5,https://ctdbase.org/detail.go?type=gene&acc=6125,,,6125.0,RPL5,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of RPL5 mrna|pentylenetetrazole affects the expression of RPL5 mrna|[gabapentin co-treated with pentylenetetrazole] affects the expression of RPL5 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1075,601620,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,6128,RPL6,https://ctdbase.org/detail.go?type=gene&acc=6128,,,6128.0,RPL6,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of RPL6 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1076,601621,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,6129,RPL7,https://ctdbase.org/detail.go?type=gene&acc=6129,,,6129.0,RPL7,7227,Drosophila melanogaster (fruit fly),[gabapentin co-treated with pentylenetetrazole] affects the expression of RPL7 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1077,601622,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,6133,RPL9,https://ctdbase.org/detail.go?type=gene&acc=6133,,,6133.0,RPL9,7227,Drosophila melanogaster (fruit fly),[gabapentin co-treated with pentylenetetrazole] affects the expression of RPL9 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1078,601623,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,2768973,RPN12R,https://ctdbase.org/detail.go?type=gene&acc=2768973,,,2768973.0,Rpn12R,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of RPN12R mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1079,601624,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,42802,RPN9,https://ctdbase.org/detail.go?type=gene&acc=42802,,,42802.0,Rpn9,7227,Drosophila melanogaster (fruit fly),Pentylenetetrazole affects the expression of RPN9 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1080,601625,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,32953,RPS10B,https://ctdbase.org/detail.go?type=gene&acc=32953,,,32953.0,RpS10b,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of RPS10B mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1081,603576,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,40836,SODH1,https://ctdbase.org/detail.go?type=gene&acc=40836,,,40836.0,Sodh1,7227,Drosophila melanogaster (fruit fly),[valproic acid co-treated with pentylenetetrazole] affects the expression of SODH1 mrna|[pentylenetetrazole co-treated with vigabatrin] affects the expression of SODH1 mrna|pentylenetetrazole affects the expression of SODH1 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1082,603577,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,41313,SODH2,https://ctdbase.org/detail.go?type=gene&acc=41313,,,41313.0,Sodh2,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of SODH2 mrna|pentylenetetrazole affects the expression of SODH2 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1083,603578,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,44014,SOL,https://ctdbase.org/detail.go?type=gene&acc=44014,,,44014.0,sol,7227,Drosophila melanogaster (fruit fly),Pentylenetetrazole affects the expression of SOL mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1084,604467,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,40171,SU(TPL),https://ctdbase.org/detail.go?type=gene&acc=40171,,,40171.0,Su(Tpl),7227,Drosophila melanogaster (fruit fly),Pentylenetetrazole affects the expression of SU(TPL) mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1085,604468,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,45739,SUUR,https://ctdbase.org/detail.go?type=gene&acc=45739,,,45739.0,SuUR,7227,Drosophila melanogaster (fruit fly),Pentylenetetrazole affects the expression of SUUR mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1086,604469,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,40217,SU(VAR)3-3,https://ctdbase.org/detail.go?type=gene&acc=40217,,,40217.0,Su(var)3-3,7227,Drosophila melanogaster (fruit fly),Pentylenetetrazole affects the expression of SU(VAR)3-3 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1087,604470,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,41627,SU(VAR)3-7,https://ctdbase.org/detail.go?type=gene&acc=41627,,,41627.0,Su(var)3-7,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of SU(VAR)3-7 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1088,604471,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,43825,SV,https://ctdbase.org/detail.go?type=gene&acc=43825,,,43825.0,sv,7227,Drosophila melanogaster (fruit fly),[pentylenetetrazole co-treated with vigabatrin] affects the expression of SV mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1089,604472,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,41954,SXE2,https://ctdbase.org/detail.go?type=gene&acc=41954,,,41954.0,sxe2,7227,Drosophila melanogaster (fruit fly),[valproic acid co-treated with pentylenetetrazole] affects the expression of SXE2 mrna|[pentylenetetrazole co-treated with vigabatrin] affects the expression of SXE2 mrna|[gabapentin co-treated with pentylenetetrazole] affects the expression of SXE2 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1090,604473,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,6854,SYN2,https://ctdbase.org/detail.go?type=gene&acc=6854,,,6854.0,SYN2,7227,Drosophila melanogaster (fruit fly),Pentylenetetrazole affects the expression of SYN2 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1091,606634,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,7428,VHL,https://ctdbase.org/detail.go?type=gene&acc=7428,,,7428.0,VHL,7227,Drosophila melanogaster (fruit fly),Pentylenetetrazole affects the expression of VHL mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1092,606635,5917,Comparative Toxicogenomics Database (CTD),Pentetrazol,D010433,Pentylenetetrazole,https://ctdbase.org/detail.go?type=chem&acc=D010433,34652,VIR-1,https://ctdbase.org/detail.go?type=gene&acc=34652,,,34652.0,vir-1,7227,Drosophila melanogaster (fruit fly),[gabapentin co-treated with pentylenetetrazole] affects the expression of VIR-1 mrna|[pentylenetetrazole co-treated with vigabatrin] affects the expression of VIR-1 mRNA,,,PMID:21503142,https://www.ncbi.nlm.nih.gov/pubmed/21503142,21503142,,
1093,589983,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,29970,SCHIP1,https://ctdbase.org/detail.go?type=gene&acc=29970,,,29970.0,SCHIP1,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of SCHIP1 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
1094,589984,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,256380,SCML4,https://ctdbase.org/detail.go?type=gene&acc=256380,,,256380.0,SCML4,10116,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of SCML4 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
1095,589985,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,6329,SCN4A,https://ctdbase.org/detail.go?type=gene&acc=6329,,,6329.0,SCN4A,10090,Mus musculus (house mouse),[piperonyl butoxide co-treated with diethylnitrosamine] affects the methylation of SCN4A gene,,,PMID:23968726,https://www.ncbi.nlm.nih.gov/pubmed/23968726,23968726,,
1096,589986,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,6330,SCN4B,https://ctdbase.org/detail.go?type=gene&acc=6330,,,6330.0,SCN4B,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of SCN4B mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
1097,589987,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,6330,SCN4B,https://ctdbase.org/detail.go?type=gene&acc=6330,,,6330.0,SCN4B,10116,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of SCN4B mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
1098,589988,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,6334,SCN8A,https://ctdbase.org/detail.go?type=gene&acc=6334,,,6334.0,SCN8A,10090,Mus musculus (house mouse),Diethylnitrosamine results in increased expression of SCN8A mRNA,,,PMID:17942915|PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/17942915|https://www.ncbi.nlm.nih.gov/pubmed/24535843,17942915|24535843,,
1099,589989,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,6334,SCN8A,https://ctdbase.org/detail.go?type=gene&acc=6334,,,6334.0,SCN8A,10090,Mus musculus (house mouse),MET protein inhibits the reaction [diethylnitrosamine results in increased expression of SCN8A mrna],,,PMID:17942915,https://www.ncbi.nlm.nih.gov/pubmed/17942915,17942915,,
1100,593091,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,283600,SLC25A47,https://ctdbase.org/detail.go?type=gene&acc=283600,,,283600.0,SLC25A47,10116,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in decreased expression of SLC25A47 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
1101,593092,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,153328,SLC25A48,https://ctdbase.org/detail.go?type=gene&acc=153328,,,153328.0,SLC25A48,10090,Mus musculus (house mouse),Diethylnitrosamine results in increased expression of SLC25A48 mrna|met protein inhibits the reaction [diethylnitrosamine results in increased expression of SLC25A48 mrna],,,PMID:17942915,https://www.ncbi.nlm.nih.gov/pubmed/17942915,17942915,,
1102,593422,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,10568,SLC34A2,https://ctdbase.org/detail.go?type=gene&acc=10568,,,10568.0,SLC34A2,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of SLC34A2 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
1103,593423,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,347734,SLC35B2,https://ctdbase.org/detail.go?type=gene&acc=347734,,,347734.0,SLC35B2,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of SLC35B2 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
1104,593424,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,55508,SLC35E3,https://ctdbase.org/detail.go?type=gene&acc=55508,,,55508.0,SLC35E3,10116,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of SLC35E3 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
1105,593425,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,2542,SLC37A4,https://ctdbase.org/detail.go?type=gene&acc=2542,,,2542.0,SLC37A4,10090,Mus musculus (house mouse),Diethylnitrosamine results in decreased expression of SLC37A4 mRNA,,,PMID:12771043,https://www.ncbi.nlm.nih.gov/pubmed/12771043,12771043,,
1106,593426,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,2542,SLC37A4,https://ctdbase.org/detail.go?type=gene&acc=2542,,,2542.0,SLC37A4,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with thioacetamide] results in decreased expression of SLC37A4 mRNA,,,PMID:28943392,https://www.ncbi.nlm.nih.gov/pubmed/28943392,28943392,,
1107,593427,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,2542,SLC37A4,https://ctdbase.org/detail.go?type=gene&acc=2542,,,2542.0,SLC37A4,10116,Rattus norvegicus (Norway rat),Diethylnitrosamine results in decreased expression of SLC37A4 mRNA,,,PMID:19638242,https://www.ncbi.nlm.nih.gov/pubmed/19638242,19638242,,
1108,593428,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,54407,SLC38A2,https://ctdbase.org/detail.go?type=gene&acc=54407,,,54407.0,SLC38A2,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of SLC38A2 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
1109,593429,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,54407,SLC38A2,https://ctdbase.org/detail.go?type=gene&acc=54407,,,54407.0,SLC38A2,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of SLC38A2 mRNA,,,PMID:20360939,https://www.ncbi.nlm.nih.gov/pubmed/20360939,20360939,,
1110,593430,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,10991,SLC38A3,https://ctdbase.org/detail.go?type=gene&acc=10991,,,10991.0,SLC38A3,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with phenobarbital] results in decreased expression of SLC38A3 mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
1111,593431,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,10991,SLC38A3,https://ctdbase.org/detail.go?type=gene&acc=10991,,,10991.0,SLC38A3,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with clofibric acid] affects the expression of SLC38A3 mRNA,,,PMID:17602206,https://www.ncbi.nlm.nih.gov/pubmed/17602206,17602206,,
1112,594565,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,27293,SMPDL3B,https://ctdbase.org/detail.go?type=gene&acc=27293,,,27293.0,SMPDL3B,10090,Mus musculus (house mouse),Diethylnitrosamine results in increased expression of SMPDL3B mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
1113,594566,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,6611,SMS,https://ctdbase.org/detail.go?type=gene&acc=6611,,,6611.0,SMS,10116,Rattus norvegicus (Norway rat),Diethylnitrosamine results in increased expression of SMS mRNA,,,PMID:19638242,https://www.ncbi.nlm.nih.gov/pubmed/19638242,19638242,,
1114,596197,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10116,Rattus norvegicus (Norway rat),Diethylnitrosamine results in increased expression of SPP1 mRNA,,,PMID:19638242,https://www.ncbi.nlm.nih.gov/pubmed/19638242,19638242,,
1115,596198,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,6698,SPRR1A,https://ctdbase.org/detail.go?type=gene&acc=6698,,,6698.0,SPRR1A,10090,Mus musculus (house mouse),Diethylnitrosamine results in increased expression of SPRR1A mrna|[diethylnitrosamine co-treated with phenobarbital] results in increased expression of SPRR1A mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
1116,596199,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,10253,SPRY2,https://ctdbase.org/detail.go?type=gene&acc=10253,,,10253.0,SPRY2,10090,Mus musculus (house mouse),Diethylnitrosamine results in increased expression of SPRY2 mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
1117,596200,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,283377,SPRYD4,https://ctdbase.org/detail.go?type=gene&acc=283377,,,283377.0,SPRYD4,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with clofibric acid] affects the expression of SPRYD4 mRNA,,,PMID:17602206,https://www.ncbi.nlm.nih.gov/pubmed/17602206,17602206,,
1118,596201,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,10558,SPTLC1,https://ctdbase.org/detail.go?type=gene&acc=10558,,,10558.0,SPTLC1,10116,Rattus norvegicus (Norway rat),Diethylnitrosamine results in increased expression of SPTLC1 mRNA,,,PMID:20387270,https://www.ncbi.nlm.nih.gov/pubmed/20387270,20387270,,
1119,596202,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,6713,SQLE,https://ctdbase.org/detail.go?type=gene&acc=6713,,,6713.0,SQLE,10090,Mus musculus (house mouse),Diethylnitrosamine results in increased expression of SQLE mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
1120,596829,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,6752,SSTR2,https://ctdbase.org/detail.go?type=gene&acc=6752,,,6752.0,SSTR2,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with lanreotide] results in increased expression of SSTR2 mRNA,,,PMID:19874807,https://www.ncbi.nlm.nih.gov/pubmed/19874807,19874807,,
1121,597340,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,92335,STRADA,https://ctdbase.org/detail.go?type=gene&acc=92335,,,92335.0,STRADA,10116,Rattus norvegicus (Norway rat),Diethylnitrosamine results in increased expression of STRADA mRNA,,,PMID:20360939,https://www.ncbi.nlm.nih.gov/pubmed/20360939,20360939,,
1122,597341,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,6801,STRN,https://ctdbase.org/detail.go?type=gene&acc=6801,,,6801.0,STRN,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of STRN mRNA,,,PMID:20360939,https://www.ncbi.nlm.nih.gov/pubmed/20360939,20360939,,
1123,598313,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,57476,GRAMD1B,https://ctdbase.org/detail.go?type=gene&acc=57476,,,57476.0,GRAMD1B,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with phenobarbital] results in increased expression of GRAMD1B mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
1124,598314,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,2888,GRB14,https://ctdbase.org/detail.go?type=gene&acc=2888,,,2888.0,GRB14,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with clofibric acid] affects the expression of GRB14 mRNA,,,PMID:17602206,https://www.ncbi.nlm.nih.gov/pubmed/17602206,17602206,,
1125,598981,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,2936,GSR,https://ctdbase.org/detail.go?type=gene&acc=2936,,,2936.0,GSR,10116,Rattus norvegicus (Norway rat),Hesperidin inhibits the reaction [[diethylnitrosamine co-treated with ferric nitrilotriacetate] results in decreased activity of GSR protein]|[diethylnitrosamine co-treated with ferric nitrilotriacetate] results in decreased activity of GSR protein,,,PMID:30098279,https://www.ncbi.nlm.nih.gov/pubmed/30098279,30098279,,
1126,599319,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,2940,GSTA3,https://ctdbase.org/detail.go?type=gene&acc=2940,,,2940.0,GSTA3,9031,Gallus gallus (chicken),Diethylnitrosamine results in decreased expression of GSTA3 mRNA,,,PMID:30102407,https://www.ncbi.nlm.nih.gov/pubmed/30102407,30102407,,
1127,599320,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,2940,GSTA3,https://ctdbase.org/detail.go?type=gene&acc=2940,,,2940.0,GSTA3,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with clofibric acid] affects the expression of GSTA3 mRNA,,,PMID:17602206,https://www.ncbi.nlm.nih.gov/pubmed/17602206,17602206,,
1128,599321,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,2940,GSTA3,https://ctdbase.org/detail.go?type=gene&acc=2940,,,2940.0,GSTA3,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTA3 mrna|[diethylnitrosamine co-treated with kojic acid co-treated with diethylnitrosamine] results in decreased expression of GSTA3 mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
1129,599322,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,2940,GSTA3,https://ctdbase.org/detail.go?type=gene&acc=2940,,,2940.0,GSTA3,10116,Rattus norvegicus (Norway rat),[fenofibrate co-treated with diethylnitrosamine] results in decreased expression of GSTA3 mRNA,,,PMID:18253720,https://www.ncbi.nlm.nih.gov/pubmed/18253720,18253720,,
1130,599323,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,2941,GSTA4,https://ctdbase.org/detail.go?type=gene&acc=2941,,,2941.0,GSTA4,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with kojic acid] results in increased expression of GSTA4 mRNA,,,PMID:18544905,https://www.ncbi.nlm.nih.gov/pubmed/18544905,18544905,,
1131,599324,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,2941,GSTA4,https://ctdbase.org/detail.go?type=gene&acc=2941,,,2941.0,GSTA4,10116,Rattus norvegicus (Norway rat),[phenobarbital co-treated with diethylnitrosamine] results in increased expression of GSTA4 protein,,,PMID:20935162,https://www.ncbi.nlm.nih.gov/pubmed/20935162,20935162,,
1132,599325,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,221357,GSTA5,https://ctdbase.org/detail.go?type=gene&acc=221357,,,221357.0,GSTA5,10116,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in increased expression of GSTA5 mrna|[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of GSTA5 mrna|acetylcysteine inhibits the reaction [[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of GSTA5 mrna],,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
1133,599326,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,221357,GSTA5,https://ctdbase.org/detail.go?type=gene&acc=221357,,,221357.0,GSTA5,10116,Rattus norvegicus (Norway rat),[copper co-treated with diethylnitrosamine] results in increased expression of GSTA5 mrna|[copper co-treated with diethylnitrosamine co-treated with iron] results in increased expression of GSTA5 mRNA,,,PMID:20302851,https://www.ncbi.nlm.nih.gov/pubmed/20302851,20302851,,
1134,599327,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3242,HPD,https://ctdbase.org/detail.go?type=gene&acc=3242,,,3242.0,HPD,10090,Mus musculus (house mouse),Diethylnitrosamine results in decreased expression of HPD mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
1135,599913,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116,Rattus norvegicus (Norway rat),[fenofibrate co-treated with diethylnitrosamine] results in decreased expression of GSTM2 mRNA,,,PMID:18253720|PMID:18775883,https://www.ncbi.nlm.nih.gov/pubmed/18253720|https://www.ncbi.nlm.nih.gov/pubmed/18775883,18253720|18775883,,
1136,599914,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,2946,GSTM2,https://ctdbase.org/detail.go?type=gene&acc=2946,,,2946.0,GSTM2,10116,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in increased expression of GSTM2 mrna|[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of GSTM2 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
1137,599915,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,2947,GSTM3,https://ctdbase.org/detail.go?type=gene&acc=2947,,,2947.0,GSTM3,10090,Mus musculus (house mouse),"[2,4,5,2',4',5'-hexachlorobiphenyl co-treated with diethylnitrosamine] results in increased expression of GSTM3 mRNA",,,PMID:23457121,https://www.ncbi.nlm.nih.gov/pubmed/23457121,23457121,,
1138,601238,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,55751,TMEM184C,https://ctdbase.org/detail.go?type=gene&acc=55751,,,55751.0,TMEM184C,10116,Rattus norvegicus (Norway rat),Diethylnitrosamine results in increased expression of TMEM184C mRNA,,,PMID:19638242,https://www.ncbi.nlm.nih.gov/pubmed/19638242,19638242,,
1139,601239,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,730130,TMEM229A,https://ctdbase.org/detail.go?type=gene&acc=730130,,,730130.0,TMEM229A,10090,Mus musculus (house mouse),Diethylnitrosamine results in increased expression of TMEM229A mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
1140,601240,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,55754,TMEM30A,https://ctdbase.org/detail.go?type=gene&acc=55754,,,55754.0,TMEM30A,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with clofibric acid] affects the expression of TMEM30A mRNA,,,PMID:17602206,https://www.ncbi.nlm.nih.gov/pubmed/17602206,17602206,,
1141,601241,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,140738,TMEM37,https://ctdbase.org/detail.go?type=gene&acc=140738,,,140738.0,TMEM37,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with phenobarbital] results in increased methylation of TMEM37 promoter|[diethylnitrosamine co-treated with phenobarbital] results in increased expression of TMEM37 mRNA,,,PMID:25374375,https://www.ncbi.nlm.nih.gov/pubmed/25374375,25374375,,
1142,601242,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,79188,TMEM43,https://ctdbase.org/detail.go?type=gene&acc=79188,,,79188.0,TMEM43,10090,Mus musculus (house mouse),Diethylnitrosamine results in increased expression of TMEM43 mRNA,,,PMID:21607683,https://www.ncbi.nlm.nih.gov/pubmed/21607683,21607683,,
1143,601243,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,120224,TMEM45B,https://ctdbase.org/detail.go?type=gene&acc=120224,,,120224.0,TMEM45B,10090,Mus musculus (house mouse),Diethylnitrosamine results in increased expression of TMEM45B mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
1144,601244,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,79639,TMEM53,https://ctdbase.org/detail.go?type=gene&acc=79639,,,79639.0,TMEM53,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with thioacetamide] results in decreased expression of TMEM53 mRNA,,,PMID:28943392,https://www.ncbi.nlm.nih.gov/pubmed/28943392,28943392,,
1145,601245,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,54968,TMEM70,https://ctdbase.org/detail.go?type=gene&acc=54968,,,54968.0,TMEM70,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with piperonyl butoxide] results in decreased expression of TMEM70 protein|[diethylnitrosamine co-treated with thioacetamide] results in decreased expression of TMEM70 protein|[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of TMEM70 protein,,,PMID:27914986|PMID:28903497,https://www.ncbi.nlm.nih.gov/pubmed/27914986|https://www.ncbi.nlm.nih.gov/pubmed/28903497,27914986|28903497,,
1146,601439,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,9407,TMPRSS11D,https://ctdbase.org/detail.go?type=gene&acc=9407,,,9407.0,TMPRSS11D,10116,Rattus norvegicus (Norway rat),Diethylnitrosamine results in decreased expression of TMPRSS11D mRNA,,,PMID:20360939,https://www.ncbi.nlm.nih.gov/pubmed/20360939,20360939,,
1147,601440,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,64699,TMPRSS3,https://ctdbase.org/detail.go?type=gene&acc=64699,,,64699.0,TMPRSS3,10090,Mus musculus (house mouse),Diethylnitrosamine results in increased expression of TMPRSS3 mrna|met protein inhibits the reaction [diethylnitrosamine results in increased expression of TMPRSS3 mrna],,,PMID:17942915,https://www.ncbi.nlm.nih.gov/pubmed/17942915,17942915,,
1148,601441,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3029,HAGH,https://ctdbase.org/detail.go?type=gene&acc=3029,,,3029.0,HAGH,10116,Rattus norvegicus (Norway rat),Diethylnitrosamine results in decreased expression of HAGH mRNA,,,PMID:19638242,https://www.ncbi.nlm.nih.gov/pubmed/19638242,19638242,,
1149,601442,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3034,HAL,https://ctdbase.org/detail.go?type=gene&acc=3034,,,3034.0,HAL,10090,Mus musculus (house mouse),[diethylnitrosamine co-treated with phenobarbital] results in decreased expression of HAL mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
1150,601443,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3034,HAL,https://ctdbase.org/detail.go?type=gene&acc=3034,,,3034.0,HAL,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of HAL mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
1151,601444,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3034,HAL,https://ctdbase.org/detail.go?type=gene&acc=3034,,,3034.0,HAL,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with clofibric acid] affects the expression of HAL mRNA,,,PMID:17602206,https://www.ncbi.nlm.nih.gov/pubmed/17602206,17602206,,
1152,601445,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3034,HAL,https://ctdbase.org/detail.go?type=gene&acc=3034,,,3034.0,HAL,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with thioacetamide] results in decreased expression of HAL mRNA,,,PMID:28943392,https://www.ncbi.nlm.nih.gov/pubmed/28943392,28943392,,
1153,601446,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3034,HAL,https://ctdbase.org/detail.go?type=gene&acc=3034,,,3034.0,HAL,10116,Rattus norvegicus (Norway rat),Diethylnitrosamine results in decreased expression of HAL mRNA,,,PMID:19638242,https://www.ncbi.nlm.nih.gov/pubmed/19638242,19638242,,
1154,601447,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,57817,HAMP,https://ctdbase.org/detail.go?type=gene&acc=57817,,,57817.0,HAMP,10090,Mus musculus (house mouse),Diethylnitrosamine results in decreased expression of HAMP mrna|iron inhibits the reaction [diethylnitrosamine results in decreased expression of HAMP mrna],,,PMID:19061943,https://www.ncbi.nlm.nih.gov/pubmed/19061943,19061943,,
1155,601448,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,57817,HAMP,https://ctdbase.org/detail.go?type=gene&acc=57817,,,57817.0,HAMP,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of HAMP mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
1156,601626,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,164656,TMPRSS6,https://ctdbase.org/detail.go?type=gene&acc=164656,,,164656.0,TMPRSS6,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with thioacetamide] results in decreased expression of TMPRSS6 mRNA,,,PMID:28943392,https://www.ncbi.nlm.nih.gov/pubmed/28943392,28943392,,
1157,602417,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,51330,TNFRSF12A,https://ctdbase.org/detail.go?type=gene&acc=51330,,,51330.0,TNFRSF12A,10090,Mus musculus (house mouse),Diethylnitrosamine results in increased expression of TNFRSF12A mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
1158,602418,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,51330,TNFRSF12A,https://ctdbase.org/detail.go?type=gene&acc=51330,,,51330.0,TNFRSF12A,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of TNFRSF12A mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
1159,602419,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,51330,TNFRSF12A,https://ctdbase.org/detail.go?type=gene&acc=51330,,,51330.0,TNFRSF12A,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with thioacetamide] results in increased expression of TNFRSF12A mRNA,,,PMID:28943392,https://www.ncbi.nlm.nih.gov/pubmed/28943392,28943392,,
1160,602420,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,51330,TNFRSF12A,https://ctdbase.org/detail.go?type=gene&acc=51330,,,51330.0,TNFRSF12A,10116,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine] results in increased expression of TNFRSF12A mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
1161,602421,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,115650,TNFRSF13C,https://ctdbase.org/detail.go?type=gene&acc=115650,,,115650.0,TNFRSF13C,10116,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in decreased expression of TNFRSF13C mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
1162,602422,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,8784,TNFRSF18,https://ctdbase.org/detail.go?type=gene&acc=8784,,,8784.0,TNFRSF18,10090,Mus musculus (house mouse),Diethylnitrosamine results in increased expression of TNFRSF18 mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
1163,602942,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3172,HNF4A,https://ctdbase.org/detail.go?type=gene&acc=3172,,,3172.0,HNF4A,10116,Rattus norvegicus (Norway rat),Diethylnitrosamine results in decreased expression of HNF4A mRNA,,,PMID:19638242,https://www.ncbi.nlm.nih.gov/pubmed/19638242,19638242,,
1164,602943,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3172,HNF4A,https://ctdbase.org/detail.go?type=gene&acc=3172,,,3172.0,HNF4A,10116,Rattus norvegicus (Norway rat),Diethylnitrosamine results in decreased expression of HNF4A protein,,,PMID:27565560,https://www.ncbi.nlm.nih.gov/pubmed/27565560,27565560,,
1165,602944,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3174,HNF4G,https://ctdbase.org/detail.go?type=gene&acc=3174,,,3174.0,HNF4G,10116,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in decreased expression of HNF4G mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
1166,602945,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3176,HNMT,https://ctdbase.org/detail.go?type=gene&acc=3176,,,3176.0,HNMT,9606,Homo sapiens (human),Diethylnitrosamine results in decreased expression of HNMT mRNA,,,PMID:21527772,https://www.ncbi.nlm.nih.gov/pubmed/21527772,21527772,,
1167,602946,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3178,HNRNPA1,https://ctdbase.org/detail.go?type=gene&acc=3178,,,3178.0,HNRNPA1,10116,Rattus norvegicus (Norway rat),Diethylnitrosamine results in increased expression of HNRNPA1 mRNA,,,PMID:19041683,https://www.ncbi.nlm.nih.gov/pubmed/19041683,19041683,,
1168,602947,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,220988,HNRNPA3,https://ctdbase.org/detail.go?type=gene&acc=220988,,,220988.0,HNRNPA3,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with phenobarbital] results in increased expression of HNRNPA3 mrna|[diethylnitrosamine co-treated with phenobarbital] results in increased methylation of HNRNPA3 promoter,,,PMID:25374375,https://www.ncbi.nlm.nih.gov/pubmed/25374375,25374375,,
1169,602948,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3183,HNRNPC,https://ctdbase.org/detail.go?type=gene&acc=3183,,,3183.0,HNRNPC,10090,Mus musculus (house mouse),MET protein inhibits the reaction [diethylnitrosamine results in increased expression of HNRNPC mrna]|diethylnitrosamine results in increased expression of HNRNPC mRNA,,,PMID:17942915,https://www.ncbi.nlm.nih.gov/pubmed/17942915,17942915,,
1170,602949,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3191,HNRNPL,https://ctdbase.org/detail.go?type=gene&acc=3191,,,3191.0,HNRNPL,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with clofibric acid] affects the expression of HNRNPL mRNA,,,PMID:17602206,https://www.ncbi.nlm.nih.gov/pubmed/17602206,17602206,,
1171,603084,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,51440,HPCAL4,https://ctdbase.org/detail.go?type=gene&acc=51440,,,51440.0,HPCAL4,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of HPCAL4 mRNA,,,PMID:20360939,https://www.ncbi.nlm.nih.gov/pubmed/20360939,20360939,,
1172,603085,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3248,HPGD,https://ctdbase.org/detail.go?type=gene&acc=3248,,,3248.0,HPGD,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in decreased expression of HPGD mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
1173,603086,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3248,HPGD,https://ctdbase.org/detail.go?type=gene&acc=3248,,,3248.0,HPGD,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with clofibric acid] affects the expression of HPGD mRNA,,,PMID:17602206,https://www.ncbi.nlm.nih.gov/pubmed/17602206,17602206,,
1174,603087,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,3251,HPRT1,https://ctdbase.org/detail.go?type=gene&acc=3251,,,3251.0,HPRT1,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with clofibric acid] affects the expression of HPRT1 mRNA,,,PMID:17602206,https://www.ncbi.nlm.nih.gov/pubmed/17602206,17602206,,
1175,603254,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116,Rattus norvegicus (Norway rat),"[5,7-dimethoxyflavone co-treated with diethylnitrosamine] results in increased expression of TP53 mrna|[5,7-dimethoxyflavone co-treated with diethylnitrosamine] results in increased expression of TP53 protein",,,PMID:21554863,https://www.ncbi.nlm.nih.gov/pubmed/21554863,21554863,,
1176,603255,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,7157,TP53,https://ctdbase.org/detail.go?type=gene&acc=7157,,,7157.0,TP53,10116,Rattus norvegicus (Norway rat),[acetoxyacetylaminofluorene co-treated with diethylnitrosamine] results in increased expression of TP53 protein,,,PMID:10741303,https://www.ncbi.nlm.nih.gov/pubmed/10741303,10741303,,
1177,604950,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,23270,TSPYL4,https://ctdbase.org/detail.go?type=gene&acc=23270,,,23270.0,TSPYL4,10090,Mus musculus (house mouse),Diethylnitrosamine results in decreased expression of TSPYL4 mrna|[diethylnitrosamine co-treated with phenobarbital] results in decreased expression of TSPYL4 mRNA,,,PMID:24535843,https://www.ncbi.nlm.nih.gov/pubmed/24535843,24535843,,
1178,607539,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,10090,Mus musculus (house mouse),Diethylnitrosamine results in increased expression of VCAM1 mRNA,,,PMID:21607683,https://www.ncbi.nlm.nih.gov/pubmed/21607683,21607683,,
1179,607540,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with clofibric acid] affects the expression of VCAM1 mRNA,,,PMID:17602206,https://www.ncbi.nlm.nih.gov/pubmed/17602206,17602206,,
1180,607541,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,7412,VCAM1,https://ctdbase.org/detail.go?type=gene&acc=7412,,,7412.0,VCAM1,10116,Rattus norvegicus (Norway rat),Diethylnitrosamine results in increased expression of VCAM1 protein,,,PMID:25051504,https://www.ncbi.nlm.nih.gov/pubmed/25051504,25051504,,
1181,607542,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,80124,VCPIP1,https://ctdbase.org/detail.go?type=gene&acc=80124,,,80124.0,VCPIP1,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of VCPIP1 mRNA,,,PMID:20360939,https://www.ncbi.nlm.nih.gov/pubmed/20360939,20360939,,
1182,607543,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,79609,VCPKMT,https://ctdbase.org/detail.go?type=gene&acc=79609,,,79609.0,VCPKMT,9031,Gallus gallus (chicken),Diethylnitrosamine results in decreased expression of VCPKMT mRNA,,,PMID:30102407,https://www.ncbi.nlm.nih.gov/pubmed/30102407,30102407,,
1183,607544,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,26609,VCX,https://ctdbase.org/detail.go?type=gene&acc=26609,,,26609.0,VCX,9606,Homo sapiens (human),Diethylnitrosamine results in increased expression of VCX mRNA,,,PMID:21527772,https://www.ncbi.nlm.nih.gov/pubmed/21527772,21527772,,
1184,607545,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,7416,VDAC1,https://ctdbase.org/detail.go?type=gene&acc=7416,,,7416.0,VDAC1,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with clofibric acid] affects the expression of VDAC1 mRNA,,,PMID:17602206,https://www.ncbi.nlm.nih.gov/pubmed/17602206,17602206,,
1185,607546,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,7421,VDR,https://ctdbase.org/detail.go?type=gene&acc=7421,,,7421.0,VDR,10090,Mus musculus (house mouse),[hexachlorobenzene co-treated with diethylnitrosamine] results in decreased expression of VDR protein|cholecalciferol inhibits the reaction [[hexachlorobenzene co-treated with diethylnitrosamine] results in increased expression of VDR protein],,,PMID:28634113,https://www.ncbi.nlm.nih.gov/pubmed/28634113,28634113,,
1186,607547,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422.0,VEGFA,10090,Mus musculus (house mouse),[carbon tetrachloride co-treated with diethylnitrosamine] results in decreased expression of VEGFA mRNA,,,PMID:26778414,https://www.ncbi.nlm.nih.gov/pubmed/26778414,26778414,,
1187,609479,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,7534,YWHAZ,https://ctdbase.org/detail.go?type=gene&acc=7534,,,7534.0,YWHAZ,10090,Mus musculus (house mouse),"[3,4,5,3',4'-pentachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with diethylnitrosamine] results in increased expression of YWHAZ protein",,,PMID:23457121,https://www.ncbi.nlm.nih.gov/pubmed/23457121,23457121,,
1188,609480,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,7528,YY1,https://ctdbase.org/detail.go?type=gene&acc=7528,,,7528.0,YY1,10116,Rattus norvegicus (Norway rat),Caffeic acid phenethyl ester inhibits the reaction [diethylnitrosamine results in decreased expression of YY1 mrna]|diethylnitrosamine results in increased expression of YY1 mRNA,,,PMID:20360939,https://www.ncbi.nlm.nih.gov/pubmed/20360939,20360939,,
1189,609481,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,79413,ZBED2,https://ctdbase.org/detail.go?type=gene&acc=79413,,,79413.0,ZBED2,9606,Homo sapiens (human),Diethylnitrosamine results in increased expression of ZBED2 mRNA,,,PMID:21527772,https://www.ncbi.nlm.nih.gov/pubmed/21527772,21527772,,
1190,609482,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,7704,ZBTB16,https://ctdbase.org/detail.go?type=gene&acc=7704,,,7704.0,ZBTB16,10116,Rattus norvegicus (Norway rat),[diethylnitrosamine co-treated with beta-naphthoflavone] results in increased expression of ZBTB16 mRNA,,,PMID:18164116,https://www.ncbi.nlm.nih.gov/pubmed/18164116,18164116,,
1191,609483,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,7704,ZBTB16,https://ctdbase.org/detail.go?type=gene&acc=7704,,,7704.0,ZBTB16,10116,Rattus norvegicus (Norway rat),[indole-3-carbinol co-treated with diethylnitrosamine co-treated with acetylcysteine] results in decreased expression of ZBTB16 mRNA,,,PMID:22129741,https://www.ncbi.nlm.nih.gov/pubmed/22129741,22129741,,
1192,609484,5921,Comparative Toxicogenomics Database (CTD),N-Nitrosodiethylamine,D004052,Diethylnitrosamine,https://ctdbase.org/detail.go?type=chem&acc=D004052,57621,ZBTB2,https://ctdbase.org/detail.go?type=gene&acc=57621,,,57621.0,ZBTB2,10090,Mus musculus (house mouse),[piperonyl butoxide co-treated with diethylnitrosamine] affects the methylation of ZBTB2 gene,,,PMID:23968726,https://www.ncbi.nlm.nih.gov/pubmed/23968726,23968726,,
1193,594567,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,9616,RNF7,https://ctdbase.org/detail.go?type=gene&acc=9616,,,9616.0,RNF7,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of RNF7 mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
1194,594568,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6050,RNH1,https://ctdbase.org/detail.go?type=gene&acc=6050,,,6050.0,RNH1,10090,Mus musculus (house mouse),Carbon tetrachloride affects the expression of RNH1 mRNA,,,PMID:17484886,https://www.ncbi.nlm.nih.gov/pubmed/17484886,17484886,,
1195,594569,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6050,RNH1,https://ctdbase.org/detail.go?type=gene&acc=6050,,,6050.0,RNH1,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of RNH1 mRNA,,,PMID:27339419|PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/27339419|https://www.ncbi.nlm.nih.gov/pubmed/31919559,27339419|31919559,,
1196,594570,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,55328,RNLS,https://ctdbase.org/detail.go?type=gene&acc=55328,,,55328.0,RNLS,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in decreased expression of RNLS mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1197,594571,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,8731,RNMT,https://ctdbase.org/detail.go?type=gene&acc=8731,,,8731.0,RNMT,10116,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of RNMT mrna]|carbon tetrachloride results in increased expression of RNMT mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1198,594572,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,55599,RNPC3,https://ctdbase.org/detail.go?type=gene&acc=55599,,,55599.0,RNPC3,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of RNPC3 mRNA,,,PMID:27339419,https://www.ncbi.nlm.nih.gov/pubmed/27339419,27339419,,
1199,594573,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6051,RNPEP,https://ctdbase.org/detail.go?type=gene&acc=6051,,,6051.0,RNPEP,10090,Mus musculus (house mouse),Carbon tetrachloride results in decreased expression of RNPEP mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
1200,594574,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,10921,RNPS1,https://ctdbase.org/detail.go?type=gene&acc=10921,,,10921.0,RNPS1,10116,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of RNPS1 mrna]|carbon tetrachloride results in increased expression of RNPS1 mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1201,596967,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6241,RRM2,https://ctdbase.org/detail.go?type=gene&acc=6241,,,6241.0,RRM2,10090,Mus musculus (house mouse),Carbon tetrachloride affects the expression of RRM2 mRNA,,,PMID:17484886,https://www.ncbi.nlm.nih.gov/pubmed/17484886,17484886,,
1202,596968,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6241,RRM2,https://ctdbase.org/detail.go?type=gene&acc=6241,,,6241.0,RRM2,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of RRM2 mRNA,,,PMID:27339419|PMID:29987408|PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/27339419|https://www.ncbi.nlm.nih.gov/pubmed/29987408|https://www.ncbi.nlm.nih.gov/pubmed/31919559,27339419|29987408|31919559,,
1203,596969,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,54700,RRN3,https://ctdbase.org/detail.go?type=gene&acc=54700,,,54700.0,RRN3,10090,Mus musculus (house mouse),Carbon tetrachloride results in decreased expression of RRN3 mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
1204,596970,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,54700,RRN3,https://ctdbase.org/detail.go?type=gene&acc=54700,,,54700.0,RRN3,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of RRN3 mRNA,,,PMID:27339419,https://www.ncbi.nlm.nih.gov/pubmed/27339419,27339419,,
1205,596971,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,54700,RRN3,https://ctdbase.org/detail.go?type=gene&acc=54700,,,54700.0,RRN3,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of RRN3 mrna|schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of RRN3 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1206,596972,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,8568,RRP1,https://ctdbase.org/detail.go?type=gene&acc=8568,,,8568.0,RRP1,10116,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of RRP1 mrna]|carbon tetrachloride results in increased expression of RRP1 mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1207,596973,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,23223,RRP12,https://ctdbase.org/detail.go?type=gene&acc=23223,,,23223.0,RRP12,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of RRP12 mRNA,,,PMID:27339419|PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/27339419|https://www.ncbi.nlm.nih.gov/pubmed/31919559,27339419|31919559,,
1208,596974,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,23223,RRP12,https://ctdbase.org/detail.go?type=gene&acc=23223,,,23223.0,RRP12,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of RRP12 mrna|schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of RRP12 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1209,597817,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,26071,RTL8A,https://ctdbase.org/detail.go?type=gene&acc=26071,,,26071.0,RTL8A,10116,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of RTL8A mrna]|carbon tetrachloride results in decreased expression of RTL8A mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1210,597818,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6252,RTN1,https://ctdbase.org/detail.go?type=gene&acc=6252,,,6252.0,RTN1,10090,Mus musculus (house mouse),Carbon tetrachloride affects the expression of RTN1 mRNA,,,PMID:17484886,https://www.ncbi.nlm.nih.gov/pubmed/17484886,17484886,,
1211,598143,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,10856,RUVBL2,https://ctdbase.org/detail.go?type=gene&acc=10856,,,10856.0,RUVBL2,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of RUVBL2 mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
1212,598144,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,10856,RUVBL2,https://ctdbase.org/detail.go?type=gene&acc=10856,,,10856.0,RUVBL2,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of RUVBL2 mrna|schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of RUVBL2 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1213,598145,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,192174,RWDD4A,https://ctdbase.org/detail.go?type=gene&acc=192174,,,192174.0,Rwdd4a,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of RWDD4A mRNA,,,PMID:27339419|PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/27339419|https://www.ncbi.nlm.nih.gov/pubmed/31919559,27339419|31919559,,
1214,598315,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in decreased activity of RXRA protein,,,PMID:25858767,https://www.ncbi.nlm.nih.gov/pubmed/25858767,25858767,,
1215,598316,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,10116,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of RXRA mrna]|carbon tetrachloride results in decreased expression of RXRA mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1216,598317,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6258,RXRG,https://ctdbase.org/detail.go?type=gene&acc=6258,,,6258.0,RXRG,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride affects the expression of RXRG mRNA,,,PMID:12734012,https://www.ncbi.nlm.nih.gov/pubmed/12734012,12734012,,
1217,598318,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6258,RXRG,https://ctdbase.org/detail.go?type=gene&acc=6258,,,6258.0,RXRG,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in decreased expression of RXRG mrna|schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of RXRG mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1218,598319,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,10329,RXYLT1,https://ctdbase.org/detail.go?type=gene&acc=10329,,,10329.0,RXYLT1,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of RXYLT1 mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
1219,598320,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6263,RYR3,https://ctdbase.org/detail.go?type=gene&acc=6263,,,6263.0,RYR3,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride affects the expression of RYR3 mRNA,,,PMID:12734012,https://www.ncbi.nlm.nih.gov/pubmed/12734012,12734012,,
1220,598321,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6271,S100A1,https://ctdbase.org/detail.go?type=gene&acc=6271,,,6271.0,S100A1,10090,Mus musculus (house mouse),Carbon tetrachloride affects the expression of S100A1 mRNA,,,PMID:17484886,https://www.ncbi.nlm.nih.gov/pubmed/17484886,17484886,,
1221,598626,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6275,S100A4,https://ctdbase.org/detail.go?type=gene&acc=6275,,,6275.0,S100A4,10090,Mus musculus (house mouse),Carbon tetrachloride affects the expression of S100A4 mRNA,,,PMID:17484886,https://www.ncbi.nlm.nih.gov/pubmed/17484886,17484886,,
1222,598627,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6275,S100A4,https://ctdbase.org/detail.go?type=gene&acc=6275,,,6275.0,S100A4,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of S100A4 mRNA,,,PMID:27339419|PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/27339419|https://www.ncbi.nlm.nih.gov/pubmed/31919559,27339419|31919559,,
1223,598628,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6275,S100A4,https://ctdbase.org/detail.go?type=gene&acc=6275,,,6275.0,S100A4,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of S100A4 protein,,,PMID:16818635|PMID:25566828,https://www.ncbi.nlm.nih.gov/pubmed/16818635|https://www.ncbi.nlm.nih.gov/pubmed/25566828,16818635|25566828,,
1224,598972,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,1903,S1PR3,https://ctdbase.org/detail.go?type=gene&acc=1903,,,1903.0,S1PR3,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of S1PR3 mRNA,,,PMID:17341687,https://www.ncbi.nlm.nih.gov/pubmed/17341687,17341687,,
1225,598973,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6288,SAA1,https://ctdbase.org/detail.go?type=gene&acc=6288,,,6288.0,SAA1,10090,Mus musculus (house mouse),Carbon tetrachloride results in decreased expression of SAA1 mRNA,,,PMID:29987408,https://www.ncbi.nlm.nih.gov/pubmed/29987408,29987408,,
1226,598974,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6288,SAA1,https://ctdbase.org/detail.go?type=gene&acc=6288,,,6288.0,SAA1,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of SAA1 mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
1227,598975,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6288,SAA1,https://ctdbase.org/detail.go?type=gene&acc=6288,,,6288.0,SAA1,10090,Mus musculus (house mouse),PLG gene mutant form promotes the reaction [carbon tetrachloride results in increased expression of SAA1 mrna],,,PMID:16006527,https://www.ncbi.nlm.nih.gov/pubmed/16006527,16006527,,
1228,598976,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6289,SAA2,https://ctdbase.org/detail.go?type=gene&acc=6289,,,6289.0,SAA2,10090,Mus musculus (house mouse),[carbon tetrachloride co-treated with ethanol] results in decreased expression of SAA2 mRNA,,,PMID:30517762,https://www.ncbi.nlm.nih.gov/pubmed/30517762,30517762,,
1229,598977,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6289,SAA2,https://ctdbase.org/detail.go?type=gene&acc=6289,,,6289.0,SAA2,10090,Mus musculus (house mouse),Carbon tetrachloride results in decreased expression of SAA2 mRNA,,,PMID:29987408,https://www.ncbi.nlm.nih.gov/pubmed/29987408,29987408,,
1230,598978,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6289,SAA2,https://ctdbase.org/detail.go?type=gene&acc=6289,,,6289.0,SAA2,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of SAA2 mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
1231,598979,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,20210,SAA3,https://ctdbase.org/detail.go?type=gene&acc=20210,,,20210.0,Saa3,10090,Mus musculus (house mouse),Carbon tetrachloride affects the expression of SAA3 mRNA,,,PMID:17484886,https://www.ncbi.nlm.nih.gov/pubmed/17484886,17484886,,
1232,598980,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,20210,SAA3,https://ctdbase.org/detail.go?type=gene&acc=20210,,,20210.0,Saa3,10090,Mus musculus (house mouse),[carbon tetrachloride co-treated with ethanol] results in decreased expression of SAA3 mRNA,,,PMID:30517762,https://www.ncbi.nlm.nih.gov/pubmed/30517762,30517762,,
1233,599511,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6301,SARS1,https://ctdbase.org/detail.go?type=gene&acc=6301,,,6301.0,SARS1,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of SARS1 mRNA,,,PMID:27339419|PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/27339419|https://www.ncbi.nlm.nih.gov/pubmed/31919559,27339419|31919559,,
1234,599512,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,6301,SARS1,https://ctdbase.org/detail.go?type=gene&acc=6301,,,6301.0,SARS1,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of SARS1 mrna|schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of SARS1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1235,599513,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,23328,SASH1,https://ctdbase.org/detail.go?type=gene&acc=23328,,,23328.0,SASH1,10090,Mus musculus (house mouse),Carbon tetrachloride results in decreased expression of SASH1 mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
1236,599514,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,112483,SAT2,https://ctdbase.org/detail.go?type=gene&acc=112483,,,112483.0,SAT2,10090,Mus musculus (house mouse),Carbon tetrachloride affects the expression of SAT2 mRNA,,,PMID:17484886,https://www.ncbi.nlm.nih.gov/pubmed/17484886,17484886,,
1237,601911,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,64218,SEMA4A,https://ctdbase.org/detail.go?type=gene&acc=64218,,,64218.0,SEMA4A,10090,Mus musculus (house mouse),Carbon tetrachloride results in decreased expression of SEMA4A mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
1238,603754,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,90637,ZFAND2A,https://ctdbase.org/detail.go?type=gene&acc=90637,,,90637.0,ZFAND2A,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of ZFAND2A mRNA,,,PMID:27339419|PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/27339419|https://www.ncbi.nlm.nih.gov/pubmed/31919559,27339419|31919559,,
1239,603755,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,90637,ZFAND2A,https://ctdbase.org/detail.go?type=gene&acc=90637,,,90637.0,ZFAND2A,10116,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of ZFAND2A mrna]|carbon tetrachloride results in increased expression of ZFAND2A mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1240,603756,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,93550,ZFAND4,https://ctdbase.org/detail.go?type=gene&acc=93550,,,93550.0,ZFAND4,10090,Mus musculus (house mouse),Carbon tetrachloride results in decreased expression of ZFAND4 mRNA,,,PMID:27339419|PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/27339419|https://www.ncbi.nlm.nih.gov/pubmed/31919559,27339419|31919559,,
1241,603757,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,93550,ZFAND4,https://ctdbase.org/detail.go?type=gene&acc=93550,,,93550.0,ZFAND4,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of ZFAND4 mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1242,603758,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,7763,ZFAND5,https://ctdbase.org/detail.go?type=gene&acc=7763,,,7763.0,ZFAND5,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of ZFAND5 mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
1243,603759,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,51663,ZFR,https://ctdbase.org/detail.go?type=gene&acc=51663,,,51663.0,ZFR,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of ZFR mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
1244,603959,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,65020,ZFP110,https://ctdbase.org/detail.go?type=gene&acc=65020,,,65020.0,Zfp110,10090,Mus musculus (house mouse),Carbon tetrachloride results in decreased expression of ZFP110 mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
1245,603960,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,56707,ZFP111,https://ctdbase.org/detail.go?type=gene&acc=56707,,,56707.0,Zfp111,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in decreased expression of ZFP111 mrna|carbon tetrachloride results in increased methylation of ZFP111 promoter,,,PMID:30690589,https://www.ncbi.nlm.nih.gov/pubmed/30690589,30690589,,
1246,605640,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,228491,ZFP770,https://ctdbase.org/detail.go?type=gene&acc=228491,,,228491.0,Zfp770,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of ZFP770 mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1247,605641,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,72306,ZFP777,https://ctdbase.org/detail.go?type=gene&acc=72306,,,72306.0,Zfp777,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of ZFP777 mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1248,607152,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,11130,ZWINT,https://ctdbase.org/detail.go?type=gene&acc=11130,,,11130.0,ZWINT,10090,Mus musculus (house mouse),Carbon tetrachloride affects the expression of ZWINT mRNA,,,PMID:17484886,https://www.ncbi.nlm.nih.gov/pubmed/17484886,17484886,,
1249,607153,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,11130,ZWINT,https://ctdbase.org/detail.go?type=gene&acc=11130,,,11130.0,ZWINT,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of ZWINT mRNA,,,PMID:27339419|PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/27339419|https://www.ncbi.nlm.nih.gov/pubmed/31919559,27339419|31919559,,
1250,607154,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,11130,ZWINT,https://ctdbase.org/detail.go?type=gene&acc=11130,,,11130.0,ZWINT,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of ZWINT mrna|schizandrin B inhibits the reaction [carbon tetrachloride results in increased expression of ZWINT mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1251,607155,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,158586,ZXDB,https://ctdbase.org/detail.go?type=gene&acc=158586,,,158586.0,ZXDB,10090,Mus musculus (house mouse),Carbon tetrachloride results in increased expression of ZXDB mRNA,,,PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/31919559,31919559,,
1252,607156,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,158586,ZXDB,https://ctdbase.org/detail.go?type=gene&acc=158586,,,158586.0,ZXDB,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of ZXDB mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1253,608762,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,376497,SLC27A1,https://ctdbase.org/detail.go?type=gene&acc=376497,,,376497.0,SLC27A1,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride affects the expression of SLC27A1 mRNA,,,PMID:15963342,https://www.ncbi.nlm.nih.gov/pubmed/15963342,15963342,,
1254,608763,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,376497,SLC27A1,https://ctdbase.org/detail.go?type=gene&acc=376497,,,376497.0,SLC27A1,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of SLC27A1 mRNA,,,PMID:16239168,https://www.ncbi.nlm.nih.gov/pubmed/16239168,16239168,,
1255,608936,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,10998,SLC27A5,https://ctdbase.org/detail.go?type=gene&acc=10998,,,10998.0,SLC27A5,10116,Rattus norvegicus (Norway rat),Schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of SLC27A5 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1256,608937,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,9153,SLC28A2,https://ctdbase.org/detail.go?type=gene&acc=9153,,,9153.0,SLC28A2,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in decreased expression of SLC28A2 mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1257,608938,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,2030,SLC29A1,https://ctdbase.org/detail.go?type=gene&acc=2030,,,2030.0,SLC29A1,10090,Mus musculus (house mouse),Carbon tetrachloride results in decreased expression of SLC29A1 mRNA,,,PMID:27339419|PMID:31919559,https://www.ncbi.nlm.nih.gov/pubmed/27339419|https://www.ncbi.nlm.nih.gov/pubmed/31919559,27339419|31919559,,
1258,608939,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,2030,SLC29A1,https://ctdbase.org/detail.go?type=gene&acc=2030,,,2030.0,SLC29A1,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in decreased expression of SLC29A1 mrna|schizandrin B inhibits the reaction [carbon tetrachloride results in decreased expression of SLC29A1 mrna],,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1259,608940,5943,Comparative Toxicogenomics Database (CTD),Carbon Tetrachloride,D002251,Carbon Tetrachloride,https://ctdbase.org/detail.go?type=chem&acc=D002251,3177,SLC29A2,https://ctdbase.org/detail.go?type=gene&acc=3177,,,3177.0,SLC29A2,10116,Rattus norvegicus (Norway rat),Carbon tetrachloride results in increased expression of SLC29A2 mRNA,,,PMID:31150632,https://www.ncbi.nlm.nih.gov/pubmed/31150632,31150632,,
1260,608941,5951,Therapeutic Target Database (TTD),Serine,D0T6GM,L-serine,https://idrblab.net/ttd/data/drug/details/D0T6GM,T72032,G-protein coupled receptor GPCR33 (GPRC6A),https://idrblab.net/ttd/data/target/details/T72032,Q5T6X5,G-protein coupled receptor family C group 6 member A,222545.0,GPRC6A,9606,Homo sapiens (human),Agonist,,,,,,,
1261,608942,5959,DrugBank,Chloramphenicol,DB00446,Chloramphenicol,https://www.drugbank.ca/drugs/DB00446,BE0004650,50S ribosomal protein L16,https://www.drugbank.ca/bio_entities/BE0004650,P0ADY7,50S ribosomal protein L16,83578283.0,,83333,Escherichia coli K-12,Inhibitor,,,PMID:7500366|PMID:4365366|PMID:3549294,https://www.ncbi.nlm.nih.gov/pubmed/7500366|https://www.ncbi.nlm.nih.gov/pubmed/4365366|https://www.ncbi.nlm.nih.gov/pubmed/3549294,7500366|4365366|3549294,,
1262,608943,5959,DrugBank,Chloramphenicol,DB00446,Chloramphenicol,https://www.drugbank.ca/drugs/DB00446,BE0001544,Dr hemagglutinin structural subunit,https://www.drugbank.ca/bio_entities/BE0001544,P24093,Dr hemagglutinin structural subunit,,,562,Escherichia coli,Antagonist,,,PMID:1670929,https://www.ncbi.nlm.nih.gov/pubmed/1670929,1670929,,
1263,608944,5959,DrugBank,Chloramphenicol,DB00446,Chloramphenicol,https://www.drugbank.ca/drugs/DB00446,BE0000929,Complement decay-accelerating factor,https://www.drugbank.ca/bio_entities/BE0000929,P08174,Complement decay-accelerating factor,1604.0,CD55,9606,Homo sapiens (human),Other,,,PMID:15331605|PMID:17376081,https://www.ncbi.nlm.nih.gov/pubmed/15331605|https://www.ncbi.nlm.nih.gov/pubmed/17376081,15331605|17376081,,
1264,609129,5959,Drug Gene Interaction database (DGIdb),Chloramphenicol,,CHLORAMPHENICOL,https://www.dgidb.org/drugs/rxcui:2348,,G6PD,https://www.dgidb.org/genes/hgnc:4057,,,2539.0,G6PD,9606,Homo sapiens (human),,,,,,,,
1265,609130,5959,Comparative Toxicogenomics Database (CTD),Chloramphenicol,D002701,Chloramphenicol,https://ctdbase.org/detail.go?type=chem&acc=D002701,59272,ACE2,https://ctdbase.org/detail.go?type=gene&acc=59272,,,59272.0,ACE2,9606,Homo sapiens (human),Chloramphenicol results in decreased expression of ACE2 mRNA,,,PMID:32808185,https://www.ncbi.nlm.nih.gov/pubmed/32808185,32808185,,
1266,609131,5959,Comparative Toxicogenomics Database (CTD),Chloramphenicol,D002701,Chloramphenicol,https://ctdbase.org/detail.go?type=chem&acc=D002701,249,ALPL,https://ctdbase.org/detail.go?type=gene&acc=249,,,249.0,ALPL,9606,Homo sapiens (human),Chloramphenicol results in increased expression of ALPL mRNA,,,PMID:22083529,https://www.ncbi.nlm.nih.gov/pubmed/22083529,22083529,,
1267,609132,5959,Comparative Toxicogenomics Database (CTD),Chloramphenicol,D002701,Chloramphenicol,https://ctdbase.org/detail.go?type=chem&acc=D002701,9140,ATG12,https://ctdbase.org/detail.go?type=gene&acc=9140,,,9140.0,ATG12,9606,Homo sapiens (human),Chloramphenicol results in increased expression of ATG12 mRNA,,,PMID:17457038,https://www.ncbi.nlm.nih.gov/pubmed/17457038,17457038,,
1268,601760,5962,DrugBank,Lysine,DB00123,Lysine,https://www.drugbank.ca/drugs/DB00123,BE0000757,Solute carrier family 22 member 4,https://www.drugbank.ca/bio_entities/BE0000757,Q9H015,Solute carrier family 22 member 4,6583.0,SLC22A4,9606,Homo sapiens (human),Inhibitor,,,PMID:10215651,https://www.ncbi.nlm.nih.gov/pubmed/10215651,10215651,,
1269,601761,5975,BindingDB,Cyanide ion,26984,CHEMBL1644697,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26984,2930,Carbonic anhydrase 15 [19-324],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2930,Q99N23,Carbonic anhydrase 15,80733.0,Car15,10090,Mus musculus (house mouse),,Ki (nM),9400,PMID:19128966|DOI:10.1016/j.bmcl.2008.12.082,https://www.ncbi.nlm.nih.gov/pubmed/19128966|https://doi.org/10.1016/j.bmcl.2008.12.082,19128966,10.1016/j.bmcl.2008.12.082,
1270,601762,5975,BindingDB,Cyanide ion,26984,CHEMBL1644697,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26984,1247,Carbonic anhydrase 4,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1247,P22748,Carbonic anhydrase 4,762.0,CA4,9606,Homo sapiens (human),,Ki (nM),770000,PMID:19128966|DOI:10.1016/j.bmcl.2008.12.082,https://www.ncbi.nlm.nih.gov/pubmed/19128966|https://doi.org/10.1016/j.bmcl.2008.12.082,19128966,10.1016/j.bmcl.2008.12.082,
1271,601763,5975,BindingDB,Cyanide ion,26984,CHEMBL1644697,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26984,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606,Homo sapiens (human),,Ki (nM),20000,PMID:19128966|DOI:10.1016/j.bmcl.2008.12.082,https://www.ncbi.nlm.nih.gov/pubmed/19128966|https://doi.org/10.1016/j.bmcl.2008.12.082,19128966,10.1016/j.bmcl.2008.12.082,
1272,601764,5975,BindingDB,Cyanide ion,26984,CHEMBL1644697,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=26984,1192,Carbonic anhydrase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1192,P00915,Carbonic anhydrase 1,759.0,CA1,9606,Homo sapiens (human),,Ki (nM),500,PMID:19128966|DOI:10.1016/j.bmcl.2008.12.082,https://www.ncbi.nlm.nih.gov/pubmed/19128966|https://doi.org/10.1016/j.bmcl.2008.12.082,19128966,10.1016/j.bmcl.2008.12.082,
1273,601765,5983,BindingDB,Physostigmine,11023,"(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-methylcarbamate; 2-hydroxybenzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11023,3620,Cholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=3620,P06276,Cholinesterase,590.0,BCHE,9606,Homo sapiens (human),,IC50 (nM),4e+1,PMID:27441832|DOI:10.1016/j.bioorg.2016.07.005,https://www.ncbi.nlm.nih.gov/pubmed/27441832|https://doi.org/10.1016/j.bioorg.2016.07.005,27441832,10.1016/j.bioorg.2016.07.005,
1274,601766,5983,BindingDB,Physostigmine,11023,"(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-methylcarbamate; 2-hydroxybenzoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=11023,236,Acetylcholinesterase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=236,P04058,Acetylcholinesterase,,,7787,Tetronarce californica (Pacific electric ray),,IC50 (nM),8.5e+2,PMID:27441832|DOI:10.1016/j.bioorg.2016.07.005,https://www.ncbi.nlm.nih.gov/pubmed/27441832|https://doi.org/10.1016/j.bioorg.2016.07.005,27441832,10.1016/j.bioorg.2016.07.005,
1275,601767,5983,Drug Gene Interaction database (DGIdb),Physostigmine,,PHYSOSTIGMINE,https://www.dgidb.org/drugs/rxcui:8299,,ACHE,https://www.dgidb.org/genes/hgnc:108,,,43.0,ACHE,9606,Homo sapiens (human),,,,,,,,
1276,601768,5984,Drug Gene Interaction database (DGIdb),D-(-)-Fructose,,FRUCTOSE,https://www.dgidb.org/drugs/rxcui:4570,,FHIT,https://www.dgidb.org/genes/hgnc:3701,,,2272.0,FHIT,9606,Homo sapiens (human),,,,,,,,
1277,602580,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,300540,OR8B101C,https://ctdbase.org/detail.go?type=gene&acc=300540,,,300540.0,Or8b101c,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of OR8B101C mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1278,602581,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,258824,OR8B57,https://ctdbase.org/detail.go?type=gene&acc=258824,,,258824.0,Or8b57,10116,Rattus norvegicus (Norway rat),[copper co-treated with dietary sucrose] results in increased expression of OR8B57 mrna|dietary sucrose results in increased expression of OR8B57 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1279,602582,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,405080,OR8G36C,https://ctdbase.org/detail.go?type=gene&acc=405080,,,405080.0,Or8g36c,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of OR8G36C mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1280,602583,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,258165,OR8G52,https://ctdbase.org/detail.go?type=gene&acc=258165,,,258165.0,Or8g52,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of OR8G52 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1281,602584,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,295786,OR8H10C,https://ctdbase.org/detail.go?type=gene&acc=295786,,,295786.0,Or8h10c,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of OR8H10C mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1282,602585,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,81168,OR8J3,https://ctdbase.org/detail.go?type=gene&acc=81168,,,81168.0,OR8J3,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of OR8J3 mrna|[copper co-treated with dietary sucrose] results in increased expression of OR8J3 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1283,602751,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,258757,OR9G19,https://ctdbase.org/detail.go?type=gene&acc=258757,,,258757.0,Or9g19,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of OR9G19 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1284,602752,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,441639,OR9K2,https://ctdbase.org/detail.go?type=gene&acc=441639,,,441639.0,OR9K2,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of OR9K2 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1285,602753,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,405021,OR9S14B,https://ctdbase.org/detail.go?type=gene&acc=405021,,,405021.0,Or9s14b,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of OR9S14B mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1286,602754,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,259039,OR9S23,https://ctdbase.org/detail.go?type=gene&acc=259039,,,259039.0,Or9s23,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of OR9S23 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1287,602755,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,316633,OR9S23B,https://ctdbase.org/detail.go?type=gene&acc=316633,,,316633.0,Or9s23b,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of OR9S23B mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1288,602756,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,23762,OSBP2,https://ctdbase.org/detail.go?type=gene&acc=23762,,,23762.0,OSBP2,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of OSBP2 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1289,602757,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,114879,OSBPL5,https://ctdbase.org/detail.go?type=gene&acc=114879,,,114879.0,OSBPL5,10090,Mus musculus (house mouse),[dietary fats co-treated with dietary sucrose] results in increased expression of OSBPL5 mRNA,,,PMID:28433925,https://www.ncbi.nlm.nih.gov/pubmed/28433925,28433925,,
1290,602758,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,9180,OSMR,https://ctdbase.org/detail.go?type=gene&acc=9180,,,9180.0,OSMR,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of OSMR mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1291,602759,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,146183,OTOA,https://ctdbase.org/detail.go?type=gene&acc=146183,,,146183.0,OTOA,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of OTOA mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1292,603408,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,57575,PCDH10,https://ctdbase.org/detail.go?type=gene&acc=57575,,,57575.0,PCDH10,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with 2,4-dichlorophenoxyacetic acid] results in increased expression of PCDH10 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1293,603409,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,27253,PCDH17,https://ctdbase.org/detail.go?type=gene&acc=27253,,,27253.0,PCDH17,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of PCDH17 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1294,603410,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,5100,PCDH8,https://ctdbase.org/detail.go?type=gene&acc=5100,,,5100.0,PCDH8,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of PCDH8 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1295,603411,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,56122,PCDHB14,https://ctdbase.org/detail.go?type=gene&acc=56122,,,56122.0,PCDHB14,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of PCDHB14 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1296,603412,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,93891,PCDHB20,https://ctdbase.org/detail.go?type=gene&acc=93891,,,93891.0,Pcdhb20,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of PCDHB20 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1297,603413,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,56131,PCDHB4,https://ctdbase.org/detail.go?type=gene&acc=56131,,,56131.0,PCDHB4,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of PCDHB4 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1298,603414,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,56127,PCDHB9,https://ctdbase.org/detail.go?type=gene&acc=56127,,,56127.0,PCDHB9,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of PCDHB9 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1299,603415,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,56114,PCDHGA1,https://ctdbase.org/detail.go?type=gene&acc=56114,,,56114.0,PCDHGA1,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of PCDHGA1 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1300,603416,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,9708,PCDHGA8,https://ctdbase.org/detail.go?type=gene&acc=9708,,,9708.0,PCDHGA8,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with 2,4-dichlorophenoxyacetic acid] results in decreased expression of PCDHGA8 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1301,603417,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,5105,PCK1,https://ctdbase.org/detail.go?type=gene&acc=5105,,,5105.0,PCK1,10090,Mus musculus (house mouse),Quercetin inhibits the reaction [[dietary fats co-treated with dietary sucrose] results in decreased expression of PCK1 mrna]|[dietary fats co-treated with dietary sucrose] results in decreased expression of PCK1 mRNA,,,PMID:21462320,https://www.ncbi.nlm.nih.gov/pubmed/21462320,21462320,,
1302,604302,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,54478,PIMREG,https://ctdbase.org/detail.go?type=gene&acc=54478,,,54478.0,PIMREG,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in increased expression of PIMREG mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1303,604794,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,21756,PRSS40,https://ctdbase.org/detail.go?type=gene&acc=21756,,,21756.0,Prss40,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of PRSS40 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1304,604795,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,5340,PLG,https://ctdbase.org/detail.go?type=gene&acc=5340,,,5340.0,PLG,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of PLG mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1305,604796,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,5346,PLIN1,https://ctdbase.org/detail.go?type=gene&acc=5346,,,5346.0,PLIN1,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of PLIN1 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1306,604797,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,5346,PLIN1,https://ctdbase.org/detail.go?type=gene&acc=5346,,,5346.0,PLIN1,10116,Rattus norvegicus (Norway rat),Apple polyphenol extract inhibits the reaction [[dietary sucrose co-treated with dietary fats] results in increased expression of PLIN1 mrna]|[dietary sucrose co-treated with dietary fats] results in increased expression of PLIN1 mRNA,,,PMID:23529981,https://www.ncbi.nlm.nih.gov/pubmed/23529981,23529981,,
1307,604798,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,729359,PLIN4,https://ctdbase.org/detail.go?type=gene&acc=729359,,,729359.0,PLIN4,10090,Mus musculus (house mouse),[dietary fats co-treated with dietary sucrose] results in increased expression of PLIN4 mRNA,,,PMID:28433925,https://www.ncbi.nlm.nih.gov/pubmed/28433925,28433925,,
1308,605965,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,64368,PRL8A7,https://ctdbase.org/detail.go?type=gene&acc=64368,,,64368.0,Prl8a7,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of PRL8A7 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1309,605966,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,74306,PRSS46,https://ctdbase.org/detail.go?type=gene&acc=74306,,,74306.0,Prss46,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of PRSS46 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1310,606636,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,5657,PRTN3,https://ctdbase.org/detail.go?type=gene&acc=5657,,,5657.0,PRTN3,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with herbicides] results in decreased expression of PRTN3 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1311,606637,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,768239,PSAPL1,https://ctdbase.org/detail.go?type=gene&acc=768239,,,768239.0,PSAPL1,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of PSAPL1 mrna|[copper co-treated with dietary sucrose] results in increased expression of PSAPL1 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1312,606638,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,84249,PSD2,https://ctdbase.org/detail.go?type=gene&acc=84249,,,84249.0,PSD2,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of PSD2 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1313,606639,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,84249,PSD2,https://ctdbase.org/detail.go?type=gene&acc=84249,,,84249.0,PSD2,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of PSD2 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1314,606640,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,5699,PSMB10,https://ctdbase.org/detail.go?type=gene&acc=5699,,,5699.0,PSMB10,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in increased expression of PSMB10 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1315,606641,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,5696,PSMB8,https://ctdbase.org/detail.go?type=gene&acc=5696,,,5696.0,PSMB8,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in increased expression of PSMB8 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1316,606642,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,170680,PSORS1C2,https://ctdbase.org/detail.go?type=gene&acc=170680,,,170680.0,PSORS1C2,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with herbicides] results in decreased expression of PSORS1C2 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1317,606643,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,170680,PSORS1C2,https://ctdbase.org/detail.go?type=gene&acc=170680,,,170680.0,PSORS1C2,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of PSORS1C2 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1318,609133,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,6550,SLC9A3,https://ctdbase.org/detail.go?type=gene&acc=6550,,,6550.0,SLC9A3,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in increased expression of SLC9A3 mRNA,,,PMID:26033743,https://www.ncbi.nlm.nih.gov/pubmed/26033743,26033743,,
1319,609134,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,677769,SCARNA17,https://ctdbase.org/detail.go?type=gene&acc=677769,,,677769.0,SCARNA17,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with 2,4-dichlorophenoxyacetic acid] results in increased expression of SCARNA17 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1320,609135,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,10090,Mus musculus (house mouse),"[dietary sucrose co-treated with dietary fats co-treated with bisphenol A co-treated with diethylhexyl phthalate co-treated with tetrachlorodibenzodioxin co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl] results in increased expression of SCD1 mrna|[dietary fats co-treated with dietary sucrose] results in increased expression of SCD1 mRNA",,,PMID:30722647,https://www.ncbi.nlm.nih.gov/pubmed/30722647,30722647,,
1321,609136,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,10116,Rattus norvegicus (Norway rat),[dietary sucrose co-treated with dietary fats] results in decreased expression of SCD1 mRNA,,,PMID:23529981,https://www.ncbi.nlm.nih.gov/pubmed/23529981,23529981,,
1322,609137,5988,Comparative Toxicogenomics Database (CTD),Sucrose,D019422,Dietary Sucrose,https://ctdbase.org/detail.go?type=chem&acc=D019422,20249,SCD1,https://ctdbase.org/detail.go?type=gene&acc=20249,,,20249.0,Scd1,10116,Rattus norvegicus (Norway rat),Dietary sucrose results in decreased expression of SCD1 mRNA,,,PMID:15763435,https://www.ncbi.nlm.nih.gov/pubmed/15763435,15763435,,
1323,421724,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,55619,DOCK10,https://ctdbase.org/detail.go?type=gene&acc=55619,,,55619.0,DOCK10,9606,Homo sapiens (human),Ethinyl estradiol results in decreased expression of DOCK10 mRNA,,,PMID:18936297,https://www.ncbi.nlm.nih.gov/pubmed/18936297,18936297,,
1324,421725,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,139818,DOCK11,https://ctdbase.org/detail.go?type=gene&acc=139818,,,139818.0,DOCK11,44932,Boreogadus saida,[benzo(a)pyrene co-treated with ethinyl estradiol] results in decreased expression of DOCK11 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1325,424666,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,55112,DYNC2I1,https://ctdbase.org/detail.go?type=gene&acc=55112,,,55112.0,DYNC2I1,10090,Mus musculus (house mouse),Ethinyl estradiol affects the expression of DYNC2I1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
1326,424667,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,55112,DYNC2I1,https://ctdbase.org/detail.go?type=gene&acc=55112,,,55112.0,DYNC2I1,10116,Rattus norvegicus (Norway rat),Ethinyl estradiol results in decreased expression of DYNC2I1 mRNA,,,PMID:29097150,https://www.ncbi.nlm.nih.gov/pubmed/29097150,29097150,,
1327,424668,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,55112,DYNC2I1,https://ctdbase.org/detail.go?type=gene&acc=55112,,,55112.0,DYNC2I1,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of DYNC2I1 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1328,424669,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,89891,DYNC2I2,https://ctdbase.org/detail.go?type=gene&acc=89891,,,89891.0,DYNC2I2,44932,Boreogadus saida,Ethinyl estradiol results in decreased expression of DYNC2I2 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1329,424670,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,89891,DYNC2I2,https://ctdbase.org/detail.go?type=gene&acc=89891,,,89891.0,DYNC2I2,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of DYNC2I2 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1330,424671,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,51626,DYNC2LI1,https://ctdbase.org/detail.go?type=gene&acc=51626,,,51626.0,DYNC2LI1,10090,Mus musculus (house mouse),Ethinyl estradiol affects the expression of DYNC2LI1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
1331,424672,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,8655,DYNLL1,https://ctdbase.org/detail.go?type=gene&acc=8655,,,8655.0,DYNLL1,10090,Mus musculus (house mouse),Ethinyl estradiol results in increased expression of DYNLL1 mRNA,,,PMID:14976129|PMID:17555576|PMID:17942748|PMID:19400957|PMID:24096037,https://www.ncbi.nlm.nih.gov/pubmed/14976129|https://www.ncbi.nlm.nih.gov/pubmed/17555576|https://www.ncbi.nlm.nih.gov/pubmed/17942748|https://www.ncbi.nlm.nih.gov/pubmed/19400957|https://www.ncbi.nlm.nih.gov/pubmed/24096037,14976129|17555576|17942748|19400957|24096037,,
1332,426254,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,10090,Mus musculus (house mouse),Ethinyl estradiol results in increased expression of EDN1 mrna|[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in decreased expression of EDN1 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
1333,426255,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906.0,EDN1,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in increased expression of EDN1 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1334,426256,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1907,EDN2,https://ctdbase.org/detail.go?type=gene&acc=1907,,,1907.0,EDN2,9606,Homo sapiens (human),Ethinyl estradiol affects the expression of EDN2 mRNA,,,PMID:20170705|PMID:26865667,https://www.ncbi.nlm.nih.gov/pubmed/20170705|https://www.ncbi.nlm.nih.gov/pubmed/26865667,20170705|26865667,,
1335,426257,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1907,EDN2,https://ctdbase.org/detail.go?type=gene&acc=1907,,,1907.0,EDN2,9606,Homo sapiens (human),Ethinyl estradiol results in decreased expression of EDN2 mRNA,,,PMID:18936297,https://www.ncbi.nlm.nih.gov/pubmed/18936297,18936297,,
1336,426258,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1909,EDNRA,https://ctdbase.org/detail.go?type=gene&acc=1909,,,1909.0,EDNRA,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of EDNRA mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1337,426259,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1910,EDNRB,https://ctdbase.org/detail.go?type=gene&acc=1910,,,1910.0,EDNRB,9606,Homo sapiens (human),[ethinyl estradiol co-treated with cholic acids] affects the expression of EDNRB mRNA,,,PMID:27344345,https://www.ncbi.nlm.nih.gov/pubmed/27344345,27344345,,
1338,426260,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1910,EDNRB,https://ctdbase.org/detail.go?type=gene&acc=1910,,,1910.0,EDNRB,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol affects the expression of EDNRB mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1339,427057,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,60678,EEFSEC,https://ctdbase.org/detail.go?type=gene&acc=60678,,,60678.0,EEFSEC,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of EEFSEC mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1340,427058,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,399665,EEIG1,https://ctdbase.org/detail.go?type=gene&acc=399665,,,399665.0,EEIG1,44932,Boreogadus saida,Ethinyl estradiol results in decreased expression of EEIG1 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1341,427059,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,399665,EEIG1,https://ctdbase.org/detail.go?type=gene&acc=399665,,,399665.0,EEIG1,9606,Homo sapiens (human),Ethinyl estradiol results in increased expression of EEIG1 mRNA,,,PMID:14605097,https://www.ncbi.nlm.nih.gov/pubmed/14605097,14605097,,
1342,427060,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,284611,EEIG2,https://ctdbase.org/detail.go?type=gene&acc=284611,,,284611.0,EEIG2,44932,Boreogadus saida,Ethinyl estradiol results in increased expression of EEIG2 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1343,428018,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1958,EGR1,https://ctdbase.org/detail.go?type=gene&acc=1958,,,1958.0,EGR1,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of EGR1 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1344,428019,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1959,EGR2,https://ctdbase.org/detail.go?type=gene&acc=1959,,,1959.0,EGR2,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of EGR2 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1345,428020,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,1961,EGR4,https://ctdbase.org/detail.go?type=gene&acc=1961,,,1961.0,EGR4,44932,Boreogadus saida,Ethinyl estradiol results in increased expression of EGR4 mRNA,,,PMID:34015484,https://www.ncbi.nlm.nih.gov/pubmed/34015484,34015484,,
1346,428021,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,100331563,EHBP1L1B,https://ctdbase.org/detail.go?type=gene&acc=100331563,,,100331563.0,ehbp1l1b,7955,Danio rerio (zebrafish),Ethinyl estradiol affects the expression of EHBP1L1B mRNA,,,PMID:25064622,https://www.ncbi.nlm.nih.gov/pubmed/25064622,25064622,,
1347,428022,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,10938,EHD1,https://ctdbase.org/detail.go?type=gene&acc=10938,,,10938.0,EHD1,10090,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of EHD1 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
1348,428023,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,10938,EHD1,https://ctdbase.org/detail.go?type=gene&acc=10938,,,10938.0,EHD1,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of EHD1 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1349,428024,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,30846,EHD2,https://ctdbase.org/detail.go?type=gene&acc=30846,,,30846.0,EHD2,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of EHD2 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1350,428025,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,30845,EHD3,https://ctdbase.org/detail.go?type=gene&acc=30845,,,30845.0,EHD3,10090,Mus musculus (house mouse),Ethinyl estradiol affects the expression of EHD3 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
1351,428026,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,30845,EHD3,https://ctdbase.org/detail.go?type=gene&acc=30845,,,30845.0,EHD3,10090,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of EHD3 mrna|ethinyl estradiol results in increased expression of EHD3 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
1352,590511,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,55559,HAUS7,https://ctdbase.org/detail.go?type=gene&acc=55559,,,55559.0,HAUS7,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in increased expression of HAUS7 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1353,590512,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,10456,HAX1,https://ctdbase.org/detail.go?type=gene&acc=10456,,,10456.0,HAX1,10090,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of HAX1 mrna|ethinyl estradiol results in increased expression of HAX1 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
1354,590513,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,15121,HBA,https://ctdbase.org/detail.go?type=gene&acc=15121,,,15121.0,Hba,7153,Chironomus tentans,Ethinyl estradiol results in decreased expression of HBA mRNA,,,PMID:16624371,https://www.ncbi.nlm.nih.gov/pubmed/16624371,16624371,,
1355,590514,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,3039,HBA1,https://ctdbase.org/detail.go?type=gene&acc=3039,,,3039.0,HBA1,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of HBA1 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1356,590515,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,548658,HBA3,https://ctdbase.org/detail.go?type=gene&acc=548658,,,548658.0,hba3,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of HBA3 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1357,590516,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,15122,HBA-A1,https://ctdbase.org/detail.go?type=gene&acc=15122,,,15122.0,Hba-a1,10090,Mus musculus (house mouse),Ethinyl estradiol affects the expression of HBA-A1 mRNA,,,PMID:17555576,https://www.ncbi.nlm.nih.gov/pubmed/17555576,17555576,,
1358,590517,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,15122,HBA-A1,https://ctdbase.org/detail.go?type=gene&acc=15122,,,15122.0,Hba-a1,10090,Mus musculus (house mouse),Ethinyl estradiol results in decreased expression of HBA-A1 mRNA,,,PMID:16174780|PMID:19400957,https://www.ncbi.nlm.nih.gov/pubmed/16174780|https://www.ncbi.nlm.nih.gov/pubmed/19400957,16174780|19400957,,
1359,590518,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,15122,HBA-A1,https://ctdbase.org/detail.go?type=gene&acc=15122,,,15122.0,Hba-a1,10090,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in decreased expression of HBA-A1 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
1360,595061,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10090,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of HMOX1 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
1361,595715,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,3182,HNRNPAB,https://ctdbase.org/detail.go?type=gene&acc=3182,,,3182.0,HNRNPAB,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in increased expression of HNRNPAB mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1362,595716,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,3183,HNRNPC,https://ctdbase.org/detail.go?type=gene&acc=3183,,,3183.0,HNRNPC,10090,Mus musculus (house mouse),[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of HNRNPC mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
1363,595717,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,3184,HNRNPD,https://ctdbase.org/detail.go?type=gene&acc=3184,,,3184.0,HNRNPD,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of HNRNPD mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1364,595718,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,9987,HNRNPDL,https://ctdbase.org/detail.go?type=gene&acc=9987,,,9987.0,HNRNPDL,10116,Rattus norvegicus (Norway rat),Ethinyl estradiol results in decreased expression of HNRNPDL mRNA,,,PMID:17557909,https://www.ncbi.nlm.nih.gov/pubmed/17557909,17557909,,
1365,595719,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,9987,HNRNPDL,https://ctdbase.org/detail.go?type=gene&acc=9987,,,9987.0,HNRNPDL,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in increased expression of HNRNPDL mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1366,595720,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,3187,HNRNPH1,https://ctdbase.org/detail.go?type=gene&acc=3187,,,3187.0,HNRNPH1,10116,Rattus norvegicus (Norway rat),Ethinyl estradiol results in decreased expression of HNRNPH1 mRNA,,,PMID:17557909,https://www.ncbi.nlm.nih.gov/pubmed/17557909,17557909,,
1367,595721,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,3187,HNRNPH1,https://ctdbase.org/detail.go?type=gene&acc=3187,,,3187.0,HNRNPH1,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in increased expression of HNRNPH1 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1368,596528,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,30344,HOXB9A,https://ctdbase.org/detail.go?type=gene&acc=30344,,,30344.0,hoxb9a,7955,Danio rerio (zebrafish),Ethinyl estradiol results in decreased expression of HOXB9A mRNA,,,PMID:17606305|PMID:20227414,https://www.ncbi.nlm.nih.gov/pubmed/17606305|https://www.ncbi.nlm.nih.gov/pubmed/20227414,17606305|20227414,,
1369,596529,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,3229,HOXC13,https://ctdbase.org/detail.go?type=gene&acc=3229,,,3229.0,HOXC13,8364,Xenopus tropicalis (tropical clawed frog),Ethinyl estradiol results in decreased expression of HOXC13 mRNA,,,PMID:23129252,https://www.ncbi.nlm.nih.gov/pubmed/23129252,23129252,,
1370,596530,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,58059,HOXC13A,https://ctdbase.org/detail.go?type=gene&acc=58059,,,58059.0,hoxc13a,7955,Danio rerio (zebrafish),Ethinyl estradiol results in decreased expression of HOXC13A mRNA,,,PMID:29458080,https://www.ncbi.nlm.nih.gov/pubmed/29458080,29458080,,
1371,596531,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,30345,HOXC4A,https://ctdbase.org/detail.go?type=gene&acc=30345,,,30345.0,hoxc4a,7955,Danio rerio (zebrafish),Ethinyl estradiol results in increased expression of HOXC4A mRNA,,,PMID:17606305,https://www.ncbi.nlm.nih.gov/pubmed/17606305,17606305,,
1372,596532,5991,Comparative Toxicogenomics Database (CTD),Ethinyl Estradiol,D004997,Ethinyl Estradiol,https://ctdbase.org/detail.go?type=chem&acc=D004997,3223,HOXC6,https://ctdbase.org/detail.go?type=gene&acc=3223,,,3223.0,HOXC6,10090,Mus musculus (house mouse),Ethinyl estradiol results in increased expression of HOXC6 mrna|[tetrachlorodibenzodioxin co-treated with ethinyl estradiol] results in increased expression of HOXC6 mRNA,,,PMID:17942748,https://www.ncbi.nlm.nih.gov/pubmed/17942748,17942748,,
1373,590855,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,10525,HYOU1,https://ctdbase.org/detail.go?type=gene&acc=10525,,,10525.0,HYOU1,9606,Homo sapiens (human),Progesterone results in increased expression of HYOU1 mRNA,,,PMID:18037150,https://www.ncbi.nlm.nih.gov/pubmed/18037150,18037150,,
1374,590856,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,200205,IBA57,https://ctdbase.org/detail.go?type=gene&acc=200205,,,200205.0,IBA57,9940,Ovis aries (sheep),Progesterone results in increased expression of IBA57 mRNA,,,PMID:19690047,https://www.ncbi.nlm.nih.gov/pubmed/19690047,19690047,,
1375,590857,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3381,IBSP,https://ctdbase.org/detail.go?type=gene&acc=3381,,,3381.0,IBSP,9913,Bos taurus (cattle),Progesterone results in increased expression of IBSP mRNA,,,PMID:19553605,https://www.ncbi.nlm.nih.gov/pubmed/19553605,19553605,,
1376,590858,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),MPO gene polymorphism affects the reaction [[estradiol co-treated with progesterone] results in decreased expression of ICAM1 protein]|[estradiol co-treated with progesterone] results in decreased expression of ICAM1 protein,,,PMID:21242819,https://www.ncbi.nlm.nih.gov/pubmed/21242819,21242819,,
1377,591048,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),Org 31710 inhibits the reaction [progesterone inhibits the reaction [lipopolysaccharides results in increased expression of ICAM1 protein]]|mifepristone inhibits the reaction [progesterone inhibits the reaction [lipopolysaccharides results in increased expression of ICAM1 protein]]|progesterone inhibits the reaction [lipopolysaccharides results in increased expression of ICAM1 protein],,,PMID:15358673,https://www.ncbi.nlm.nih.gov/pubmed/15358673,15358673,,
1378,591049,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,9606,Homo sapiens (human),[progesterone co-treated with estradiol] results in increased expression of ICAM1 mRNA,,,PMID:20226447,https://www.ncbi.nlm.nih.gov/pubmed/20226447,20226447,,
1379,591050,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10090,Mus musculus (house mouse),U 0126 inhibits the reaction [[progesterone co-treated with halothane] results in increased expression of ICAM1 mrna]|gadolinium chloride inhibits the reaction [[progesterone co-treated with halothane] results in increased expression of ICAM1 mrna]|[progesterone co-treated with halothane] results in increased expression of ICAM1 mRNA,,,PMID:22157104,https://www.ncbi.nlm.nih.gov/pubmed/22157104,22157104,,
1380,591051,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10090,Mus musculus (house mouse),Progesterone promotes the reaction [halothane results in increased expression of ICAM1 mrna]|mifepristone inhibits the reaction [progesterone promotes the reaction [halothane results in increased expression of ICAM1 mrna]],,,PMID:21501669,https://www.ncbi.nlm.nih.gov/pubmed/21501669,21501669,,
1381,591052,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10116,Rattus norvegicus (Norway rat),Progesterone results in decreased expression of ICAM1 mRNA,,,PMID:22903158,https://www.ncbi.nlm.nih.gov/pubmed/22903158,22903158,,
1382,591053,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10116,Rattus norvegicus (Norway rat),Progesterone results in decreased expression of ICAM1 protein,,,PMID:17868700,https://www.ncbi.nlm.nih.gov/pubmed/17868700,17868700,,
1383,591054,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,23463,ICMT,https://ctdbase.org/detail.go?type=gene&acc=23463,,,23463.0,ICMT,10090,Mus musculus (house mouse),Progesterone affects the expression of ICMT mRNA,,,PMID:17251523,https://www.ncbi.nlm.nih.gov/pubmed/17251523,17251523,,
1384,591055,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3397,ID1,https://ctdbase.org/detail.go?type=gene&acc=3397,,,3397.0,ID1,9606,Homo sapiens (human),Progesterone results in decreased expression of ID1 protein,,,PMID:18045962,https://www.ncbi.nlm.nih.gov/pubmed/18045962,18045962,,
1385,591056,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3397,ID1,https://ctdbase.org/detail.go?type=gene&acc=3397,,,3397.0,ID1,9606,Homo sapiens (human),Progesterone results in increased expression of ID1 mRNA,,,PMID:18037150,https://www.ncbi.nlm.nih.gov/pubmed/18037150,18037150,,
1386,591738,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,2537,IFI6,https://ctdbase.org/detail.go?type=gene&acc=2537,,,2537.0,IFI6,9940,Ovis aries (sheep),Progesterone results in increased expression of IFI6 mRNA,,,PMID:19690047,https://www.ncbi.nlm.nih.gov/pubmed/19690047,19690047,,
1387,591739,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,64135,IFIH1,https://ctdbase.org/detail.go?type=gene&acc=64135,,,64135.0,IFIH1,9913,Bos taurus (cattle),Progesterone results in increased expression of IFIH1 mRNA,,,PMID:23012394,https://www.ncbi.nlm.nih.gov/pubmed/23012394,23012394,,
1388,591740,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,64135,IFIH1,https://ctdbase.org/detail.go?type=gene&acc=64135,,,64135.0,IFIH1,9940,Ovis aries (sheep),Progesterone results in increased expression of IFIH1 mRNA,,,PMID:19690047,https://www.ncbi.nlm.nih.gov/pubmed/19690047,19690047,,
1389,591741,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3434,IFIT1,https://ctdbase.org/detail.go?type=gene&acc=3434,,,3434.0,IFIT1,9606,Homo sapiens (human),Progesterone results in decreased expression of IFIT1 mRNA,,,PMID:20864642,https://www.ncbi.nlm.nih.gov/pubmed/20864642,20864642,,
1390,591742,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3437,IFIT3,https://ctdbase.org/detail.go?type=gene&acc=3437,,,3437.0,IFIT3,9606,Homo sapiens (human),Progesterone results in increased expression of IFIT3 mrna|[progesterone co-treated with TGFB1 protein] results in increased expression of IFIT3 mRNA,,,PMID:21768398,https://www.ncbi.nlm.nih.gov/pubmed/21768398,21768398,,
1391,591743,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3437,IFIT3,https://ctdbase.org/detail.go?type=gene&acc=3437,,,3437.0,IFIT3,9940,Ovis aries (sheep),Progesterone results in increased expression of IFIT3 mRNA,,,PMID:19690047,https://www.ncbi.nlm.nih.gov/pubmed/19690047,19690047,,
1392,591744,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,8519,IFITM1,https://ctdbase.org/detail.go?type=gene&acc=8519,,,8519.0,IFITM1,10116,Rattus norvegicus (Norway rat),Progesterone results in increased expression of IFITM1 mRNA,,,PMID:21770760,https://www.ncbi.nlm.nih.gov/pubmed/21770760,21770760,,
1393,591745,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,10581,IFITM2,https://ctdbase.org/detail.go?type=gene&acc=10581,,,10581.0,IFITM2,10116,Rattus norvegicus (Norway rat),Progesterone results in increased expression of IFITM2 mRNA,,,PMID:21770760,https://www.ncbi.nlm.nih.gov/pubmed/21770760,21770760,,
1394,591746,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3440,IFNA2,https://ctdbase.org/detail.go?type=gene&acc=3440,,,3440.0,IFNA2,9606,Homo sapiens (human),Progesterone results in increased expression of IFNA2 mRNA,,,PMID:22615136,https://www.ncbi.nlm.nih.gov/pubmed/22615136,22615136,,
1395,591747,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3455,IFNAR2,https://ctdbase.org/detail.go?type=gene&acc=3455,,,3455.0,IFNAR2,9606,Homo sapiens (human),Progesterone results in increased expression of IFNAR2 mRNA,,,PMID:18070364,https://www.ncbi.nlm.nih.gov/pubmed/18070364,18070364,,
1396,592796,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3480,IGF1R,https://ctdbase.org/detail.go?type=gene&acc=3480,,,3480.0,IGF1R,10116,Rattus norvegicus (Norway rat),[estradiol co-treated with progesterone co-treated with methylnitrosourea] results in increased expression of IGF1R protein|[estradiol co-treated with progesterone co-treated with methylnitrosourea] results in increased expression of IGF1R mRNA,,,PMID:22465879,https://www.ncbi.nlm.nih.gov/pubmed/22465879,22465879,,
1397,592797,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3480,IGF1R,https://ctdbase.org/detail.go?type=gene&acc=3480,,,3480.0,IGF1R,10116,Rattus norvegicus (Norway rat),Progesterone results in increased expression of IGF1R mRNA,,,PMID:19853640,https://www.ncbi.nlm.nih.gov/pubmed/19853640,19853640,,
1398,592798,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3481,IGF2,https://ctdbase.org/detail.go?type=gene&acc=3481,,,3481.0,IGF2,9913,Bos taurus (cattle),Progesterone affects the localization of IGF2 protein,,,PMID:22085906,https://www.ncbi.nlm.nih.gov/pubmed/22085906,22085906,,
1399,592799,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3481,IGF2,https://ctdbase.org/detail.go?type=gene&acc=3481,,,3481.0,IGF2,9606,Homo sapiens (human),Progesterone results in increased expression of IGF2 mRNA,,,PMID:18497975,https://www.ncbi.nlm.nih.gov/pubmed/18497975,18497975,,
1400,592800,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3484,IGFBP1,https://ctdbase.org/detail.go?type=gene&acc=3484,,,3484.0,IGFBP1,9913,Bos taurus (cattle),Progesterone results in increased expression of IGFBP1 mRNA,,,PMID:23018184,https://www.ncbi.nlm.nih.gov/pubmed/23018184,23018184,,
1401,592801,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3484,IGFBP1,https://ctdbase.org/detail.go?type=gene&acc=3484,,,3484.0,IGFBP1,9606,Homo sapiens (human),Progesterone promotes the reaction [8-bromo cyclic adenosine monophosphate results in increased expression of IGFBP1 mrna]|hydrocortisone promotes the reaction [progesterone promotes the reaction [8-bromo cyclic adenosine monophosphate results in increased expression of IGFBP1 mrna]]|4'-cyanobiphenyl-4-sulfonic acid (6-aminopyridin-2-yl)amide inhibits the reaction [progesterone promotes the reaction [8-bromo cyclic adenosine monophosphate results in increased expression of IGFBP1 mrna]],,,PMID:23275455,https://www.ncbi.nlm.nih.gov/pubmed/23275455,23275455,,
1402,592802,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3484,IGFBP1,https://ctdbase.org/detail.go?type=gene&acc=3484,,,3484.0,IGFBP1,9606,Homo sapiens (human),[estradiol co-treated with progesterone] results in increased expression of IGFBP1 mrna|[estradiol co-treated with progesterone] results in increased secretion of IGFBP1 protein|bmp7 protein inhibits the reaction [[estradiol co-treated with progesterone] results in increased expression of IGFBP1 mrna]|bmp7 protein inhibits the reaction [[estradiol co-treated with progesterone] results in increased secretion of IGFBP1 protein],,,PMID:20085912,https://www.ncbi.nlm.nih.gov/pubmed/20085912,20085912,,
1403,596674,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,10788,IQGAP2,https://ctdbase.org/detail.go?type=gene&acc=10788,,,10788.0,IQGAP2,9606,Homo sapiens (human),Progesterone results in increased expression of IQGAP2 mRNA,,,PMID:21795739,https://www.ncbi.nlm.nih.gov/pubmed/21795739,21795739,,
1404,596675,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,128239,IQGAP3,https://ctdbase.org/detail.go?type=gene&acc=128239,,,128239.0,IQGAP3,9606,Homo sapiens (human),Progesterone results in decreased expression of IQGAP3 mRNA,,,PMID:21795739,https://www.ncbi.nlm.nih.gov/pubmed/21795739,21795739,,
1405,596676,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,10335,IRAG1,https://ctdbase.org/detail.go?type=gene&acc=10335,,,10335.0,IRAG1,9940,Ovis aries (sheep),Progesterone results in increased expression of IRAG1 mRNA,,,PMID:19690047,https://www.ncbi.nlm.nih.gov/pubmed/19690047,19690047,,
1406,596677,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3654,IRAK1,https://ctdbase.org/detail.go?type=gene&acc=3654,,,3654.0,IRAK1,9606,Homo sapiens (human),Progesterone results in increased expression of IRAK1 mRNA,,,PMID:17701593,https://www.ncbi.nlm.nih.gov/pubmed/17701593,17701593,,
1407,596678,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3654,IRAK1,https://ctdbase.org/detail.go?type=gene&acc=3654,,,3654.0,IRAK1,9940,Ovis aries (sheep),Progesterone results in decreased expression of IRAK1 mRNA,,,PMID:19690047,https://www.ncbi.nlm.nih.gov/pubmed/19690047,19690047,,
1408,599125,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3773,KCNJ16,https://ctdbase.org/detail.go?type=gene&acc=3773,,,3773.0,KCNJ16,9606,Homo sapiens (human),Progesterone results in increased expression of KCNJ16 mRNA,,,PMID:18070364,https://www.ncbi.nlm.nih.gov/pubmed/18070364,18070364,,
1409,599126,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3764,KCNJ8,https://ctdbase.org/detail.go?type=gene&acc=3764,,,3764.0,KCNJ8,9606,Homo sapiens (human),Progesterone results in increased expression of KCNJ8 mrna|[progesterone co-treated with estradiol] results in increased expression of KCNJ8 mRNA,,,PMID:17404688,https://www.ncbi.nlm.nih.gov/pubmed/17404688,17404688,,
1410,599127,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3764,KCNJ8,https://ctdbase.org/detail.go?type=gene&acc=3764,,,3764.0,KCNJ8,9940,Ovis aries (sheep),Progesterone results in increased expression of KCNJ8 mRNA,,,PMID:19690047,https://www.ncbi.nlm.nih.gov/pubmed/19690047,19690047,,
1411,599128,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3775,KCNK1,https://ctdbase.org/detail.go?type=gene&acc=3775,,,3775.0,KCNK1,9940,Ovis aries (sheep),Progesterone results in decreased expression of KCNK1 mRNA,,,PMID:19690047,https://www.ncbi.nlm.nih.gov/pubmed/19690047,19690047,,
1412,599129,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,3777,KCNK3,https://ctdbase.org/detail.go?type=gene&acc=3777,,,3777.0,KCNK3,9606,Homo sapiens (human),Progesterone results in decreased expression of KCNK3 mRNA,,,PMID:18070364,https://www.ncbi.nlm.nih.gov/pubmed/18070364,18070364,,
1413,600397,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,401265,KLHL31,https://ctdbase.org/detail.go?type=gene&acc=401265,,,401265.0,KLHL31,9606,Homo sapiens (human),[estradiol co-treated with progesterone] results in increased expression of KLHL31 mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
1414,600398,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,401265,KLHL31,https://ctdbase.org/detail.go?type=gene&acc=401265,,,401265.0,KLHL31,10090,Mus musculus (house mouse),Progesterone results in decreased expression of KLHL31 mRNA,,,PMID:22238285,https://www.ncbi.nlm.nih.gov/pubmed/22238285,22238285,,
1415,600399,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,5655,KLK10,https://ctdbase.org/detail.go?type=gene&acc=5655,,,5655.0,KLK10,9606,Homo sapiens (human),[estrogens co-treated with progesterone] results in increased expression of KLK10 mRNA,,,PMID:20686372,https://www.ncbi.nlm.nih.gov/pubmed/20686372,20686372,,
1416,600400,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,11012,KLK11,https://ctdbase.org/detail.go?type=gene&acc=11012,,,11012.0,KLK11,10090,Mus musculus (house mouse),Progesterone results in decreased expression of KLK11 mRNA,,,PMID:22238285,https://www.ncbi.nlm.nih.gov/pubmed/22238285,22238285,,
1417,600401,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,25818,KLK5,https://ctdbase.org/detail.go?type=gene&acc=25818,,,25818.0,KLK5,10090,Mus musculus (house mouse),[progesterone results in increased activity of PGR protein] which results in increased expression of KLK5 mRNA,,,PMID:15845616,https://www.ncbi.nlm.nih.gov/pubmed/15845616,15845616,,
1418,605434,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,51050,PI15,https://ctdbase.org/detail.go?type=gene&acc=51050,,,51050.0,PI15,9913,Bos taurus (cattle),Progesterone results in decreased expression of PI15 mRNA,,,PMID:23012394,https://www.ncbi.nlm.nih.gov/pubmed/23012394,23012394,,
1419,605435,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,51050,PI15,https://ctdbase.org/detail.go?type=gene&acc=51050,,,51050.0,PI15,9606,Homo sapiens (human),[estradiol co-treated with progesterone] results in increased expression of PI15 mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
1420,605436,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,10464,PIBF1,https://ctdbase.org/detail.go?type=gene&acc=10464,,,10464.0,PIBF1,9606,Homo sapiens (human),Progesterone results in increased expression of PIBF1 mrna|progesterone results in increased expression of PIBF1 protein,,,PMID:17701593,https://www.ncbi.nlm.nih.gov/pubmed/17701593,17701593,,
1421,605437,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,55022,PID1,https://ctdbase.org/detail.go?type=gene&acc=55022,,,55022.0,PID1,9606,Homo sapiens (human),[estradiol co-treated with progesterone] results in increased expression of PID1 mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
1422,605438,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,55022,PID1,https://ctdbase.org/detail.go?type=gene&acc=55022,,,55022.0,PID1,9606,Homo sapiens (human),[progesterone co-treated with estradiol] results in increased expression of PID1 mrna|progesterone results in increased expression of PID1 mRNA,,,PMID:17404688,https://www.ncbi.nlm.nih.gov/pubmed/17404688,17404688,,
1423,605439,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,63895,PIEZO2,https://ctdbase.org/detail.go?type=gene&acc=63895,,,63895.0,PIEZO2,9606,Homo sapiens (human),[estradiol co-treated with progesterone] results in decreased expression of PIEZO2 mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
1424,605440,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,5283,PIGH,https://ctdbase.org/detail.go?type=gene&acc=5283,,,5283.0,PIGH,9940,Ovis aries (sheep),Progesterone results in decreased expression of PIGH mRNA,,,PMID:19690047,https://www.ncbi.nlm.nih.gov/pubmed/19690047,19690047,,
1425,605441,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,5288,PIK3C2G,https://ctdbase.org/detail.go?type=gene&acc=5288,,,5288.0,PIK3C2G,9940,Ovis aries (sheep),Progesterone results in increased expression of PIK3C2G mRNA,,,PMID:19690047,https://www.ncbi.nlm.nih.gov/pubmed/19690047,19690047,,
1426,608208,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,64840,PORCN,https://ctdbase.org/detail.go?type=gene&acc=64840,,,64840.0,PORCN,9606,Homo sapiens (human),[estradiol co-treated with progesterone] results in decreased expression of PORCN mRNA,,,PMID:20660070,https://www.ncbi.nlm.nih.gov/pubmed/20660070,20660070,,
1427,608209,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,10631,POSTN,https://ctdbase.org/detail.go?type=gene&acc=10631,,,10631.0,POSTN,9940,Ovis aries (sheep),Progesterone results in increased expression of POSTN mRNA,,,PMID:19635739,https://www.ncbi.nlm.nih.gov/pubmed/19635739,19635739,,
1428,608210,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,5460,POU5F1,https://ctdbase.org/detail.go?type=gene&acc=5460,,,5460.0,POU5F1,9606,Homo sapiens (human),[progesterone co-treated with estradiol] results in increased expression of POU5F1 mRNA,,,PMID:17404688,https://www.ncbi.nlm.nih.gov/pubmed/17404688,17404688,,
1429,608211,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,5464,PPA1,https://ctdbase.org/detail.go?type=gene&acc=5464,,,5464.0,PPA1,9913,Bos taurus (cattle),Progesterone results in decreased expression of PPA1 mRNA,,,PMID:23018184,https://www.ncbi.nlm.nih.gov/pubmed/23018184,23018184,,
1430,608212,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468.0,PPARG,10116,Rattus norvegicus (Norway rat),Progesterone results in increased expression of PPARG mRNA,,,PMID:16954335,https://www.ncbi.nlm.nih.gov/pubmed/16954335,16954335,,
1431,608213,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,9913,Bos taurus (cattle),Progesterone results in increased expression of PPARGC1A mRNA,,,PMID:23018184,https://www.ncbi.nlm.nih.gov/pubmed/23018184,23018184,,
1432,608214,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,9606,Homo sapiens (human),[progesterone co-treated with estradiol] results in increased expression of PPARGC1A mRNA,,,PMID:17404688,https://www.ncbi.nlm.nih.gov/pubmed/17404688,17404688,,
1433,608215,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,9606,Homo sapiens (human),Progesterone results in increased expression of PPARGC1A mRNA,,,PMID:17404688|PMID:23056435,https://www.ncbi.nlm.nih.gov/pubmed/17404688|https://www.ncbi.nlm.nih.gov/pubmed/23056435,17404688|23056435,,
1434,608216,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,10891,PPARGC1A,https://ctdbase.org/detail.go?type=gene&acc=10891,,,10891.0,PPARGC1A,10116,Rattus norvegicus (Norway rat),Progesterone results in increased expression of PPARGC1A mRNA,,,PMID:23056435,https://www.ncbi.nlm.nih.gov/pubmed/23056435,23056435,,
1435,608217,5994,Comparative Toxicogenomics Database (CTD),Progesterone,D011374,Progesterone,https://ctdbase.org/detail.go?type=chem&acc=D011374,728045,PPBPP1,https://ctdbase.org/detail.go?type=gene&acc=728045,,,728045.0,PPBPP1,9606,Homo sapiens (human),Progesterone results in increased expression of PPBPP1 mRNA,,,PMID:16888808,https://www.ncbi.nlm.nih.gov/pubmed/16888808,16888808,,
1436,594717,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3817,KLK2,https://ctdbase.org/detail.go?type=gene&acc=3817,,,3817.0,KLK2,9606,Homo sapiens (human),Testosterone results in increased expression of KLK2 mRNA,,,PMID:12376534|PMID:21592394|PMID:31586605,https://www.ncbi.nlm.nih.gov/pubmed/12376534|https://www.ncbi.nlm.nih.gov/pubmed/21592394|https://www.ncbi.nlm.nih.gov/pubmed/31586605,12376534|21592394|31586605,,
1437,594718,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,354,KLK3,https://ctdbase.org/detail.go?type=gene&acc=354,,,354.0,KLK3,9606,Homo sapiens (human),"Flutamide inhibits the reaction [testosterone results in increased expression of KLK3 mrna]|flutamide inhibits the reaction [testosterone results in increased expression of KLK3 protein]|6-formylindolo(3,2-b)carbazole inhibits the reaction [testosterone results in increased expression of KLK3 protein]|6-formylindolo(3,2-b)carbazole inhibits the reaction [testosterone results in increased expression of KLK3 mrna]",,,PMID:31586605,https://www.ncbi.nlm.nih.gov/pubmed/31586605,31586605,,
1438,594719,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,354,KLK3,https://ctdbase.org/detail.go?type=gene&acc=354,,,354.0,KLK3,9606,Homo sapiens (human),Bicalutamide inhibits the reaction [testosterone results in increased expression of KLK3 mrna],,,PMID:22101440|PMID:33207735,https://www.ncbi.nlm.nih.gov/pubmed/22101440|https://www.ncbi.nlm.nih.gov/pubmed/33207735,22101440|33207735,,
1439,595885,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,27074,LAMP3,https://ctdbase.org/detail.go?type=gene&acc=27074,,,27074.0,LAMP3,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with testosterone] results in increased expression of LAMP3 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
1440,595886,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,24141,LAMP5,https://ctdbase.org/detail.go?type=gene&acc=24141,,,24141.0,LAMP5,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with testosterone] results in increased expression of LAMP5 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
1441,595887,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,28956,LAMTOR2,https://ctdbase.org/detail.go?type=gene&acc=28956,,,28956.0,LAMTOR2,9606,Homo sapiens (human),Testosterone results in decreased expression of LAMTOR2 mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
1442,595888,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,51056,LAP3,https://ctdbase.org/detail.go?type=gene&acc=51056,,,51056.0,LAP3,10090,Mus musculus (house mouse),Testosterone results in decreased expression of LAP3 mRNA,,,PMID:19693291,https://www.ncbi.nlm.nih.gov/pubmed/19693291,19693291,,
1443,595889,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,55353,LAPTM4B,https://ctdbase.org/detail.go?type=gene&acc=55353,,,55353.0,LAPTM4B,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with testosterone] results in increased expression of LAPTM4B mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
1444,596044,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,7805,LAPTM5,https://ctdbase.org/detail.go?type=gene&acc=7805,,,7805.0,LAPTM5,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of LAPTM5 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
1445,596045,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,100286788,LARGE,https://ctdbase.org/detail.go?type=gene&acc=100286788,,,100286788.0,Large,9606,Homo sapiens (human),Testosterone results in increased expression of LARGE mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
1446,596046,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,81887,LAS1L,https://ctdbase.org/detail.go?type=gene&acc=81887,,,81887.0,LAS1L,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with testosterone] results in decreased expression of LAS1L mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
1447,596047,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3927,LASP1,https://ctdbase.org/detail.go?type=gene&acc=3927,,,3927.0,LASP1,10090,Mus musculus (house mouse),Testosterone results in increased expression of LASP1 mRNA,,,PMID:21669218,https://www.ncbi.nlm.nih.gov/pubmed/21669218,21669218,,
1448,596048,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,27040,LAT,https://ctdbase.org/detail.go?type=gene&acc=27040,,,27040.0,LAT,9606,Homo sapiens (human),Testosterone results in decreased expression of LAT mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
1449,596049,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,7462,LAT2,https://ctdbase.org/detail.go?type=gene&acc=7462,,,7462.0,LAT2,9606,Homo sapiens (human),Testosterone results in increased expression of LAT2 mrna|[testosterone co-treated with calcitriol] results in increased expression of LAT2 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1450,596050,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,7462,LAT2,https://ctdbase.org/detail.go?type=gene&acc=7462,,,7462.0,LAT2,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of LAT2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
1451,596051,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,81606,LBH,https://ctdbase.org/detail.go?type=gene&acc=81606,,,81606.0,LBH,10090,Mus musculus (house mouse),Testosterone deficiency results in increased expression of LBH mRNA,,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
1452,596052,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,3929,LBP,https://ctdbase.org/detail.go?type=gene&acc=3929,,,3929.0,LBP,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of LBP mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
1453,605787,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,8776,MTMR1,https://ctdbase.org/detail.go?type=gene&acc=8776,,,8776.0,MTMR1,9606,Homo sapiens (human),Testosterone results in decreased expression of MTMR1 mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
1454,605788,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,10903,MTMR11,https://ctdbase.org/detail.go?type=gene&acc=10903,,,10903.0,MTMR11,9606,Homo sapiens (human),Testosterone results in decreased expression of MTMR11 mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
1455,605789,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,9110,MTMR4,https://ctdbase.org/detail.go?type=gene&acc=9110,,,9110.0,MTMR4,10090,Mus musculus (house mouse),Testosterone results in decreased expression of MTMR4 mRNA,,,PMID:19693291,https://www.ncbi.nlm.nih.gov/pubmed/19693291,19693291,,
1456,605790,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,4544,MTNR1B,https://ctdbase.org/detail.go?type=gene&acc=4544,,,4544.0,MTNR1B,9606,Homo sapiens (human),MTNR1B gene polymorphism affects the abundance of testosterone,,,PMID:20207350,https://www.ncbi.nlm.nih.gov/pubmed/20207350,20207350,,
1457,605791,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,25821,MTO1,https://ctdbase.org/detail.go?type=gene&acc=25821,,,25821.0,MTO1,9606,Homo sapiens (human),Testosterone results in increased expression of MTO1 mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
1458,605792,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,9940,Ovis aries (sheep),Testosterone affects the expression of MTOR mRNA,,,PMID:20843997,https://www.ncbi.nlm.nih.gov/pubmed/20843997,20843997,,
1459,605793,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475.0,MTOR,10116,Rattus norvegicus (Norway rat),[methylnitrosourea co-treated with testosterone] results in increased expression of MTOR protein|quercetin inhibits the reaction [[methylnitrosourea co-treated with testosterone] results in increased expression of MTOR protein],,,PMID:25164625,https://www.ncbi.nlm.nih.gov/pubmed/25164625,25164625,,
1460,605794,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,55149,MTPAP,https://ctdbase.org/detail.go?type=gene&acc=55149,,,55149.0,MTPAP,9606,Homo sapiens (human),Testosterone results in decreased expression of MTPAP mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
1461,605795,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,222166,MTURN,https://ctdbase.org/detail.go?type=gene&acc=222166,,,222166.0,MTURN,9606,Homo sapiens (human),[testosterone co-treated with calcitriol] results in decreased expression of MTURN mrna|testosterone results in decreased expression of MTURN mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1462,605796,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,57509,MTUS1,https://ctdbase.org/detail.go?type=gene&acc=57509,,,57509.0,MTUS1,10116,Rattus norvegicus (Norway rat),Testosterone inhibits the reaction [dexamethasone results in decreased expression of MTUS1 mrna],,,PMID:20032058,https://www.ncbi.nlm.nih.gov/pubmed/20032058,20032058,,
1463,608754,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,4818,NKG7,https://ctdbase.org/detail.go?type=gene&acc=4818,,,4818.0,NKG7,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of NKG7 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
1464,608755,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,390010,NKX1-2,https://ctdbase.org/detail.go?type=gene&acc=390010,,,390010.0,NKX1-2,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in decreased expression of NKX1-2 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
1465,608756,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,1482,NKX2-5,https://ctdbase.org/detail.go?type=gene&acc=1482,,,1482.0,NKX2-5,9606,Homo sapiens (human),Testosterone results in decreased expression of NKX2-5 mRNA,,,PMID:33359661,https://www.ncbi.nlm.nih.gov/pubmed/33359661,33359661,,
1466,608757,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,137814,NKX2-6,https://ctdbase.org/detail.go?type=gene&acc=137814,,,137814.0,NKX2-6,10090,Mus musculus (house mouse),"1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in decreased expression of NKX2-6 mrna]|testosterone deficiency results in decreased expression of NKX2-6 mRNA",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
1467,608758,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,4824,NKX3-1,https://ctdbase.org/detail.go?type=gene&acc=4824,,,4824.0,NKX3-1,10090,Mus musculus (house mouse),"Testosterone deficiency results in decreased expression of NKX3-1 mrna|1,2-dibromo-4-(1,2-dibromoethyl)cyclohexane inhibits the reaction [testosterone deficiency results in decreased expression of NKX3-1 mrna]",,,PMID:33848595,https://www.ncbi.nlm.nih.gov/pubmed/33848595,33848595,,
1468,608759,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,197358,NLRC3,https://ctdbase.org/detail.go?type=gene&acc=197358,,,197358.0,NLRC3,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of NLRC3 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
1469,608760,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,84166,NLRC5,https://ctdbase.org/detail.go?type=gene&acc=84166,,,84166.0,NLRC5,9606,Homo sapiens (human),[testosterone co-treated with calcitriol] results in increased expression of NLRC5 mrna|testosterone results in increased expression of NLRC5 mRNA,,,PMID:21592394,https://www.ncbi.nlm.nih.gov/pubmed/21592394,21592394,,
1470,608761,6013,Comparative Toxicogenomics Database (CTD),Testosterone,D013739,Testosterone,https://ctdbase.org/detail.go?type=chem&acc=D013739,84166,NLRC5,https://ctdbase.org/detail.go?type=gene&acc=84166,,,84166.0,NLRC5,10116,Rattus norvegicus (Norway rat),[estradiol 3-benzoate co-treated with [testosterone co-treated with estradiol]] results in increased expression of NLRC5 mRNA,,,PMID:32741896,https://www.ncbi.nlm.nih.gov/pubmed/32741896,32741896,,
1471,534790,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,51741,WWOX,https://ctdbase.org/detail.go?type=gene&acc=51741,,,51741.0,WWOX,9606,Homo sapiens (human),WWOX gene SNP affects the susceptibility to cycloheximide,,,PMID:25622337,https://www.ncbi.nlm.nih.gov/pubmed/25622337,25622337,,
1472,534791,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,331,XIAP,https://ctdbase.org/detail.go?type=gene&acc=331,,,331.0,XIAP,10090,Mus musculus (house mouse),Cycloheximide inhibits the reaction [thapsigargin affects the localization of XIAP mrna],,,PMID:29576526,https://www.ncbi.nlm.nih.gov/pubmed/29576526,29576526,,
1473,534792,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,10413,YAP1,https://ctdbase.org/detail.go?type=gene&acc=10413,,,10413.0,YAP1,9606,Homo sapiens (human),[tetrachlorodibenzodioxin co-treated with cycloheximide] results in increased expression of YAP1 mRNA,,,PMID:19684285,https://www.ncbi.nlm.nih.gov/pubmed/19684285,19684285,,
1474,534793,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,10730,YME1L1,https://ctdbase.org/detail.go?type=gene&acc=10730,,,10730.0,YME1L1,9606,Homo sapiens (human),YME1L1 mutant form inhibits the reaction [cycloheximide results in increased degradation of TIMM17A protein],,,PMID:24315374,https://www.ncbi.nlm.nih.gov/pubmed/24315374,24315374,,
1475,534794,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Cycloheximide inhibits the reaction [TNF protein results in increased expression of CCL5 protein]|cycloheximide inhibits the reaction [TNF protein results in increased expression of CCL2 protein]|cycloheximide inhibits the reaction [tofacitinib inhibits the reaction [TNF protein results in increased expression of CCL2 protein]]|cycloheximide inhibits the reaction [TNF protein results in increased expression of CXCL10 protein]|cycloheximide inhibits the reaction [tofacitinib inhibits the reaction [TNF protein results in increased expression of CXCL10 protein]]|cycloheximide inhibits the reaction [tofacitinib inhibits the reaction [TNF protein results in increased expression of CCL5 protein]],,,PMID:22121136,https://www.ncbi.nlm.nih.gov/pubmed/22121136,22121136,,
1476,534795,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Cycloheximide inhibits the reaction [TNF protein results in increased expression of MYLK protein],,,PMID:15701621,https://www.ncbi.nlm.nih.gov/pubmed/15701621,15701621,,
1477,534796,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Cycloheximide promotes the reaction [TNF protein results in increased expression of SOD2 mrna],,,PMID:8037686,https://www.ncbi.nlm.nih.gov/pubmed/8037686,8037686,,
1478,534797,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,8795,TNFRSF10B,https://ctdbase.org/detail.go?type=gene&acc=8795,,,8795.0,TNFRSF10B,9606,Homo sapiens (human),Cycloheximide inhibits the reaction [paclitaxel results in increased expression of TNFRSF10B protein]|cycloheximide inhibits the reaction [docetaxel results in increased expression of TNFRSF10B protein],,,PMID:11212279,https://www.ncbi.nlm.nih.gov/pubmed/11212279,11212279,,
1479,534798,6197,Comparative Toxicogenomics Database (CTD),Cycloheximide,D003513,Cycloheximide,https://ctdbase.org/detail.go?type=chem&acc=D003513,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),TNF protein promotes the reaction [cycloheximide results in increased expression of CCL2 mrna]|[tnf protein co-treated with cycloheximide] results in increased expression of TNFAIP3 mrna|tnf protein promotes the reaction [cycloheximide results in increased expression of CXCL8 mrna]|ursodeoxycholic acid analog inhibits the reaction [[TNF protein co-treated with cycloheximide] results in increased secretion of CXCL8 protein]|tnf protein promotes the reaction [cycloheximide results in increased secretion of IL6 protein]|ursodeoxycholic acid analog inhibits the reaction [TNF protein promotes the reaction [cycloheximide results in increased expression of CXCL8 mrna]]|ursodeoxycholic acid analog inhibits the reaction [TNF protein promotes the reaction [cycloheximide results in increased secretion of IL6 protein]]|ursodeoxycholic acid analog promotes the reaction [[TNF protein co-treated with cycloheximide] results in increased expression of TNFAIP3 mrna]|tnf protein promotes the reaction [cycloheximide results in increased expression of NFKB1 mrna]|tnf protein promotes the reaction [cycloheximide results in increased expression of CCL5 mrna]|[tnf protein co-treated with cycloheximide] results in increased secretion of CXCL8 protein|ursodeoxycholic acid analog inhibits the reaction [TNF protein promotes the reaction [cycloheximide results in increased expression of NFKB1 mrna]]|ursodeoxycholic acid analog inhibits the reaction [TNF protein promotes the reaction [cycloheximide results in increased expression of CCL5 mrna]]|ursodeoxycholic acid analog inhibits the reaction [TNF protein promotes the reaction [cycloheximide results in increased expression of CCL2 mrna]]|tnf protein promotes the reaction [cycloheximide results in increased expression of IL6 mrna]|ursodeoxycholic acid analog inhibits the reaction [TNF protein promotes the reaction [cycloheximide results in increased expression of IL6 mrna]],,,PMID:21146893,https://www.ncbi.nlm.nih.gov/pubmed/21146893,21146893,,
1480,534127,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,4917,NTN3,https://ctdbase.org/detail.go?type=gene&acc=4917,,,4917.0,NTN3,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of NTN3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1481,534483,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,64710,NUCKS1,https://ctdbase.org/detail.go?type=gene&acc=64710,,,64710.0,NUCKS1,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased methylation of NUCKS1 gene,,,PMID:27618143,https://www.ncbi.nlm.nih.gov/pubmed/27618143,27618143,,
1482,534484,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,83594,NUDT12,https://ctdbase.org/detail.go?type=gene&acc=83594,,,83594.0,NUDT12,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased methylation of NUDT12 gene,,,PMID:27618143,https://www.ncbi.nlm.nih.gov/pubmed/27618143,27618143,,
1483,534485,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,200035,NUDT17,https://ctdbase.org/detail.go?type=gene&acc=200035,,,200035.0,NUDT17,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of NUDT17 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1484,592254,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,7855,FZD5,https://ctdbase.org/detail.go?type=gene&acc=7855,,,7855.0,FZD5,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of FZD5 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1485,592255,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,8323,FZD6,https://ctdbase.org/detail.go?type=gene&acc=8323,,,8323.0,FZD6,10090,Mus musculus (house mouse),Trichloroethylene results in increased expression of FZD6 mRNA,,,PMID:15363585,https://www.ncbi.nlm.nih.gov/pubmed/15363585,15363585,,
1486,592256,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,8323,FZD6,https://ctdbase.org/detail.go?type=gene&acc=8323,,,8323.0,FZD6,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of FZD6 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1487,592257,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,8323,FZD6,https://ctdbase.org/detail.go?type=gene&acc=8323,,,8323.0,FZD6,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased methylation of FZD6 gene,,,PMID:27618143,https://www.ncbi.nlm.nih.gov/pubmed/27618143,27618143,,
1488,592258,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,8324,FZD7,https://ctdbase.org/detail.go?type=gene&acc=8324,,,8324.0,FZD7,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of FZD7 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1489,592259,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,8325,FZD8,https://ctdbase.org/detail.go?type=gene&acc=8325,,,8325.0,FZD8,10090,Mus musculus (house mouse),Trichloroethylene results in decreased expression of FZD8 mRNA,,,PMID:25549359,https://www.ncbi.nlm.nih.gov/pubmed/25549359,25549359,,
1490,592919,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2589,GALNT1,https://ctdbase.org/detail.go?type=gene&acc=2589,,,2589.0,GALNT1,10090,Mus musculus (house mouse),Trichloroethylene results in increased expression of GALNT1 mRNA,,,PMID:19448997,https://www.ncbi.nlm.nih.gov/pubmed/19448997,19448997,,
1491,592920,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2589,GALNT1,https://ctdbase.org/detail.go?type=gene&acc=2589,,,2589.0,GALNT1,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of GALNT1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1492,592921,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,114805,GALNT13,https://ctdbase.org/detail.go?type=gene&acc=114805,,,114805.0,GALNT13,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of GALNT13 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1493,592922,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,79623,GALNT14,https://ctdbase.org/detail.go?type=gene&acc=79623,,,79623.0,GALNT14,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of GALNT14 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1494,592923,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,374378,GALNT18,https://ctdbase.org/detail.go?type=gene&acc=374378,,,374378.0,GALNT18,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of GALNT18 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1495,596821,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2899,GRIK3,https://ctdbase.org/detail.go?type=gene&acc=2899,,,2899.0,GRIK3,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of GRIK3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1496,596822,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2900,GRIK4,https://ctdbase.org/detail.go?type=gene&acc=2900,,,2900.0,GRIK4,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of GRIK4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1497,596823,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2903,GRIN2A,https://ctdbase.org/detail.go?type=gene&acc=2903,,,2903.0,GRIN2A,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of GRIN2A mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1498,596824,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2906,GRIN2D,https://ctdbase.org/detail.go?type=gene&acc=2906,,,2906.0,GRIN2D,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of GRIN2D mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1499,596825,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,116444,GRIN3B,https://ctdbase.org/detail.go?type=gene&acc=116444,,,116444.0,GRIN3B,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of GRIN3B mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1500,596826,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2907,GRINA,https://ctdbase.org/detail.go?type=gene&acc=2907,,,2907.0,GRINA,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of GRINA mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1501,596827,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,6011,GRK1,https://ctdbase.org/detail.go?type=gene&acc=6011,,,6011.0,GRK1,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of GRK1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1502,596828,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2868,GRK4,https://ctdbase.org/detail.go?type=gene&acc=2868,,,2868.0,GRK4,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of GRK4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1503,597483,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,14869,GSTP2,https://ctdbase.org/detail.go?type=gene&acc=14869,,,14869.0,Gstp2,7955,Danio rerio (zebrafish),Resveratrol inhibits the reaction [trichloroethylene results in increased expression of GSTP2 mrna]|trichloroethylene results in increased expression of GSTP2 mRNA,,,PMID:33524428,https://www.ncbi.nlm.nih.gov/pubmed/33524428,33524428,,
1504,597484,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2952,GSTT1,https://ctdbase.org/detail.go?type=gene&acc=2952,,,2952.0,GSTT1,10090,Mus musculus (house mouse),Trichloroethylene results in decreased expression of GSTT1 mRNA,,,PMID:19448997,https://www.ncbi.nlm.nih.gov/pubmed/19448997,19448997,,
1505,597485,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2952,GSTT1,https://ctdbase.org/detail.go?type=gene&acc=2952,,,2952.0,GSTT1,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of GSTT1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1506,597486,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2953,GSTT2,https://ctdbase.org/detail.go?type=gene&acc=2953,,,2953.0,GSTT2,10090,Mus musculus (house mouse),Trichloroethylene results in increased expression of GSTT2 mRNA,,,PMID:25549359|PMID:28973375,https://www.ncbi.nlm.nih.gov/pubmed/25549359|https://www.ncbi.nlm.nih.gov/pubmed/28973375,25549359|28973375,,
1507,597487,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,103140,GSTT3,https://ctdbase.org/detail.go?type=gene&acc=103140,,,103140.0,Gstt3,10090,Mus musculus (house mouse),Trichloroethylene results in increased expression of GSTT3 mRNA,,,PMID:19254012,https://www.ncbi.nlm.nih.gov/pubmed/19254012,19254012,,
1508,597819,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2980,GUCA2A,https://ctdbase.org/detail.go?type=gene&acc=2980,,,2980.0,GUCA2A,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of GUCA2A mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1509,597820,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2980,GUCA2A,https://ctdbase.org/detail.go?type=gene&acc=2980,,,2980.0,GUCA2A,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased methylation of GUCA2A gene,,,PMID:27618143,https://www.ncbi.nlm.nih.gov/pubmed/27618143,27618143,,
1510,597821,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2982,GUCY1A1,https://ctdbase.org/detail.go?type=gene&acc=2982,,,2982.0,GUCY1A1,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of GUCY1A1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1511,597822,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2977,GUCY1A2,https://ctdbase.org/detail.go?type=gene&acc=2977,,,2977.0,GUCY1A2,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased methylation of GUCY1A2 gene,,,PMID:27618143,https://www.ncbi.nlm.nih.gov/pubmed/27618143,27618143,,
1512,597823,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,2977,GUCY1A2,https://ctdbase.org/detail.go?type=gene&acc=2977,,,2977.0,GUCY1A2,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of GUCY1A2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1513,597824,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,14919,GUCY2E,https://ctdbase.org/detail.go?type=gene&acc=14919,,,14919.0,Gucy2e,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of GUCY2E mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1514,597825,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,268756,GULO,https://ctdbase.org/detail.go?type=gene&acc=268756,,,268756.0,Gulo,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of GULO mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1515,597966,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,80838,H1F1,https://ctdbase.org/detail.go?type=gene&acc=80838,,,80838.0,H1f1,10090,Mus musculus (house mouse),Trichloroethylene results in decreased expression of H1F1 mRNA,,,PMID:28973375,https://www.ncbi.nlm.nih.gov/pubmed/28973375,28973375,,
1516,597967,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,243529,H1F10,https://ctdbase.org/detail.go?type=gene&acc=243529,,,243529.0,H1f10,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of H1F10 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1517,597968,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,50709,H1F4,https://ctdbase.org/detail.go?type=gene&acc=50709,,,50709.0,H1f4,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of H1F4 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1518,597969,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,56702,H1F5,https://ctdbase.org/detail.go?type=gene&acc=56702,,,56702.0,H1f5,10090,Mus musculus (house mouse),Trichloroethylene results in increased expression of H1F5 mRNA,,,PMID:25549359,https://www.ncbi.nlm.nih.gov/pubmed/25549359,25549359,,
1519,597970,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,8335,H2AC4,https://ctdbase.org/detail.go?type=gene&acc=8335,,,8335.0,H2AC4,10090,Mus musculus (house mouse),Trichloroethylene results in increased expression of H2AC4 mRNA,,,PMID:25549359,https://www.ncbi.nlm.nih.gov/pubmed/25549359,25549359,,
1520,597971,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,9606,Homo sapiens (human),1-aminobenzotriazole inhibits the reaction [trichloroethylene results in increased phosphorylation of H2AX protein]|disulfiram inhibits the reaction [trichloroethylene results in increased phosphorylation of H2AX protein]|2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one inhibits the reaction [trichloroethylene results in increased phosphorylation of H2AX protein]|trichloroethylene results in increased phosphorylation of H2AX protein,,,PMID:29722447,https://www.ncbi.nlm.nih.gov/pubmed/29722447,29722447,,
1521,597972,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,3014,H2AX,https://ctdbase.org/detail.go?type=gene&acc=3014,,,3014.0,H2AX,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of H2AX mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1522,597973,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,3015,H2AZ1,https://ctdbase.org/detail.go?type=gene&acc=3015,,,3015.0,H2AZ1,10090,Mus musculus (house mouse),Trichloroethylene results in decreased expression of H2AZ1 mRNA,,,PMID:19448997,https://www.ncbi.nlm.nih.gov/pubmed/19448997,19448997,,
1523,597974,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,255626,H2BC1,https://ctdbase.org/detail.go?type=gene&acc=255626,,,255626.0,H2BC1,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of H2BC1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1524,598146,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,630499,H2-K2,https://ctdbase.org/detail.go?type=gene&acc=630499,,,630499.0,H2-K2,10090,Mus musculus (house mouse),Trichloroethylene results in decreased expression of H2-K2 mRNA,,,PMID:19448997,https://www.ncbi.nlm.nih.gov/pubmed/19448997,19448997,,
1525,598147,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,15001,H2-OA,https://ctdbase.org/detail.go?type=gene&acc=15001,,,15001.0,H2-Oa,10090,Mus musculus (house mouse),PPARA protein inhibits the reaction [trichloroethylene results in increased expression of H2-OA protein]|trichloroethylene results in increased expression of H2-OA mRNA,,,PMID:15363585,https://www.ncbi.nlm.nih.gov/pubmed/15363585,15363585,,
1526,598148,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,15006,H2-Q1,https://ctdbase.org/detail.go?type=gene&acc=15006,,,15006.0,H2-Q1,10090,Mus musculus (house mouse),Trichloroethylene results in increased expression of H2-Q1 mRNA,,,PMID:19448997,https://www.ncbi.nlm.nih.gov/pubmed/19448997,19448997,,
1527,598149,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,15015,H2-Q4,https://ctdbase.org/detail.go?type=gene&acc=15015,,,15015.0,H2-Q4,10090,Mus musculus (house mouse),Trichloroethylene results in decreased expression of H2-Q4 mRNA,,,PMID:19448997,https://www.ncbi.nlm.nih.gov/pubmed/19448997,19448997,,
1528,598150,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,15040,H2-T23,https://ctdbase.org/detail.go?type=gene&acc=15040,,,15040.0,H2-T23,10090,Mus musculus (house mouse),Trichloroethylene results in increased expression of H2-T23 mRNA,,,PMID:19448997,https://www.ncbi.nlm.nih.gov/pubmed/19448997,19448997,,
1529,598151,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,8350,H3C1,https://ctdbase.org/detail.go?type=gene&acc=8350,,,8350.0,H3C1,10116,Rattus norvegicus (Norway rat),Trichloroethylene affects the expression of H3C1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1530,598152,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,653604,H3C13,https://ctdbase.org/detail.go?type=gene&acc=653604,,,653604.0,H3C13,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of H3C13 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1531,599721,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,7290,HIRA,https://ctdbase.org/detail.go?type=gene&acc=7290,,,7290.0,HIRA,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of HIRA mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1532,599722,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,502125,HIST1H2AH,https://ctdbase.org/detail.go?type=gene&acc=502125,,,502125.0,Hist1h2ah,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of HIST1H2AH mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1533,599723,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,291159,HIST1H2AIL1,https://ctdbase.org/detail.go?type=gene&acc=291159,,,291159.0,Hist1h2ail1,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of HIST1H2AIL1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1534,600061,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,3142,HLX,https://ctdbase.org/detail.go?type=gene&acc=3142,,,3142.0,HLX,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of HLX mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1535,600062,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,81502,HM13,https://ctdbase.org/detail.go?type=gene&acc=81502,,,81502.0,HM13,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in increased expression of HM13 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1536,600063,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,10363,HMG20A,https://ctdbase.org/detail.go?type=gene&acc=10363,,,10363.0,HMG20A,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased methylation of HMG20A gene,,,PMID:27618143,https://www.ncbi.nlm.nih.gov/pubmed/27618143,27618143,,
1537,600064,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,3148,HMGB2,https://ctdbase.org/detail.go?type=gene&acc=3148,,,3148.0,HMGB2,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of HMGB2 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1538,600065,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,498072,HMGB2L1,https://ctdbase.org/detail.go?type=gene&acc=498072,,,498072.0,Hmgb2l1,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of HMGB2L1 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1539,600066,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,498988,HMGB2-PS6,https://ctdbase.org/detail.go?type=gene&acc=498988,,,498988.0,Hmgb2-ps6,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of HMGB2-PS6 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1540,600067,6575,Comparative Toxicogenomics Database (CTD),Trichloroethylene,D014241,Trichloroethylene,https://ctdbase.org/detail.go?type=chem&acc=D014241,3149,HMGB3,https://ctdbase.org/detail.go?type=gene&acc=3149,,,3149.0,HMGB3,10116,Rattus norvegicus (Norway rat),Trichloroethylene results in decreased expression of HMGB3 mRNA,,,PMID:33387578,https://www.ncbi.nlm.nih.gov/pubmed/33387578,33387578,,
1541,601061,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,38,ACAT1,https://ctdbase.org/detail.go?type=gene&acc=38,,,38.0,ACAT1,10090,Mus musculus (house mouse),Acrylamide results in decreased expression of ACAT1 mrna|acrylamide inhibits the reaction [streptozocin results in decreased expression of ACAT1 mrna],,,PMID:34896238,https://www.ncbi.nlm.nih.gov/pubmed/34896238,34896238,,
1542,601246,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of ACHE mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
1543,601247,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,43,ACHE,https://ctdbase.org/detail.go?type=gene&acc=43,,,43.0,ACHE,10116,Rattus norvegicus (Norway rat),Rutin inhibits the reaction [acrylamide results in increased expression of ACHE protein]|acrylamide results in increased expression of ACHE protein,,,PMID:36657526,https://www.ncbi.nlm.nih.gov/pubmed/36657526,36657526,,
1544,602076,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,79924,ADM2,https://ctdbase.org/detail.go?type=gene&acc=79924,,,79924.0,ADM2,9606,Homo sapiens (human),Acrylamide results in increased expression of ADM2 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
1545,602077,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,199800,ADM5,https://ctdbase.org/detail.go?type=gene&acc=199800,,,199800.0,ADM5,9606,Homo sapiens (human),Acrylamide results in increased expression of ADM5 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
1546,602078,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,22850,ADNP2,https://ctdbase.org/detail.go?type=gene&acc=22850,,,22850.0,ADNP2,10116,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of ADNP2 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
1547,602259,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,175,AGA,https://ctdbase.org/detail.go?type=gene&acc=175,,,175.0,AGA,10116,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of AGA mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
1548,602260,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,116986,AGAP2,https://ctdbase.org/detail.go?type=gene&acc=116986,,,116986.0,AGAP2,9606,Homo sapiens (human),Acrylamide results in decreased expression of AGAP2 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
1549,602950,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,205,AK4,https://ctdbase.org/detail.go?type=gene&acc=205,,,205.0,AK4,9606,Homo sapiens (human),Acrylamide results in decreased expression of AK4 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
1550,602951,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,102157402,AK6,https://ctdbase.org/detail.go?type=gene&acc=102157402,,,102157402.0,AK6,9606,Homo sapiens (human),Acrylamide results in increased expression of AK6 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
1551,603088,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,556208,AKAP1B,https://ctdbase.org/detail.go?type=gene&acc=556208,,,556208.0,akap1b,7955,Danio rerio (zebrafish),Acrylamide results in increased expression of AKAP1B protein modified form,,,PMID:29784925,https://www.ncbi.nlm.nih.gov/pubmed/29784925,29784925,,
1552,603089,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,9472,AKAP6,https://ctdbase.org/detail.go?type=gene&acc=9472,,,9472.0,AKAP6,10116,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of AKAP6 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
1553,603090,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,9465,AKAP7,https://ctdbase.org/detail.go?type=gene&acc=9465,,,9465.0,AKAP7,9606,Homo sapiens (human),Acrylamide results in decreased expression of AKAP7 mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
1554,603091,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,9465,AKAP7,https://ctdbase.org/detail.go?type=gene&acc=9465,,,9465.0,AKAP7,10116,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of AKAP7 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
1555,603092,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,10142,AKAP9,https://ctdbase.org/detail.go?type=gene&acc=10142,,,10142.0,AKAP9,10116,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of AKAP9 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
1556,603093,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,56672,AKIP1,https://ctdbase.org/detail.go?type=gene&acc=56672,,,56672.0,AKIP1,10116,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of AKIP1 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
1557,606977,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,116969,ART5,https://ctdbase.org/detail.go?type=gene&acc=116969,,,116969.0,ART5,10116,Rattus norvegicus (Norway rat),Acrylamide results in decreased expression of ART5 mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
1558,606978,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,9048,ARTN,https://ctdbase.org/detail.go?type=gene&acc=9048,,,9048.0,ARTN,10116,Rattus norvegicus (Norway rat),Acrylamide results in increased expression of ARTN mRNA,,,PMID:28959563,https://www.ncbi.nlm.nih.gov/pubmed/28959563,28959563,,
1559,606979,6579,Comparative Toxicogenomics Database (CTD),Acrylamide,D020106,Acrylamide,https://ctdbase.org/detail.go?type=chem&acc=D020106,421,ARVCF,https://ctdbase.org/detail.go?type=gene&acc=421,,,421.0,ARVCF,9606,Homo sapiens (human),Acrylamide results in decreased expression of ARVCF mRNA,,,PMID:32763439,https://www.ncbi.nlm.nih.gov/pubmed/32763439,32763439,,
1560,534936,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8822,FGF17,https://ctdbase.org/detail.go?type=gene&acc=8822,,,8822.0,FGF17,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of FGF17 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1561,534937,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8822,FGF17,https://ctdbase.org/detail.go?type=gene&acc=8822,,,8822.0,FGF17,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FGF17 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1562,534938,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8817,FGF18,https://ctdbase.org/detail.go?type=gene&acc=8817,,,8817.0,FGF18,9606,Homo sapiens (human),Bisphenol A affects the expression of FGF18 mRNA,,,PMID:20170705,https://www.ncbi.nlm.nih.gov/pubmed/20170705,20170705,,
1563,534939,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8817,FGF18,https://ctdbase.org/detail.go?type=gene&acc=8817,,,8817.0,FGF18,10090,Mus musculus (house mouse),Bisphenol A results in increased expression of FGF18 mRNA,,,PMID:27022677|PMID:30892605|PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/27022677|https://www.ncbi.nlm.nih.gov/pubmed/30892605|https://www.ncbi.nlm.nih.gov/pubmed/32156529,27022677|30892605|32156529,,
1564,534940,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8817,FGF18,https://ctdbase.org/detail.go?type=gene&acc=8817,,,8817.0,FGF18,10090,Mus musculus (house mouse),Fulvestrant inhibits the reaction [bisphenol A results in increased expression of FGF18 mrna],,,PMID:30892605,https://www.ncbi.nlm.nih.gov/pubmed/30892605,30892605,,
1565,534941,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8817,FGF18,https://ctdbase.org/detail.go?type=gene&acc=8817,,,8817.0,FGF18,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of FGF18 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1566,534942,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,8817,FGF18,https://ctdbase.org/detail.go?type=gene&acc=8817,,,8817.0,FGF18,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of FGF18 mRNA,,,PMID:34973380,https://www.ncbi.nlm.nih.gov/pubmed/34973380,34973380,,
1567,589820,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55915,LANCL2,https://ctdbase.org/detail.go?type=gene&acc=55915,,,55915.0,LANCL2,9606,Homo sapiens (human),Bisphenol A results in increased expression of LANCL2 protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1568,589821,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55915,LANCL2,https://ctdbase.org/detail.go?type=gene&acc=55915,,,55915.0,LANCL2,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of LANCL2 mRNA,,,PMID:25181051|PMID:30816183|PMID:32528016|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016|https://www.ncbi.nlm.nih.gov/pubmed/34947998,25181051|30816183|32528016|34947998,,
1569,592914,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3933,LCN1,https://ctdbase.org/detail.go?type=gene&acc=3933,,,3933.0,LCN1,9606,Homo sapiens (human),Bisphenol A results in decreased methylation of LCN1 gene|[bisphenol A co-treated with fulvestrant] results in decreased methylation of LCN1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1570,592915,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3933,LCN1,https://ctdbase.org/detail.go?type=gene&acc=3933,,,3933.0,LCN1,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of LCN1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1571,592916,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,414332,LCN10,https://ctdbase.org/detail.go?type=gene&acc=414332,,,414332.0,LCN10,9606,Homo sapiens (human),Bisphenol A results in decreased methylation of LCN10 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1572,592917,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,414332,LCN10,https://ctdbase.org/detail.go?type=gene&acc=414332,,,414332.0,LCN10,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of LCN10 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1573,592918,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,227630,LCN11,https://ctdbase.org/detail.go?type=gene&acc=227630,,,227630.0,Lcn11,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of LCN11 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1574,593093,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,286256,LCN12,https://ctdbase.org/detail.go?type=gene&acc=286256,,,286256.0,LCN12,10116,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of LCN12 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1575,593094,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,389812,LCN15,https://ctdbase.org/detail.go?type=gene&acc=389812,,,389812.0,LCN15,7955,Danio rerio (zebrafish),Bisphenol A results in increased expression of LCN15 mRNA,,,PMID:30248606|PMID:33243503,https://www.ncbi.nlm.nih.gov/pubmed/30248606|https://www.ncbi.nlm.nih.gov/pubmed/33243503,30248606|33243503,,
1576,593095,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,389812,LCN15,https://ctdbase.org/detail.go?type=gene&acc=389812,,,389812.0,LCN15,9606,Homo sapiens (human),Bisphenol A affects the expression of LCN15 mRNA,,,PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/30903817,30903817,,
1577,593096,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3934,LCN2,https://ctdbase.org/detail.go?type=gene&acc=3934,,,3934.0,LCN2,9606,Homo sapiens (human),Bisphenol A results in decreased expression of LCN2 mRNA,,,PMID:36232920,https://www.ncbi.nlm.nih.gov/pubmed/36232920,36232920,,
1578,593097,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3934,LCN2,https://ctdbase.org/detail.go?type=gene&acc=3934,,,3934.0,LCN2,9606,Homo sapiens (human),Bisphenol A results in increased expression of LCN2 mRNA,,,PMID:29718440,https://www.ncbi.nlm.nih.gov/pubmed/29718440,29718440,,
1579,593098,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3934,LCN2,https://ctdbase.org/detail.go?type=gene&acc=3934,,,3934.0,LCN2,10090,Mus musculus (house mouse),[XRCC6 gene mutant form results in increased susceptibility to potassium bromate] affects the reaction [bisphenol A affects the expression of LCN2 mrna]|bisphenol A affects the expression of LCN2 mRNA,,,PMID:27082013,https://www.ncbi.nlm.nih.gov/pubmed/27082013,27082013,,
1580,593099,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3934,LCN2,https://ctdbase.org/detail.go?type=gene&acc=3934,,,3934.0,LCN2,10090,Mus musculus (house mouse),Bisphenol A results in decreased expression of LCN2 mRNA,,,PMID:27312807|PMID:32926169|PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/27312807|https://www.ncbi.nlm.nih.gov/pubmed/32926169|https://www.ncbi.nlm.nih.gov/pubmed/33221593,27312807|32926169|33221593,,
1581,593100,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3934,LCN2,https://ctdbase.org/detail.go?type=gene&acc=3934,,,3934.0,LCN2,10090,Mus musculus (house mouse),Bisphenol A results in decreased expression of LCN2 protein,,,PMID:32926169,https://www.ncbi.nlm.nih.gov/pubmed/32926169,32926169,,
1582,593268,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,16820,LCN3,https://ctdbase.org/detail.go?type=gene&acc=16820,,,16820.0,Lcn3,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of LCN3 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1583,593269,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,16821,LCN4,https://ctdbase.org/detail.go?type=gene&acc=16821,,,16821.0,Lcn4,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of LCN4 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1584,593270,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,13863,LCN5,https://ctdbase.org/detail.go?type=gene&acc=13863,,,13863.0,Lcn5,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of LCN5 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1585,593271,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,158062,LCN6,https://ctdbase.org/detail.go?type=gene&acc=158062,,,158062.0,LCN6,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of LCN6 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1586,593272,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,138307,LCN8,https://ctdbase.org/detail.go?type=gene&acc=138307,,,138307.0,LCN8,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of LCN8 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1587,593273,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,392399,LCN9,https://ctdbase.org/detail.go?type=gene&acc=392399,,,392399.0,LCN9,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of LCN9 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1588,593274,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,392399,LCN9,https://ctdbase.org/detail.go?type=gene&acc=392399,,,392399.0,LCN9,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of LCN9 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
1589,593275,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84458,LCOR,https://ctdbase.org/detail.go?type=gene&acc=84458,,,84458.0,LCOR,9606,Homo sapiens (human),[bisphenol A binds to and affects the folding of AR protein] inhibits the reaction [AR protein modified form binds to LCOR protein modified form],,,PMID:28751236,https://www.ncbi.nlm.nih.gov/pubmed/28751236,28751236,,
1590,593276,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84458,LCOR,https://ctdbase.org/detail.go?type=gene&acc=84458,,,84458.0,LCOR,10090,Mus musculus (house mouse),Bisphenol A affects the methylation of LCOR promoter,,,PMID:27334623,https://www.ncbi.nlm.nih.gov/pubmed/27334623,27334623,,
1591,593956,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,60526,LDAH,https://ctdbase.org/detail.go?type=gene&acc=60526,,,60526.0,LDAH,10090,Mus musculus (house mouse),Bisphenol A results in increased expression of LDAH mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
1592,593957,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,60526,LDAH,https://ctdbase.org/detail.go?type=gene&acc=60526,,,60526.0,LDAH,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of LDAH mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
1593,594713,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3945,LDHB,https://ctdbase.org/detail.go?type=gene&acc=3945,,,3945.0,LDHB,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of LDHB protein,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
1594,594714,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3945,LDHB,https://ctdbase.org/detail.go?type=gene&acc=3945,,,3945.0,LDHB,10116,Rattus norvegicus (Norway rat),[fructose co-treated with bisphenol A] results in decreased expression of LDHB protein,,,PMID:26930160,https://www.ncbi.nlm.nih.gov/pubmed/26930160,26930160,,
1595,594715,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,30497,LDHBA,https://ctdbase.org/detail.go?type=gene&acc=30497,,,30497.0,ldhba,7955,Danio rerio (zebrafish),Bisphenol A affects the expression of LDHBA mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
1596,594716,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,30497,LDHBA,https://ctdbase.org/detail.go?type=gene&acc=30497,,,30497.0,ldhba,7955,Danio rerio (zebrafish),Bisphenol A results in increased methylation of LDHBA exon|bisphenol A results in increased methylation of LDHBA promoter|bisphenol A results in increased methylation of LDHBA intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
1597,594891,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3948,LDHC,https://ctdbase.org/detail.go?type=gene&acc=3948,,,3948.0,LDHC,10090,Mus musculus (house mouse),Bisphenol A results in increased expression of LDHC mRNA,,,PMID:26063408,https://www.ncbi.nlm.nih.gov/pubmed/26063408,26063408,,
1598,594892,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,197257,LDHD,https://ctdbase.org/detail.go?type=gene&acc=197257,,,197257.0,LDHD,10090,Mus musculus (house mouse),Bisphenol A results in increased expression of LDHD mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
1599,594893,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,197257,LDHD,https://ctdbase.org/detail.go?type=gene&acc=197257,,,197257.0,LDHD,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with genistein] results in increased methylation of LDHD gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
1600,594894,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,197257,LDHD,https://ctdbase.org/detail.go?type=gene&acc=197257,,,197257.0,LDHD,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of LDHD mRNA,,,PMID:25181051|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/34947998,25181051|34947998,,
1601,594895,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,9606,Homo sapiens (human),Bisphenol A affects the expression of LDLR mRNA,,,PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/30903817,30903817,,
1602,594896,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,9606,Homo sapiens (human),Bisphenol A analog results in decreased expression of LDLR mRNA,,,PMID:32387340,https://www.ncbi.nlm.nih.gov/pubmed/32387340,32387340,,
1603,594897,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,9606,Homo sapiens (human),Bisphenol A results in increased expression of LDLR mRNA,,,PMID:25047013|PMID:28483554|PMID:29275510,https://www.ncbi.nlm.nih.gov/pubmed/25047013|https://www.ncbi.nlm.nih.gov/pubmed/28483554|https://www.ncbi.nlm.nih.gov/pubmed/29275510,25047013|28483554|29275510,,
1604,594898,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,3949,LDLR,https://ctdbase.org/detail.go?type=gene&acc=3949,,,3949.0,LDLR,10090,Mus musculus (house mouse),Bisphenol A results in increased expression of LDLR mRNA,,,PMID:23704952|PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/23704952|https://www.ncbi.nlm.nih.gov/pubmed/25270620,23704952|25270620,,
1605,595387,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100527949,GIMAP1-GIMAP5,https://ctdbase.org/detail.go?type=gene&acc=100527949,,,100527949.0,GIMAP1-GIMAP5,9606,Homo sapiens (human),Bisphenol A results in decreased methylation of GIMAP1-GIMAP5 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1606,595388,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,55303,GIMAP4,https://ctdbase.org/detail.go?type=gene&acc=55303,,,55303.0,GIMAP4,9606,Homo sapiens (human),Bisphenol A results in decreased expression of GIMAP4 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1607,598464,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23180,RFTN1,https://ctdbase.org/detail.go?type=gene&acc=23180,,,23180.0,RFTN1,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of RFTN1 mRNA,,,PMID:30816183|PMID:32528016|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016|https://www.ncbi.nlm.nih.gov/pubmed/34947998,30816183|32528016|34947998,,
1608,598465,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23180,RFTN1,https://ctdbase.org/detail.go?type=gene&acc=23180,,,23180.0,RFTN1,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of RFTN1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1609,598466,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,23180,RFTN1,https://ctdbase.org/detail.go?type=gene&acc=23180,,,23180.0,RFTN1,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of RFTN1 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
1610,598467,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100149692,RFTN1A,https://ctdbase.org/detail.go?type=gene&acc=100149692,,,100149692.0,rftn1a,7955,Danio rerio (zebrafish),Bisphenol A results in decreased methylation of RFTN1A intron,,,PMID:30906313,https://www.ncbi.nlm.nih.gov/pubmed/30906313,30906313,,
1611,598468,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,130132,RFTN2,https://ctdbase.org/detail.go?type=gene&acc=130132,,,130132.0,RFTN2,9606,Homo sapiens (human),Bisphenol A results in increased expression of RFTN2 mRNA,,,PMID:27685785,https://www.ncbi.nlm.nih.gov/pubmed/27685785,27685785,,
1612,598469,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,130132,RFTN2,https://ctdbase.org/detail.go?type=gene&acc=130132,,,130132.0,RFTN2,90988,Pimephales promelas (fathead minnow),Bisphenol A affects the expression of RFTN2 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
1613,598470,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,130132,RFTN2,https://ctdbase.org/detail.go?type=gene&acc=130132,,,130132.0,RFTN2,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of RFTN2 mRNA,,,PMID:25181051|PMID:30816183,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/30816183,25181051|30816183,,
1614,598619,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,219770,GJD4,https://ctdbase.org/detail.go?type=gene&acc=219770,,,219770.0,GJD4,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of GJD4 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1615,598620,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100126572,GJE1,https://ctdbase.org/detail.go?type=gene&acc=100126572,,,100126572.0,GJE1,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of GJE1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1616,598621,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2710,GK,https://ctdbase.org/detail.go?type=gene&acc=2710,,,2710.0,GK,9606,Homo sapiens (human),Bisphenol A affects the expression of GK mRNA,,,PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/30903817,30903817,,
1617,598622,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2710,GK,https://ctdbase.org/detail.go?type=gene&acc=2710,,,2710.0,GK,9606,Homo sapiens (human),Bisphenol A results in increased expression of GK mRNA,,,PMID:29275510,https://www.ncbi.nlm.nih.gov/pubmed/29275510,29275510,,
1618,598623,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2710,GK,https://ctdbase.org/detail.go?type=gene&acc=2710,,,2710.0,GK,10090,Mus musculus (house mouse),Bisphenol A results in increased expression of GK mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
1619,598624,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2710,GK,https://ctdbase.org/detail.go?type=gene&acc=2710,,,2710.0,GK,10116,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of GK mRNA,,,PMID:25181051|PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/30903817,25181051|30903817,,
1620,598625,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2710,GK,https://ctdbase.org/detail.go?type=gene&acc=2710,,,2710.0,GK,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of GK mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
1621,599515,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,113263,GLCCI1,https://ctdbase.org/detail.go?type=gene&acc=113263,,,113263.0,GLCCI1,7955,Danio rerio (zebrafish),Bisphenol A affects the expression of GLCCI1 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
1622,599516,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,113263,GLCCI1,https://ctdbase.org/detail.go?type=gene&acc=113263,,,113263.0,GLCCI1,143606,Gobiocypris rarus,Bisphenol A results in decreased expression of GLCCI1 mRNA,,,PMID:26364221,https://www.ncbi.nlm.nih.gov/pubmed/26364221,26364221,,
1623,599517,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,113263,GLCCI1,https://ctdbase.org/detail.go?type=gene&acc=113263,,,113263.0,GLCCI1,10090,Mus musculus (house mouse),Bisphenol A affects the methylation of GLCCI1 gene,,,PMID:21829099,https://www.ncbi.nlm.nih.gov/pubmed/21829099,21829099,,
1624,599518,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,113263,GLCCI1,https://ctdbase.org/detail.go?type=gene&acc=113263,,,113263.0,GLCCI1,10090,Mus musculus (house mouse),Bisphenol A results in decreased expression of GLCCI1 mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
1625,599519,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,113263,GLCCI1,https://ctdbase.org/detail.go?type=gene&acc=113263,,,113263.0,GLCCI1,10116,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of GLCCI1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1626,599520,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,113263,GLCCI1,https://ctdbase.org/detail.go?type=gene&acc=113263,,,113263.0,GLCCI1,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of GLCCI1 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
1627,600229,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2736,GLI2,https://ctdbase.org/detail.go?type=gene&acc=2736,,,2736.0,GLI2,10090,Mus musculus (house mouse),Bisphenol A results in decreased methylation of GLI2 promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
1628,600230,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2736,GLI2,https://ctdbase.org/detail.go?type=gene&acc=2736,,,2736.0,GLI2,10116,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of GLI2 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1629,600231,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2736,GLI2,https://ctdbase.org/detail.go?type=gene&acc=2736,,,2736.0,GLI2,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of GLI2 mRNA,,,PMID:30816183,https://www.ncbi.nlm.nih.gov/pubmed/30816183,30816183,,
1630,602070,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,791729,RH50,https://ctdbase.org/detail.go?type=gene&acc=791729,,,791729.0,rh50,7955,Danio rerio (zebrafish),Bisphenol A results in decreased expression of RH50 mRNA,,,PMID:36851052,https://www.ncbi.nlm.nih.gov/pubmed/36851052,36851052,,
1631,602071,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,43071,RHA,https://ctdbase.org/detail.go?type=gene&acc=43071,,,43071.0,rha,7227,Drosophila melanogaster (fruit fly),Bisphenol A results in decreased expression of RHA mRNA,,,PMID:35041872,https://www.ncbi.nlm.nih.gov/pubmed/35041872,35041872,,
1632,602072,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,6005,RHAG,https://ctdbase.org/detail.go?type=gene&acc=6005,,,6005.0,RHAG,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of RHAG mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1633,602073,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,6005,RHAG,https://ctdbase.org/detail.go?type=gene&acc=6005,,,6005.0,RHAG,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of RHAG mRNA,,,PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/32145629,32145629,,
1634,602074,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84236,RHBDD1,https://ctdbase.org/detail.go?type=gene&acc=84236,,,84236.0,RHBDD1,9606,Homo sapiens (human),Bisphenol A results in increased expression of RHBDD1 mRNA,,,PMID:29275510,https://www.ncbi.nlm.nih.gov/pubmed/29275510,29275510,,
1635,602075,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84236,RHBDD1,https://ctdbase.org/detail.go?type=gene&acc=84236,,,84236.0,RHBDD1,9606,Homo sapiens (human),Bisphenol A results in increased methylation of RHBDD1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1636,602261,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,84236,RHBDD1,https://ctdbase.org/detail.go?type=gene&acc=84236,,,84236.0,RHBDD1,10090,Mus musculus (house mouse),Bisphenol A results in increased expression of RHBDD1 mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
1637,602262,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,57414,RHBDD2,https://ctdbase.org/detail.go?type=gene&acc=57414,,,57414.0,RHBDD2,9606,Homo sapiens (human),Bisphenol A affects the expression of RHBDD2 mRNA,,,PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/30903817,30903817,,
1638,602263,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,57414,RHBDD2,https://ctdbase.org/detail.go?type=gene&acc=57414,,,57414.0,RHBDD2,9606,Homo sapiens (human),Bisphenol A results in increased expression of RHBDD2 mRNA,,,PMID:29275510,https://www.ncbi.nlm.nih.gov/pubmed/29275510,29275510,,
1639,602264,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,57414,RHBDD2,https://ctdbase.org/detail.go?type=gene&acc=57414,,,57414.0,RHBDD2,10116,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of RHBDD2 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1640,602265,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,57414,RHBDD2,https://ctdbase.org/detail.go?type=gene&acc=57414,,,57414.0,RHBDD2,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of RHBDD2 mRNA,,,PMID:30816183|PMID:32145629|PMID:32528016,https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32145629|https://www.ncbi.nlm.nih.gov/pubmed/32528016,30816183|32145629|32528016,,
1641,602266,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,25807,RHBDD3,https://ctdbase.org/detail.go?type=gene&acc=25807,,,25807.0,RHBDD3,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of RHBDD3 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1642,602267,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,64285,RHBDF1,https://ctdbase.org/detail.go?type=gene&acc=64285,,,64285.0,RHBDF1,9606,Homo sapiens (human),Bisphenol A results in decreased expression of RHBDF1 mRNA,,,PMID:28711546,https://www.ncbi.nlm.nih.gov/pubmed/28711546,28711546,,
1643,602268,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,64285,RHBDF1,https://ctdbase.org/detail.go?type=gene&acc=64285,,,64285.0,RHBDF1,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of RHBDF1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1644,603256,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,9606,Homo sapiens (human),Bisphenol A results in increased expression of RHOA protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1645,603257,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,10090,Mus musculus (house mouse),Bisphenol A results in decreased expression of RHOA mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
1646,603258,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of RHOA mRNA,,,PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/34947998,34947998,,
1647,603259,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of RHOA protein|u 0126 inhibits the reaction [bisphenol A results in decreased expression of RHOA protein]|dizocilpine maleate inhibits the reaction [bisphenol A results in decreased expression of RHOA protein],,,PMID:24231043,https://www.ncbi.nlm.nih.gov/pubmed/24231043,24231043,,
1648,603260,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,387,RHOA,https://ctdbase.org/detail.go?type=gene&acc=387,,,387.0,RHOA,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of RHOA mrna|bisphenol A results in increased expression of RHOA protein,,,PMID:32714078,https://www.ncbi.nlm.nih.gov/pubmed/32714078,32714078,,
1649,603261,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,406411,RHOAA,https://ctdbase.org/detail.go?type=gene&acc=406411,,,406411.0,rhoaa,7955,Danio rerio (zebrafish),Bisphenol A results in increased expression of RHOAA mRNA,,,PMID:30248606,https://www.ncbi.nlm.nih.gov/pubmed/30248606,30248606,,
1650,603262,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,100006041,RHOAB,https://ctdbase.org/detail.go?type=gene&acc=100006041,,,100006041.0,rhoab,7955,Danio rerio (zebrafish),Bisphenol A results in increased expression of RHOAB mRNA,,,PMID:30248606,https://www.ncbi.nlm.nih.gov/pubmed/30248606,30248606,,
1651,603263,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,406659,RHOAC,https://ctdbase.org/detail.go?type=gene&acc=406659,,,406659.0,rhoac,7955,Danio rerio (zebrafish),Bisphenol A affects the expression of RHOAC mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
1652,603569,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2752,GLUL,https://ctdbase.org/detail.go?type=gene&acc=2752,,,2752.0,GLUL,9606,Homo sapiens (human),Bisphenol A results in increased expression of GLUL protein,,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1653,603570,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2752,GLUL,https://ctdbase.org/detail.go?type=gene&acc=2752,,,2752.0,GLUL,9606,Homo sapiens (human),Bisphenol A results in increased methylation of GLUL gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1654,603571,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2752,GLUL,https://ctdbase.org/detail.go?type=gene&acc=2752,,,2752.0,GLUL,10090,Mus musculus (house mouse),Bisphenol A results in decreased expression of GLUL mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
1655,603572,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2752,GLUL,https://ctdbase.org/detail.go?type=gene&acc=2752,,,2752.0,GLUL,10090,Mus musculus (house mouse),Bisphenol A results in decreased methylation of GLUL promoter,,,PMID:27312807,https://www.ncbi.nlm.nih.gov/pubmed/27312807,27312807,,
1656,603573,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2752,GLUL,https://ctdbase.org/detail.go?type=gene&acc=2752,,,2752.0,GLUL,10116,Rattus norvegicus (Norway rat),Astragaloside A inhibits the reaction [bisphenol A results in decreased activity of GLUL protein]|bisphenol A results in decreased activity of GLUL protein|saponins inhibits the reaction [bisphenol A results in decreased activity of GLUL protein],,,PMID:34434659,https://www.ncbi.nlm.nih.gov/pubmed/34434659,34434659,,
1657,603574,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2752,GLUL,https://ctdbase.org/detail.go?type=gene&acc=2752,,,2752.0,GLUL,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GLUL mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
1658,603575,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2752,GLUL,https://ctdbase.org/detail.go?type=gene&acc=2752,,,2752.0,GLUL,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of GLUL mRNA,,,PMID:15901920|PMID:30816183|PMID:32528016|PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/15901920|https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016|https://www.ncbi.nlm.nih.gov/pubmed/34947998,15901920|30816183|32528016|34947998,,
1659,604464,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2762,GMDS,https://ctdbase.org/detail.go?type=gene&acc=2762,,,2762.0,GMDS,9606,Homo sapiens (human),Bisphenol A results in decreased expression of GMDS protein,,,PMID:37567409,https://www.ncbi.nlm.nih.gov/pubmed/37567409,37567409,,
1660,604465,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2762,GMDS,https://ctdbase.org/detail.go?type=gene&acc=2762,,,2762.0,GMDS,9606,Homo sapiens (human),Bisphenol A results in increased expression of GMDS mRNA,,,PMID:29275510,https://www.ncbi.nlm.nih.gov/pubmed/29275510,29275510,,
1661,604466,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2762,GMDS,https://ctdbase.org/detail.go?type=gene&acc=2762,,,2762.0,GMDS,10090,Mus musculus (house mouse),Bisphenol A results in increased expression of GMDS mRNA,,,PMID:26063408|PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/26063408|https://www.ncbi.nlm.nih.gov/pubmed/32156529,26063408|32156529,,
1662,606460,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2769,GNA15,https://ctdbase.org/detail.go?type=gene&acc=2769,,,2769.0,GNA15,9606,Homo sapiens (human),Bisphenol A results in decreased methylation of GNA15 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1663,606461,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2769,GNA15,https://ctdbase.org/detail.go?type=gene&acc=2769,,,2769.0,GNA15,10090,Mus musculus (house mouse),Bisphenol A results in increased expression of GNA15 mRNA,,,PMID:32156529,https://www.ncbi.nlm.nih.gov/pubmed/32156529,32156529,,
1664,606462,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2769,GNA15,https://ctdbase.org/detail.go?type=gene&acc=2769,,,2769.0,GNA15,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of GNA15 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
1665,606463,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2769,GNA15,https://ctdbase.org/detail.go?type=gene&acc=2769,,,2769.0,GNA15,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with estradiol] results in increased expression of GNA15 mRNA,,,PMID:26496021,https://www.ncbi.nlm.nih.gov/pubmed/26496021,26496021,,
1666,606464,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2769,GNA15,https://ctdbase.org/detail.go?type=gene&acc=2769,,,2769.0,GNA15,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of GNA15 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1667,606825,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,79890,RIN3,https://ctdbase.org/detail.go?type=gene&acc=79890,,,79890.0,RIN3,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of RIN3 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
1668,606826,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,6015,RING1,https://ctdbase.org/detail.go?type=gene&acc=6015,,,6015.0,RING1,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of RING1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1669,606827,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,6015,RING1,https://ctdbase.org/detail.go?type=gene&acc=6015,,,6015.0,RING1,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of RING1 mRNA,,,PMID:36041667,https://www.ncbi.nlm.nih.gov/pubmed/36041667,36041667,,
1670,606828,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,6015,RING1,https://ctdbase.org/detail.go?type=gene&acc=6015,,,6015.0,RING1,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of RING1 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1671,607147,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2778,GNAS,https://ctdbase.org/detail.go?type=gene&acc=2778,,,2778.0,GNAS,7955,Danio rerio (zebrafish),Bisphenol A results in decreased expression of GNAS mRNA,,,PMID:33243503,https://www.ncbi.nlm.nih.gov/pubmed/33243503,33243503,,
1672,607148,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2778,GNAS,https://ctdbase.org/detail.go?type=gene&acc=2778,,,2778.0,GNAS,9606,Homo sapiens (human),Bisphenol A affects the expression of GNAS mRNA,,,PMID:30903817,https://www.ncbi.nlm.nih.gov/pubmed/30903817,30903817,,
1673,607149,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2778,GNAS,https://ctdbase.org/detail.go?type=gene&acc=2778,,,2778.0,GNAS,9606,Homo sapiens (human),Bisphenol A results in decreased methylation of GNAS gene|[bisphenol A co-treated with fulvestrant] results in decreased methylation of GNAS gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1674,607150,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2778,GNAS,https://ctdbase.org/detail.go?type=gene&acc=2778,,,2778.0,GNAS,9606,Homo sapiens (human),Bisphenol A results in decreased methylation of GNAS promoter,,,PMID:27271280,https://www.ncbi.nlm.nih.gov/pubmed/27271280,27271280,,
1675,607151,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2778,GNAS,https://ctdbase.org/detail.go?type=gene&acc=2778,,,2778.0,GNAS,9606,Homo sapiens (human),Bisphenol A results in increased expression of GNAS mRNA,,,PMID:29275510,https://www.ncbi.nlm.nih.gov/pubmed/29275510,29275510,,
1676,608035,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,322104,GNB1A,https://ctdbase.org/detail.go?type=gene&acc=322104,,,322104.0,gnb1a,7955,Danio rerio (zebrafish),Bisphenol A results in decreased expression of GNB1A mRNA,,,PMID:33243503,https://www.ncbi.nlm.nih.gov/pubmed/33243503,33243503,,
1677,608036,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,406796,GNB1B,https://ctdbase.org/detail.go?type=gene&acc=406796,,,406796.0,gnb1b,7955,Danio rerio (zebrafish),Bisphenol A affects the expression of GNB1B mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
1678,608037,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,105378949,GNB1-DT,https://ctdbase.org/detail.go?type=gene&acc=105378949,,,105378949.0,GNB1-DT,9606,Homo sapiens (human),Bisphenol A results in decreased expression of GNB1-DT mRNA,,,PMID:33670352,https://www.ncbi.nlm.nih.gov/pubmed/33670352,33670352,,
1679,608038,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,54584,GNB1L,https://ctdbase.org/detail.go?type=gene&acc=54584,,,54584.0,GNB1L,7955,Danio rerio (zebrafish),Bisphenol A affects the expression of GNB1L mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
1680,608039,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,54584,GNB1L,https://ctdbase.org/detail.go?type=gene&acc=54584,,,54584.0,GNB1L,10116,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of GNB1L mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1681,608040,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,54584,GNB1L,https://ctdbase.org/detail.go?type=gene&acc=54584,,,54584.0,GNB1L,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of GNB1L mRNA,,,PMID:30816183,https://www.ncbi.nlm.nih.gov/pubmed/30816183,30816183,,
1682,608041,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2783,GNB2,https://ctdbase.org/detail.go?type=gene&acc=2783,,,2783.0,GNB2,9606,Homo sapiens (human),Bisphenol A results in decreased expression of GNB2 protein,,,PMID:31675489|PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/31675489|https://www.ncbi.nlm.nih.gov/pubmed/34186270,31675489|34186270,,
1683,608042,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2783,GNB2,https://ctdbase.org/detail.go?type=gene&acc=2783,,,2783.0,GNB2,9606,Homo sapiens (human),Bisphenol A results in increased expression of GNB2 protein,,,PMID:37567409,https://www.ncbi.nlm.nih.gov/pubmed/37567409,37567409,,
1684,608043,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2783,GNB2,https://ctdbase.org/detail.go?type=gene&acc=2783,,,2783.0,GNB2,10090,Mus musculus (house mouse),Bisphenol A results in increased expression of GNB2 mRNA,,,PMID:33221593,https://www.ncbi.nlm.nih.gov/pubmed/33221593,33221593,,
1685,608417,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10681,GNB5,https://ctdbase.org/detail.go?type=gene&acc=10681,,,10681.0,GNB5,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of GNB5 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1686,608418,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10681,GNB5,https://ctdbase.org/detail.go?type=gene&acc=10681,,,10681.0,GNB5,10116,Rattus norvegicus (Norway rat),Bisphenol A affects the expression of GNB5 mRNA,,,PMID:25181051,https://www.ncbi.nlm.nih.gov/pubmed/25181051,25181051,,
1687,608419,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10681,GNB5,https://ctdbase.org/detail.go?type=gene&acc=10681,,,10681.0,GNB5,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of GNB5 mRNA,,,PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/34947998,34947998,,
1688,608420,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10681,GNB5,https://ctdbase.org/detail.go?type=gene&acc=10681,,,10681.0,GNB5,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased methylation of GNB5 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
1689,608421,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,562813,GNB5A,https://ctdbase.org/detail.go?type=gene&acc=562813,,,562813.0,gnb5a,7955,Danio rerio (zebrafish),Bisphenol A results in decreased expression of GNB5A mRNA,,,PMID:33243503,https://www.ncbi.nlm.nih.gov/pubmed/33243503,33243503,,
1690,608422,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,562813,GNB5A,https://ctdbase.org/detail.go?type=gene&acc=562813,,,562813.0,gnb5a,90988,Pimephales promelas (fathead minnow),Bisphenol A affects the expression of GNB5A mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
1691,608423,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,10020,GNE,https://ctdbase.org/detail.go?type=gene&acc=10020,,,10020.0,GNE,8478,Chrysemys picta bellii (western painted turtle),Bisphenol A results in decreased expression of GNE mRNA,,,PMID:28159858,https://www.ncbi.nlm.nih.gov/pubmed/28159858,28159858,,
1692,609316,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2787,GNG5,https://ctdbase.org/detail.go?type=gene&acc=2787,,,2787.0,GNG5,9606,Homo sapiens (human),Bisphenol A results in increased methylation of GNG5 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
1693,609317,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2787,GNG5,https://ctdbase.org/detail.go?type=gene&acc=2787,,,2787.0,GNG5,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with genistein] results in increased methylation of GNG5 gene|bisphenol A results in increased methylation of GNG5 gene,,,PMID:28505145,https://www.ncbi.nlm.nih.gov/pubmed/28505145,28505145,,
1694,609318,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2787,GNG5,https://ctdbase.org/detail.go?type=gene&acc=2787,,,2787.0,GNG5,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of GNG5 mRNA,,,PMID:25181051|PMID:32145629,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/32145629,25181051|32145629,,
1695,609319,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2788,GNG7,https://ctdbase.org/detail.go?type=gene&acc=2788,,,2788.0,GNG7,7955,Danio rerio (zebrafish),Bisphenol A affects the expression of GNG7 mRNA,,,PMID:21786754,https://www.ncbi.nlm.nih.gov/pubmed/21786754,21786754,,
1696,609320,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2788,GNG7,https://ctdbase.org/detail.go?type=gene&acc=2788,,,2788.0,GNG7,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of GNG7 mRNA,,,PMID:25181051|PMID:30816183|PMID:32528016,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/30816183|https://www.ncbi.nlm.nih.gov/pubmed/32528016,25181051|30816183|32528016,,
1697,609321,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,2788,GNG7,https://ctdbase.org/detail.go?type=gene&acc=2788,,,2788.0,GNG7,10116,Rattus norvegicus (Norway rat),Bisphenol A results in increased expression of GNG7 mRNA,,,PMID:34947998,https://www.ncbi.nlm.nih.gov/pubmed/34947998,34947998,,
1698,609322,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,94235,GNG8,https://ctdbase.org/detail.go?type=gene&acc=94235,,,94235.0,GNG8,10090,Mus musculus (house mouse),Bisphenol A affects the methylation of GNG8 promoter,,,PMID:27334623,https://www.ncbi.nlm.nih.gov/pubmed/27334623,27334623,,
1699,609323,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,94235,GNG8,https://ctdbase.org/detail.go?type=gene&acc=94235,,,94235.0,GNG8,10116,Rattus norvegicus (Norway rat),[bisphenol A co-treated with diethylhexyl phthalate co-treated with dibutyl phthalate] affects the methylation of GNG8 promoter,,,PMID:23359474,https://www.ncbi.nlm.nih.gov/pubmed/23359474,23359474,,
1700,609324,6623,Comparative Toxicogenomics Database (CTD),Bisphenol A,C006780,bisphenol A,https://ctdbase.org/detail.go?type=chem&acc=C006780,94235,GNG8,https://ctdbase.org/detail.go?type=gene&acc=94235,,,94235.0,GNG8,10116,Rattus norvegicus (Norway rat),Bisphenol A results in decreased expression of GNG8 mRNA,,,PMID:25181051|PMID:33296240,https://www.ncbi.nlm.nih.gov/pubmed/25181051|https://www.ncbi.nlm.nih.gov/pubmed/33296240,25181051|33296240,,
1701,591562,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,55612,FERMT1,https://ctdbase.org/detail.go?type=gene&acc=55612,,,55612.0,FERMT1,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of FERMT1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of FERMT1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1702,591563,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,10979,FERMT2,https://ctdbase.org/detail.go?type=gene&acc=10979,,,10979.0,FERMT2,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of FERMT2 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of FERMT2 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1703,591564,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,121512,FGD4,https://ctdbase.org/detail.go?type=gene&acc=121512,,,121512.0,FGD4,9606,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased expression of FGD4 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased expression of FGD4 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1704,591565,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,2247,FGF2,https://ctdbase.org/detail.go?type=gene&acc=2247,,,2247.0,FGF2,9606,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of FGF2 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of FGF2 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1705,591566,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,65056,GPBP1,https://ctdbase.org/detail.go?type=gene&acc=65056,,,65056.0,GPBP1,9606,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of and results in increased oxidation of GPBP1 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of and results in increased oxidation of GPBP1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1706,592645,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,26993,AKAP8L,https://ctdbase.org/detail.go?type=gene&acc=26993,,,26993.0,AKAP8L,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased expression of AKAP8L mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased expression of AKAP8L mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1707,592646,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,56672,AKIP1,https://ctdbase.org/detail.go?type=gene&acc=56672,,,56672.0,AKIP1,9606,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of AKIP1 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of AKIP1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1708,592647,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,79647,AKIRIN1,https://ctdbase.org/detail.go?type=gene&acc=79647,,,79647.0,AKIRIN1,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased expression of AKIRIN1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased expression of AKIRIN1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1709,592648,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,8644,AKR1C3,https://ctdbase.org/detail.go?type=gene&acc=8644,,,8644.0,AKR1C3,9606,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of AKR1C3 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of AKR1C3 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1710,594889,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,8412,BCAR3,https://ctdbase.org/detail.go?type=gene&acc=8412,,,8412.0,BCAR3,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of BCAR3 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of BCAR3 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1711,594890,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,54828,BCAS3,https://ctdbase.org/detail.go?type=gene&acc=54828,,,54828.0,BCAS3,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of BCAS3 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of BCAS3 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1712,596203,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,55704,CCDC88A,https://ctdbase.org/detail.go?type=gene&acc=55704,,,55704.0,CCDC88A,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in decreased expression of and results in increased oxidation of CCDC88A mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in decreased expression of and results in increased oxidation of CCDC88A mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1713,596204,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606,Homo sapiens (human),[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of CCNB1 mrna|[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of CCNB1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1714,596205,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,57820,CCNB1IP1,https://ctdbase.org/detail.go?type=gene&acc=57820,,,57820.0,CCNB1IP1,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of CCNB1IP1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of CCNB1IP1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1715,596206,6654,Comparative Toxicogenomics Database (CTD),alpha-PINENE,C005451,alpha-pinene,https://ctdbase.org/detail.go?type=chem&acc=C005451,900,CCNG1,https://ctdbase.org/detail.go?type=gene&acc=900,,,900.0,CCNG1,9606,Homo sapiens (human),[air pollutants results in increased abundance of [acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone]] which results in increased oxidation of CCNG1 mrna|[acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with ozone] results in increased oxidation of CCNG1 mRNA,,,PMID:32699268,https://www.ncbi.nlm.nih.gov/pubmed/32699268,32699268,,
1716,597651,6675,Comparative Toxicogenomics Database (CTD),Taurocholic acid,D013656,Taurocholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D013656,8878,SQSTM1,https://ctdbase.org/detail.go?type=gene&acc=8878,,,8878.0,SQSTM1,10090,Mus musculus (house mouse),Taurocholic acid results in increased expression of SQSTM1 protein,,,PMID:24189133,https://www.ncbi.nlm.nih.gov/pubmed/24189133,24189133,,
1717,597652,6675,Comparative Toxicogenomics Database (CTD),Taurocholic acid,D013656,Taurocholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D013656,6554,SLC10A1,https://ctdbase.org/detail.go?type=gene&acc=6554,,,6554.0,SLC10A1,9606,Homo sapiens (human),Taurocholic acid promotes the reaction [SLC10A1 protein results in increased uptake of fluorescein-5-isothiocyanate]|taurocholic acid inhibits the reaction [SLC10A1 protein results in increased uptake of indocyanine green],,,PMID:32209977,https://www.ncbi.nlm.nih.gov/pubmed/32209977,32209977,,
1718,597653,6675,Comparative Toxicogenomics Database (CTD),Taurocholic acid,D013656,Taurocholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D013656,6554,SLC10A1,https://ctdbase.org/detail.go?type=gene&acc=6554,,,6554.0,SLC10A1,9606,Homo sapiens (human),Tobacco smoke pollution inhibits the reaction [SLC10A1 protein results in increased import of taurocholic acid],,,PMID:27450509,https://www.ncbi.nlm.nih.gov/pubmed/27450509,27450509,,
1719,597654,6675,Comparative Toxicogenomics Database (CTD),Taurocholic acid,D013656,Taurocholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D013656,6554,SLC10A1,https://ctdbase.org/detail.go?type=gene&acc=6554,,,6554.0,SLC10A1,10090,Mus musculus (house mouse),Taurocholic acid results in increased expression of SLC10A1 mRNA,,,PMID:27160211,https://www.ncbi.nlm.nih.gov/pubmed/27160211,27160211,,
1720,597655,6675,Comparative Toxicogenomics Database (CTD),Taurocholic acid,D013656,Taurocholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D013656,6554,SLC10A1,https://ctdbase.org/detail.go?type=gene&acc=6554,,,6554.0,SLC10A1,10114,Rattus,SLC10A1 protein affects the transport of taurocholic acid,,,PMID:15297262,https://www.ncbi.nlm.nih.gov/pubmed/15297262,15297262,,
1721,597656,6675,Comparative Toxicogenomics Database (CTD),Taurocholic acid,D013656,Taurocholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D013656,6555,SLC10A2,https://ctdbase.org/detail.go?type=gene&acc=6555,,,6555.0,SLC10A2,9606,Homo sapiens (human),SLC10A2 protein results in increased transport of taurocholic acid|chenodeoxycholic acid inhibits the reaction [SLC10A2 protein results in increased transport of taurocholic acid],,,PMID:25466967,https://www.ncbi.nlm.nih.gov/pubmed/25466967,25466967,,
1722,597657,6675,Comparative Toxicogenomics Database (CTD),Taurocholic acid,D013656,Taurocholic Acid,https://ctdbase.org/detail.go?type=chem&acc=D013656,6555,SLC10A2,https://ctdbase.org/detail.go?type=gene&acc=6555,,,6555.0,SLC10A2,10114,Rattus,SLC10A2 protein results in increased uptake of taurocholic acid,,,PMID:15209631,https://www.ncbi.nlm.nih.gov/pubmed/15209631,15209631,,
1723,602423,6811,Comparative Toxicogenomics Database (CTD),Phthalic anhydride,C043103,phthalic anhydride,https://ctdbase.org/detail.go?type=chem&acc=C043103,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Phthalic anhydride results in increased expression of TNF protein,,,PMID:20219652,https://www.ncbi.nlm.nih.gov/pubmed/20219652,20219652,,
1724,602424,6843,DrugBank,Propoxycaine,DB09342,Propoxycaine,https://www.drugbank.ca/drugs/DB09342,BE0009738,Sodium channel protein type 1 subunit alpha,https://www.drugbank.ca/bio_entities/BE0009738,P35498,Sodium channel protein type 1 subunit alpha,6323.0,SCN1A,9606,Homo sapiens (human),Blocker,,,PMID:22053156,https://www.ncbi.nlm.nih.gov/pubmed/22053156,22053156,,
1725,602425,6843,DrugBank,Propoxycaine,DB09342,Propoxycaine,https://www.drugbank.ca/drugs/DB09342,BE0009738,Sodium channel protein type 10 subunit alpha,https://www.drugbank.ca/bio_entities/BE0009738,Q9Y5Y9,Sodium channel protein type 10 subunit alpha,6336.0,SCN10A,9606,Homo sapiens (human),Blocker,,,PMID:22053156,https://www.ncbi.nlm.nih.gov/pubmed/22053156,22053156,,
1726,602426,6843,DrugBank,Propoxycaine,DB09342,Propoxycaine,https://www.drugbank.ca/drugs/DB09342,BE0009738,Sodium channel protein type 11 subunit alpha,https://www.drugbank.ca/bio_entities/BE0009738,Q9UI33,Sodium channel protein type 11 subunit alpha,11280.0,SCN11A,9606,Homo sapiens (human),Blocker,,,PMID:22053156,https://www.ncbi.nlm.nih.gov/pubmed/22053156,22053156,,
1727,604951,7430,Toxin and Toxin Target Database (T3DB),"2,6-Dichloro-4-nitroaniline",T3D3823,Dichloran,http://www.t3db.ca/toxins/T3D3823,BE0003336,Cytochrome P450 2A6,http://www.t3db.ca/biodb/bio_entities/BE0003336,P11509,Cytochrome P450 2A6,1548.0,CYP2A6,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1728,604952,7430,Toxin and Toxin Target Database (T3DB),"2,6-Dichloro-4-nitroaniline",T3D3823,Dichloran,http://www.t3db.ca/toxins/T3D3823,BE0000920,Interstitial collagenase,http://www.t3db.ca/biodb/bio_entities/BE0000920,P03956,Interstitial collagenase,4312.0,MMP1,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1729,604953,7430,Toxin and Toxin Target Database (T3DB),"2,6-Dichloro-4-nitroaniline",T3D3823,Dichloran,http://www.t3db.ca/toxins/T3D3823,BE0000717,Urokinase plasminogen activator surface receptor,http://www.t3db.ca/biodb/bio_entities/BE0000717,Q03405,Urokinase plasminogen activator surface receptor,5329.0,PLAUR,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1730,604954,7430,Toxin and Toxin Target Database (T3DB),"2,6-Dichloro-4-nitroaniline",T3D3823,Dichloran,http://www.t3db.ca/toxins/T3D3823,BE0003549,Cytochrome P450 2B6,http://www.t3db.ca/biodb/bio_entities/BE0003549,P20813,Cytochrome P450 2B6,1555.0,CYP2B6,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1731,604955,7430,Toxin and Toxin Target Database (T3DB),"2,6-Dichloro-4-nitroaniline",T3D3823,Dichloran,http://www.t3db.ca/toxins/T3D3823,BE0003541,UDP-glucuronosyltransferase 1-1,http://www.t3db.ca/biodb/bio_entities/BE0003541,P22309,UDP-glucuronosyltransferase 1A1 ,54658.0,UGT1A1,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1732,604956,7430,Toxin and Toxin Target Database (T3DB),"2,6-Dichloro-4-nitroaniline",T3D3823,Dichloran,http://www.t3db.ca/toxins/T3D3823,BE0002638,Cytochrome P450 3A4,http://www.t3db.ca/biodb/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1733,604957,7430,Toxin and Toxin Target Database (T3DB),"2,6-Dichloro-4-nitroaniline",T3D3823,Dichloran,http://www.t3db.ca/toxins/T3D3823,BE0002433,Cytochrome P450 1A2,http://www.t3db.ca/biodb/bio_entities/BE0002433,P05177,Cytochrome P450 1A2,1544.0,CYP1A2,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1734,604958,7430,Toxin and Toxin Target Database (T3DB),"2,6-Dichloro-4-nitroaniline",T3D3823,Dichloran,http://www.t3db.ca/toxins/T3D3823,BE0003543,Cytochrome P450 1A1,http://www.t3db.ca/biodb/bio_entities/BE0003543,P04798,Cytochrome P450 1A1,1543.0,CYP1A1,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
1735,604959,7443,Comparative Toxicogenomics Database (CTD),"3,4-Dichloronitrobenzene",C028328,"1,2-dichloro-4-nitrobenzene",https://ctdbase.org/detail.go?type=chem&acc=C028328,2938,GSTA1,https://ctdbase.org/detail.go?type=gene&acc=2938,,,2938.0,GSTA1,9541,Macaca fascicularis (crab-eating macaque),"GSTA1 protein affects the metabolism of 1,2-dichloro-4-nitrobenzene",,,PMID:12388831,https://www.ncbi.nlm.nih.gov/pubmed/12388831,12388831,,
1736,605124,7443,Comparative Toxicogenomics Database (CTD),"3,4-Dichloronitrobenzene",C028328,"1,2-dichloro-4-nitrobenzene",https://ctdbase.org/detail.go?type=chem&acc=C028328,100379159,GSTA1.2,https://ctdbase.org/detail.go?type=gene&acc=100379159,,,100379159.0,,9103,Meleagris gallopavo (turkey),"GSTA1.2 protein results in increased glutathionylation of 1,2-dichloro-4-nitrobenzene",,,PMID:21876218,https://www.ncbi.nlm.nih.gov/pubmed/21876218,21876218,,
1737,605125,7443,Comparative Toxicogenomics Database (CTD),"3,4-Dichloronitrobenzene",C028328,"1,2-dichloro-4-nitrobenzene",https://ctdbase.org/detail.go?type=chem&acc=C028328,100379160,GSTA1.3,https://ctdbase.org/detail.go?type=gene&acc=100379160,,,100379160.0,,9103,Meleagris gallopavo (turkey),"GSTA1.3 protein results in increased glutathionylation of 1,2-dichloro-4-nitrobenzene",,,PMID:21876218,https://www.ncbi.nlm.nih.gov/pubmed/21876218,21876218,,
1738,605126,7443,Comparative Toxicogenomics Database (CTD),"3,4-Dichloronitrobenzene",C028328,"1,2-dichloro-4-nitrobenzene",https://ctdbase.org/detail.go?type=chem&acc=C028328,2939,GSTA2,https://ctdbase.org/detail.go?type=gene&acc=2939,,,2939.0,GSTA2,9103,Meleagris gallopavo (turkey),"GSTA2 protein results in increased glutathionylation of 1,2-dichloro-4-nitrobenzene",,,PMID:21876218,https://www.ncbi.nlm.nih.gov/pubmed/21876218,21876218,,
1739,605127,7443,Comparative Toxicogenomics Database (CTD),"3,4-Dichloronitrobenzene",C028328,"1,2-dichloro-4-nitrobenzene",https://ctdbase.org/detail.go?type=chem&acc=C028328,2940,GSTA3,https://ctdbase.org/detail.go?type=gene&acc=2940,,,2940.0,GSTA3,9103,Meleagris gallopavo (turkey),"GSTA3 protein results in increased glutathionylation of 1,2-dichloro-4-nitrobenzene",,,PMID:21876218,https://www.ncbi.nlm.nih.gov/pubmed/21876218,21876218,,
1740,605128,7443,Comparative Toxicogenomics Database (CTD),"3,4-Dichloronitrobenzene",C028328,"1,2-dichloro-4-nitrobenzene",https://ctdbase.org/detail.go?type=chem&acc=C028328,2941,GSTA4,https://ctdbase.org/detail.go?type=gene&acc=2941,,,2941.0,GSTA4,9103,Meleagris gallopavo (turkey),"GSTA4 protein results in increased glutathionylation of 1,2-dichloro-4-nitrobenzene",,,PMID:21876218,https://www.ncbi.nlm.nih.gov/pubmed/21876218,21876218,,
1741,605129,7443,Comparative Toxicogenomics Database (CTD),"3,4-Dichloronitrobenzene",C028328,"1,2-dichloro-4-nitrobenzene",https://ctdbase.org/detail.go?type=chem&acc=C028328,41503,GSTD1,https://ctdbase.org/detail.go?type=gene&acc=41503,,,41503.0,GstD1,6973,Blattella germanica (German cockroach),"GSTD1 protein results in increased glutathionylation of 1,2-dichloro-4-nitrobenzene",,,PMID:17331184,https://www.ncbi.nlm.nih.gov/pubmed/17331184,17331184,,
1742,605967,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,4552,MTRR,https://ctdbase.org/detail.go?type=gene&acc=4552,,,4552.0,MTRR,10090,Mus musculus (house mouse),"4,4'-diaminodiphenylmethane results in decreased expression of MTRR mRNA",,,PMID:18648102,https://www.ncbi.nlm.nih.gov/pubmed/18648102,18648102,,
1743,605968,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,9788,MTSS1,https://ctdbase.org/detail.go?type=gene&acc=9788,,,9788.0,MTSS1,10090,Mus musculus (house mouse),"4,4'-diaminodiphenylmethane results in increased expression of MTSS1 mRNA",,,PMID:18648102,https://www.ncbi.nlm.nih.gov/pubmed/18648102,18648102,,
1744,605969,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,4547,MTTP,https://ctdbase.org/detail.go?type=gene&acc=4547,,,4547.0,MTTP,10090,Mus musculus (house mouse),"4,4'-diaminodiphenylmethane results in increased expression of MTTP mRNA",,,PMID:18648102,https://www.ncbi.nlm.nih.gov/pubmed/18648102,18648102,,
1745,605970,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,246754,MTVR2,https://ctdbase.org/detail.go?type=gene&acc=246754,,,246754.0,MTVR2,10090,Mus musculus (house mouse),"4,4'-diaminodiphenylmethane results in decreased expression of MTVR2 mRNA",,,PMID:18648102,https://www.ncbi.nlm.nih.gov/pubmed/18648102,18648102,,
1746,605971,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,17843,MUP4,https://ctdbase.org/detail.go?type=gene&acc=17843,,,17843.0,Mup4,10090,Mus musculus (house mouse),"4,4'-diaminodiphenylmethane results in decreased expression of MUP4 mRNA",,,PMID:18648102,https://www.ncbi.nlm.nih.gov/pubmed/18648102,18648102,,
1747,605972,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,4593,MUSK,https://ctdbase.org/detail.go?type=gene&acc=4593,,,4593.0,MUSK,10090,Mus musculus (house mouse),"4,4'-diaminodiphenylmethane results in increased expression of MUSK mRNA",,,PMID:18648102,https://www.ncbi.nlm.nih.gov/pubmed/18648102,18648102,,
1748,605973,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,4595,MUTYH,https://ctdbase.org/detail.go?type=gene&acc=4595,,,4595.0,MUTYH,10090,Mus musculus (house mouse),"4,4'-diaminodiphenylmethane results in decreased expression of MUTYH mRNA",,,PMID:18648102,https://www.ncbi.nlm.nih.gov/pubmed/18648102,18648102,,
1749,605974,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,4597,MVD,https://ctdbase.org/detail.go?type=gene&acc=4597,,,4597.0,MVD,10090,Mus musculus (house mouse),"4,4'-diaminodiphenylmethane results in increased expression of MVD mRNA",,,PMID:18648102,https://www.ncbi.nlm.nih.gov/pubmed/18648102,18648102,,
1750,607548,7577,Comparative Toxicogenomics Database (CTD),"4,4'-Methylenedianiline",C009505,"4,4'-diaminodiphenylmethane",https://ctdbase.org/detail.go?type=chem&acc=C009505,4713,NDUFB7,https://ctdbase.org/detail.go?type=gene&acc=4713,,,4713.0,NDUFB7,10090,Mus musculus (house mouse),"4,4'-diaminodiphenylmethane results in decreased expression of NDUFB7 mRNA",,,PMID:18648102,https://www.ncbi.nlm.nih.gov/pubmed/18648102,18648102,,
1751,1440415,62920,Drug Gene Interaction database (DGIdb),Diltiazem Hydrochloride,,DILTIAZEM HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:203211,,CACNA1D,https://www.dgidb.org/genes/hgnc:1391,,,776.0,CACNA1D,9606,Homo sapiens (human),Blocker,,,,,,,
1752,1440416,62978,Drug Gene Interaction database (DGIdb),Doxazosin Mesylate,,DOXAZOSIN MESYLATE,https://www.dgidb.org/drugs/rxcui:39173,,ADRA1D,https://www.dgidb.org/genes/hgnc:280,,,146.0,ADRA1D,9606,Homo sapiens (human),,,,,,,,
1753,1440417,63002,Drug Gene Interaction database (DGIdb),Fexofenadine Hydrochloride,,FEXOFENADINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:236474,,CCL17,https://www.dgidb.org/genes/hgnc:10615,,,6361.0,CCL17,9606,Homo sapiens (human),,,,,,,,
1754,1440418,63002,Drug Gene Interaction database (DGIdb),Fexofenadine Hydrochloride,,FEXOFENADINE HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:236474,,ALOX15,https://www.dgidb.org/genes/hgnc:433,,,246.0,ALOX15,9606,Homo sapiens (human),,,,,,,,
1755,1440419,63016,Drug Gene Interaction database (DGIdb),Hytrin,,TERAZOSIN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:235224,,ADRA1B,https://www.dgidb.org/genes/hgnc:278,,,147.0,ADRA1B,9606,Homo sapiens (human),Inhibitor,,,,,,,
1756,1440420,63016,Drug Gene Interaction database (DGIdb),Hytrin,,TERAZOSIN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:235224,,ADRA1D,https://www.dgidb.org/genes/hgnc:280,,,146.0,ADRA1D,9606,Homo sapiens (human),Inhibitor,,,,,,,
1757,1440421,63016,Drug Gene Interaction database (DGIdb),Hytrin,,TERAZOSIN HYDROCHLORIDE,https://www.dgidb.org/drugs/rxcui:235224,,GAA,https://www.dgidb.org/genes/hgnc:4065,,,2548.0,GAA,9606,Homo sapiens (human),,,,,,,,
1758,1440422,63952,Drug Gene Interaction database (DGIdb),Carmoterol,,CARMOTEROL,https://www.dgidb.org/drugs/ncit:C171749,,ADRB2,https://www.dgidb.org/genes/hgnc:286,,,154.0,ADRB2,9606,Homo sapiens (human),Agonist,,,,,,,
1759,1445772,65064,Comparative Toxicogenomics Database (CTD),Epigallocatechin Gallate,C045651,epigallocatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C045651,10254,STAM2,https://ctdbase.org/detail.go?type=gene&acc=10254,,,10254.0,STAM2,9606,Homo sapiens (human),[potassium chromate(vi) co-treated with epigallocatechin gallate] results in decreased expression of STAM2 mRNA,,,PMID:22079256,https://www.ncbi.nlm.nih.gov/pubmed/22079256,22079256,,
1760,1441972,66589,Comparative Toxicogenomics Database (CTD),1-Naphthyl isocyanate,C061621,alpha-naphthyl isocyanate,https://ctdbase.org/detail.go?type=chem&acc=C061621,5698,PSMB9,https://ctdbase.org/detail.go?type=gene&acc=5698,,,5698.0,PSMB9,10116,Rattus norvegicus (Norway rat),Alpha-naphthyl isocyanate results in decreased expression of PSMB9 mRNA,,,PMID:17202759,https://www.ncbi.nlm.nih.gov/pubmed/17202759,17202759,,
1761,1441973,66589,Comparative Toxicogenomics Database (CTD),1-Naphthyl isocyanate,C061621,alpha-naphthyl isocyanate,https://ctdbase.org/detail.go?type=chem&acc=C061621,309622,RT1-BB,https://ctdbase.org/detail.go?type=gene&acc=309622,,,309622.0,RT1-Bb,10116,Rattus norvegicus (Norway rat),Alpha-naphthyl isocyanate results in decreased expression of RT1-BB mRNA,,,PMID:17202759,https://www.ncbi.nlm.nih.gov/pubmed/17202759,17202759,,
1762,1449987,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,436864,RND3B,https://ctdbase.org/detail.go?type=gene&acc=436864,,,436864.0,rnd3b,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of RND3B mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1763,1453383,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,353189,SLCO4C1,https://ctdbase.org/detail.go?type=gene&acc=353189,,,353189.0,SLCO4C1,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SLCO4C1 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
1764,1453384,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,353189,SLCO4C1,https://ctdbase.org/detail.go?type=gene&acc=353189,,,353189.0,SLCO4C1,10116,Rattus norvegicus (Norway rat),"Perfluoro-n-nonanoic acid results in decreased expression of SLCO4C1 protein|[phytochemicals co-treated with environmental pollutants co-treated with food preservatives co-treated with plasticizers co-treated with sunscreening agents co-treated with insecticides co-treated with fungicides, industrial co-treated with herbicides] inhibits the reaction [perfluoro-n-nonanoic acid results in decreased expression of SLCO4C1 protein]",,,PMID:25588985,https://www.ncbi.nlm.nih.gov/pubmed/25588985,25588985,,
1765,1453385,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,162394,SLFN5,https://ctdbase.org/detail.go?type=gene&acc=162394,,,162394.0,SLFN5,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of SLFN5 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
1766,1453386,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,4088,SMAD3,https://ctdbase.org/detail.go?type=gene&acc=4088,,,4088.0,SMAD3,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SMAD3 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1767,1453387,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,4091,SMAD6,https://ctdbase.org/detail.go?type=gene&acc=4091,,,4091.0,SMAD6,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of SMAD6 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1768,1454851,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,80765,STARD5,https://ctdbase.org/detail.go?type=gene&acc=80765,,,80765.0,STARD5,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of STARD5 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
1769,1454852,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,55061,SUSD4,https://ctdbase.org/detail.go?type=gene&acc=55061,,,55061.0,SUSD4,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of SUSD4 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1770,1454853,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774.0,STAT3,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of STAT3 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1771,1454854,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,6777,STAT5B,https://ctdbase.org/detail.go?type=gene&acc=6777,,,6777.0,STAT5B,10090,Mus musculus (house mouse),Perfluoro-n-nonanoic acid results in decreased activity of STAT5B protein,,,PMID:30114225,https://www.ncbi.nlm.nih.gov/pubmed/30114225,30114225,,
1772,1454855,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,6781,STC1,https://ctdbase.org/detail.go?type=gene&acc=6781,,,6781.0,STC1,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of STC1 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
1773,1457387,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,8743,TNFSF10,https://ctdbase.org/detail.go?type=gene&acc=8743,,,8743.0,TNFSF10,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of TNFSF10 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
1774,1457388,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,8740,TNFSF14,https://ctdbase.org/detail.go?type=gene&acc=8740,,,8740.0,TNFSF14,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in decreased expression of TNFSF14 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
1775,1457389,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,9966,TNFSF15,https://ctdbase.org/detail.go?type=gene&acc=9966,,,9966.0,TNFSF15,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TNFSF15 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1776,1457390,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,565809,TNS2B,https://ctdbase.org/detail.go?type=gene&acc=565809,,,565809.0,tns2b,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of TNS2B mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1777,1457391,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,64759,TNS3,https://ctdbase.org/detail.go?type=gene&acc=64759,,,64759.0,TNS3,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of TNS3 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1778,1457392,67821,Comparative Toxicogenomics Database (CTD),Perfluorononanoic acid,C101816,perfluoro-n-nonanoic acid,https://ctdbase.org/detail.go?type=chem&acc=C101816,222699,TOB2P1,https://ctdbase.org/detail.go?type=gene&acc=222699,,,222699.0,TOB2P1,9606,Homo sapiens (human),Perfluoro-n-nonanoic acid results in increased expression of TOB2P1 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
1779,1458708,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,4883,NPR3,https://ctdbase.org/detail.go?type=gene&acc=4883,,,4883.0,NPR3,10116,Rattus norvegicus (Norway rat),Flusilazole results in increased expression of NPR3 mRNA,,,PMID:28263823,https://www.ncbi.nlm.nih.gov/pubmed/28263823,28263823,,
1780,1458709,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,8204,NRIP1,https://ctdbase.org/detail.go?type=gene&acc=8204,,,8204.0,NRIP1,10116,Rattus norvegicus (Norway rat),Flusilazole results in increased expression of NRIP1 mRNA,,,PMID:28263823,https://www.ncbi.nlm.nih.gov/pubmed/28263823,28263823,,
1781,1458710,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,50814,NSDHL,https://ctdbase.org/detail.go?type=gene&acc=50814,,,50814.0,NSDHL,10090,Mus musculus (house mouse),Flusilazole affects the expression of NSDHL mRNA,,,PMID:22634333,https://www.ncbi.nlm.nih.gov/pubmed/22634333,22634333,,
1782,1458916,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,5100,PCDH8,https://ctdbase.org/detail.go?type=gene&acc=5100,,,5100.0,PCDH8,10090,Mus musculus (house mouse),Flusilazole affects the expression of PCDH8 mRNA,,,PMID:22634333,https://www.ncbi.nlm.nih.gov/pubmed/22634333,22634333,,
1783,1458917,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,5106,PCK2,https://ctdbase.org/detail.go?type=gene&acc=5106,,,5106.0,PCK2,7955,Danio rerio (zebrafish),Flusilazole results in increased expression of PCK2 mrna|flusilazole results in decreased expression of PCK2 mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
1784,1458918,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,7955,Danio rerio (zebrafish),Flusilazole affects the expression of PCNA mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
1785,1458919,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,255738,PCSK9,https://ctdbase.org/detail.go?type=gene&acc=255738,,,255738.0,PCSK9,10116,Rattus norvegicus (Norway rat),Flusilazole results in increased expression of PCSK9 mRNA,,,PMID:28263823,https://www.ncbi.nlm.nih.gov/pubmed/28263823,28263823,,
1786,1458920,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,50940,PDE11A,https://ctdbase.org/detail.go?type=gene&acc=50940,,,50940.0,PDE11A,10116,Rattus norvegicus (Norway rat),Flusilazole results in decreased expression of PDE11A mRNA,,,PMID:22664269,https://www.ncbi.nlm.nih.gov/pubmed/22664269,22664269,,
1787,1458921,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,5150,PDE7A,https://ctdbase.org/detail.go?type=gene&acc=5150,,,5150.0,PDE7A,7955,Danio rerio (zebrafish),Flusilazole results in increased expression of PDE7A mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
1788,1458922,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,57026,PDXP,https://ctdbase.org/detail.go?type=gene&acc=57026,,,57026.0,PDXP,10090,Mus musculus (house mouse),Flusilazole affects the expression of PDXP mRNA,,,PMID:21195148,https://www.ncbi.nlm.nih.gov/pubmed/21195148,21195148,,
1789,1458923,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,27412,PEG12,https://ctdbase.org/detail.go?type=gene&acc=27412,,,27412.0,Peg12,10090,Mus musculus (house mouse),Flusilazole affects the expression of PEG12 mRNA,,,PMID:22634333,https://www.ncbi.nlm.nih.gov/pubmed/22634333,22634333,,
1790,1459640,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,162494,RHBDL3,https://ctdbase.org/detail.go?type=gene&acc=162494,,,162494.0,RHBDL3,7955,Danio rerio (zebrafish),Flusilazole results in decreased expression of RHBDL3 mrna|flusilazole results in increased expression of RHBDL3 mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
1791,1459641,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,6188,RPS3,https://ctdbase.org/detail.go?type=gene&acc=6188,,,6188.0,RPS3,7955,Danio rerio (zebrafish),Flusilazole affects the expression of RPS3 mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
1792,1459642,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,6236,RRAD,https://ctdbase.org/detail.go?type=gene&acc=6236,,,6236.0,RRAD,7955,Danio rerio (zebrafish),Flusilazole results in decreased expression of RRAD mRNA,,,PMID:22664269,https://www.ncbi.nlm.nih.gov/pubmed/22664269,22664269,,
1793,1459643,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,6241,RRM2,https://ctdbase.org/detail.go?type=gene&acc=6241,,,6241.0,RRM2,7955,Danio rerio (zebrafish),Flusilazole affects the expression of RRM2 mRNA,,,PMID:21621602,https://www.ncbi.nlm.nih.gov/pubmed/21621602,21621602,,
1794,1459644,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,84870,RSPO3,https://ctdbase.org/detail.go?type=gene&acc=84870,,,84870.0,RSPO3,10090,Mus musculus (house mouse),Flusilazole affects the expression of RSPO3 mRNA,,,PMID:22634333,https://www.ncbi.nlm.nih.gov/pubmed/22634333,22634333,,
1795,1459645,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,57035,RSRP1,https://ctdbase.org/detail.go?type=gene&acc=57035,,,57035.0,RSRP1,10090,Mus musculus (house mouse),Flusilazole affects the expression of RSRP1 mRNA,,,PMID:21195148,https://www.ncbi.nlm.nih.gov/pubmed/21195148,21195148,,
1796,1459646,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,30464,RXRGA,https://ctdbase.org/detail.go?type=gene&acc=30464,,,30464.0,rxrga,7955,Danio rerio (zebrafish),Flusilazole results in decreased expression of RXRGA mrna|flusilazole results in increased expression of RXRGA mRNA,,,PMID:22382673,https://www.ncbi.nlm.nih.gov/pubmed/22382673,22382673,,
1797,1459647,73675,Comparative Toxicogenomics Database (CTD),Flusilazole,C061365,flusilazole,https://ctdbase.org/detail.go?type=chem&acc=C061365,6286,S100P,https://ctdbase.org/detail.go?type=gene&acc=6286,,,6286.0,S100P,9606,Homo sapiens (human),Flusilazole results in increased expression of S100P protein|flusilazole results in increased expression of S100P mRNA,,,PMID:32194361,https://www.ncbi.nlm.nih.gov/pubmed/32194361,32194361,,
1798,1452056,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3028,HSD17B10,https://ctdbase.org/detail.go?type=gene&acc=3028,,,3028.0,HSD17B10,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of HSD17B10 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1799,1452057,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,51144,HSD17B12,https://ctdbase.org/detail.go?type=gene&acc=51144,,,51144.0,HSD17B12,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of HSD17B12 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1800,1452058,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3293,HSD17B3,https://ctdbase.org/detail.go?type=gene&acc=3293,,,3293.0,HSD17B3,10116,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of HSD17B3 mRNA",,,PMID:22504055|PMID:35605789,https://www.ncbi.nlm.nih.gov/pubmed/22504055|https://www.ncbi.nlm.nih.gov/pubmed/35605789,22504055|35605789,,
1801,1452059,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3293,HSD17B3,https://ctdbase.org/detail.go?type=gene&acc=3293,,,3293.0,HSD17B3,10116,Rattus norvegicus (Norway rat),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of HSD17B3 protein",,,PMID:35605789,https://www.ncbi.nlm.nih.gov/pubmed/35605789,35605789,,
1802,1452060,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3295,HSD17B4,https://ctdbase.org/detail.go?type=gene&acc=3295,,,3295.0,HSD17B4,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of HSD17B4 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1803,1452061,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3283,HSD3B1,https://ctdbase.org/detail.go?type=gene&acc=3283,,,3283.0,HSD3B1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in decreased activity of HSD3B1 protein",,,PMID:36374910,https://www.ncbi.nlm.nih.gov/pubmed/36374910,36374910,,
1804,1452062,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3283,HSD3B1,https://ctdbase.org/detail.go?type=gene&acc=3283,,,3283.0,HSD3B1,10090,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of HSD3B1 protein|4,4'-hexafluorisopropylidene diphenol results in decreased expression of HSD3B1 mRNA",,,PMID:36098747|PMID:37216864,https://www.ncbi.nlm.nih.gov/pubmed/36098747|https://www.ncbi.nlm.nih.gov/pubmed/37216864,36098747|37216864,,
1805,1452063,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,3283,HSD3B1,https://ctdbase.org/detail.go?type=gene&acc=3283,,,3283.0,HSD3B1,10090,Mus musculus (house mouse),"Fulvestrant inhibits the reaction [4,4'-hexafluorisopropylidene diphenol results in decreased expression of HSD3B1 protein]",,,PMID:36098747,https://www.ncbi.nlm.nih.gov/pubmed/36098747,36098747,,
1806,1456190,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594.0,MAPK1,9606,Homo sapiens (human),"AREG protein affects the reaction [4,4'-hexafluorisopropylidene diphenol results in increased phosphorylation of MAPK1 protein]",,,PMID:31059536,https://www.ncbi.nlm.nih.gov/pubmed/31059536,31059536,,
1807,1456191,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5600,MAPK11,https://ctdbase.org/detail.go?type=gene&acc=5600,,,5600.0,MAPK11,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of MAPK11 mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
1808,1456192,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,30681,MAPK12A,https://ctdbase.org/detail.go?type=gene&acc=30681,,,30681.0,mapk12a,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MAPK12A mRNA",,,PMID:36157705,https://www.ncbi.nlm.nih.gov/pubmed/36157705,36157705,,
1809,1456193,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,7955,Danio rerio (zebrafish),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MAPK3 mRNA",,,PMID:37556959,https://www.ncbi.nlm.nih.gov/pubmed/37556959,37556959,,
1810,1456194,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MAPK3 mRNA",,,PMID:36190352,https://www.ncbi.nlm.nih.gov/pubmed/36190352,36190352,,
1811,1456195,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MAPK3 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1812,1459639,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,58526,MID1IP1,https://ctdbase.org/detail.go?type=gene&acc=58526,,,58526.0,MID1IP1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of MID1IP1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1813,1461697,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,8774,NAPG,https://ctdbase.org/detail.go?type=gene&acc=8774,,,8774.0,NAPG,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NAPG protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1814,1461698,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4677,NARS1,https://ctdbase.org/detail.go?type=gene&acc=4677,,,4677.0,NARS1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NARS1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1815,1463078,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,4929,NR4A2,https://ctdbase.org/detail.go?type=gene&acc=4929,,,4929.0,NR4A2,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of NR4A2 mRNA",,,PMID:33885253,https://www.ncbi.nlm.nih.gov/pubmed/33885253,33885253,,
1816,1464326,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,59342,SCPEP1,https://ctdbase.org/detail.go?type=gene&acc=59342,,,59342.0,SCPEP1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SCPEP1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1817,1464327,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,11341,SCRG1,https://ctdbase.org/detail.go?type=gene&acc=11341,,,11341.0,SCRG1,10090,Mus musculus (house mouse),"4,4'-hexafluorisopropylidene diphenol results in decreased expression of SCRG1 mRNA",,,PMID:34850234,https://www.ncbi.nlm.nih.gov/pubmed/34850234,34850234,,
1818,1464328,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,9805,SCRN1,https://ctdbase.org/detail.go?type=gene&acc=9805,,,9805.0,SCRN1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SCRN1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1819,1464329,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,90507,SCRN2,https://ctdbase.org/detail.go?type=gene&acc=90507,,,90507.0,SCRN2,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SCRN2 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1820,1464330,73864,Comparative Toxicogenomics Database (CTD),Bisphenol AF,C583074,"4,4'-hexafluorisopropylidene diphenol",https://ctdbase.org/detail.go?type=chem&acc=C583074,57410,SCYL1,https://ctdbase.org/detail.go?type=gene&acc=57410,,,57410.0,SCYL1,9606,Homo sapiens (human),"4,4'-hexafluorisopropylidene diphenol results in increased expression of SCYL1 protein",,,PMID:34186270,https://www.ncbi.nlm.nih.gov/pubmed/34186270,34186270,,
1821,1447288,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5310,PKD1,https://ctdbase.org/detail.go?type=gene&acc=5310,,,5310.0,PKD1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PKD1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1822,1447289,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5311,PKD2,https://ctdbase.org/detail.go?type=gene&acc=5311,,,5311.0,PKD2,8049,Gadus morhua (Atlantic cod),"[hydrocarbons, chlorinated co-treated with pentabromodiphenyl ether co-treated with perfluorooctane sulfonic acid] results in increased expression of PKD2 mrna|perfluorooctane sulfonic acid results in increased expression of PKD2 mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1823,1447290,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5311,PKD2,https://ctdbase.org/detail.go?type=gene&acc=5311,,,5311.0,PKD2,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of PKD2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1824,1447291,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,27039,PKD2L2,https://ctdbase.org/detail.go?type=gene&acc=27039,,,27039.0,PKD2L2,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of PKD2L2 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1825,1447292,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5313,PKLR,https://ctdbase.org/detail.go?type=gene&acc=5313,,,5313.0,PKLR,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of PKLR mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
1826,1447293,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5313,PKLR,https://ctdbase.org/detail.go?type=gene&acc=5313,,,5313.0,PKLR,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of PKLR mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
1827,1451137,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5496,PPM1G,https://ctdbase.org/detail.go?type=gene&acc=5496,,,5496.0,PPM1G,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of PPM1G mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1828,1451138,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,57460,PPM1H,https://ctdbase.org/detail.go?type=gene&acc=57460,,,57460.0,PPM1H,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of PPM1H mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1829,1451139,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,152926,PPM1K,https://ctdbase.org/detail.go?type=gene&acc=152926,,,152926.0,PPM1K,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PPM1K mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1830,1451140,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,503713,PPM1KB,https://ctdbase.org/detail.go?type=gene&acc=503713,,,503713.0,ppm1kb,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of PPM1KB mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1831,1451141,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,151742,PPM1L,https://ctdbase.org/detail.go?type=gene&acc=151742,,,151742.0,PPM1L,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PPM1L mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1832,1451142,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,556994,PPM1LA,https://ctdbase.org/detail.go?type=gene&acc=556994,,,556994.0,ppm1la,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of PPM1LA mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1833,1452064,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401.0,CRP,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of CRP mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
1834,1452065,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1401,CRP,https://ctdbase.org/detail.go?type=gene&acc=1401,,,1401.0,CRP,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of CRP mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CRP mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1835,1456186,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,13099,CYP2C40,https://ctdbase.org/detail.go?type=gene&acc=13099,,,13099.0,Cyp2c40,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of CYP2C40 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of CYP2C40 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1836,1456187,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,107141,CYP2C50,https://ctdbase.org/detail.go?type=gene&acc=107141,,,107141.0,Cyp2c50,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of CYP2C50 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
1837,1456188,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,2944,GSTM1,https://ctdbase.org/detail.go?type=gene&acc=2944,,,2944.0,GSTM1,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of GSTM1 mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
1838,1456189,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,107141,CYP2C50,https://ctdbase.org/detail.go?type=gene&acc=107141,,,107141.0,Cyp2c50,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in increased expression of CYP2C50 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in increased expression of CYP2C50 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in increased expression of CYP2C50 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1839,1458567,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5789,PTPRD,https://ctdbase.org/detail.go?type=gene&acc=5789,,,5789.0,PTPRD,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of PTPRD mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
1840,1458568,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5789,PTPRD,https://ctdbase.org/detail.go?type=gene&acc=5789,,,5789.0,PTPRD,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PTPRD mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1841,1458569,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5791,PTPRE,https://ctdbase.org/detail.go?type=gene&acc=5791,,,5791.0,PTPRE,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of PTPRE mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1842,1458570,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5792,PTPRF,https://ctdbase.org/detail.go?type=gene&acc=5792,,,5792.0,PTPRF,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of PTPRF mrna|perfluorooctane sulfonic acid results in increased expression of PTPRF mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1843,1458571,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5792,PTPRF,https://ctdbase.org/detail.go?type=gene&acc=5792,,,5792.0,PTPRF,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid affects the expression of PTPRF mRNA,,,PMID:19429403,https://www.ncbi.nlm.nih.gov/pubmed/19429403,19429403,,
1844,1458572,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5792,PTPRF,https://ctdbase.org/detail.go?type=gene&acc=5792,,,5792.0,PTPRF,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of PTPRF mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1845,1460052,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84267,QNG1,https://ctdbase.org/detail.go?type=gene&acc=84267,,,84267.0,QNG1,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in increased expression of QNG1 mRNA,,,PMID:25812627,https://www.ncbi.nlm.nih.gov/pubmed/25812627,25812627,,
1846,1460053,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,5768,QSOX1,https://ctdbase.org/detail.go?type=gene&acc=5768,,,5768.0,QSOX1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of QSOX1 mrna|[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of QSOX1 mrna|[perfluorooctane sulfonic acid co-treated with pectins] results in decreased expression of QSOX1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1847,1461255,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8694,DGAT1,https://ctdbase.org/detail.go?type=gene&acc=8694,,,8694.0,DGAT1,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in increased expression of DGAT1 mRNA,,,PMID:21705711,https://www.ncbi.nlm.nih.gov/pubmed/21705711,21705711,,
1848,1461256,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,325875,DGAT1A,https://ctdbase.org/detail.go?type=gene&acc=325875,,,325875.0,dgat1a,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of DGAT1A mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1849,1461257,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,436731,DGAT1B,https://ctdbase.org/detail.go?type=gene&acc=436731,,,436731.0,dgat1b,7955,Danio rerio (zebrafish),Perfluorooctane sulfonic acid results in decreased expression of DGAT1B mRNA,,,PMID:27193966,https://www.ncbi.nlm.nih.gov/pubmed/27193966,27193966,,
1850,1461258,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,436731,DGAT1B,https://ctdbase.org/detail.go?type=gene&acc=436731,,,436731.0,dgat1b,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of DGAT1B mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1851,1461259,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84649,DGAT2,https://ctdbase.org/detail.go?type=gene&acc=84649,,,84649.0,DGAT2,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of DGAT2 mRNA,,,PMID:32588087,https://www.ncbi.nlm.nih.gov/pubmed/32588087,32588087,,
1852,1461260,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84649,DGAT2,https://ctdbase.org/detail.go?type=gene&acc=84649,,,84649.0,DGAT2,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of DGAT2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1853,1461261,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,84649,DGAT2,https://ctdbase.org/detail.go?type=gene&acc=84649,,,84649.0,DGAT2,10090,Mus musculus (house mouse),Perfluorooctane sulfonic acid results in decreased expression of DGAT2 mRNA,,,PMID:21705711,https://www.ncbi.nlm.nih.gov/pubmed/21705711,21705711,,
1854,1461262,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,8214,DGCR6,https://ctdbase.org/detail.go?type=gene&acc=8214,,,8214.0,DGCR6,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in increased expression of DGCR6 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1855,1461263,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,54487,DGCR8,https://ctdbase.org/detail.go?type=gene&acc=54487,,,54487.0,DGCR8,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with cellulose] results in decreased expression of DGCR8 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1856,1461988,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,57148,RALGAPB,https://ctdbase.org/detail.go?type=gene&acc=57148,,,57148.0,RALGAPB,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in decreased expression of RALGAPB mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1857,1461989,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,57148,RALGAPB,https://ctdbase.org/detail.go?type=gene&acc=57148,,,57148.0,RALGAPB,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of RALGAPB mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1858,1461990,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,55103,RALGPS2,https://ctdbase.org/detail.go?type=gene&acc=55103,,,55103.0,RALGPS2,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of RALGPS2 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1859,1461991,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10267,RAMP1,https://ctdbase.org/detail.go?type=gene&acc=10267,,,10267.0,RAMP1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of RAMP1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1860,1461992,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,10268,RAMP3,https://ctdbase.org/detail.go?type=gene&acc=10268,,,10268.0,RAMP3,8049,Gadus morhua (Atlantic cod),[perfluorooctane sulfonic acid co-treated with perfluorooctanoic acid co-treated with perfluoro-n-nonanoic acid] results in increased expression of RAMP3 mRNA,,,PMID:33138996,https://www.ncbi.nlm.nih.gov/pubmed/33138996,33138996,,
1861,1462796,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1739,DLG1,https://ctdbase.org/detail.go?type=gene&acc=1739,,,1739.0,DLG1,9606,Homo sapiens (human),Perfluorooctane sulfonic acid results in decreased expression of DLG1 mRNA,,,PMID:27153767,https://www.ncbi.nlm.nih.gov/pubmed/27153767,27153767,,
1862,1462797,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1739,DLG1,https://ctdbase.org/detail.go?type=gene&acc=1739,,,1739.0,DLG1,10090,Mus musculus (house mouse),[perfluorooctane sulfonic acid co-treated with inulin] results in decreased expression of DLG1 mRNA,,,PMID:36331819,https://www.ncbi.nlm.nih.gov/pubmed/36331819,36331819,,
1863,1462798,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,497648,DLG1B,https://ctdbase.org/detail.go?type=gene&acc=497648,,,497648.0,dlg1b,8049,Gadus morhua (Atlantic cod),"[hydrocarbons, chlorinated co-treated with pentabromodiphenyl ether co-treated with perfluorooctane sulfonic acid] results in decreased expression of DLG1B mrna|perfluorooctane sulfonic acid results in decreased expression of DLG1B mRNA",,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1864,1462799,74483,Comparative Toxicogenomics Database (CTD),Perfluorooctanesulfonic acid,C076994,perfluorooctane sulfonic acid,https://ctdbase.org/detail.go?type=chem&acc=C076994,1740,DLG2,https://ctdbase.org/detail.go?type=gene&acc=1740,,,1740.0,DLG2,8049,Gadus morhua (Atlantic cod),Perfluorooctane sulfonic acid results in decreased expression of DLG2 mRNA,,,PMID:37528559,https://www.ncbi.nlm.nih.gov/pubmed/37528559,37528559,,
1865,1448338,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,2115,ETV1,https://ctdbase.org/detail.go?type=gene&acc=2115,,,2115.0,ETV1,9606,Homo sapiens (human),Thifluzamide results in decreased expression of ETV1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1866,1448339,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,54512,EXOSC4,https://ctdbase.org/detail.go?type=gene&acc=54512,,,54512.0,EXOSC4,9606,Homo sapiens (human),Thifluzamide results in decreased expression of EXOSC4 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1867,1448340,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,11340,EXOSC8,https://ctdbase.org/detail.go?type=gene&acc=11340,,,11340.0,EXOSC8,9606,Homo sapiens (human),Thifluzamide results in increased expression of EXOSC8 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1868,1448759,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,8352,H3C3,https://ctdbase.org/detail.go?type=gene&acc=8352,,,8352.0,H3C3,9606,Homo sapiens (human),Thifluzamide results in increased expression of H3C3 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1869,1448760,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,8351,H3C4,https://ctdbase.org/detail.go?type=gene&acc=8351,,,8351.0,H3C4,9606,Homo sapiens (human),Thifluzamide results in increased expression of H3C4 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1870,1448761,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,9709,HERPUD1,https://ctdbase.org/detail.go?type=gene&acc=9709,,,9709.0,HERPUD1,9606,Homo sapiens (human),Thifluzamide results in increased expression of HERPUD1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1871,1448762,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,388585,HES5,https://ctdbase.org/detail.go?type=gene&acc=388585,,,388585.0,HES5,9606,Homo sapiens (human),Thifluzamide results in decreased expression of HES5 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1872,1448763,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,3087,HHEX,https://ctdbase.org/detail.go?type=gene&acc=3087,,,3087.0,HHEX,7955,Danio rerio (zebrafish),Thifluzamide results in increased expression of HHEX mRNA,,,PMID:34635929,https://www.ncbi.nlm.nih.gov/pubmed/34635929,34635929,,
1873,1448764,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,64399,HHIP,https://ctdbase.org/detail.go?type=gene&acc=64399,,,64399.0,HHIP,9606,Homo sapiens (human),Thifluzamide results in increased expression of HHIP mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1874,1449403,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,8974,P4HA2,https://ctdbase.org/detail.go?type=gene&acc=8974,,,8974.0,P4HA2,9606,Homo sapiens (human),Thifluzamide results in increased expression of P4HA2 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1875,1449404,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,7849,PAX8,https://ctdbase.org/detail.go?type=gene&acc=7849,,,7849.0,PAX8,7955,Danio rerio (zebrafish),Thifluzamide results in increased expression of PAX8 mRNA,,,PMID:34635929,https://www.ncbi.nlm.nih.gov/pubmed/34635929,34635929,,
1876,1449405,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,5100,PCDH8,https://ctdbase.org/detail.go?type=gene&acc=5100,,,5100.0,PCDH8,9606,Homo sapiens (human),Thifluzamide results in increased expression of PCDH8 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1877,1449406,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,5155,PDGFB,https://ctdbase.org/detail.go?type=gene&acc=5155,,,5155.0,PDGFB,9606,Homo sapiens (human),Thifluzamide results in decreased expression of PDGFB mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1878,1449407,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,5037,PEBP1,https://ctdbase.org/detail.go?type=gene&acc=5037,,,5037.0,PEBP1,9606,Homo sapiens (human),Thifluzamide results in decreased expression of PEBP1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1879,1449408,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,23089,PEG10,https://ctdbase.org/detail.go?type=gene&acc=23089,,,23089.0,PEG10,9606,Homo sapiens (human),Thifluzamide results in decreased expression of PEG10 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1880,1449409,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,5222,PGA5,https://ctdbase.org/detail.go?type=gene&acc=5222,,,5222.0,PGA5,9606,Homo sapiens (human),Thifluzamide results in increased expression of PGA5 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1881,1449410,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,26227,PHGDH,https://ctdbase.org/detail.go?type=gene&acc=26227,,,26227.0,PHGDH,9606,Homo sapiens (human),Thifluzamide results in increased expression of PHGDH mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1882,1449411,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,22822,PHLDA1,https://ctdbase.org/detail.go?type=gene&acc=22822,,,22822.0,PHLDA1,9606,Homo sapiens (human),Thifluzamide results in decreased expression of PHLDA1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1883,1449412,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,65018,PINK1,https://ctdbase.org/detail.go?type=gene&acc=65018,,,65018.0,PINK1,9606,Homo sapiens (human),Thifluzamide results in decreased expression of PINK1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1884,1453734,92391,Toxin and Toxin Target Database (T3DB),"2,2',3,4',5,6'-Hexachlorobiphenyl",T3D0537,"2,2',3,4',5,6'-Hexachlorobiphenyl",http://www.t3db.ca/toxins/T3D0537,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606,Homo sapiens (human),"Dioxin-like pcbs bind to the aryl hydrocarbon receptor, which disrupts cell function by altering the transcription of genes, mainly be inducing the expression of hepatic phase I and phase II enzymes, especially of the cytochrome P450 family. (A4)",,,PMID:2992927,https://www.ncbi.nlm.nih.gov/pubmed/2992927,2992927,,
1885,1453735,92391,Toxin and Toxin Target Database (T3DB),"2,2',3,4',5,6'-Hexachlorobiphenyl",T3D0537,"2,2',3,4',5,6'-Hexachlorobiphenyl",http://www.t3db.ca/toxins/T3D0537,BE0000614,Tyrosine 3-monooxygenase,http://www.t3db.ca/biodb/bio_entities/BE0000614,P07101,Tyrosine 3-monooxygenase,7054.0,TH,9606,Homo sapiens (human),PCB inhibition of tyrosine 3-monooxygenase is believed to cause decreased dopamine synthesis. (L4),,,,,,,
1886,1453736,92391,Toxin and Toxin Target Database (T3DB),"2,2',3,4',5,6'-Hexachlorobiphenyl",T3D0537,"2,2',3,4',5,6'-Hexachlorobiphenyl",http://www.t3db.ca/toxins/T3D0537,BE0004289,Uteroglobin,http://www.t3db.ca/biodb/bio_entities/BE0004289,P11684,Uteroglobin,7356.0,SCGB1A1,9606,Homo sapiens (human),Pcbs will bioaccumulate by binding to receptor proteins such as uteroglobin. (A30),,,PMID:11205532,https://www.ncbi.nlm.nih.gov/pubmed/11205532,11205532,,
1887,1453737,92392,Toxin and Toxin Target Database (T3DB),"2,2',3,4,4',6,6'-Heptachlorobiphenyl",T3D0573,"2,2',3,4,4',6,6'-Heptachlorobiphenyl",http://www.t3db.ca/toxins/T3D0573,BE0000123,Estrogen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000123,P03372,Estrogen receptor,2099.0,ESR1,9606,Homo sapiens (human),Causes endocrine disruption in humans by binding to and inhibiting the estrogen receptor. (A590),,,PMID:16531984,https://www.ncbi.nlm.nih.gov/pubmed/16531984,16531984,,
1888,1443189,92997,BindingDB,3b-Hydroxy-5-cholenoic acid,20190,"(4R)-4-[(1S,2R,5S,10S,11S,14R,15R)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-yl]pentanoic acid",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20190,877,Oxysterols receptor LXR-alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=877,Q13133,Oxysterols receptor LXR-alpha,10062.0,NR1H3,9606,Homo sapiens (human),,,,PMID:11300870|DOI:10.1021/jm0004749,https://www.ncbi.nlm.nih.gov/pubmed/11300870|https://doi.org/10.1021/jm0004749,11300870,10.1021/jm0004749,
1889,1454334,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,7097,TLR2,https://ctdbase.org/detail.go?type=gene&acc=7097,,,7097.0,TLR2,10090,Mus musculus (house mouse),Peptidoglycan results in increased expression of TLR2 mrna|peptidoglycan binds to and results in increased activity of TLR2 protein|peptidoglycan results in increased expression of TLR2 protein|tlr2 protein affects the susceptibility to peptidoglycan,,,PMID:15593098,https://www.ncbi.nlm.nih.gov/pubmed/15593098,15593098,,
1890,1454335,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,7097,TLR2,https://ctdbase.org/detail.go?type=gene&acc=7097,,,7097.0,TLR2,10090,Mus musculus (house mouse),TLR2 protein promotes the reaction [peptidoglycan results in increased metabolism of eicosanoids],,,PMID:17369491,https://www.ncbi.nlm.nih.gov/pubmed/17369491,17369491,,
1891,1454336,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Peptidoglycan results in increased expression of TNF mRNA,,,PMID:15860229|PMID:15893496,https://www.ncbi.nlm.nih.gov/pubmed/15860229|https://www.ncbi.nlm.nih.gov/pubmed/15893496,15860229|15893496,,
1892,1454337,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),Peptidoglycan results in increased expression of TNF protein,,,PMID:11169223,https://www.ncbi.nlm.nih.gov/pubmed/11169223,11169223,,
1893,1454338,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Cannabidiol analog inhibits the reaction [peptidoglycan results in increased expression of TNF protein]|peptidoglycan results in increased expression of TNF protein,,,PMID:30796934,https://www.ncbi.nlm.nih.gov/pubmed/30796934,30796934,,
1894,1454339,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10116,Rattus norvegicus (Norway rat),Oxygen promotes the reaction [[peptidoglycan co-treated with polysaccharides] results in increased expression of TNF protein]|[peptidoglycan co-treated with polysaccharides] results in increased expression of TNF protein|ozone inhibits the reaction [[peptidoglycan co-treated with polysaccharides] results in increased expression of TNF protein]|[ozone co-treated with peptidoglycan co-treated with polysaccharides] results in decreased expression of TNF mRNA,,,PMID:23911887,https://www.ncbi.nlm.nih.gov/pubmed/23911887,23911887,,
1895,1454340,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,7130,TNFAIP6,https://ctdbase.org/detail.go?type=gene&acc=7130,,,7130.0,TNFAIP6,9606,Homo sapiens (human),Peptidoglycan results in increased expression of TNFAIP6 mRNA,,,PMID:15860229,https://www.ncbi.nlm.nih.gov/pubmed/15860229,15860229,,
1896,1454341,93035,Comparative Toxicogenomics Database (CTD),"2,3-Epoxypropyl nitrate",D010457,Peptidoglycan,https://ctdbase.org/detail.go?type=chem&acc=D010457,25828,TXN2,https://ctdbase.org/detail.go?type=gene&acc=25828,,,25828.0,TXN2,9606,Homo sapiens (human),[lipopolysaccharides co-treated with peptidoglycan] results in increased expression of TXN2 protein|thiomalates promotes the reaction [[lipopolysaccharides co-treated with peptidoglycan] results in increased expression of TXN2 protein],,,PMID:21355852,https://www.ncbi.nlm.nih.gov/pubmed/21355852,21355852,,
1897,1443190,93365,Comparative Toxicogenomics Database (CTD),Fenpropimorph,C050435,fenpropimorph,https://ctdbase.org/detail.go?type=chem&acc=C050435,8854,ALDH1A2,https://ctdbase.org/detail.go?type=gene&acc=8854,,,8854.0,ALDH1A2,10090,Mus musculus (house mouse),Fenpropimorph results in increased expression of ALDH1A2 mRNA,,,PMID:34737147,https://www.ncbi.nlm.nih.gov/pubmed/34737147,34737147,,
1898,1443191,93365,Comparative Toxicogenomics Database (CTD),Fenpropimorph,C050435,fenpropimorph,https://ctdbase.org/detail.go?type=chem&acc=C050435,1592,CYP26A1,https://ctdbase.org/detail.go?type=gene&acc=1592,,,1592.0,CYP26A1,10090,Mus musculus (house mouse),Fenpropimorph results in increased expression of CYP26A1 mRNA,,,PMID:34737147,https://www.ncbi.nlm.nih.gov/pubmed/34737147,34737147,,
1899,1443192,93365,Comparative Toxicogenomics Database (CTD),Fenpropimorph,C050435,fenpropimorph,https://ctdbase.org/detail.go?type=chem&acc=C050435,13121,CYP51,https://ctdbase.org/detail.go?type=gene&acc=13121,,,13121.0,Cyp51,10090,Mus musculus (house mouse),Fenpropimorph results in increased expression of CYP51 mRNA,,,PMID:34737147,https://www.ncbi.nlm.nih.gov/pubmed/34737147,34737147,,
1900,1443193,93365,Comparative Toxicogenomics Database (CTD),Fenpropimorph,C050435,fenpropimorph,https://ctdbase.org/detail.go?type=chem&acc=C050435,793907,IGFBP1B,https://ctdbase.org/detail.go?type=gene&acc=793907,,,793907.0,igfbp1b,7955,Danio rerio (zebrafish),Fenpropimorph results in increased expression of IGFBP1B mRNA,,,PMID:32553615,https://www.ncbi.nlm.nih.gov/pubmed/32553615,32553615,,
1901,1456482,93505,Therapeutic Target Database (TTD),6-Amino-2-benzothiazolesulfonamide,D0O1QT,6-Amino-benzothiazole-2-sulfonic acid amide,https://idrblab.net/ttd/data/drug/details/D0O1QT,T20401,Carbonic anhydrase II (CA-II),https://idrblab.net/ttd/data/target/details/T20401,P00918,Carbonic anhydrase 2,760.0,CA2,9606,Homo sapiens (human),Inhibitor,,,,,,,
1902,1456483,93505,Therapeutic Target Database (TTD),6-Amino-2-benzothiazolesulfonamide,D0O1QT,6-Amino-benzothiazole-2-sulfonic acid amide,https://idrblab.net/ttd/data/drug/details/D0O1QT,T13201,Carbonic anhydrase I (CA-I),https://idrblab.net/ttd/data/target/details/T13201,P00915,Carbonic anhydrase 1,759.0,CA1,9606,Homo sapiens (human),Inhibitor,,,,,,,
1903,1456484,93558,Therapeutic Target Database (TTD),"Purine, 6-(benzylthio)-",D0BH7S,6-Benzylsulfanyl-9H-purine,https://idrblab.net/ttd/data/drug/details/D0BH7S,T52316,Raf messenger RNA (Raf mRNA),https://idrblab.net/ttd/data/target/details/T52316,P04049,RAF proto-oncogene serine/threonine-protein kinase,5894.0,RAF1,9606,Homo sapiens (human),Inhibitor,,,,,,,
1904,1456485,93558,Therapeutic Target Database (TTD),"Purine, 6-(benzylthio)-",D0BH7S,6-Benzylsulfanyl-9H-purine,https://idrblab.net/ttd/data/drug/details/D0BH7S,T65864,Stress-activated protein kinase 2a (p38 alpha),https://idrblab.net/ttd/data/target/details/T65864,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606,Homo sapiens (human),Inhibitor,,,,,,,
1905,1456486,94996,BindingDB,"1,3-Bis(4-chlorophenyl)urea",25728,"1,3-bis(4-chlorophenyl)urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25728,2887,Epoxide hydrolase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2887,P95276,Epoxide hydrolase B,,,83331,Mycobacterium tuberculosis CDC1551,,IC50 (nM),170,PMID:18585390|DOI:10.1016/j.jmb.2008.06.030,https://www.ncbi.nlm.nih.gov/pubmed/18585390|https://doi.org/10.1016/j.jmb.2008.06.030,18585390,10.1016/j.jmb.2008.06.030,
1906,1456487,95065,Therapeutic Target Database (TTD),"Purine, 6-(phenylthio)-",D04CRB,6-Phenylsulfanyl-9H-purine,https://idrblab.net/ttd/data/drug/details/D04CRB,T65864,Stress-activated protein kinase 2a (p38 alpha),https://idrblab.net/ttd/data/target/details/T65864,Q16539,Mitogen-activated protein kinase 14,1432.0,MAPK14,9606,Homo sapiens (human),Inhibitor,,,,,,,
1907,1456488,95783,BindingDB,"1,3-Bis(3,4-dichlorophenyl)urea",25729,"1,3-bis(3,4-dichlorophenyl)urea",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=25729,2887,Epoxide hydrolase B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2887,P95276,Epoxide hydrolase B,,,83331,Mycobacterium tuberculosis CDC1551,,IC50 (nM),480,PMID:18585390|DOI:10.1016/j.jmb.2008.06.030,https://www.ncbi.nlm.nih.gov/pubmed/18585390|https://doi.org/10.1016/j.jmb.2008.06.030,18585390,10.1016/j.jmb.2008.06.030,
1908,1456489,96430,Therapeutic Target Database (TTD),"4,4'-Dibromobenzil",D06FFD,"1,2-Bis-(4-bromo-phenyl)-ethane-1,2-dione",https://idrblab.net/ttd/data/drug/details/D06FFD,T76369,Liver carboxylesterase (CES1),https://idrblab.net/ttd/data/target/details/T76369,P23141,Liver carboxylesterase 1,1066.0,CES1,9606,Homo sapiens (human),Inhibitor,,,,,,,
1909,1456490,96851,BindingDB,8-Aminoadenosine,32370,"adenosine-derived inhibitor (Grp78), 2",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=32370,49001168,Endoplasmic reticulum chaperone BiP,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=49001168,P11021,Endoplasmic reticulum chaperone BiP,3309.0,HSPA5,9606,Homo sapiens (human),,koff (s-1),>1,PMID:21526763|DOI:10.1021/jm101625x,https://www.ncbi.nlm.nih.gov/pubmed/21526763|https://doi.org/10.1021/jm101625x,21526763,10.1021/jm101625x,
1910,1450190,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6143,RPL19,https://ctdbase.org/detail.go?type=gene&acc=6143,,,6143.0,RPL19,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPL19 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1911,1450191,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,218997,RPL19-PS3,https://ctdbase.org/detail.go?type=gene&acc=218997,,,218997.0,Rpl19-ps3,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of RPL19-PS3 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1912,1450192,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,9349,RPL23,https://ctdbase.org/detail.go?type=gene&acc=9349,,,9349.0,RPL23,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPL23 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1913,1450193,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6147,RPL23A,https://ctdbase.org/detail.go?type=gene&acc=6147,,,6147.0,RPL23A,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPL23A mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1914,1450194,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6152,RPL24,https://ctdbase.org/detail.go?type=gene&acc=6152,,,6152.0,RPL24,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPL24 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1915,1450195,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,628726,RPL26-PS6,https://ctdbase.org/detail.go?type=gene&acc=628726,,,628726.0,Rpl26-ps6,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in increased expression of RPL26-PS6 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1916,1450196,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6159,RPL29,https://ctdbase.org/detail.go?type=gene&acc=6159,,,6159.0,RPL29,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPL29 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1917,1450426,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6210,RPS15A,https://ctdbase.org/detail.go?type=gene&acc=6210,,,6210.0,RPS15A,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPS15A mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1918,1450427,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,664903,RPS15A-PS4,https://ctdbase.org/detail.go?type=gene&acc=664903,,,664903.0,Rps15a-ps4,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of RPS15A-PS4 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1919,1450428,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6218,RPS17,https://ctdbase.org/detail.go?type=gene&acc=6218,,,6218.0,RPS17,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of RPS17 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
1920,1451143,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10090,Mus musculus (house mouse),Glucose results in increased expression of RUNX2 mRNA,,,PMID:17178593,https://www.ncbi.nlm.nih.gov/pubmed/17178593,17178593,,
1921,1451144,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,860,RUNX2,https://ctdbase.org/detail.go?type=gene&acc=860,,,860.0,RUNX2,10116,Rattus norvegicus (Norway rat),Morroniside inhibits the reaction [glucose results in decreased expression of RUNX2 protein]|glucose results in decreased expression of RUNX2 protein|glucose results in decreased expression of RUNX2 mrna|morroniside inhibits the reaction [glucose results in decreased expression of RUNX2 mrna],,,PMID:32643284,https://www.ncbi.nlm.nih.gov/pubmed/32643284,32643284,,
1922,1451145,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,864,RUNX3,https://ctdbase.org/detail.go?type=gene&acc=864,,,864.0,RUNX3,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in increased expression of RUNX3 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
1923,1451146,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6256,RXRA,https://ctdbase.org/detail.go?type=gene&acc=6256,,,6256.0,RXRA,40674,Mammalia (mammals),Pyrazinamide inhibits the reaction [glucose promotes the reaction [clofibrate results in increased activity of [PPARA protein binds to RXRA protein]]]|tolmetin inhibits the reaction [glucose promotes the reaction [clofibrate results in increased activity of [PPARA protein binds to RXRA protein]]]|glucose promotes the reaction [clofibrate results in increased activity of [PPARA protein binds to RXRA protein]]|gedunin inhibits the reaction [glucose promotes the reaction [clofibrate results in increased activity of [PPARA protein binds to RXRA protein]]]|budesonide inhibits the reaction [glucose promotes the reaction [clofibrate results in increased activity of [PPARA protein binds to RXRA protein]]]|glucose results in increased activity of [PPARA protein binds to RXRA protein],,,PMID:18812576,https://www.ncbi.nlm.nih.gov/pubmed/18812576,18812576,,
1924,1455377,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,9606,Homo sapiens (human),Glucose results in increased expression of SLC2A1 mRNA,,,PMID:15864539,https://www.ncbi.nlm.nih.gov/pubmed/15864539,15864539,,
1925,1455378,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,9606,Homo sapiens (human),SLC2A1 protein results in increased uptake of glucose|resveratrol inhibits the reaction [SLC2A1 protein results in increased uptake of glucose],,,PMID:23615963,https://www.ncbi.nlm.nih.gov/pubmed/23615963,23615963,,
1926,1455379,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,9606,Homo sapiens (human),SLC2A1 protein results in increased transport of glucose,,,PMID:18455367|PMID:8457197,https://www.ncbi.nlm.nih.gov/pubmed/18455367|https://www.ncbi.nlm.nih.gov/pubmed/8457197,18455367|8457197,,
1927,1455380,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,10090,Mus musculus (house mouse),[cinnamyl alcohol co-treated with glucose deficiency] results in decreased activity of SLC2A1 protein|cysteine inhibits the reaction [[cinnamaldehyde co-treated with glucose deficiency] results in decreased activity of SLC2A1 protein]|[cinnamaldehyde co-treated with glucose deficiency] results in decreased activity of SLC2A1 protein|mercaptoethanol inhibits the reaction [[cinnamaldehyde co-treated with glucose deficiency] results in decreased activity of SLC2A1 protein]|[propionaldehyde co-treated with glucose deficiency] results in decreased activity of SLC2A1 protein|[3-phenylpropanol-1 co-treated with glucose deficiency] results in decreased activity of SLC2A1 protein|[benzaldehyde co-treated with glucose deficiency] results in decreased activity of SLC2A1 protein|[2-butenal co-treated with glucose deficiency] results in decreased activity of SLC2A1 protein,,,PMID:20955755,https://www.ncbi.nlm.nih.gov/pubmed/20955755,20955755,,
1928,1455381,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,10090,Mus musculus (house mouse),[bromopyruvate results in decreased expression of SLC2A1 protein] which results in decreased uptake of glucose,,,PMID:28433571,https://www.ncbi.nlm.nih.gov/pubmed/28433571,28433571,,
1929,1455382,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6513,SLC2A1,https://ctdbase.org/detail.go?type=gene&acc=6513,,,6513.0,SLC2A1,10090,Mus musculus (house mouse),Oxophenylarsine inhibits the reaction [glucose deficiency results in increased activity of SLC2A1 protein]|glucose deficiency results in increased activity of SLC2A1 protein,,,PMID:19686715,https://www.ncbi.nlm.nih.gov/pubmed/19686715,19686715,,
1930,1457858,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6616,SNAP25,https://ctdbase.org/detail.go?type=gene&acc=6616,,,6616.0,SNAP25,10116,Rattus norvegicus (Norway rat),Glucose results in decreased expression of SNAP25 protein,,,PMID:23776493,https://www.ncbi.nlm.nih.gov/pubmed/23776493,23776493,,
1931,1457859,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,6622,SNCA,https://ctdbase.org/detail.go?type=gene&acc=6622,,,6622.0,SNCA,6239,Caenorhabditis elegans,[glucose co-treated with monocrotophos] results in increased expression of SNCA protein,,,PMID:29763691,https://www.ncbi.nlm.nih.gov/pubmed/29763691,29763691,,
1932,1458206,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843.0,NOS2,9606,Homo sapiens (human),[epigallocatechin gallate co-treated with gallocatechol co-treated with epicatechin gallate co-treated with catechin analog] inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of NOS2 protein],,,PMID:26187476,https://www.ncbi.nlm.nih.gov/pubmed/26187476,26187476,,
1933,1458207,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),BMAL1 protein affects the reaction [[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] results in increased expression of NQO1 protein]|[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] results in increased expression of NQO1 protein,,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
1934,1458208,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,8431,NR0B2,https://ctdbase.org/detail.go?type=gene&acc=8431,,,8431.0,NR0B2,9606,Homo sapiens (human),Epicatechin gallate results in increased expression of NR0B2 mRNA,,,PMID:22178739,https://www.ncbi.nlm.nih.gov/pubmed/22178739,22178739,,
1935,1458209,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,9971,NR1H4,https://ctdbase.org/detail.go?type=gene&acc=9971,,,9971.0,NR1H4,9606,Homo sapiens (human),[epicatechin gallate co-treated with gallocatechol] results in increased activity of NR1H4 protein|epicatechin gallate results in increased activity of NR1H4 protein,,,PMID:22178739,https://www.ncbi.nlm.nih.gov/pubmed/22178739,22178739,,
1936,1458210,107905,Comparative Toxicogenomics Database (CTD),(-)-Epicatechin gallate,C062669,epicatechin gallate,https://ctdbase.org/detail.go?type=chem&acc=C062669,5187,PER1,https://ctdbase.org/detail.go?type=gene&acc=5187,,,5187.0,PER1,9606,Homo sapiens (human),[gallic acid co-treated with gallocatechol co-treated with epigallocatechin gallate co-treated with epicatechin gallate] affects the reaction [hydrogen peroxide affects the expression of PER1 mrna],,,PMID:29061316,https://www.ncbi.nlm.nih.gov/pubmed/29061316,29061316,,
1937,1454342,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,22901,ARSG,https://ctdbase.org/detail.go?type=gene&acc=22901,,,22901.0,ARSG,9606,Homo sapiens (human),Deguelin results in increased expression of ARSG mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1938,1454343,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,10973,ASCC3,https://ctdbase.org/detail.go?type=gene&acc=10973,,,10973.0,ASCC3,9606,Homo sapiens (human),Deguelin results in increased expression of ASCC3 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1939,1459272,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,2887,GRB10,https://ctdbase.org/detail.go?type=gene&acc=2887,,,2887.0,GRB10,9606,Homo sapiens (human),Deguelin results in increased expression of GRB10 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1940,1459273,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,2888,GRB14,https://ctdbase.org/detail.go?type=gene&acc=2888,,,2888.0,GRB14,9606,Homo sapiens (human),Deguelin results in increased expression of GRB14 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1941,1459274,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,2891,GRIA2,https://ctdbase.org/detail.go?type=gene&acc=2891,,,2891.0,GRIA2,9606,Homo sapiens (human),Deguelin results in decreased expression of GRIA2 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1942,1459275,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,2906,GRIN2D,https://ctdbase.org/detail.go?type=gene&acc=2906,,,2906.0,GRIN2D,9606,Homo sapiens (human),Deguelin results in decreased expression of GRIN2D mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1943,1459276,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,2914,GRM4,https://ctdbase.org/detail.go?type=gene&acc=2914,,,2914.0,GRM4,9606,Homo sapiens (human),Deguelin results in decreased expression of GRM4 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1944,1459277,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,2896,GRN,https://ctdbase.org/detail.go?type=gene&acc=2896,,,2896.0,GRN,9606,Homo sapiens (human),Deguelin results in decreased expression of GRN mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1945,1459278,107935,Comparative Toxicogenomics Database (CTD),Deguelin,C107676,deguelin,https://ctdbase.org/detail.go?type=chem&acc=C107676,55876,GSDMB,https://ctdbase.org/detail.go?type=gene&acc=55876,,,55876.0,GSDMB,9606,Homo sapiens (human),Deguelin results in decreased expression of GSDMB mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
1946,1462329,114852,Comparative Toxicogenomics Database (CTD),16-Hydroxyestrone,C026702,16-hydroxyestrone,https://ctdbase.org/detail.go?type=chem&acc=C026702,10549,PRDX4,https://ctdbase.org/detail.go?type=gene&acc=10549,,,10549.0,PRDX4,9606,Homo sapiens (human),16-hydroxyestrone results in increased expression of PRDX4 mrna|16-hydroxyestrone results in increased expression of PRDX4 protein,,,PMID:18272409,https://www.ncbi.nlm.nih.gov/pubmed/18272409,18272409,,
1947,1462330,114852,Comparative Toxicogenomics Database (CTD),16-Hydroxyestrone,C026702,16-hydroxyestrone,https://ctdbase.org/detail.go?type=chem&acc=C026702,7366,UGT2B15,https://ctdbase.org/detail.go?type=gene&acc=7366,,,7366.0,UGT2B15,9606,Homo sapiens (human),UGT2B15 protein results in increased metabolism of 16-hydroxyestrone,,,PMID:7835232,https://www.ncbi.nlm.nih.gov/pubmed/7835232,7835232,,
1948,1464576,119599,Comparative Toxicogenomics Database (CTD),"L-Methioninamide, N-(5-amino-1-oxopentyl)-L-phenylalanyl-L-phenylalanyl-L-prolyl-N-methyl-L-leucyl-",C068032,GR 73632,https://ctdbase.org/detail.go?type=chem&acc=C068032,6869,TACR1,https://ctdbase.org/detail.go?type=gene&acc=6869,,,6869.0,TACR1,10116,Rattus norvegicus (Norway rat),GR 73632 results in increased expression of TACR1 protein,,,PMID:18809416,https://www.ncbi.nlm.nih.gov/pubmed/18809416,18809416,,
1949,1464577,119599,Comparative Toxicogenomics Database (CTD),"L-Methioninamide, N-(5-amino-1-oxopentyl)-L-phenylalanyl-L-phenylalanyl-L-prolyl-N-methyl-L-leucyl-",C068032,GR 73632,https://ctdbase.org/detail.go?type=chem&acc=C068032,6869,TACR1,https://ctdbase.org/detail.go?type=gene&acc=6869,,,6869.0,TACR1,9606,Homo sapiens (human),GR 73632 binds to and results in increased activity of TACR1 protein,,,PMID:18809416|PMID:21229983,https://www.ncbi.nlm.nih.gov/pubmed/18809416|https://www.ncbi.nlm.nih.gov/pubmed/21229983,18809416|21229983,,
1950,1464578,119599,Comparative Toxicogenomics Database (CTD),"L-Methioninamide, N-(5-amino-1-oxopentyl)-L-phenylalanyl-L-phenylalanyl-L-prolyl-N-methyl-L-leucyl-",C068032,GR 73632,https://ctdbase.org/detail.go?type=chem&acc=C068032,7442,TRPV1,https://ctdbase.org/detail.go?type=gene&acc=7442,,,7442.0,TRPV1,10116,Rattus norvegicus (Norway rat),"1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione inhibits the reaction [GR 73632 results in increased phosphorylation of TRPV1 protein]|gr 73632 results in increased expression of TRPV1 protein|bisindolylmaleimide I inhibits the reaction [GR 73632 results in increased phosphorylation of TRPV1 protein]|go 6976 inhibits the reaction [GR 73632 results in increased phosphorylation of TRPV1 protein]|indomethacin inhibits the reaction [GR 73632 results in increased phosphorylation of TRPV1 protein]|cp 96345 inhibits the reaction [GR 73632 results in increased phosphorylation of TRPV1 protein]|gr 73632 results in increased phosphorylation of TRPV1 protein|n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [GR 73632 results in increased phosphorylation of TRPV1 protein]|u 0126 inhibits the reaction [GR 73632 results in increased phosphorylation of TRPV1 protein]|sb 203580 inhibits the reaction [GR 73632 results in increased phosphorylation of TRPV1 protein]",,,PMID:18809416,https://www.ncbi.nlm.nih.gov/pubmed/18809416,18809416,,
1951,1464579,119845,IUPHAR/BPS Guide to PHARMACOLOGY,Benzodrocortisone,9731,benzodrocortisone,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9731,626,Mineralocorticoid receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=626,P08235,Mineralocorticoid receptor ,4306.0,NR3C2,9606,Homo sapiens (human),Agonist,,4.42,,,,,
1952,1464580,119845,IUPHAR/BPS Guide to PHARMACOLOGY,Benzodrocortisone,9731,benzodrocortisone,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=9731,625,Glucocorticoid receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=625,P04150,Glucocorticoid receptor,2908.0,NR3C1,9606,Homo sapiens (human),Agonist,,8.89,,,,,
1953,1464765,121396,DrugBank,Carglumic Acid,DB06775,Carglumic acid,https://www.drugbank.ca/drugs/DB06775,BE0004671,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",https://www.drugbank.ca/bio_entities/BE0004671,P31327,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",1373.0,CPS1,9606,Homo sapiens (human),Allosteric modulator,,,PMID:18516804|PMID:19106093|PMID:21207059,https://www.ncbi.nlm.nih.gov/pubmed/18516804|https://www.ncbi.nlm.nih.gov/pubmed/19106093|https://www.ncbi.nlm.nih.gov/pubmed/21207059,18516804|19106093|21207059,,
1954,1440680,124052,Comparative Toxicogenomics Database (CTD),Glabridin,C107601,glabridin,https://ctdbase.org/detail.go?type=chem&acc=C107601,842,CASP9,https://ctdbase.org/detail.go?type=gene&acc=842,,,842.0,CASP9,10090,Mus musculus (house mouse),[glabridin co-treated with paclitaxel] results in increased cleavage of CASP9 protein|[glabridin co-treated with paclitaxel] results in decreased expression of CASP9 protein,,,PMID:37419298,https://www.ncbi.nlm.nih.gov/pubmed/37419298,37419298,,
1955,1440681,124052,Comparative Toxicogenomics Database (CTD),Glabridin,C107601,glabridin,https://ctdbase.org/detail.go?type=chem&acc=C107601,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,10090,Mus musculus (house mouse),[glabridin co-treated with paclitaxel] results in increased expression of CDH1 protein,,,PMID:37419298,https://www.ncbi.nlm.nih.gov/pubmed/37419298,37419298,,
1956,1440682,124052,Comparative Toxicogenomics Database (CTD),Glabridin,C107601,glabridin,https://ctdbase.org/detail.go?type=chem&acc=C107601,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205.0,CYCS,10090,Mus musculus (house mouse),Glabridin inhibits the reaction [antimycin A affects the localization of CYCS protein],,,PMID:21621525,https://www.ncbi.nlm.nih.gov/pubmed/21621525,21621525,,
1957,1440683,124052,Comparative Toxicogenomics Database (CTD),Glabridin,C107601,glabridin,https://ctdbase.org/detail.go?type=chem&acc=C107601,1558,CYP2C8,https://ctdbase.org/detail.go?type=gene&acc=1558,,,1558.0,CYP2C8,10090,Mus musculus (house mouse),[glabridin co-treated with paclitaxel] results in decreased expression of CYP2C8 protein,,,PMID:37419298,https://www.ncbi.nlm.nih.gov/pubmed/37419298,37419298,,
1958,1440684,124052,Comparative Toxicogenomics Database (CTD),Glabridin,C107601,glabridin,https://ctdbase.org/detail.go?type=chem&acc=C107601,1573,CYP2J2,https://ctdbase.org/detail.go?type=gene&acc=1573,,,1573.0,CYP2J2,10090,Mus musculus (house mouse),[glabridin co-treated with paclitaxel] results in decreased expression of CYP2J2 protein,,,PMID:37419298,https://www.ncbi.nlm.nih.gov/pubmed/37419298,37419298,,
1959,1441308,128805,Drug Gene Interaction database (DGIdb),"1,2,3,4-Tetrahydro-8-methoxy-5-(methylthio)-2-naphthalenamine",,(+)-JQ1,https://www.dgidb.org/drugs/iuphar.ligand:7511,,BRDT,https://www.dgidb.org/genes/hgnc:1105,,,676.0,BRDT,9606,Homo sapiens (human),,,,,,,,
1960,1441309,128878,DrugBank,2-Iminobiotin,DB03353,2-Iminobiotin,https://www.drugbank.ca/drugs/DB03353,BE0001668,Streptavidin,https://www.drugbank.ca/bio_entities/BE0001668,P22629,Streptavidin,,,1895,Streptomyces avidinii,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
1961,1441310,129148,DrugBank,1-O-Octyl-2-heptylphosphonyl-SN-glycero-3-phosphoethanolamine,DB03565,1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine,https://www.drugbank.ca/drugs/DB03565,BE0003997,Phospholipase A2,https://www.drugbank.ca/bio_entities/BE0003997,P04054,Phospholipase A2,5319.0,PLA2G1B,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
1962,1443879,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10090,Mus musculus (house mouse),SOD1 protein results in increased abundance of nitric oxide,,,PMID:21443684,https://www.ncbi.nlm.nih.gov/pubmed/21443684,21443684,,
1963,1443880,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,10116,Rattus norvegicus (Norway rat),Nitric oxide deficiency inhibits the reaction [formaldehyde results in increased expression of SOD1 mrna],,,PMID:21983654,https://www.ncbi.nlm.nih.gov/pubmed/21983654,21983654,,
1964,1443881,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6647,SOD1,https://ctdbase.org/detail.go?type=gene&acc=6647,,,6647.0,SOD1,9606,Homo sapiens (human),SOD1 protein inhibits the reaction [nitroprusside results in increased secretion of nitric oxide],,,PMID:10691295,https://www.ncbi.nlm.nih.gov/pubmed/10691295,10691295,,
1965,1443882,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),[NOS3 protein polymorphism results in decreased chemical synthesis of nitric oxide] which results in increased expression of SOD2 mrna|[nos3 protein polymorphism results in decreased chemical synthesis of nitric oxide] which results in increased expression of SOD2 protein,,,PMID:19320461,https://www.ncbi.nlm.nih.gov/pubmed/19320461,19320461,,
1966,1443883,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),SOD2 protein affects the abundance of nitric oxide,,,PMID:20110409,https://www.ncbi.nlm.nih.gov/pubmed/20110409,20110409,,
1967,1443884,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,9606,Homo sapiens (human),SOD2 protein results in decreased abundance of nitric oxide,,,PMID:23964924,https://www.ncbi.nlm.nih.gov/pubmed/23964924,23964924,,
1968,1443885,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,7099,TLR4,https://ctdbase.org/detail.go?type=gene&acc=7099,,,7099.0,TLR4,10090,Mus musculus (house mouse),TLR4 gene mutant form inhibits the reaction [fungal polysaccharides results in increased abundance of nitric oxide],,,PMID:22687552,https://www.ncbi.nlm.nih.gov/pubmed/22687552,22687552,,
1969,1443886,145068,Comparative Toxicogenomics Database (CTD),Nitric Oxide,D009569,Nitric Oxide,https://ctdbase.org/detail.go?type=chem&acc=D009569,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10116,Rattus norvegicus (Norway rat),"1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of nitric oxide] which results in increased expression of and results in increased activity of SOD2 protein]|dactinomycin inhibits the reaction [[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of nitric oxide] which results in increased expression of SOD2 mrna]|[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of nitric oxide] which results in increased expression of SOD2 mrna|1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one inhibits the reaction [[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of nitric oxide] which results in increased expression of SOD2 mrna]|[s-nitroso-N-acetylpenicillamine results in increased abundance of nitric oxide] which results in increased expression of and results in increased activity of SOD2 protein|[s-nitroso-N-acetylpenicillamine results in increased abundance of nitric oxide] which results in increased expression of SOD2 mrna|[2,2'-(hydroxynitrosohydrazono)bis-ethanamine results in increased abundance of nitric oxide] which results in increased expression of and results in increased activity of SOD2 protein",,,PMID:14996425,https://www.ncbi.nlm.nih.gov/pubmed/14996425,14996425,,
1970,1439729,151202,Comparative Toxicogenomics Database (CTD),3-O-Acetyloleanolic acid,C052658,oleanolic acid 3-acetate,https://ctdbase.org/detail.go?type=chem&acc=C052658,3567,IL5,https://ctdbase.org/detail.go?type=gene&acc=3567,,,3567.0,IL5,10090,Mus musculus (house mouse),"Oleanolic acid 3-acetate inhibits the reaction [[antigens, dermatophagoides co-treated with dinitrochlorobenzene] results in increased expression of IL5 mrna]",,,PMID:23499868,https://www.ncbi.nlm.nih.gov/pubmed/23499868,23499868,,
1971,1439730,151202,Comparative Toxicogenomics Database (CTD),3-O-Acetyloleanolic acid,C052658,oleanolic acid 3-acetate,https://ctdbase.org/detail.go?type=chem&acc=C052658,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569.0,IL6,9606,Homo sapiens (human),Oleanolic acid 3-acetate inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of IL6 mrna],,,PMID:23499868,https://www.ncbi.nlm.nih.gov/pubmed/23499868,23499868,,
1972,1439731,151202,Comparative Toxicogenomics Database (CTD),3-O-Acetyloleanolic acid,C052658,oleanolic acid 3-acetate,https://ctdbase.org/detail.go?type=chem&acc=C052658,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,9606,Homo sapiens (human),"Oleanolic acid 3-acetate inhibits the reaction [dinitrofluorobenzene results in increased expression of TNF mrna]|oleanolic acid 3-acetate inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of IL1B mrna]|oleanolic acid 3-acetate inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of IL6 mrna]|oleanolic acid 3-acetate inhibits the reaction [[antigens, dermatophagoides co-treated with dinitrochlorobenzene] results in increased expression of TNF mrna]|oleanolic acid 3-acetate inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased expression of CCL17 mrna]",,,PMID:23499868,https://www.ncbi.nlm.nih.gov/pubmed/23499868,23499868,,
1973,1460045,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9361,LONP1,https://ctdbase.org/detail.go?type=gene&acc=9361,,,9361.0,LONP1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of LONP1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1974,1460046,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,987,LRBA,https://ctdbase.org/detail.go?type=gene&acc=987,,,987.0,LRBA,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of LRBA protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1975,1460047,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,53353,LRP1B,https://ctdbase.org/detail.go?type=gene&acc=53353,,,53353.0,LRP1B,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of LRP1B protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1976,1460048,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,4036,LRP2,https://ctdbase.org/detail.go?type=gene&acc=4036,,,4036.0,LRP2,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of LRP2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1977,1460049,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,55631,LRRC40,https://ctdbase.org/detail.go?type=gene&acc=55631,,,55631.0,LRRC40,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of LRRC40 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1978,1460050,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,57819,LSM2,https://ctdbase.org/detail.go?type=gene&acc=57819,,,57819.0,LSM2,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of LSM2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1979,1460051,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,10434,LYPLA1,https://ctdbase.org/detail.go?type=gene&acc=10434,,,10434.0,LYPLA1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of LYPLA1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1980,1461032,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,55739,NAXD,https://ctdbase.org/detail.go?type=gene&acc=55739,,,55739.0,NAXD,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of NAXD protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1981,1461033,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,23218,NBEAL2,https://ctdbase.org/detail.go?type=gene&acc=23218,,,23218.0,NBEAL2,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of NBEAL2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1982,1461034,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,57552,NCEH1,https://ctdbase.org/detail.go?type=gene&acc=57552,,,57552.0,NCEH1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of NCEH1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1983,1461035,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,4688,NCF2,https://ctdbase.org/detail.go?type=gene&acc=4688,,,4688.0,NCF2,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of NCF2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1984,1461699,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9885,OSBPL2,https://ctdbase.org/detail.go?type=gene&acc=9885,,,9885.0,OSBPL2,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of OSBPL2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1985,1461700,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,114883,OSBPL9,https://ctdbase.org/detail.go?type=gene&acc=114883,,,114883.0,OSBPL9,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of OSBPL9 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1986,1461701,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,55644,OSGEP,https://ctdbase.org/detail.go?type=gene&acc=55644,,,55644.0,OSGEP,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of OSGEP protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1987,1461702,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9943,OXSR1,https://ctdbase.org/detail.go?type=gene&acc=9943,,,9943.0,OXSR1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of OXSR1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1988,1461703,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,5033,P4HA1,https://ctdbase.org/detail.go?type=gene&acc=5033,,,5033.0,P4HA1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of P4HA1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1989,1461704,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,26986,PABPC1,https://ctdbase.org/detail.go?type=gene&acc=26986,,,26986.0,PABPC1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of PABPC1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1990,1461705,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,8761,PABPC4,https://ctdbase.org/detail.go?type=gene&acc=8761,,,8761.0,PABPC4,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of PABPC4 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1991,1461706,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,27143,PALD1,https://ctdbase.org/detail.go?type=gene&acc=27143,,,27143.0,PALD1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of PALD1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1992,1462331,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,84457,PHYHIPL,https://ctdbase.org/detail.go?type=gene&acc=84457,,,84457.0,PHYHIPL,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of PHYHIPL protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1993,1462332,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,5297,PI4KA,https://ctdbase.org/detail.go?type=gene&acc=5297,,,5297.0,PI4KA,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of PI4KA protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1994,1462333,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,8301,PICALM,https://ctdbase.org/detail.go?type=gene&acc=8301,,,8301.0,PICALM,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of PICALM protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1995,1462334,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,5291,PIK3CB,https://ctdbase.org/detail.go?type=gene&acc=5291,,,5291.0,PIK3CB,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of PIK3CB protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1996,1462335,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,5295,PIK3R1,https://ctdbase.org/detail.go?type=gene&acc=5295,,,5295.0,PIK3R1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of PIK3R1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1997,1462336,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,5296,PIK3R2,https://ctdbase.org/detail.go?type=gene&acc=5296,,,5296.0,PIK3R2,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of PIK3R2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1998,1462337,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,30849,PIK3R4,https://ctdbase.org/detail.go?type=gene&acc=30849,,,30849.0,PIK3R4,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of PIK3R4 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
1999,1462501,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,8985,PLOD3,https://ctdbase.org/detail.go?type=gene&acc=8985,,,8985.0,PLOD3,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of PLOD3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2000,1462502,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,5357,PLS1,https://ctdbase.org/detail.go?type=gene&acc=5357,,,5357.0,PLS1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of PLS1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2001,1462503,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,5360,PLTP,https://ctdbase.org/detail.go?type=gene&acc=5360,,,5360.0,PLTP,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of PLTP protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2002,1462504,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,23275,POFUT2,https://ctdbase.org/detail.go?type=gene&acc=23275,,,23275.0,POFUT2,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of POFUT2 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2003,1462505,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,9533,POLR1C,https://ctdbase.org/detail.go?type=gene&acc=9533,,,9533.0,POLR1C,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of POLR1C protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2004,1462506,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,5430,POLR2A,https://ctdbase.org/detail.go?type=gene&acc=5430,,,5430.0,POLR2A,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of POLR2A protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2005,1462791,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,5528,PPP2R5D,https://ctdbase.org/detail.go?type=gene&acc=5528,,,5528.0,PPP2R5D,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of PPP2R5D protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2006,1462792,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,55671,PPP4R3A,https://ctdbase.org/detail.go?type=gene&acc=55671,,,55671.0,PPP4R3A,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of PPP4R3A protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2007,1462793,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,57223,PPP4R3B,https://ctdbase.org/detail.go?type=gene&acc=57223,,,57223.0,PPP4R3B,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of PPP4R3B protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2008,1462794,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,22870,PPP6R1,https://ctdbase.org/detail.go?type=gene&acc=22870,,,22870.0,PPP6R1,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in decreased expression of PPP6R1 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2009,1462795,154083,Comparative Toxicogenomics Database (CTD),"1,3,5-Tribromo-2-(2,4-dibromophenoxy)benzene",C517827,pentabrominated diphenyl ether 100,https://ctdbase.org/detail.go?type=chem&acc=C517827,55291,PPP6R3,https://ctdbase.org/detail.go?type=gene&acc=55291,,,55291.0,PPP6R3,9606,Homo sapiens (human),Pentabrominated diphenyl ether 100 results in increased expression of PPP6R3 protein,,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
2010,1447284,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,100874214,TM4SF19-AS1,https://ctdbase.org/detail.go?type=gene&acc=100874214,,,100874214.0,TM4SF19-AS1,9606,Homo sapiens (human),[[hydroxyl radical results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mrna] which results in decreased expression of TM4SF19 mrna|[[hydroxyl radical results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mrna] which results in increased expression of DYNLT2B mrna|[hydroxyl radical results in increased oxidation of dimethylselenide] which results in decreased expression of TM4SF19-AS1 mRNA,,,PMID:33656867,https://www.ncbi.nlm.nih.gov/pubmed/33656867,33656867,,
2011,1447285,157350,Comparative Toxicogenomics Database (CTD),Hydroxyl radical,D017665,Hydroxyl Radical,https://ctdbase.org/detail.go?type=chem&acc=D017665,8797,TNFRSF10A,https://ctdbase.org/detail.go?type=gene&acc=8797,,,8797.0,TNFRSF10A,9606,Homo sapiens (human),[[hydroxyl radical results in increased oxidation of dimethylselenide] which results in increased expression of TNFRSF10A-AS1 mrna] which results in increased expression of TNFRSF10A mRNA,,,PMID:33656867,https://www.ncbi.nlm.nih.gov/pubmed/33656867,33656867,,
2012,1447286,157806,Therapeutic Target Database (TTD),N-benzyl-N-hydroxy-5-phenylpentanamide,D07ARK,5-Phenyl-pentanoic acid benzyl-hydroxy-amide,https://idrblab.net/ttd/data/drug/details/D07ARK,T66665,Prostaglandin G/H synthase 2 (COX-2),https://idrblab.net/ttd/data/target/details/T66665,P35354,Prostaglandin G/H synthase 2,5743.0,PTGS2,9606,Homo sapiens (human),Inhibitor,,,,,,,
2013,1447287,157806,Therapeutic Target Database (TTD),N-benzyl-N-hydroxy-5-phenylpentanamide,D07ARK,5-Phenyl-pentanoic acid benzyl-hydroxy-amide,https://idrblab.net/ttd/data/drug/details/D07ARK,T60529,Prostaglandin G/H synthase 1 (COX-1),https://idrblab.net/ttd/data/target/details/T60529,P23219,Prostaglandin G/H synthase 1,5742.0,PTGS1,9606,Homo sapiens (human),Inhibitor,,,,,,,
2014,1440685,159296,DrugBank,Adenosine-3'-5'-diphosphate,DB01812,"Adenosine 3',5'-diphosphate",https://www.drugbank.ca/drugs/DB01812,BE0003317,Ribonuclease pancreatic,https://www.drugbank.ca/bio_entities/BE0003317,P07998,Ribonuclease pancreatic,6035.0,RNASE1,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
2015,1440686,159296,DrugBank,Adenosine-3'-5'-diphosphate,DB01812,"Adenosine 3',5'-diphosphate",https://www.drugbank.ca/drugs/DB01812,BE0000886,Bile salt sulfotransferase,https://www.drugbank.ca/bio_entities/BE0000886,Q06520,Sulfotransferase 2A1,6822.0,SULT2A1,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
2016,1440687,159296,DrugBank,Adenosine-3'-5'-diphosphate,DB01812,"Adenosine 3',5'-diphosphate",https://www.drugbank.ca/drugs/DB01812,BE0000951,Estrogen sulfotransferase,https://www.drugbank.ca/bio_entities/BE0000951,P49888,Sulfotransferase 1E1,6783.0,SULT1E1,9606,Homo sapiens (human),,,,PMID:17139284|PMID:17016423|PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423|https://www.ncbi.nlm.nih.gov/pubmed/10592235,17139284|17016423|10592235,,
2017,1440688,159296,DrugBank,Adenosine-3'-5'-diphosphate,DB01812,"Adenosine 3',5'-diphosphate",https://www.drugbank.ca/drugs/DB01812,BE0001950,DNA topoisomerase 1,https://www.drugbank.ca/bio_entities/BE0001950,P06612,DNA topoisomerase 1,945862.0,topA,83333,Escherichia coli K-12,,,,PMID:17139284|PMID:17016423,https://www.ncbi.nlm.nih.gov/pubmed/17139284|https://www.ncbi.nlm.nih.gov/pubmed/17016423,17139284|17016423,,
2018,1440689,159296,DrugBank,Adenosine-3'-5'-diphosphate,DB01812,"Adenosine 3',5'-diphosphate",https://www.drugbank.ca/drugs/DB01812,BE0002559,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,https://www.drugbank.ca/bio_entities/BE0002559,P52848,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,3340.0,NDST1,9606,Homo sapiens (human),,,,,,,,
2019,1441301,160024,Comparative Toxicogenomics Database (CTD),Fidarestat,C077139,fidarestat,https://ctdbase.org/detail.go?type=chem&acc=C077139,6778,STAT6,https://ctdbase.org/detail.go?type=gene&acc=6778,,,6778.0,STAT6,9606,Homo sapiens (human),Fidarestat results in decreased phosphorylation of STAT6 protein|fidarestat inhibits the reaction [plant extracts results in increased phosphorylation of STAT6 protein]|fidarestat inhibits the reaction [IL13 protein results in increased phosphorylation of STAT6 protein],,,PMID:21203431,https://www.ncbi.nlm.nih.gov/pubmed/21203431,21203431,,
2020,1441302,160024,Comparative Toxicogenomics Database (CTD),Fidarestat,C077139,fidarestat,https://ctdbase.org/detail.go?type=chem&acc=C077139,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),Fidarestat inhibits the reaction [lipopolysaccharides results in increased expression of TNF protein]|fidarestat inhibits the reaction [lipopolysaccharides results in increased expression of TNF mrna],,,PMID:22253906,https://www.ncbi.nlm.nih.gov/pubmed/22253906,22253906,,
2021,1441303,160142,BindingDB,Miltirone,50009219,"2-isopropyl-8,8-dimethyl-5,6,7,8-tetrahydrophenanthrene-3,4-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50009219,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009,Severe acute respiratory syndrome-related coronavirus,,IC50 (nM),21100,PMID:34798775|DOI:10.1021/acs.jmedchem.1c00409,https://www.ncbi.nlm.nih.gov/pubmed/34798775|https://doi.org/10.1021/acs.jmedchem.1c00409,34798775,10.1021/acs.jmedchem.1c00409,
2022,1441304,160254,BindingDB,Cryptotanshinone,57938,"(1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[1,2-g][1]benzofuran-10,11-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=57938,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009,Severe acute respiratory syndrome-related coronavirus,,IC50 (nM),226700,PMID:34798775|DOI:10.1021/acs.jmedchem.1c00409,https://www.ncbi.nlm.nih.gov/pubmed/34798775|https://doi.org/10.1021/acs.jmedchem.1c00409,34798775,10.1021/acs.jmedchem.1c00409,
2023,1441305,160254,BindingDB,Cryptotanshinone,57938,"(1R)-1,6,6-trimethyl-2,7,8,9-tetrahydro-1H-naphtho[1,2-g][1]benzofuran-10,11-dione",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=57938,4753,Replicase polyprotein 1ab,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=4753,P0C6X7,Replicase polyprotein 1ab,1489680.0,ORF1ab,694009,Severe acute respiratory syndrome-related coronavirus,,Ki (nM),9000,PMID:34798775|DOI:10.1021/acs.jmedchem.1c00409,https://www.ncbi.nlm.nih.gov/pubmed/34798775|https://doi.org/10.1021/acs.jmedchem.1c00409,34798775,10.1021/acs.jmedchem.1c00409,
2024,1441306,160306,Comparative Toxicogenomics Database (CTD),Territrem C,C040403,territrem C,https://ctdbase.org/detail.go?type=chem&acc=C040403,266682,CYP3A2,https://ctdbase.org/detail.go?type=gene&acc=266682,,,266682.0,Cyp3a2,10116,Rattus norvegicus (Norway rat),CYP3A2 protein affects the metabolism of territrem C,,,PMID:15799453,https://www.ncbi.nlm.nih.gov/pubmed/15799453,15799453,,
2025,1441307,160306,Comparative Toxicogenomics Database (CTD),Territrem C,C040403,territrem C,https://ctdbase.org/detail.go?type=chem&acc=C040403,25642,CYP3A23-3A1,https://ctdbase.org/detail.go?type=gene&acc=25642,,,25642.0,Cyp3a23-3a1,10116,Rattus norvegicus (Norway rat),CYP3A23-3A1 protein affects the metabolism of territrem C,,,PMID:15799453,https://www.ncbi.nlm.nih.gov/pubmed/15799453,15799453,,
2026,1446335,164448,Comparative Toxicogenomics Database (CTD),"Monoisoamyl-2,3-dimercaptosuccinate",C091888,"monoisoamyl-2,3-dimercaptosuccinate",https://ctdbase.org/detail.go?type=chem&acc=C091888,9429,ABCG2,https://ctdbase.org/detail.go?type=gene&acc=9429,,,9429.0,ABCG2,9606,Homo sapiens (human),"Monoisoamyl-2,3-dimercaptosuccinate results in decreased expression of ABCG2 mRNA",,,PMID:19615344,https://www.ncbi.nlm.nih.gov/pubmed/19615344,19615344,,
2027,1447870,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0001071,Tyrosine-protein phosphatase non-receptor type 11,http://www.t3db.ca/biodb/bio_entities/BE0001071,Q06124,Tyrosine-protein phosphatase non-receptor type 11,5781.0,PTPN11,9606,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2028,1447871,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005231,Tyrosine-protein phosphatase non-receptor type 12,http://www.t3db.ca/biodb/bio_entities/BE0005231,Q05209,Tyrosine-protein phosphatase non-receptor type 12,5782.0,PTPN12,9606,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2029,1447872,166888,Toxin and Toxin Target Database (T3DB),Vanadium trisulfate,T3D1635,Vanadium(III) sulfate,http://www.t3db.ca/toxins/T3D1635,BE0005232,Tyrosine-protein phosphatase non-receptor type 13,http://www.t3db.ca/biodb/bio_entities/BE0005232,Q12923,Tyrosine-protein phosphatase non-receptor type 13,5783.0,PTPN13,9606,Homo sapiens (human),"Vanadium inhibits protein tyrosine phosphatases, producing insulin-like effects. (A251)",,,PMID:11398143,https://www.ncbi.nlm.nih.gov/pubmed/11398143,11398143,,
2030,1452821,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,10116,Rattus norvegicus (Norway rat),Bathocuproine sulfonate inhibits the reaction [[pyrrolidine dithiocarbamic acid co-treated with copper] results in increased activity of MAPK8 protein],,,PMID:10941151,https://www.ncbi.nlm.nih.gov/pubmed/10941151,10941151,,
2031,1452822,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,4176,MCM7,https://ctdbase.org/detail.go?type=gene&acc=4176,,,4176.0,MCM7,7227,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of MCM7 mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2032,1452823,170300,Comparative Toxicogenomics Database (CTD),Bathocuproine disulfonate,C028559,bathocuproine sulfonate,https://ctdbase.org/detail.go?type=chem&acc=C028559,44887,MDY,https://ctdbase.org/detail.go?type=gene&acc=44887,,,44887.0,mdy,7227,Drosophila melanogaster (fruit fly),Bathocuproine sulfonate results in decreased expression of MDY mRNA,,,PMID:16973896,https://www.ncbi.nlm.nih.gov/pubmed/16973896,16973896,,
2033,1444415,174174,IUPHAR/BPS Guide to PHARMACOLOGY,Atropine,320,atropine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=320,25,2A-adrenoceptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=25,P08913,Alpha-2A adrenergic receptor,150.0,ADRA2A,9606,Homo sapiens (human),Antagonist,pKi,4.85,PMID:29860464,https://www.ncbi.nlm.nih.gov/pubmed/29860464,29860464,,
2034,1444416,174174,Drug Gene Interaction database (DGIdb),Atropine,,ATROPINE,https://www.dgidb.org/drugs/rxcui:1223,,CHRM1,https://www.dgidb.org/genes/hgnc:1950,,,1128.0,CHRM1,9606,Homo sapiens (human),,,,,,,,
2035,1444417,176077,IUPHAR/BPS Guide to PHARMACOLOGY,Migalastat,10200,migalastat,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=10200,2611,alpha glucosidase,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2611,P10253,Lysosomal alpha-glucosidase,2548.0,GAA,9606,Homo sapiens (human),Binding,pIC50,7.4,PMID:10866822,https://www.ncbi.nlm.nih.gov/pubmed/10866822,10866822,,
2036,1457383,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,15953,IFI47,https://ctdbase.org/detail.go?type=gene&acc=15953,,,15953.0,Ifi47,10090,Mus musculus (house mouse),SB 203580 inhibits the reaction [[1-methylanthracene co-treated with fluoranthene] results in increased expression of IFI47 mrna],,,PMID:28329830,https://www.ncbi.nlm.nih.gov/pubmed/28329830,28329830,,
2037,1457384,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3551,IKBKB,https://ctdbase.org/detail.go?type=gene&acc=3551,,,3551.0,IKBKB,10116,Rattus norvegicus (Norway rat),SB 203580 inhibits the reaction [sodium arsenite results in increased phosphorylation of IKBKB protein],,,PMID:19616567,https://www.ncbi.nlm.nih.gov/pubmed/19616567,19616567,,
2038,1457385,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,9606,Homo sapiens (human),[SB 203580 co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] results in decreased susceptibility to [IL1B protein co-treated with IFNG protein]|[2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one co-treated with SB 203580] inhibits the reaction [[IL1B protein co-treated with IFNG protein] results in increased chemical synthesis of nitrites],,,PMID:10903806,https://www.ncbi.nlm.nih.gov/pubmed/10903806,10903806,,
2039,1457386,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458.0,IFNG,9606,Homo sapiens (human),SB 203580 inhibits the reaction [deoxynivalenol inhibits the reaction [[IFNG protein co-treated with TNF protein co-treated with IL1B protein] results in increased expression of NOS2 protein]],,,PMID:25766886,https://www.ncbi.nlm.nih.gov/pubmed/25766886,25766886,,
2040,1461993,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,9534,Chlorocebus aethiops (grivet),SB 203580 results in decreased activity of MAPK14 protein,,,PMID:15659807,https://www.ncbi.nlm.nih.gov/pubmed/15659807,15659807,,
2041,1461994,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,9606,Homo sapiens (human),MAPK14 protein mutant form inhibits the reaction [SB 203580 inhibits the reaction [arsenite results in increased phosphorylation of EIF4E protein]],,,PMID:12781867,https://www.ncbi.nlm.nih.gov/pubmed/12781867,12781867,,
2042,1461995,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,9606,Homo sapiens (human),"SB 203580 inhibits the reaction [11,11'-dideoxyverticilin results in increased expression of and results in increased phosphorylation of MAPK14 protein]",,,PMID:15963507,https://www.ncbi.nlm.nih.gov/pubmed/15963507,15963507,,
2043,1461996,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,9606,Homo sapiens (human),"SB 203580 inhibits the reaction [indeno(1,2,3-cd)pyrene results in increased phosphorylation of MAPK14 protein]|sb 203580 inhibits the reaction [benz(a)anthracene results in increased phosphorylation of MAPK14 protein]|sb 203580 inhibits the reaction [benzo(k)fluoranthene results in increased phosphorylation of MAPK14 protein]",,,PMID:21635667,https://www.ncbi.nlm.nih.gov/pubmed/21635667,21635667,,
2044,1461997,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,1432,MAPK14,https://ctdbase.org/detail.go?type=gene&acc=1432,,,1432.0,MAPK14,9606,Homo sapiens (human),SB 203580 inhibits the reaction [cadmium chloride results in decreased expression of MAPK14 mrna],,,PMID:19757093,https://www.ncbi.nlm.nih.gov/pubmed/19757093,19757093,,
2045,1463079,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116,Rattus norvegicus (Norway rat),SB 203580 promotes the reaction [ferrous sulfate results in increased phosphorylation of MAPK3 protein]|sb 203580 promotes the reaction [iron results in increased phosphorylation of MAPK3 protein],,,PMID:17172471,https://www.ncbi.nlm.nih.gov/pubmed/17172471,17172471,,
2046,1463080,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,10116,Rattus norvegicus (Norway rat),SB 203580 results in increased phosphorylation of MAPK3 protein,,,PMID:28087833,https://www.ncbi.nlm.nih.gov/pubmed/28087833,28087833,,
2047,1463081,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595.0,MAPK3,9823,Sus scrofa (pig),SB 203580 inhibits the reaction [etoxazole results in increased phosphorylation of MAPK3 protein],,,PMID:31744678,https://www.ncbi.nlm.nih.gov/pubmed/31744678,31744678,,
2048,1463082,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606,Homo sapiens (human),"SB 203580 inhibits the reaction [4-vinyl-2,6-dimethoxyphenol results in increased phosphorylation of MAPK8 protein]",,,PMID:30653946,https://www.ncbi.nlm.nih.gov/pubmed/30653946,30653946,,
2049,1463083,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606,Homo sapiens (human),SB 203580 inhibits the reaction [cinnamaldehyde results in increased phosphorylation of MAPK8 protein],,,PMID:15964311,https://www.ncbi.nlm.nih.gov/pubmed/15964311,15964311,,
2050,1463084,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606,Homo sapiens (human),SB 203580 inhibits the reaction [oxygen deficiency results in increased activity of MAPK8 protein],,,PMID:13679210,https://www.ncbi.nlm.nih.gov/pubmed/13679210,13679210,,
2051,1463085,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606,Homo sapiens (human),SB 203580 inhibits the reaction [polyhexamethyleneguanidine results in increased phosphorylation of MAPK8 protein],,,PMID:30935901,https://www.ncbi.nlm.nih.gov/pubmed/30935901,30935901,,
2052,1463086,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606,Homo sapiens (human),SB 203580 promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK8 protein],,,PMID:16818652,https://www.ncbi.nlm.nih.gov/pubmed/16818652,16818652,,
2053,1463087,176155,Comparative Toxicogenomics Database (CTD),4-(4-Fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole,C093642,SB 203580,https://ctdbase.org/detail.go?type=chem&acc=C093642,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,9606,Homo sapiens (human),SB 203580 promotes the reaction [nickel sulfate results in increased phosphorylation of MAPK8 protein],,,PMID:18495191,https://www.ncbi.nlm.nih.gov/pubmed/18495191,18495191,,
2054,1444418,176157,Therapeutic Target Database (TTD),"5-chloro-4-N-(cyclopropylmethyl)-2-methyl-4-N-propyl-6-N-(2,4,6-trichlorophenyl)pyrimidine-4,6-diamine",D04KWH,Des-Arg(9)-[Leu(8)]-BK,https://idrblab.net/ttd/data/drug/details/D04KWH,T45262,Corticotropin-releasing factor receptor 1 (CRHR1),https://idrblab.net/ttd/data/target/details/T45262,P34998,Corticotropin-releasing factor receptor 1,1394.0,CRHR1,9606,Homo sapiens (human),Antagonist,,,,,,,
2055,1444419,176167,Drug Gene Interaction database (DGIdb),Enzastaurin,,ENZASTAURIN,https://www.dgidb.org/drugs/ncit:C77392,,PRKCB,https://www.dgidb.org/genes/hgnc:9395,,,5579.0,PRKCB,9606,Homo sapiens (human),Inhibitor,,,,,,,
2056,1444420,176167,Drug Gene Interaction database (DGIdb),Enzastaurin,,ENZASTAURIN,https://www.dgidb.org/drugs/ncit:C77392,,PRKCB,https://www.dgidb.org/genes/hgnc:9395,,,5579.0,PRKCB,9606,Homo sapiens (human),Inhibitor,,,,,,,
2057,1444421,176167,ChEMBL,Enzastaurin,CHEMBL300138,ENZASTAURIN,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL300138/,CHEMBL3045,Protein kinase C beta,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL3045/,P05771,Protein kinase C beta type,5579.0,PRKCB,9606,Homo sapiens (human),Protein kinase C beta inhibitor,,,PMID:12749884|PMID:17671157,https://www.ncbi.nlm.nih.gov/pubmed/12749884|https://www.ncbi.nlm.nih.gov/pubmed/17671157,12749884|17671157,,
2058,1463767,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4023,LPL,https://ctdbase.org/detail.go?type=gene&acc=4023,,,4023.0,LPL,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LPL mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2059,1463768,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,9404,LPXN,https://ctdbase.org/detail.go?type=gene&acc=9404,,,9404.0,LPXN,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LPXN mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2060,1463769,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,121227,LRIG3,https://ctdbase.org/detail.go?type=gene&acc=121227,,,121227.0,LRIG3,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in increased expression of LRIG3 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2061,1463770,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4035,LRP1,https://ctdbase.org/detail.go?type=gene&acc=4035,,,4035.0,LRP1,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LRP1 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2062,1463771,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,4038,LRP4,https://ctdbase.org/detail.go?type=gene&acc=4038,,,4038.0,LRP4,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of LRP4 mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
2063,1440009,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,266682,CYP3A2,https://ctdbase.org/detail.go?type=gene&acc=266682,,,266682.0,Cyp3a2,10116,Rattus norvegicus (Norway rat),CYP3A2 protein results in increased activity of aflatoxin B1,,,PMID:11346484,https://www.ncbi.nlm.nih.gov/pubmed/11346484,11346484,,
2064,1440010,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,56388,CYP3A25,https://ctdbase.org/detail.go?type=gene&acc=56388,,,56388.0,Cyp3a25,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CYP3A25 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2065,1440011,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,678669,CYP3A37,https://ctdbase.org/detail.go?type=gene&acc=678669,,,678669.0,,9103,Meleagris gallopavo (turkey),CYP3A37 protein results in increased metabolism of aflatoxin B1,,,PMID:20707407|PMID:21616088|PMID:23613737,https://www.ncbi.nlm.nih.gov/pubmed/20707407|https://www.ncbi.nlm.nih.gov/pubmed/21616088|https://www.ncbi.nlm.nih.gov/pubmed/23613737,20707407|21616088|23613737,,
2066,1440012,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,678669,CYP3A37,https://ctdbase.org/detail.go?type=gene&acc=678669,,,678669.0,,9103,Meleagris gallopavo (turkey),"[CYP3A37 protein results in increased metabolism of aflatoxin B1] which results in increased chemical synthesis of aflatoxin B1-2,3-oxide",,,PMID:20707407|PMID:23613737,https://www.ncbi.nlm.nih.gov/pubmed/20707407|https://www.ncbi.nlm.nih.gov/pubmed/23613737,20707407|23613737,,
2067,1440013,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,678669,CYP3A37,https://ctdbase.org/detail.go?type=gene&acc=678669,,,678669.0,,9103,Meleagris gallopavo (turkey),"Ethinyl estradiol inhibits the reaction [[CYP3A37 protein results in increased metabolism of aflatoxin B1] which results in increased chemical synthesis of aflatoxin B1-2,3-oxide]|ethinyl estradiol inhibits the reaction [[CYP3A37 protein results in increased metabolism of aflatoxin B1] which results in increased chemical synthesis of aflatoxin Q1]|[CYP3A37 protein results in increased metabolism of aflatoxin B1] which results in increased chemical synthesis of aflatoxin Q1",,,PMID:20707407,https://www.ncbi.nlm.nih.gov/pubmed/20707407,20707407,,
2068,1440014,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,678669,CYP3A37,https://ctdbase.org/detail.go?type=gene&acc=678669,,,678669.0,,9103,Meleagris gallopavo (turkey),CYP3A37 results in increased activity of aflatoxin B1,,,PMID:21876218,https://www.ncbi.nlm.nih.gov/pubmed/21876218,21876218,,
2069,1440015,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9031,Gallus gallus (chicken),Aflatoxin B1 results in increased expression of CYP3A4 mRNA,,,PMID:29327633,https://www.ncbi.nlm.nih.gov/pubmed/29327633,29327633,,
2070,1440016,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of CYP3A4 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2071,1440017,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),Aflatoxin B1 promotes the reaction [NR1I2 protein binds to CYP3A4 promoter],,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
2072,1445773,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8531,YBX3,https://ctdbase.org/detail.go?type=gene&acc=8531,,,8531.0,YBX3,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of YBX3 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2073,1445774,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8531,YBX3,https://ctdbase.org/detail.go?type=gene&acc=8531,,,8531.0,YBX3,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of YBX3 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2074,1445775,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8531,YBX3,https://ctdbase.org/detail.go?type=gene&acc=8531,,,8531.0,YBX3,10090,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of YBX3 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2075,1445776,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55689,YEATS2,https://ctdbase.org/detail.go?type=gene&acc=55689,,,55689.0,YEATS2,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of YEATS2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2076,1445777,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55689,YEATS2,https://ctdbase.org/detail.go?type=gene&acc=55689,,,55689.0,YEATS2,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of YEATS2 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2077,1445778,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7525,YES1,https://ctdbase.org/detail.go?type=gene&acc=7525,,,7525.0,YES1,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of YES1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2078,1445779,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7525,YES1,https://ctdbase.org/detail.go?type=gene&acc=7525,,,7525.0,YES1,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of YES1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2079,1445780,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7525,YES1,https://ctdbase.org/detail.go?type=gene&acc=7525,,,7525.0,YES1,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of YES1 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2080,1446326,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7709,ZBTB17,https://ctdbase.org/detail.go?type=gene&acc=7709,,,7709.0,ZBTB17,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZBTB17 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2081,1446327,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,7709,ZBTB17,https://ctdbase.org/detail.go?type=gene&acc=7709,,,7709.0,ZBTB17,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZBTB17 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2082,1446328,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,26137,ZBTB20,https://ctdbase.org/detail.go?type=gene&acc=26137,,,26137.0,ZBTB20,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of ZBTB20 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
2083,1446329,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,26137,ZBTB20,https://ctdbase.org/detail.go?type=gene&acc=26137,,,26137.0,ZBTB20,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of ZBTB20 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
2084,1446330,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,26137,ZBTB20,https://ctdbase.org/detail.go?type=gene&acc=26137,,,26137.0,ZBTB20,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of ZBTB20 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
2085,1446331,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,26137,ZBTB20,https://ctdbase.org/detail.go?type=gene&acc=26137,,,26137.0,ZBTB20,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZBTB20 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2086,1446332,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,26137,ZBTB20,https://ctdbase.org/detail.go?type=gene&acc=26137,,,26137.0,ZBTB20,10090,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of ZBTB20 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2087,1446333,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,49854,ZBTB21,https://ctdbase.org/detail.go?type=gene&acc=49854,,,49854.0,ZBTB21,10090,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of ZBTB21 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2088,1446334,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,57684,ZBTB26,https://ctdbase.org/detail.go?type=gene&acc=57684,,,57684.0,ZBTB26,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of ZBTB26 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2089,1447863,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,224691,ZFP472,https://ctdbase.org/detail.go?type=gene&acc=224691,,,224691.0,Zfp472,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP472 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2090,1447864,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,287361,ZFP496,https://ctdbase.org/detail.go?type=gene&acc=287361,,,287361.0,Zfp496,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of ZFP496 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2091,1447865,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,22709,ZFP51,https://ctdbase.org/detail.go?type=gene&acc=22709,,,22709.0,Zfp51,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased mutagenesis of ZFP51 gene,,,PMID:36908029,https://www.ncbi.nlm.nih.gov/pubmed/36908029,36908029,,
2092,1447866,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,69752,ZFP511,https://ctdbase.org/detail.go?type=gene&acc=69752,,,69752.0,Zfp511,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP511 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2093,1447867,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,269639,ZFP512,https://ctdbase.org/detail.go?type=gene&acc=269639,,,269639.0,Zfp512,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP512 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2094,1447868,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,22710,ZFP52,https://ctdbase.org/detail.go?type=gene&acc=22710,,,22710.0,Zfp52,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP52 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2095,1447869,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,24132,ZFP53,https://ctdbase.org/detail.go?type=gene&acc=24132,,,24132.0,Zfp53,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP53 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2096,1448092,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,78834,ZFP623,https://ctdbase.org/detail.go?type=gene&acc=78834,,,78834.0,Zfp623,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of ZFP623 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2097,1448093,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,18139,ZFP638,https://ctdbase.org/detail.go?type=gene&acc=18139,,,18139.0,Zfp638,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP638 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2098,1448094,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55734,ZFP64,https://ctdbase.org/detail.go?type=gene&acc=55734,,,55734.0,ZFP64,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of ZFP64 mRNA,,,PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/25378103,25378103,,
2099,1448095,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,52397,ZFP644,https://ctdbase.org/detail.go?type=gene&acc=52397,,,52397.0,Zfp644,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP644 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2100,1448096,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,235907,ZFP65,https://ctdbase.org/detail.go?type=gene&acc=235907,,,235907.0,Zfp65,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP65 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2101,1448097,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,72611,ZFP655,https://ctdbase.org/detail.go?type=gene&acc=72611,,,72611.0,Zfp655,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP655 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2102,1448098,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,72180,ZFP661,https://ctdbase.org/detail.go?type=gene&acc=72180,,,72180.0,Zfp661,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP661 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2103,1448099,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,269704,ZFP664,https://ctdbase.org/detail.go?type=gene&acc=269704,,,269704.0,Zfp664,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP664 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2104,1448100,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,24135,ZFP68,https://ctdbase.org/detail.go?type=gene&acc=24135,,,24135.0,Zfp68,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP68 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2105,1448101,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,69234,ZFP688,https://ctdbase.org/detail.go?type=gene&acc=69234,,,69234.0,Zfp688,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of ZFP688 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
2106,1448755,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55345,ZGRF1,https://ctdbase.org/detail.go?type=gene&acc=55345,,,55345.0,ZGRF1,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of ZGRF1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
2107,1448756,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,55345,ZGRF1,https://ctdbase.org/detail.go?type=gene&acc=55345,,,55345.0,ZGRF1,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of ZGRF1 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2108,1448757,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,22882,ZHX2,https://ctdbase.org/detail.go?type=gene&acc=22882,,,22882.0,ZHX2,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of ZHX2 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
2109,1448758,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23051,ZHX3,https://ctdbase.org/detail.go?type=gene&acc=23051,,,23051.0,ZHX3,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of ZHX3 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
2110,1454847,219564,IUPHAR/BPS Guide to PHARMACOLOGY,4-[[(8-Hydroxyquinolin-7-yl)-phenylmethyl]amino]benzoic acid,8556,compound 3 [PMID: 17942791],https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8556,2412,Ras converting CAAX endopeptidase 1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2412,Q9Y256,CAAX prenyl protease 2,9986.0,RCE1,9606,Homo sapiens (human),Inhibition,pIC50,5.05,PMID:17942791,https://www.ncbi.nlm.nih.gov/pubmed/17942791,17942791,,
2111,1454848,219925,Drug Gene Interaction database (DGIdb),"2-Naphthalenesulfonic acid, 7-[p-(p-aminobenzamido)benzamido]-4-hydroxy-",,CHEMBL:CHEMBL483302,https://www.dgidb.org/drugs/chembl:CHEMBL483302,,ENPP2,https://www.dgidb.org/genes/hgnc:3357,,,5168.0,ENPP2,9606,Homo sapiens (human),,,,,,,,
2112,1454849,221493,Drug Gene Interaction database (DGIdb),Cholic Acid,,CHOLIC ACID,https://www.dgidb.org/drugs/rxcui:1440856,,HSD3B7,https://www.dgidb.org/genes/hgnc:18324,,,80270.0,HSD3B7,9606,Homo sapiens (human),,,,,,,,
2113,1454850,222865,Therapeutic Target Database (TTD),Androstanedione,D0T5MO,"5alpha-Androstan-3,17-Dione",https://idrblab.net/ttd/data/drug/details/D0T5MO,T40628,Hydroxysteroid dehydrogenase 3-beta (HSD3B),https://idrblab.net/ttd/data/target/details/T40628,P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,3283.0,HSD3B1,9606,Homo sapiens (human),Inhibitor,,,,,,,
2114,1445003,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,134,ADORA1,https://ctdbase.org/detail.go?type=gene&acc=134,,,134.0,ADORA1,9606,Homo sapiens (human),"1,1-bis(4-hydroxyphenyl)cyclohexane results in increased expression of ADORA1 mRNA",,,PMID:32387340,https://www.ncbi.nlm.nih.gov/pubmed/32387340,32387340,,
2115,1445004,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,155465,AGR3,https://ctdbase.org/detail.go?type=gene&acc=155465,,,155465.0,AGR3,9606,Homo sapiens (human),"1,1-bis(4-hydroxyphenyl)cyclohexane results in increased expression of AGR3 mRNA",,,PMID:28591870,https://www.ncbi.nlm.nih.gov/pubmed/28591870,28591870,,
2116,1445005,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,220,ALDH1A3,https://ctdbase.org/detail.go?type=gene&acc=220,,,220.0,ALDH1A3,9606,Homo sapiens (human),"1,1-bis(4-hydroxyphenyl)cyclohexane results in decreased expression of ALDH1A3 mRNA",,,PMID:28591870,https://www.ncbi.nlm.nih.gov/pubmed/28591870,28591870,,
2117,1445006,232446,Comparative Toxicogenomics Database (CTD),"1,1-Bis(4-hydroxyphenyl)cyclohexane",C517113,"1,1-bis(4-hydroxyphenyl)cyclohexane",https://ctdbase.org/detail.go?type=chem&acc=C517113,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,9606,Homo sapiens (human),"1,1-bis(4-hydroxyphenyl)cyclohexane inhibits the reaction [dihydrotestosterone binds to and results in increased activity of AR protein]",,,PMID:27561732,https://www.ncbi.nlm.nih.gov/pubmed/27561732,27561732,,
2118,1443887,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,28998,MRPL13,https://ctdbase.org/detail.go?type=gene&acc=28998,,,28998.0,MRPL13,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of MRPL13 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
2119,1443888,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,55052,MRPL20,https://ctdbase.org/detail.go?type=gene&acc=55052,,,55052.0,MRPL20,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of MRPL20 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
2120,1445007,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,5827,PXMP2,https://ctdbase.org/detail.go?type=gene&acc=5827,,,5827.0,PXMP2,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of PXMP2 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
2121,1445008,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,84795,PYROXD2,https://ctdbase.org/detail.go?type=gene&acc=84795,,,84795.0,PYROXD2,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of PYROXD2 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
2122,1445009,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,100996939,PYURF,https://ctdbase.org/detail.go?type=gene&acc=100996939,,,100996939.0,PYURF,10116,Rattus norvegicus (Norway rat),Aconitine results in increased expression of PYURF protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
2123,1445010,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,5860,QDPR,https://ctdbase.org/detail.go?type=gene&acc=5860,,,5860.0,QDPR,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of QDPR protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
2124,1445011,245005,Comparative Toxicogenomics Database (CTD),Aconitine,D000157,Aconitine,https://ctdbase.org/detail.go?type=chem&acc=D000157,10890,RAB10,https://ctdbase.org/detail.go?type=gene&acc=10890,,,10890.0,RAB10,10116,Rattus norvegicus (Norway rat),Aconitine results in decreased expression of RAB10 protein,,,PMID:33236894,https://www.ncbi.nlm.nih.gov/pubmed/33236894,33236894,,
2125,1458702,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,54510,PCDH18,https://ctdbase.org/detail.go?type=gene&acc=54510,,,54510.0,PCDH18,9606,Homo sapiens (human),NSC668394 results in decreased expression of PCDH18 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2126,1458703,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,84108,PCGF6,https://ctdbase.org/detail.go?type=gene&acc=84108,,,84108.0,PCGF6,9606,Homo sapiens (human),NSC668394 results in increased expression of PCGF6 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2127,1458704,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,5106,PCK2,https://ctdbase.org/detail.go?type=gene&acc=5106,,,5106.0,PCK2,9606,Homo sapiens (human),NSC668394 results in increased expression of PCK2 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2128,1458705,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,57161,PELI2,https://ctdbase.org/detail.go?type=gene&acc=57161,,,57161.0,PELI2,9606,Homo sapiens (human),NSC668394 results in increased expression of PELI2 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2129,1458706,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,5209,PFKFB3,https://ctdbase.org/detail.go?type=gene&acc=5209,,,5209.0,PFKFB3,9606,Homo sapiens (human),NSC668394 results in increased expression of PFKFB3 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2130,1458707,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,80119,PIF1,https://ctdbase.org/detail.go?type=gene&acc=80119,,,80119.0,PIF1,9606,Homo sapiens (human),NSC668394 results in decreased expression of PIF1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2131,1458915,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,100164616,PPAP2A,https://ctdbase.org/detail.go?type=gene&acc=100164616,,,100164616.0,,9606,Homo sapiens (human),NSC668394 results in decreased expression of PPAP2A mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2132,1459269,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,121268,RHEBL1,https://ctdbase.org/detail.go?type=gene&acc=121268,,,121268.0,RHEBL1,9606,Homo sapiens (human),NSC668394 results in increased expression of RHEBL1 mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2133,1459270,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,388,RHOB,https://ctdbase.org/detail.go?type=gene&acc=388,,,388.0,RHOB,9606,Homo sapiens (human),NSC668394 results in increased expression of RHOB mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2134,1459271,381594,Comparative Toxicogenomics Database (CTD),"7-((2-(3,5-Dibromo-4-hydroxyphenyl)ethyl)amino)-5,8-quinolinedione",C570897,NSC668394,https://ctdbase.org/detail.go?type=chem&acc=C570897,125050,RN7SK,https://ctdbase.org/detail.go?type=gene&acc=125050,,,125050.0,RN7SK,9606,Homo sapiens (human),NSC668394 results in increased expression of RN7SK mRNA,,,PMID:27137931,https://www.ncbi.nlm.nih.gov/pubmed/27137931,27137931,,
2135,1463059,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,10678,B3GNT2,https://ctdbase.org/detail.go?type=gene&acc=10678,,,10678.0,B3GNT2,9606,Homo sapiens (human),Bortezomib results in decreased expression of B3GNT2 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
2136,1463060,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,9331,B4GALT6,https://ctdbase.org/detail.go?type=gene&acc=9331,,,9331.0,B4GALT6,9606,Homo sapiens (human),Bortezomib results in increased expression of B4GALT6 mRNA,,,PMID:20977926,https://www.ncbi.nlm.nih.gov/pubmed/20977926,20977926,,
2137,1463061,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,9531,BAG3,https://ctdbase.org/detail.go?type=gene&acc=9531,,,9531.0,BAG3,9606,Homo sapiens (human),Bortezomib results in increased expression of BAG3 mRNA,,,PMID:15509775|PMID:17659339|PMID:20471514,https://www.ncbi.nlm.nih.gov/pubmed/15509775|https://www.ncbi.nlm.nih.gov/pubmed/17659339|https://www.ncbi.nlm.nih.gov/pubmed/20471514,15509775|17659339|20471514,,
2138,1463062,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,9606,Homo sapiens (human),Bortezomib results in increased expression of BAK1 protein|bak1 affects the reaction [bortezomib results in increased susceptibility to and results in increased activity of TNFSF10 protein],,,PMID:17326159,https://www.ncbi.nlm.nih.gov/pubmed/17326159,17326159,,
2139,1463063,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,9606,Homo sapiens (human),[nutlin 3 co-treated with bortezomib] results in increased activity of BAK1 protein,,,PMID:20850924,https://www.ncbi.nlm.nih.gov/pubmed/20850924,20850924,,
2140,1463064,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578.0,BAK1,10090,Mus musculus (house mouse),BAK1 protein results in increased susceptibility to [bortezomib co-treated with TNFSF10 protein],,,PMID:12902978,https://www.ncbi.nlm.nih.gov/pubmed/12902978,12902978,,
2141,1463065,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,580,BARD1,https://ctdbase.org/detail.go?type=gene&acc=580,,,580.0,BARD1,9606,Homo sapiens (human),BARD1 mutant form results in increased susceptibility to bortezomib,,,PMID:25522274,https://www.ncbi.nlm.nih.gov/pubmed/25522274,25522274,,
2142,1463066,387447,Comparative Toxicogenomics Database (CTD),Bortezomib,D000069286,Bortezomib,https://ctdbase.org/detail.go?type=chem&acc=D000069286,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,9606,Homo sapiens (human),BAX results in increased susceptibility to [bortezomib co-treated with panobinostat],,,PMID:18445700,https://www.ncbi.nlm.nih.gov/pubmed/18445700,18445700,,
2143,1441964,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,404039,NPSN,https://ctdbase.org/detail.go?type=gene&acc=404039,,,404039.0,npsn,7955,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of NPSN mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
2144,1441965,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4885,NPTX2,https://ctdbase.org/detail.go?type=gene&acc=4885,,,4885.0,NPTX2,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of NPTX2 mRNA,,,PMID:23179753|PMID:26272509|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|28001369,,
2145,1441966,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4885,NPTX2,https://ctdbase.org/detail.go?type=gene&acc=4885,,,4885.0,NPTX2,9606,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NPTX2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
2146,1441967,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4852,NPY,https://ctdbase.org/detail.go?type=gene&acc=4852,,,4852.0,NPY,10090,Mus musculus (house mouse),Methylmercuric chloride results in decreased expression of NPY mRNA,,,PMID:33301842|PMID:33338554,https://www.ncbi.nlm.nih.gov/pubmed/33301842|https://www.ncbi.nlm.nih.gov/pubmed/33338554,33301842|33338554,,
2147,1441968,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4886,NPY1R,https://ctdbase.org/detail.go?type=gene&acc=4886,,,4886.0,NPY1R,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NPY1R mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
2148,1441969,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,4887,NPY2R,https://ctdbase.org/detail.go?type=gene&acc=4887,,,4887.0,NPY2R,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of NPY2R mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
2149,1441970,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5540,NPY4R,https://ctdbase.org/detail.go?type=gene&acc=5540,,,5540.0,NPY4R,10090,Mus musculus (house mouse),Methylmercuric chloride results in decreased expression of NPY4R mRNA,,,PMID:21385734,https://www.ncbi.nlm.nih.gov/pubmed/21385734,21385734,,
2150,1441971,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of NQO1 mRNA,,,PMID:23179753|PMID:26272509|PMID:27188386|PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509|https://www.ncbi.nlm.nih.gov/pubmed/27188386|https://www.ncbi.nlm.nih.gov/pubmed/28001369,23179753|26272509|27188386|28001369,,
2151,1442647,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,515,ATP5PB,https://ctdbase.org/detail.go?type=gene&acc=515,,,515.0,ATP5PB,9483,Callithrix jacchus (white-tufted-ear marmoset),Methylmercuric chloride affects the expression of ATP5PB protein,,,PMID:27012723,https://www.ncbi.nlm.nih.gov/pubmed/27012723,27012723,,
2152,1442648,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,245972,ATP6V0D2,https://ctdbase.org/detail.go?type=gene&acc=245972,,,245972.0,ATP6V0D2,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ATP6V0D2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
2153,1442649,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,155066,ATP6V0E2,https://ctdbase.org/detail.go?type=gene&acc=155066,,,155066.0,ATP6V0E2,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ATP6V0E2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
2154,1442650,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,528,ATP6V1C1,https://ctdbase.org/detail.go?type=gene&acc=528,,,528.0,ATP6V1C1,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of ATP6V1C1 mrna|methylmercuric chloride results in decreased expression of ATP6V1C1 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
2155,1442651,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,51382,ATP6V1D,https://ctdbase.org/detail.go?type=gene&acc=51382,,,51382.0,ATP6V1D,9483,Callithrix jacchus (white-tufted-ear marmoset),Methylmercuric chloride results in decreased expression of ATP6V1D protein,,,PMID:25809596,https://www.ncbi.nlm.nih.gov/pubmed/25809596,25809596,,
2156,1442652,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,534,ATP6V1G2,https://ctdbase.org/detail.go?type=gene&acc=534,,,534.0,ATP6V1G2,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ATP6V1G2 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
2157,1442653,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,51606,ATP6V1H,https://ctdbase.org/detail.go?type=gene&acc=51606,,,51606.0,ATP6V1H,9483,Callithrix jacchus (white-tufted-ear marmoset),Methylmercuric chloride results in decreased expression of ATP6V1H protein,,,PMID:25809596,https://www.ncbi.nlm.nih.gov/pubmed/25809596,25809596,,
2158,1442654,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,538,ATP7A,https://ctdbase.org/detail.go?type=gene&acc=538,,,538.0,ATP7A,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of ATP7A mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
2159,1442655,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,538,ATP7A,https://ctdbase.org/detail.go?type=gene&acc=538,,,538.0,ATP7A,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of ATP7A mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
2160,1443184,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,181899,B0281.5,https://ctdbase.org/detail.go?type=gene&acc=181899,,,181899.0,B0281.5,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of B0281.5 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
2161,1443185,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,175566,B0284.3,https://ctdbase.org/detail.go?type=gene&acc=175566,,,175566.0,B0284.3,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of B0284.3 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
2162,1443186,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,176222,B0303.11,https://ctdbase.org/detail.go?type=gene&acc=176222,,,176222.0,B0303.11,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of B0303.11 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
2163,1443187,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,181930,B0334.10,https://ctdbase.org/detail.go?type=gene&acc=181930,,,181930.0,B0334.10,6239,Caenorhabditis elegans,Methylmercuric chloride results in increased expression of B0334.10 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
2164,1443188,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,3565810,B0334.13,https://ctdbase.org/detail.go?type=gene&acc=3565810,,,3565810.0,B0334.13,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of B0334.13 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
2165,1444412,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),Thioctic acid inhibits the reaction [methylmercuric chloride results in decreased expression of BCL2 protein]|methylmercuric chloride results in decreased expression of BCL2 mrna|thioctic acid inhibits the reaction [methylmercuric chloride results in decreased expression of BCL2 mrna],,,PMID:32061141,https://www.ncbi.nlm.nih.gov/pubmed/32061141,32061141,,
2166,1444413,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596.0,BCL2,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride results in decreased expression of BCL2 protein,,,PMID:28821999|PMID:32061141|PMID:35678294,https://www.ncbi.nlm.nih.gov/pubmed/28821999|https://www.ncbi.nlm.nih.gov/pubmed/32061141|https://www.ncbi.nlm.nih.gov/pubmed/35678294,28821999|32061141|35678294,,
2167,1444414,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,598,BCL2L1,https://ctdbase.org/detail.go?type=gene&acc=598,,,598.0,BCL2L1,7955,Danio rerio (zebrafish),Methylmercuric chloride results in increased expression of BCL2L1 mRNA,,,PMID:23458150,https://www.ncbi.nlm.nih.gov/pubmed/23458150,23458150,,
2168,1448341,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,181490,PIX-1,https://ctdbase.org/detail.go?type=gene&acc=181490,,,181490.0,pix-1,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of PIX-1 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
2169,1448342,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,91461,PKDCC,https://ctdbase.org/detail.go?type=gene&acc=91461,,,91461.0,PKDCC,9606,Homo sapiens (human),Methylmercuric chloride results in increased expression of PKDCC mRNA,,,PMID:23179753|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/23179753|https://www.ncbi.nlm.nih.gov/pubmed/26272509,23179753|26272509,,
2170,1448343,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,91461,PKDCC,https://ctdbase.org/detail.go?type=gene&acc=91461,,,91461.0,PKDCC,9606,Homo sapiens (human),"[NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PKDCC mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
2171,1448344,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,177659,PKG-2,https://ctdbase.org/detail.go?type=gene&acc=177659,,,177659.0,pkg-2,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of PKG-2 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
2172,1448345,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,93035,PKHD1L1,https://ctdbase.org/detail.go?type=gene&acc=93035,,,93035.0,PKHD1L1,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in decreased expression of PKHD1L1 mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
2173,1448346,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5570,PKIB,https://ctdbase.org/detail.go?type=gene&acc=5570,,,5570.0,PKIB,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of PKIB mRNA,,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
2174,1448347,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,5313,PKLR,https://ctdbase.org/detail.go?type=gene&acc=5313,,,5313.0,PKLR,8049,Gadus morhua (Atlantic cod),Methylmercuric chloride results in increased expression of PKLR mRNA,,,PMID:23103053,https://www.ncbi.nlm.nih.gov/pubmed/23103053,23103053,,
2175,1458211,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,35948,CYP4P3,https://ctdbase.org/detail.go?type=gene&acc=35948,,,35948.0,Cyp4p3,7227,Drosophila melanogaster (fruit fly),[methylmercuric chloride results in decreased susceptibility to methylmercuric chloride] which results in decreased expression of CYP4P3 mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
2176,1458212,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,35837,CYP6A13,https://ctdbase.org/detail.go?type=gene&acc=35837,,,35837.0,Cyp6a13,7227,Drosophila melanogaster (fruit fly),Methylmercuric chloride results in decreased expression of CYP6A13 mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
2177,1458213,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,36317,CYP6G2,https://ctdbase.org/detail.go?type=gene&acc=36317,,,36317.0,Cyp6g2,7227,Drosophila melanogaster (fruit fly),Methylmercuric chloride results in decreased expression of CYP6G2 mRNA,,,PMID:20375079,https://www.ncbi.nlm.nih.gov/pubmed/20375079,20375079,,
2178,1458214,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,9420,CYP7B1,https://ctdbase.org/detail.go?type=gene&acc=9420,,,9420.0,CYP7B1,10116,Rattus norvegicus (Norway rat),Methylmercuric chloride results in decreased expression of CYP7B1 mRNA,,,PMID:20864626,https://www.ncbi.nlm.nih.gov/pubmed/20864626,20864626,,
2179,1458215,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,78996,CYREN,https://ctdbase.org/detail.go?type=gene&acc=78996,,,78996.0,CYREN,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of CYREN mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
2180,1462507,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,1760,DMPK,https://ctdbase.org/detail.go?type=gene&acc=1760,,,1760.0,DMPK,10090,Mus musculus (house mouse),DMPK results in decreased susceptibility to methylmercuric chloride,,,PMID:9694217,https://www.ncbi.nlm.nih.gov/pubmed/9694217,9694217,,
2181,1462508,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,58524,DMRT3,https://ctdbase.org/detail.go?type=gene&acc=58524,,,58524.0,DMRT3,9606,Homo sapiens (human),Methylmercuric chloride results in decreased expression of DMRT3 mRNA,,,PMID:28001369,https://www.ncbi.nlm.nih.gov/pubmed/28001369,28001369,,
2182,1464758,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,177210,FBXB-74,https://ctdbase.org/detail.go?type=gene&acc=177210,,,177210.0,fbxb-74,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-74 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
2183,1464759,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,3565845,FBXB-75,https://ctdbase.org/detail.go?type=gene&acc=3565845,,,3565845.0,fbxb-75,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-75 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
2184,1464760,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,189469,FBXB-77,https://ctdbase.org/detail.go?type=gene&acc=189469,,,189469.0,fbxb-77,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-77 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
2185,1464761,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,184032,FBXB-78,https://ctdbase.org/detail.go?type=gene&acc=184032,,,184032.0,fbxb-78,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-78 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
2186,1464762,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188566,FBXB-82,https://ctdbase.org/detail.go?type=gene&acc=188566,,,188566.0,fbxb-82,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-82 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
2187,1464763,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,188568,FBXB-84,https://ctdbase.org/detail.go?type=gene&acc=188568,,,188568.0,fbxb-84,6239,Caenorhabditis elegans,Methylmercuric chloride results in decreased expression of FBXB-84 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
2188,1464764,409301,Comparative Toxicogenomics Database (CTD),Methylmercury chloride,C004925,methylmercuric chloride,https://ctdbase.org/detail.go?type=chem&acc=C004925,189002,FBXB-86,https://ctdbase.org/detail.go?type=gene&acc=189002,,,189002.0,fbxb-86,6239,Caenorhabditis elegans,FBXB-86 protein results in decreased susceptibility to methylmercuric chloride|methylmercuric chloride results in increased expression of FBXB-86 mRNA,,,PMID:24118919,https://www.ncbi.nlm.nih.gov/pubmed/24118919,24118919,,
2189,1452814,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),Lithium chloride inhibits the reaction [tretinoin results in increased degradation of and results in decreased expression of CCND1 protein],,,PMID:16024653,https://www.ncbi.nlm.nih.gov/pubmed/16024653,16024653,,
2190,1452815,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),[lithium chloride results in decreased activity of GSK3B protein] inhibits the reaction [sirolimus results in decreased expression of CCND1 protein],,,PMID:15753396,https://www.ncbi.nlm.nih.gov/pubmed/15753396,15753396,,
2191,1452816,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),Lithium chloride results in decreased expression of CCND1 protein,,,PMID:19196980,https://www.ncbi.nlm.nih.gov/pubmed/19196980,19196980,,
2192,1452817,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),Lithium chloride results in decreased phosphorylation of CCND1 protein,,,PMID:16076840,https://www.ncbi.nlm.nih.gov/pubmed/16076840,16076840,,
2193,1452818,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),Lithium chloride results in increased expression of CCND1 mRNA,,,PMID:17440966|PMID:20074550|PMID:22493441,https://www.ncbi.nlm.nih.gov/pubmed/17440966|https://www.ncbi.nlm.nih.gov/pubmed/20074550|https://www.ncbi.nlm.nih.gov/pubmed/22493441,17440966|20074550|22493441,,
2194,1452819,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,9606,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [lithium chloride results in increased expression of CCND1 mrna],,,PMID:22493441,https://www.ncbi.nlm.nih.gov/pubmed/22493441,22493441,,
2195,1452820,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595.0,CCND1,10090,Mus musculus (house mouse),Lithium chloride inhibits the reaction [progesterone inhibits the reaction [estradiol affects the localization of CCND1 protein]],,,PMID:15845746,https://www.ncbi.nlm.nih.gov/pubmed/15845746,15845746,,
2196,1453388,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,999,CDH1,https://ctdbase.org/detail.go?type=gene&acc=999,,,999.0,CDH1,9606,Homo sapiens (human),Lithium chloride results in decreased expression of CDH1 protein,,,PMID:32112862|PMID:35985571,https://www.ncbi.nlm.nih.gov/pubmed/32112862|https://www.ncbi.nlm.nih.gov/pubmed/35985571,32112862|35985571,,
2197,1453389,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1009,CDH11,https://ctdbase.org/detail.go?type=gene&acc=1009,,,1009.0,CDH11,9606,Homo sapiens (human),CTNNB1 protein affects the reaction [[lithium chloride results in decreased activity of GSK3B protein] which results in decreased expression of CDH11 protein]|[lithium chloride results in decreased activity of GSK3B protein] which results in decreased expression of CDH11 protein|[lithium chloride results in decreased activity of GSK3B protein] which results in decreased expression of CDH11 mRNA,,,PMID:19274078,https://www.ncbi.nlm.nih.gov/pubmed/19274078,19274078,,
2198,1453390,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1000,CDH2,https://ctdbase.org/detail.go?type=gene&acc=1000,,,1000.0,CDH2,9606,Homo sapiens (human),Lithium chloride results in increased expression of CDH2 protein|lithium chloride inhibits the reaction [thymoquinone results in decreased expression of CDH2 protein],,,PMID:32112862,https://www.ncbi.nlm.nih.gov/pubmed/32112862,32112862,,
2199,1453391,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1000,CDH2,https://ctdbase.org/detail.go?type=gene&acc=1000,,,1000.0,CDH2,9606,Homo sapiens (human),Lithium chloride results in decreased expression of CDH2 mRNA,,,PMID:23527032,https://www.ncbi.nlm.nih.gov/pubmed/23527032,23527032,,
2200,1453392,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,9606,Homo sapiens (human),Lithium chloride results in increased expression of CDKN1A mRNA,,,PMID:17440966,https://www.ncbi.nlm.nih.gov/pubmed/17440966,17440966,,
2201,1457632,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10090,Mus musculus (house mouse),Lithium chloride promotes the reaction [cisplatin results in increased phosphorylation of GSK3B protein]|[lithium chloride co-treated with cisplatin] results in increased phosphorylation of GSK3B protein,,,PMID:31220555,https://www.ncbi.nlm.nih.gov/pubmed/31220555,31220555,,
2202,1457633,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10090,Mus musculus (house mouse),Lithium chloride results in decreased activity of GSK3B protein,,,PMID:15364539|PMID:15585669|PMID:19442631|PMID:20694829,https://www.ncbi.nlm.nih.gov/pubmed/15364539|https://www.ncbi.nlm.nih.gov/pubmed/15585669|https://www.ncbi.nlm.nih.gov/pubmed/19442631|https://www.ncbi.nlm.nih.gov/pubmed/20694829,15364539|15585669|19442631|20694829,,
2203,1457634,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10090,Mus musculus (house mouse),[lithium chloride results in decreased activity of GSK3B protein] which results in increased expression of AHR mrna|[lithium chloride results in decreased activity of GSK3B protein] which results in increased expression of AXIN2 mRNA,,,PMID:21498875,https://www.ncbi.nlm.nih.gov/pubmed/21498875,21498875,,
2204,1457635,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10090,Mus musculus (house mouse),Lithium chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein,,,PMID:19440036|PMID:19582394,https://www.ncbi.nlm.nih.gov/pubmed/19440036|https://www.ncbi.nlm.nih.gov/pubmed/19582394,19440036|19582394,,
2205,1457636,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10090,Mus musculus (house mouse),[lithium chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] which results in decreased expression of SNAI1 protein,,,PMID:19440036,https://www.ncbi.nlm.nih.gov/pubmed/19440036,19440036,,
2206,1457860,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10090,Mus musculus (house mouse),[[lithium chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased localization of CTNNB1 protein] which results in increased expression of GIP mrna|[lithium chloride results in increased phosphorylation of and results in decreased activity of GSK3B protein] which results in increased localization of CTNNB1 protein,,,PMID:19582394,https://www.ncbi.nlm.nih.gov/pubmed/19582394,19582394,,
2207,1457861,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10090,Mus musculus (house mouse),Lithium chloride results in increased stability of GSK3B protein,,,PMID:19448134,https://www.ncbi.nlm.nih.gov/pubmed/19448134,19448134,,
2208,1457862,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116,Rattus norvegicus (Norway rat),Calyculin A promotes the reaction [lithium chloride results in increased phosphorylation of GSK3B protein],,,PMID:12813129,https://www.ncbi.nlm.nih.gov/pubmed/12813129,12813129,,
2209,1457863,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116,Rattus norvegicus (Norway rat),Lithium chloride affects the phosphorylation of GSK3B protein,,,PMID:21364661,https://www.ncbi.nlm.nih.gov/pubmed/21364661,21364661,,
2210,1457864,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116,Rattus norvegicus (Norway rat),Lithium chloride inhibits the reaction [manganese chloride results in decreased phosphorylation of and results in increased activity of GSK3B protein],,,PMID:24464479,https://www.ncbi.nlm.nih.gov/pubmed/24464479,24464479,,
2211,1457865,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116,Rattus norvegicus (Norway rat),Lithium chloride inhibits the reaction [matrines results in decreased phosphorylation of GSK3B protein],,,PMID:37075934,https://www.ncbi.nlm.nih.gov/pubmed/37075934,37075934,,
2212,1457866,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116,Rattus norvegicus (Norway rat),Lithium chloride inhibits the reaction [sevoflurane results in decreased phosphorylation of GSK3B protein],,,PMID:20807582,https://www.ncbi.nlm.nih.gov/pubmed/20807582,20807582,,
2213,1457867,433294,Comparative Toxicogenomics Database (CTD),Lithium Chloride,D018021,Lithium Chloride,https://ctdbase.org/detail.go?type=chem&acc=D018021,2932,GSK3B,https://ctdbase.org/detail.go?type=gene&acc=2932,,,2932.0,GSK3B,10116,Rattus norvegicus (Norway rat),Lithium chloride inhibits the reaction [triptolide results in increased phosphorylation of GSK3B protein],,,PMID:30926361,https://www.ncbi.nlm.nih.gov/pubmed/30926361,30926361,,
2214,1456481,439260,Comparative Toxicogenomics Database (CTD),Norepinephrine,D009638,Norepinephrine,https://ctdbase.org/detail.go?type=chem&acc=D009638,100533418,DOP1,https://ctdbase.org/detail.go?type=gene&acc=100533418,,,100533418.0,,7159,Aedes aegypti (yellow fever mosquito),Norepinephrine results in increased activity of DOP1 protein,,,PMID:22292096,https://www.ncbi.nlm.nih.gov/pubmed/22292096,22292096,,
2215,1449978,441374,ChEMBL,Kanamycin sulfate,CHEMBL1446,KANAMYCIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1446/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7M6,50S ribosomal protein L29,948483.0,rplA,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:3054810,https://www.ncbi.nlm.nih.gov/pubmed/3054810,3054810,,
2216,1449979,441374,ChEMBL,Kanamycin sulfate,CHEMBL1446,KANAMYCIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1446/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7M9,50S ribosomal protein L31,75205501.0,rplA,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:3054810,https://www.ncbi.nlm.nih.gov/pubmed/3054810,3054810,,
2217,1449980,441374,ChEMBL,Kanamycin sulfate,CHEMBL1446,KANAMYCIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1446/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7N1,50S ribosomal protein L31 type B,945152.0,rplT,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:3054810,https://www.ncbi.nlm.nih.gov/pubmed/3054810,3054810,,
2218,1449981,441374,ChEMBL,Kanamycin sulfate,CHEMBL1446,KANAMYCIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1446/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7N4,50S ribosomal protein L32,83674610.0,,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:3054810,https://www.ncbi.nlm.nih.gov/pubmed/3054810,3054810,,
2219,1449982,441374,ChEMBL,Kanamycin sulfate,CHEMBL1446,KANAMYCIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1446/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7N9,50S ribosomal protein L33,945190.0,rpmA,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:3054810,https://www.ncbi.nlm.nih.gov/pubmed/3054810,3054810,,
2220,1449983,441374,ChEMBL,Kanamycin sulfate,CHEMBL1446,KANAMYCIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1446/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7P5,50S ribosomal protein L34,75206041.0,rpmA,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:3054810,https://www.ncbi.nlm.nih.gov/pubmed/3054810,3054810,,
2221,1449984,441374,ChEMBL,Kanamycin sulfate,CHEMBL1446,KANAMYCIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1446/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7Q1,50S ribosomal protein L35,946941.0,rpmB,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:3054810,https://www.ncbi.nlm.nih.gov/pubmed/3054810,3054810,,
2222,1449985,441374,ChEMBL,Kanamycin sulfate,CHEMBL1446,KANAMYCIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1446/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7Q6,50S ribosomal protein L36,83578845.0,,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:3054810,https://www.ncbi.nlm.nih.gov/pubmed/3054810,3054810,,
2223,1449986,441374,ChEMBL,Kanamycin sulfate,CHEMBL1446,KANAMYCIN SULFATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1446/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7R5,30S ribosomal protein S10,947807.0,rpmC,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:3054810,https://www.ncbi.nlm.nih.gov/pubmed/3054810,3054810,,
2224,1455712,441401,ChEMBL,Linezolid,CHEMBL126,LINEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL126/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7L8,50S ribosomal protein L27,947096.0,rplS,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:15992144,https://www.ncbi.nlm.nih.gov/pubmed/15992144,15992144,,
2225,1455713,441401,ChEMBL,Linezolid,CHEMBL126,LINEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL126/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7M2,50S ribosomal protein L28,83579846.0,,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:15992144,https://www.ncbi.nlm.nih.gov/pubmed/15992144,15992144,,
2226,1455714,441401,ChEMBL,Linezolid,CHEMBL126,LINEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL126/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7M6,50S ribosomal protein L29,948483.0,rplA,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:15992144,https://www.ncbi.nlm.nih.gov/pubmed/15992144,15992144,,
2227,1455715,441401,ChEMBL,Linezolid,CHEMBL126,LINEZOLID,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL126/,CHEMBL2363135,Bacterial 70S ribosome,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL2363135/,P0A7M9,50S ribosomal protein L31,75205501.0,rplA,2,Bacteria (eubacteria),Bacterial 70S ribosome inhibitor,,,PMID:15992144,https://www.ncbi.nlm.nih.gov/pubmed/15992144,15992144,,
2228,1453738,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,3043,HBB,https://ctdbase.org/detail.go?type=gene&acc=3043,,,3043.0,HBB,10116,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of HBB protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
2229,1453739,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,3069,HDLBP,https://ctdbase.org/detail.go?type=gene&acc=3069,,,3069.0,HDLBP,10116,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of HDLBP protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
2230,1453740,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,3146,HMGB1,https://ctdbase.org/detail.go?type=gene&acc=3146,,,3146.0,HMGB1,10116,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of HMGB1 protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
2231,1453741,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,3155,HMGCL,https://ctdbase.org/detail.go?type=gene&acc=3155,,,3155.0,HMGCL,10116,Rattus norvegicus (Norway rat),Mesaconitine results in increased expression of HMGCL protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
2232,1453742,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,3158,HMGCS2,https://ctdbase.org/detail.go?type=gene&acc=3158,,,3158.0,HMGCS2,10116,Rattus norvegicus (Norway rat),Mesaconitine results in decreased expression of HMGCS2 protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
2233,1453743,441747,Comparative Toxicogenomics Database (CTD),Mesaconitine,C019470,mesaconitine,https://ctdbase.org/detail.go?type=chem&acc=C019470,3161,HMMR,https://ctdbase.org/detail.go?type=gene&acc=3161,,,3161.0,HMMR,10116,Rattus norvegicus (Norway rat),Mesaconitine results in decreased expression of HMMR protein,,,PMID:37182599,https://www.ncbi.nlm.nih.gov/pubmed/37182599,37182599,,
2234,1460797,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Notoginsenoside R1 inhibits the reaction [APP protein modified form results in increased cleavage of CASP3 protein],,,PMID:24975829,https://www.ncbi.nlm.nih.gov/pubmed/24975829,24975829,,
2235,1460798,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Notoginsenoside R1 inhibits the reaction [hydrogen peroxide results in increased activity of CASP3 protein],,,PMID:24437944,https://www.ncbi.nlm.nih.gov/pubmed/24437944,24437944,,
2236,1460799,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Notoginsenoside R1 inhibits the reaction [lipopolysaccharides results in increased activity of CASP3 protein],,,PMID:25738436,https://www.ncbi.nlm.nih.gov/pubmed/25738436,25738436,,
2237,1460800,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836.0,CASP3,10116,Rattus norvegicus (Norway rat),Notoginsenoside R1 inhibits the reaction [[oxygen co-treated with [oxygen deficiency co-treated with glucose deficiency]] results in increased activity of CASP3 protein],,,PMID:24720662,https://www.ncbi.nlm.nih.gov/pubmed/24720662,24720662,,
2238,1461264,441934,Comparative Toxicogenomics Database (CTD),Notoginsenoside R1,C072936,notoginsenoside R1,https://ctdbase.org/detail.go?type=chem&acc=C072936,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099.0,ESR1,9606,Homo sapiens (human),Notoginsenoside R1 results in increased phosphorylation of and results in increased activity of ESR1 protein,,,PMID:26362186,https://www.ncbi.nlm.nih.gov/pubmed/26362186,26362186,,
2239,1440423,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1645,AKR1C1,https://ctdbase.org/detail.go?type=gene&acc=1645,,,1645.0,AKR1C1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of AKR1C1 protein,,,PMID:19696165,https://www.ncbi.nlm.nih.gov/pubmed/19696165,19696165,,
2240,1440424,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,105387,AKR1C14,https://ctdbase.org/detail.go?type=gene&acc=105387,,,105387.0,Akr1c14,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of AKR1C14 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
2241,1450197,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23245,ASTN2,https://ctdbase.org/detail.go?type=gene&acc=23245,,,23245.0,ASTN2,9606,Homo sapiens (human),Sodium arsenite affects the methylation of ASTN2 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
2242,1450198,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,171023,ASXL1,https://ctdbase.org/detail.go?type=gene&acc=171023,,,171023.0,ASXL1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of ASXL1 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
2243,1450429,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,9606,Homo sapiens (human),Sodium arsenite results in increased activity of ATF2 protein,,,PMID:12220541|PMID:15292961,https://www.ncbi.nlm.nih.gov/pubmed/12220541|https://www.ncbi.nlm.nih.gov/pubmed/15292961,12220541|15292961,,
2244,1450430,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,9606,Homo sapiens (human),Sodium arsenite results in increased expression of ATF2 mRNA,,,PMID:12016162|PMID:17879257|PMID:23591579|PMID:30090515,https://www.ncbi.nlm.nih.gov/pubmed/12016162|https://www.ncbi.nlm.nih.gov/pubmed/17879257|https://www.ncbi.nlm.nih.gov/pubmed/23591579|https://www.ncbi.nlm.nih.gov/pubmed/30090515,12016162|17879257|23591579|30090515,,
2245,1450431,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,9606,Homo sapiens (human),Sodium arsenite results in increased expression of ATF2 protein,,,PMID:23591579|PMID:30090515,https://www.ncbi.nlm.nih.gov/pubmed/23591579|https://www.ncbi.nlm.nih.gov/pubmed/30090515,23591579|30090515,,
2246,1450432,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,9606,Homo sapiens (human),Sodium arsenite results in increased phosphorylation of ATF2 protein,,,PMID:9728050,https://www.ncbi.nlm.nih.gov/pubmed/9728050,9728050,,
2247,1450433,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,10090,Mus musculus (house mouse),Sodium arsenite results in increased phosphorylation of ATF2 protein,,,PMID:11807808,https://www.ncbi.nlm.nih.gov/pubmed/11807808,11807808,,
2248,1450434,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,10116,Rattus norvegicus (Norway rat),Sodium arsenite promotes the reaction [[[ATF2 protein binds to ATF2 protein] which binds to PCK1 promoter] which results in increased expression of PCK1 mrna],,,PMID:9712902,https://www.ncbi.nlm.nih.gov/pubmed/9712902,9712902,,
2249,1450435,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1386,ATF2,https://ctdbase.org/detail.go?type=gene&acc=1386,,,1386.0,ATF2,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of ATF2 protein modified form,,,PMID:16797887,https://www.ncbi.nlm.nih.gov/pubmed/16797887,16797887,,
2250,1455098,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,10677,AVIL,https://ctdbase.org/detail.go?type=gene&acc=10677,,,10677.0,AVIL,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of AVIL mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2251,1455099,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23080,AVL9,https://ctdbase.org/detail.go?type=gene&acc=23080,,,23080.0,AVL9,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of AVL9 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2252,1455100,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,552,AVPR1A,https://ctdbase.org/detail.go?type=gene&acc=552,,,552.0,AVPR1A,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of AVPR1A mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
2253,1455101,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,571591,AVPR1AA,https://ctdbase.org/detail.go?type=gene&acc=571591,,,571591.0,avpr1aa,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of AVPR1AA mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2254,1455102,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,553,AVPR1B,https://ctdbase.org/detail.go?type=gene&acc=553,,,553.0,AVPR1B,9606,Homo sapiens (human),Sodium arsenite results in increased expression of AVPR1B mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
2255,1455103,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,554,AVPR2,https://ctdbase.org/detail.go?type=gene&acc=554,,,554.0,AVPR2,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of AVPR2 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
2256,1455104,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100151502,AVPR2AB,https://ctdbase.org/detail.go?type=gene&acc=100151502,,,100151502.0,avpr2ab,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of AVPR2AB mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2257,1455105,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,158833,AWAT1,https://ctdbase.org/detail.go?type=gene&acc=158833,,,158833.0,AWAT1,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of AWAT1 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
2258,1455106,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,126859,AXDND1,https://ctdbase.org/detail.go?type=gene&acc=126859,,,126859.0,AXDND1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of AXDND1 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
2259,1455107,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8312,AXIN1,https://ctdbase.org/detail.go?type=gene&acc=8312,,,8312.0,AXIN1,9606,Homo sapiens (human),Sodium arsenite affects the methylation of AXIN1 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
2260,1455374,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64343,AZI2,https://ctdbase.org/detail.go?type=gene&acc=64343,,,64343.0,AZI2,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of AZI2 mRNA,,,PMID:28595984|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|34032870,,
2261,1455375,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,113451,AZIN2,https://ctdbase.org/detail.go?type=gene&acc=113451,,,113451.0,AZIN2,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of AZIN2 mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
2262,1455707,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,391004,PRAMEF17,https://ctdbase.org/detail.go?type=gene&acc=391004,,,391004.0,PRAMEF17,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of PRAMEF17 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
2263,1455708,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,83491,PRAMEL1,https://ctdbase.org/detail.go?type=gene&acc=83491,,,83491.0,Pramel1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PRAMEL1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
2264,1455709,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,381654,PRAMEL34,https://ctdbase.org/detail.go?type=gene&acc=381654,,,381654.0,Pramel34,10090,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of PRAMEL34 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
2265,1455710,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,384077,PRAMEL5,https://ctdbase.org/detail.go?type=gene&acc=384077,,,384077.0,Pramel5,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of PRAMEL5 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
2266,1455711,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,118471,PRAP1,https://ctdbase.org/detail.go?type=gene&acc=118471,,,118471.0,PRAP1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of PRAP1 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
2267,1457637,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606,Homo sapiens (human),Sodium arsenite promotes the reaction [ethanol results in increased phosphorylation of PRKCD protein],,,PMID:18182400,https://www.ncbi.nlm.nih.gov/pubmed/18182400,18182400,,
2268,1457638,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PRKCD mRNA,,,PMID:12016162|PMID:12377979,https://www.ncbi.nlm.nih.gov/pubmed/12016162|https://www.ncbi.nlm.nih.gov/pubmed/12377979,12016162|12377979,,
2269,1457639,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of and results in increased phosphorylation of PRKCD protein|rottlerin inhibits the reaction [sodium arsenite results in increased phosphorylation of PRKCD protein]|taurine inhibits the reaction [sodium arsenite results in increased expression of and results in increased phosphorylation of PRKCD protein],,,PMID:20830294,https://www.ncbi.nlm.nih.gov/pubmed/20830294,20830294,,
2270,1457640,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5580,PRKCD,https://ctdbase.org/detail.go?type=gene&acc=5580,,,5580.0,PRKCD,9823,Sus scrofa (pig),Sodium arsenite results in increased phosphorylation of PRKCD protein,,,PMID:15089098,https://www.ncbi.nlm.nih.gov/pubmed/15089098,15089098,,
2271,1457641,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,334571,PRKCDA,https://ctdbase.org/detail.go?type=gene&acc=334571,,,334571.0,prkcda,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PRKCDA mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2272,1460515,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84249,PSD2,https://ctdbase.org/detail.go?type=gene&acc=84249,,,84249.0,PSD2,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PSD2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2273,1460516,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,84249,PSD2,https://ctdbase.org/detail.go?type=gene&acc=84249,,,84249.0,PSD2,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PSD2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
2274,1460517,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,559329,PSD3L,https://ctdbase.org/detail.go?type=gene&acc=559329,,,559329.0,psd3l,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PSD3L mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2275,1460518,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23550,PSD4,https://ctdbase.org/detail.go?type=gene&acc=23550,,,23550.0,PSD4,9606,Homo sapiens (human),Sodium arsenite affects the expression of PSD4 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
2276,1460519,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,23550,PSD4,https://ctdbase.org/detail.go?type=gene&acc=23550,,,23550.0,PSD4,9606,Homo sapiens (human),Sodium arsenite affects the methylation of PSD4 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
2277,1460520,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,570918,PSDA,https://ctdbase.org/detail.go?type=gene&acc=570918,,,570918.0,psda,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PSDA mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2278,1460521,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5663,PSEN1,https://ctdbase.org/detail.go?type=gene&acc=5663,,,5663.0,PSEN1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of PSEN1 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
2279,1460522,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5664,PSEN2,https://ctdbase.org/detail.go?type=gene&acc=5664,,,5664.0,PSEN2,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PSEN2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2280,1460523,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55851,PSENEN,https://ctdbase.org/detail.go?type=gene&acc=55851,,,55851.0,PSENEN,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PSENEN mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2281,1460524,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5669,PSG1,https://ctdbase.org/detail.go?type=gene&acc=5669,,,5669.0,PSG1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of PSG1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
2282,1460801,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,9606,Homo sapiens (human),TP53 protein promotes the reaction [sodium arsenite results in increased expression of MDM2 protein],,,PMID:20375080,https://www.ncbi.nlm.nih.gov/pubmed/20375080,20375080,,
2283,1460802,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of MDM2 protein,,,PMID:16166651,https://www.ncbi.nlm.nih.gov/pubmed/16166651,16166651,,
2284,1460803,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4193,MDM2,https://ctdbase.org/detail.go?type=gene&acc=4193,,,4193.0,MDM2,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of MDM2 mRNA,,,PMID:11353140|PMID:20477944,https://www.ncbi.nlm.nih.gov/pubmed/11353140|https://www.ncbi.nlm.nih.gov/pubmed/20477944,11353140|20477944,,
2285,1460804,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4199,ME1,https://ctdbase.org/detail.go?type=gene&acc=4199,,,4199.0,ME1,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of ME1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2286,1460805,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4199,ME1,https://ctdbase.org/detail.go?type=gene&acc=4199,,,4199.0,ME1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of ME1 mRNA,,,PMID:25493608|PMID:28713220|PMID:36586010,https://www.ncbi.nlm.nih.gov/pubmed/25493608|https://www.ncbi.nlm.nih.gov/pubmed/28713220|https://www.ncbi.nlm.nih.gov/pubmed/36586010,25493608|28713220|36586010,,
2287,1460806,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4199,ME1,https://ctdbase.org/detail.go?type=gene&acc=4199,,,4199.0,ME1,10090,Mus musculus (house mouse),[sodium arsenite results in increased abundance of arsenic] which results in decreased expression of ME1 mRNA,,,PMID:32045263,https://www.ncbi.nlm.nih.gov/pubmed/32045263,32045263,,
2288,1461036,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5686,PSMA5,https://ctdbase.org/detail.go?type=gene&acc=5686,,,5686.0,PSMA5,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PSMA5 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2289,1461037,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5686,PSMA5,https://ctdbase.org/detail.go?type=gene&acc=5686,,,5686.0,PSMA5,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of PSMA5 mRNA,,,PMID:36209798,https://www.ncbi.nlm.nih.gov/pubmed/36209798,36209798,,
2290,1461038,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,171585,PSMA6A,https://ctdbase.org/detail.go?type=gene&acc=171585,,,171585.0,psma6a,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PSMA6A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2291,1461039,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,436862,PSMA6B,https://ctdbase.org/detail.go?type=gene&acc=436862,,,436862.0,psma6b,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PSMA6B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2292,1461040,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5688,PSMA7,https://ctdbase.org/detail.go?type=gene&acc=5688,,,5688.0,PSMA7,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PSMA7 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
2293,1461041,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,143471,PSMA8,https://ctdbase.org/detail.go?type=gene&acc=143471,,,143471.0,PSMA8,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PSMA8 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2294,1463057,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,406449,PTGES3A,https://ctdbase.org/detail.go?type=gene&acc=406449,,,406449.0,ptges3a,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PTGES3A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2295,1463058,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,415227,PTGES3B,https://ctdbase.org/detail.go?type=gene&acc=415227,,,415227.0,ptges3b,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PTGES3B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2296,1463370,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4242,MFNG,https://ctdbase.org/detail.go?type=gene&acc=4242,,,4242.0,MFNG,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of MFNG mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2297,1463371,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4242,MFNG,https://ctdbase.org/detail.go?type=gene&acc=4242,,,4242.0,MFNG,9606,Homo sapiens (human),Sodium arsenite affects the methylation of MFNG gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
2298,1463372,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64747,MFSD1,https://ctdbase.org/detail.go?type=gene&acc=64747,,,64747.0,MFSD1,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of MFSD1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
2299,1463373,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,79157,MFSD11,https://ctdbase.org/detail.go?type=gene&acc=79157,,,79157.0,MFSD11,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of MFSD11 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2300,1463374,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,126321,MFSD12,https://ctdbase.org/detail.go?type=gene&acc=126321,,,126321.0,MFSD12,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of MFSD12 mRNA,,,PMID:20371982,https://www.ncbi.nlm.nih.gov/pubmed/20371982,20371982,,
2301,1463375,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,126321,MFSD12,https://ctdbase.org/detail.go?type=gene&acc=126321,,,126321.0,MFSD12,10090,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in decreased expression of MFSD12 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
2302,1463991,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2673,GFPT1,https://ctdbase.org/detail.go?type=gene&acc=2673,,,2673.0,GFPT1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of GFPT1 mRNA,,,PMID:28595984|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|34032870,,
2303,1463992,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9945,GFPT2,https://ctdbase.org/detail.go?type=gene&acc=9945,,,9945.0,GFPT2,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of GFPT2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2304,1464322,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,569014,GGT1B,https://ctdbase.org/detail.go?type=gene&acc=569014,,,569014.0,ggt1b,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of GGT1B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2305,1464323,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100333757,GGT5B,https://ctdbase.org/detail.go?type=gene&acc=100333757,,,100333757.0,ggt5b,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of GGT5B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
2306,1464324,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,124975,GGT6,https://ctdbase.org/detail.go?type=gene&acc=124975,,,124975.0,GGT6,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of GGT6 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
2307,1464325,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,2688,GH1,https://ctdbase.org/detail.go?type=gene&acc=2688,,,2688.0,GH1,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of GH1 protein,,,PMID:32531574,https://www.ncbi.nlm.nih.gov/pubmed/32531574,32531574,,
2308,1455376,443873,Comparative Toxicogenomics Database (CTD),Temocapril hydrochloride,C055603,temocapril hydrochloride,https://ctdbase.org/detail.go?type=chem&acc=C055603,1636,ACE,https://ctdbase.org/detail.go?type=gene&acc=1636,,,1636.0,ACE,9606,Homo sapiens (human),Temocapril hydrochloride results in decreased activity of ACE protein,,,PMID:10975594,https://www.ncbi.nlm.nih.gov/pubmed/10975594,10975594,,
2309,1458564,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,81849,ST6GALNAC5,https://ctdbase.org/detail.go?type=gene&acc=81849,,,81849.0,ST6GALNAC5,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ST6GALNAC5 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
2310,1458565,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,81849,ST6GALNAC5,https://ctdbase.org/detail.go?type=gene&acc=81849,,,81849.0,ST6GALNAC5,9606,Homo sapiens (human),Trichostatin A results in decreased expression of ST6GALNAC5 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
2311,1458566,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7982,ST7,https://ctdbase.org/detail.go?type=gene&acc=7982,,,7982.0,ST7,9606,Homo sapiens (human),Trichostatin A affects the expression of ST7 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
2312,1463366,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,123283,TARS3,https://ctdbase.org/detail.go?type=gene&acc=123283,,,123283.0,TARS3,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TARS3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
2313,1463367,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,123283,TARS3,https://ctdbase.org/detail.go?type=gene&acc=123283,,,123283.0,TARS3,9606,Homo sapiens (human),Trichostatin A results in decreased expression of TARS3 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
2314,1463368,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54906,TASOR2,https://ctdbase.org/detail.go?type=gene&acc=54906,,,54906.0,TASOR2,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TASOR2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
2315,1463369,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54906,TASOR2,https://ctdbase.org/detail.go?type=gene&acc=54906,,,54906.0,TASOR2,9606,Homo sapiens (human),Trichostatin A results in increased expression of TASOR2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
2316,1463772,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23329,TBC1D30,https://ctdbase.org/detail.go?type=gene&acc=23329,,,23329.0,TBC1D30,9606,Homo sapiens (human),Trichostatin A results in decreased expression of TBC1D30 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
2317,1463773,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23329,TBC1D30,https://ctdbase.org/detail.go?type=gene&acc=23329,,,23329.0,TBC1D30,9606,Homo sapiens (human),Trichostatin A results in increased expression of TBC1D30 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
2318,1463774,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,93594,TBC1D31,https://ctdbase.org/detail.go?type=gene&acc=93594,,,93594.0,TBC1D31,9606,Homo sapiens (human),Trichostatin A results in increased expression of TBC1D31 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
2319,1463775,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,93594,TBC1D31,https://ctdbase.org/detail.go?type=gene&acc=93594,,,93594.0,TBC1D31,8355,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of TBC1D31 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
2320,1463776,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,221322,TBC1D32,https://ctdbase.org/detail.go?type=gene&acc=221322,,,221322.0,TBC1D32,9606,Homo sapiens (human),Trichostatin A results in increased expression of TBC1D32 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
2321,1463993,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6907,TBL1X,https://ctdbase.org/detail.go?type=gene&acc=6907,,,6907.0,TBL1X,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBL1X mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
2322,1463994,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6907,TBL1X,https://ctdbase.org/detail.go?type=gene&acc=6907,,,6907.0,TBL1X,9606,Homo sapiens (human),Trichostatin A results in decreased expression of TBL1X mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
2323,1463995,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,79718,TBL1XR1,https://ctdbase.org/detail.go?type=gene&acc=79718,,,79718.0,TBL1XR1,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TBL1XR1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
2324,1463996,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,79718,TBL1XR1,https://ctdbase.org/detail.go?type=gene&acc=79718,,,79718.0,TBL1XR1,9606,Homo sapiens (human),Trichostatin A results in decreased expression of TBL1XR1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
2325,1463997,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10716,TBR1,https://ctdbase.org/detail.go?type=gene&acc=10716,,,10716.0,TBR1,7955,Danio rerio (zebrafish),Trichostatin A results in decreased expression of TBR1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
2326,1463998,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6909,TBX2,https://ctdbase.org/detail.go?type=gene&acc=6909,,,6909.0,TBX2,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TBX2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
2327,1463999,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,6909,TBX2,https://ctdbase.org/detail.go?type=gene&acc=6909,,,6909.0,TBX2,9606,Homo sapiens (human),Trichostatin A results in increased expression of TBX2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
2328,1464572,444732,Drug Gene Interaction database (DGIdb),trichostatin A,,TRICHOSTATIN A,https://www.dgidb.org/drugs/ncit:C1261,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606,Homo sapiens (human),,,,,,,,
2329,1464573,444732,Drug Gene Interaction database (DGIdb),trichostatin A,,TRICHOSTATIN A,https://www.dgidb.org/drugs/ncit:C1261,,BRD4,https://www.dgidb.org/genes/hgnc:13575,,,23476.0,BRD4,9606,Homo sapiens (human),,,,,,,,
2330,1464574,444732,Drug Gene Interaction database (DGIdb),trichostatin A,,TRICHOSTATIN A,https://www.dgidb.org/drugs/drugbank:DB04297,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606,Homo sapiens (human),,,,,,,,
2331,1464575,444732,Drug Gene Interaction database (DGIdb),trichostatin A,,TRICHOSTATIN A,https://www.dgidb.org/drugs/drugbank:DB04297,,HDAC3,https://www.dgidb.org/genes/hgnc:4854,,,8841.0,HDAC3,9606,Homo sapiens (human),,,,,,,,
